Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005013	p-psa-v	ug/l (ug/l)	37895	98921	0.01%
3005013	p-psa-v	— (—)	21760	51558	100.00%	Distribution not available
3005013	s-psa-v	— (—)	17042	27050	100.00%	Distribution not available
3005013	s-psa-v	ug/l (ug/l)	8497	17871	0.00%
3005013	s-prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	436	523	0.00%
3005013	p-prostataspesifinenantigeeni,vapaa	— (—)	218	285	100.00%	Distribution not available
3005013	prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	214	251	0.00%
3005013	p-prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	87	114	0.00%
3005013	s-prostataspesifinenantigeeni,vapaa	— (—)	69	78	100.00%	Distribution not available
3005013	prostataspesifinenantigeeni,vapaa(p-psa-v)	ug/l (ug/l)	65	113	0.00%
3005013	prostataspesifinenantigeeni,vapaa	— (—)	59	82	100.00%	Distribution not available
3005013	prostataspesifinenantigeeni,vapaa(psa-v)	ug/l (ug/l)	54	83	0.00%
3005013	prostataspesifinenantigeeni,vapaa(4900p-psa-v)	ug/l (ug/l)	41	64	0.00%
3005013	s-fpsa	ug/l (ug/l)	28	29	0.00%
3005013	s-psa-v(pi)	ug/l (ug/l)	16	21	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on examination of blood, without diagnosis

7591

47330

1.76

313.29

4.2

3.0

1.08

0.73

ug/l

49.40

5977

32225

malignant neoplasm of male genital organs

9949

41450

2.07

307.65

4.8

2.8

1.08

0.73

ug/l

47.66

7655

29065

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

8029

31235

2.19

307.65

4.8

2.7

1.06

0.71

ug/l

43.49

6367

21265

Abnormal serum enzyme levels

6298

39850

2.09

307.65

4.4

3.0

1.15

0.73

ug/l

52.69

5120

27757

Diseases of male genital organs

11990

40657

1.79

307.65

3.3

2.4

0.75

0.73

ug/l

0.75

8274

23419

Symptoms and signs involving the urinary system

10548

49005

1.89

307.65

3.5

2.9

0.81

0.75

ug/l

4.43

7928

31592

Hyperplasia of prostate

10010

34353

2.40

307.65

3.9

2.6

0.81

0.76

ug/l

4.35

7990

21451

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

8143

32127

2.17

307.65

4.8

2.7

1.05

0.70

ug/l

43.28

6429

21596

Sleep apnoea

11179

52198

1.58

307.65

3.1

2.9

0.68

0.78

ug/l

20.88

7122

33534

Hernia

10795

49261

1.60

307.65

2.9

2.8

0.72

0.77

ug/l

3.32

6961

30671

Malignant neoplasm of prostate

9807

40694

2.08

307.65

4.8

2.8

1.08

0.73

ug/l

48.36

7573

28781

Sleep disorders (combined)

11272

51824

1.53

298.80

3.0

2.9

0.68

0.78

ug/l

21.32

7191

33230

Sleep apnoea, including avohilmo

11300

51651

1.53

294.99

3.1

2.9

0.68

0.78

ug/l

21.00

7166

33225

Abnormal spermatozoa

2903

16953

3.12

273.07

5.6

3.1

0.95

0.77

ug/l

17.22

2599

11958

Inguinal hernia

9959

49016

1.52

231.40

3.0

2.8

0.74

0.77

ug/l

0.99

6572

30612

Genitourinary diseases

9148

32514

1.52

221.32

3.1

2.4

0.74

0.71

ug/l

1.24

6098

18042

Unspecified haematuria

6386

37593

1.66

219.14

3.6

3.0

0.88

0.78

ug/l

7.15

4827

25719

Coxibs

3691

11443

1.89

208.65

3.2

2.9

0.75

0.89

ug/l

7.04

2389

7782

Pain in throat and chest

9388

42210

1.43

183.71

3.0

2.8

0.69

0.78

ug/l

14.45

6214

26355

158

8671

0.14

170.62

1.8

3.1

0.73

0.82

ug/l

0.38

5973

Acetic acid derivatives and related substances

3509

11438

1.73

150.23

3.1

2.9

0.76

0.89

ug/l

5.90

2286

7780

Retention of urine

5235

31972

1.57

138.89

3.5

3.1

0.94

0.79

ug/l

9.18

4103

22440

Oter anti-inflammatory and antirheumatic agents, non-steroids

3119

11016

1.74

131.26

3.3

2.9

0.71

0.89

ug/l

17.26

2130

7641

Artrosis, including avohilmo

10207

43793

1.34

130.44

3.0

2.8

0.71

0.79

ug/l

8.72

6576

27456

Hypothyreosis and Thyroxine purchase for inclusion criteria

4895

45255

0.69

126.48

3.1

0.71

0.79

ug/l

6.23

3322

30564

Inflammatory diseases of prostate (prostatitis)

2548

16821

1.97

125.73

3.6

2.6

0.73

0.75

ug/l

0.52

1791

10488

Dental operations, only avohilmo

8735

34454

1.37

124.33

3.1

2.8

0.77

0.81

ug/l

1.17

5981

21653

Oxicams

3080

11241

1.70

123.74

3.1

2.9

0.72

0.89

ug/l

9.76

2014

7716

Hypothyroidism, other/unspecified

4875

44853

0.69

122.52

3.1

3.0

0.71

0.78

ug/l

5.96

3311

30244

Benign neoplasms

8100

35054

1.36

119.18

2.9

2.4

0.73

0.67

ug/l

3.20

5187

19990

Chronic periodontitis, including avohilmo

9581

56011

1.33

118.51

3.1

2.9

0.74

0.76

ug/l

0.48

6643

35591

Malignant neoplasm of respiratory system and intrathoracic organs

1161

19672

0.48

117.56

2.8

3.3

0.82

0.85

ug/l

0.34

803

14281

Parodontitis or operation codes

9609

56010

1.33

117.14

3.1

2.9

0.74

0.76

ug/l

0.46

6670

35587

Exposure to unspecified factor

9470

57930

1.32

116.86

2.9

0.71

0.77

ug/l

4.45

6154

36975

Parodontitis

9598

56016

1.32

116.59

3.1

2.9

0.74

0.76

ug/l

0.46

6662

35595

Malignant neoplasm of bronchus and lung

899

16694

0.44

115.09

2.8

3.3

0.82

0.86

ug/l

0.29

609

12085

Hypothyroidism, strict autoimmune

4069

38157

0.68

112.68

3.1

0.72

0.80

ug/l

5.46

2743

25846

Other diseases of intestines

10900

50739

1.29

112.21

3.0

2.8

0.71

0.77

ug/l

6.74

7262

31600

Mood [affective] disorders

6282

54621

0.73

111.27

2.7

2.8

0.63

0.76

ug/l

12.13

4238

33967

Mood disorders

6315

54723

0.73

110.26

2.7

2.8

0.64

0.76

ug/l

12.07

4264

34050

Codeine or tramadol medication

11930

53554

1.28

109.90

2.9

0.71

0.78

ug/l

8.62

7688

34256

Mood disorders, excluding more controls

6264

50286

0.73

109.37

2.7

2.9

0.64

0.77

ug/l

15.06

4241

31467

Benign neoplasms

11257

50770

1.29

107.86

3.0

2.8

0.75

0.76

ug/l

0.79

7534

31607

Injuries to the head

10852

57094

1.28

105.45

2.9

0.74

0.77

ug/l

1.32

7072

36438

Depression

5555

50968

0.72

104.40

2.7

2.8

0.64

0.75

ug/l

9.20

3746

31241

Dental operations

8178

32847

1.34

102.71

3.1

2.9

0.78

0.81

ug/l

0.97

5568

20655

Dental caries 1, only avohilmo

9178

37206

1.32

102.64

3.1

2.9

0.78

0.80

ug/l

0.57

6319

23581

Codeine

9970

43845

1.30

102.39

2.9

0.70

0.77

ug/l

8.17

6365

27793

Polyuria

2860

19532

1.66

102.23

3.6

3.1

0.63

0.79

ug/l

13.53

2119

13535

Dental pulpitis 2, only avohilmo

8343

33467

1.33

102.15

3.1

2.9

0.80

ug/l

0.06

5769

21110

Disorders of the thyroid gland

6070

51949

0.74

101.07

3.1

3.0

0.73

0.78

ug/l

3.61

4154

34791

Abnormalities of breathing

8958

42248

1.31

99.35

2.9

2.8

0.71

0.78

ug/l

7.16

5692

26366

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

5132

26289

1.44

99.17

3.5

2.8

0.81

0.72

ug/l

6.78

3763

18212

Dental caries 3, only avohilmo

9435

38587

1.30

97.49

3.1

2.9

0.78

0.79

ug/l

0.55

6488

24428

Neoplasms

8056

33836

1.32

97.30

3.0

2.4

0.75

0.67

ug/l

5.02

5202

19118

COPD, hospital admissions 1, only main diagnosis

2535

31557

0.62

97.00

2.9

3.3

0.77

0.82

ug/l

1.11

1737

22702

Dental pulpitis 2

8146

32824

1.33

96.54

3.1

2.9

0.80

ug/l

0.05

5635

20681

Mental and behavioural disorders due to alcohol

4472

57922

0.70

95.41

2.7

2.9

0.67

0.77

ug/l

5.94

3102

36663

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3921

52984

0.69

95.38

2.6

2.9

0.65

0.76

ug/l

9.20

2727

33560

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

5027

25966

1.43

93.65

3.5

2.8

0.82

0.72

ug/l

6.95

3692

18037

Basal cell carcinoma, including avohilmo

6135

37404

1.37

92.74

3.5

3.2

0.82

0.81

ug/l

0.19

4526

26789

Tramadol

8473

43488

1.31

92.70

2.9

0.70

0.78

ug/l

7.17

5645

27745

Other disorders of ear

9637

52067

1.28

92.69

3.2

2.9

0.76

0.77

ug/l

0.63

6603

33902

Benign neoplasm of colon, rectum, anus and anal canal

5815

31818

1.38

92.47

3.2

2.6

0.76

0.70

ug/l

3.06

4265

20435

Dental caries 1 and operation codes

9797

40672

1.28

91.38

3.2

2.8

0.76

0.79

ug/l

1.41

6743

25662

Lung cancer and mesothelioma

1238

17811

0.53

91.09

2.9

3.3

0.80

0.84

ug/l

0.51

860

13022

Dental caries 1

8919

36525

1.30

90.95

3.1

2.9

0.79

0.80

ug/l

0.25

6155

23097

Benign neoplasm: Colon

5134

29765

1.41

90.69

3.2

2.7

0.76

0.70

ug/l

2.34

3797

19564

Parodontitis and operation codes

8873

55762

1.29

90.67

3.2

2.9

0.73

0.76

ug/l

0.92

6161

35505

Injuries to the wrist and hand

9623

56655

1.28

90.64

2.9

0.71

0.76

ug/l

3.11

6037

36401

COPD related to multimorbidity

3079

36086

0.66

90.25

2.9

3.3

0.75

0.82

ug/l

2.56

2151

26060

Hypothyroidism, strict autoimmune, 3 medication purchases required

4021

37606

0.71

90.24

3.1

0.72

0.79

ug/l

4.38

2709

25522

Dental caries, including avohilmo

8901

36506

1.30

89.72

3.1

2.9

0.78

0.80

ug/l

0.32

6140

23084

Paracetamol of NSAID medication

2081

6504

1.71

89.01

3.0

2.8

0.77

0.88

ug/l

3.19

1315

4296

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

8914

42430

1.29

88.58

3.5

2.5

0.83

0.68

ug/l

16.53

6395

25495

COPD, hospital admission 2, with asthma infections

2322

28910

0.63

88.44

2.8

3.3

0.76

0.82

ug/l

1.41

1594

20640

Propionic acid derivatives

3303

11464

1.53

88.35

3.0

2.8

0.74

0.89

ug/l

8.83

2136

7791

Dental caries 3 and operation codes

10014

41814

1.27

88.34

3.2

2.9

0.76

0.79

ug/l

1.61

6888

26347

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

8913

42437

1.29

88.30

3.5

2.5

0.83

0.68

ug/l

16.41

6395

25499

Malignant neoplasm, wide definition for exclusion

8913

42441

1.29

88.25

3.5

2.5

0.83

0.68

ug/l

16.41

6395

25502

Basal cell carcinoma

5956

36851

1.37

88.18

3.5

3.2

0.82

0.81

ug/l

0.32

4397

26439

Malignant neoplasm of skin

6690

39657

1.34

87.87

3.5

3.2

0.82

0.80

ug/l

0.66

4930

28092

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

5741

30169

1.38

87.79

3.4

2.7

0.81

0.71

ug/l

7.47

4177

20379

Artificial joint operation, meniscal resection

10210

55900

1.27

87.10

3.0

2.9

0.69

0.78

ug/l

16.02

6689

36195

Substance abuse

4810

60002

0.72

87.03

2.6

2.9

0.65

0.77

ug/l

10.39

3329

37882

Statin medication

6550

28468

1.34

86.74

2.7

2.6

0.71

0.76

ug/l

3.03

4000

16549

Dental caries 3

9176

37930

1.28

85.79

3.1

2.9

0.79

ug/l

0.16

6323

23962

COPD, hospital admissions 3, with asthma pneumonia sepsis

1909

24437

0.60

85.77

2.7

3.3

0.78

0.83

ug/l

0.98

1313

17720

Alcohol use disorder, ICD-based

3568

48142

0.69

85.15

2.6

2.9

0.64

0.76

ug/l

7.81

2467

30527

In situ neoplasms

2500

16037

1.57

84.97

3.6

2.9

0.79

0.74

ug/l

1.32

1848

11522

Persons encountering health services in other circumstances, wide

12560

54523

1.23

83.09

3.1

2.8

0.73

0.77

ug/l

3.22

8263

34615

COPD, early/later onset

3711

41816

0.70

81.85

2.9

3.2

0.75

0.81

ug/l

2.06

2589

29887

Injuries to the shoulder and upper arm

8607

58824

1.28

81.67

2.9

0.71

0.77

ug/l

3.93

5572

37588

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

5134

26985

1.38

81.08

3.5

2.8

0.81

0.71

ug/l

6.82

3728

18641

Gingivitis and periodontal diseases

9899

41995

1.26

79.52

3.1

2.9

0.73

0.78

ug/l

3.00

6664

26574

COPD, hospital admissions

3696

41574

0.70

79.10

2.9

3.2

0.75

0.81

ug/l

1.88

2584

29714

Myocardial infarction, unclassifiable

1479

20651

0.58

78.77

2.8

3.3

0.89

0.84

ug/l

0.57

1056

14799

Anti-inflammatory and antirheumatic products, non-steroids

3241

11464

1.49

78.35

3.1

2.8

0.76

0.89

ug/l

7.34

2099

7791

Heart failure and coronary heart disease

2517

26396

0.65

78.08

2.8

3.4

0.80

0.82

ug/l

0.46

1741

19329

Mental and behavioural disorders due to psychoactive substance use

5001

60364

0.74

76.93

2.6

2.9

0.66

0.77

ug/l

8.46

3462

38139

Anxiety disorders, excluding more controls

4901

42212

0.75

76.08

2.7

2.8

0.61

0.76

ug/l

24.44

3153

25366

Arthrosis

8533

38272

1.28

75.91

3.0

2.8

0.70

0.80

ug/l

12.04

5583

24228

Other malignant neoplasms of skin (=non-melanoma skin cancer)

5771

35947

1.34

75.19

3.5

3.2

0.82

0.81

ug/l

0.39

4238

25756

Diseases of oral cavity, salivary glands and jaws

9978

42325

1.25

74.95

3.1

2.9

0.75

0.79

ug/l

1.50

6689

26779

Other joint disorders

9024

39371

1.26

73.94

2.9

2.8

0.70

0.79

ug/l

10.21

5728

24517

5293

61276

0.75

73.38

2.7

2.9

0.67

0.77

ug/l

7.51

3665

39076

Sub-endpoint used in defining T1D endpoints

1466

22631

0.60

73.32

2.4

2.9

0.73

0.77

ug/l

0.55

955

14262

Renal tubulo-interstitial diseases

8101

50864

1.26

71.61

3.1

3.0

0.90

0.75

ug/l

13.33

6047

33778

Alcohol dependence

2309

32299

0.65

71.57

2.6

2.9

0.63

0.76

ug/l

5.64

1598

20559

Acute alcohol intoxication

1933

27998

0.63

71.13

2.7

2.9

0.68

0.76

ug/l

1.91

1353

18081

Disorders of lipoprotein metabolism and other lipidaemias

9552

50079

1.25

70.85

3.0

2.9

0.78

0.76

ug/l

0.64

6640

31830

Non-invasive ventilation

1000

15990

0.55

70.49

2.3

3.0

0.76

0.79

ug/l

0.48

539

10186

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1203

16090

0.57

69.95

2.9

0.79

0.75

ug/l

0.55

831

11572

Finngen Rheumatological endpoints

9939

47430

1.23

66.45

2.9

2.8

0.71

0.78

ug/l

7.38

6498

29474

Alcohol use disorder, Swedish definition

5194

60109

0.76

65.88

2.7

2.9

0.66

0.77

ug/l

11.83

3585

38259

Bacterial pneumonia (organism specified)

2953

36269

0.70

65.63

2.7

3.1

0.74

0.80

ug/l

2.49

2016

24608

Meniscus derangement

6677

37111

1.29

65.56

3.0

2.9

0.70

0.79

ug/l

10.50

4333

23621

Diverticular disease of intestine

8014

44032

1.26

65.23

3.3

3.0

0.74

0.79

ug/l

3.21

5815

29263

Malignant neoplasm

8890

43865

1.24

64.77

3.5

2.5

0.84

0.69

ug/l

16.73

6410

26998

Bacterial pneumonia, not elsewhere classified

2579

31331

0.69

64.55

2.7

3.1

0.73

0.79

ug/l

2.11

1769

21343

Dental pulpitis 1, only avohilmo

11022

48678

1.21

64.39

3.1

2.9

0.75

0.78

ug/l

1.00

7552

30809

Dental pulpitis 4, only avohilmo

10991

48535

1.21

64.18

3.1

2.9

0.75

0.78

ug/l

1.21

7521

30733

L02BX Other hormone antagonists and related agents

1058

6915

2.35

63.79

5.0

3.3

1.94

0.78

ug/l

19.58

861

5070

Any event in cancer register

8880

43831

1.24

63.78

3.5

2.5

0.83

0.70

ug/l

13.60

6382

26986

Testicular dysfunction

697

3949

2.60

63.54

3.0

2.5

0.64

0.67

ug/l

0.49

385

2202

Bacterial pneumoniae

2776

33237

0.70

63.04

2.7

3.1

0.73

0.79

ug/l

1.69

1898

22500

Shoulder lesions

8590

43839

1.25

62.86

3.0

2.9

0.69

0.79

ug/l

12.47

5722

28066

Metabolic disorders

9793

51256

1.23

62.79

2.9

0.77

0.76

ug/l

0.66

6696

32168

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1513

18902

0.62

62.61

2.9

0.79

0.74

ug/l

0.96

1054

13513

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3038

18105

1.41

62.03

5.5

3.1

0.94

0.77

ug/l

16.43

2685

12693

L02BB Anti-androgens

1642

11560

1.80

60.77

5.3

3.3

1.71

0.81

ug/l

17.48

1236

8510

Other chronic obstructive pulmonary disease

3644

38976

0.73

60.69

2.9

3.2

0.75

0.82

ug/l

2.88

2545

27765

Early onset COPD

1573

22897

0.63

60.22

2.8

3.0

0.69

0.76

ug/l

1.71

1069

15607

Later onset COPD

2175

23522

0.67

59.92

3.0

3.5

0.80

0.86

ug/l

1.54

1540

17712

Soft tissue disorders

10401

45737

1.21

59.76

3.0

2.8

0.70

0.79

ug/l

11.87

6708

28776

Early onset COPD, excluding more controls

1573

22849

0.63

59.73

2.8

3.1

0.69

0.80

ug/l

3.02

1069

15521

Substance abuse, excluding more controls

4810

52563

0.77

59.57

2.6

2.9

0.65

0.78

ug/l

13.21

3329

33202

Status post-ami

415

6974

0.42

59.35

3.1

3.5

0.82

0.93

ug/l

1.26

293

5136

Testicular hypofunction

624

3509

2.66

58.69

3.0

2.5

0.64

0.67

ug/l

0.54

346

1961

Spondylopathies

8737

44576

1.23

58.43

3.0

2.9

0.69

0.79

ug/l

11.82

6010

28599

Benign neoplasm of colon, rectum, anus and anal canal

6474

48120

1.27

58.34

3.3

3.1

0.76

0.79

ug/l

0.90

4783

33076

Gonarthrosis

7755

37012

1.25

57.88

3.0

2.9

0.71

0.80

ug/l

10.94

5228

23853

Fall on same level

11402

54563

1.20

57.77

2.9

0.73

0.77

ug/l

1.93

7392

34693

Pure hypercholesterolaemia

8456

47789

1.24

57.42

3.1

2.9

0.79

0.76

ug/l

0.80

5993

31019

Anxiety disorders

4945

43954

0.78

57.29

2.7

0.61

0.73

ug/l

17.77

3172

26176

Intracranial trauma

5381

32219

1.29

57.23

2.8

0.71

0.79

ug/l

5.84

3497

19995

Dislocation, sprain and strain of joints and ligaments of knee

5552

41707

1.28

56.74

2.7

0.66

0.73

ug/l

6.99

3285

25352

Insulin, combination of fast acting with intermediate-acting or long-acting

4929

56265

0.77

56.51

2.7

3.0

0.80

0.77

ug/l

0.52

3361

37159

Dental pulpitis 1

10689

47366

1.20

56.36

3.1

2.9

0.76

0.78

ug/l

0.53

7296

29929

Dental pulpitis 4

10683

47355

1.20

55.96

3.1

2.9

0.76

0.78

ug/l

0.53

7290

29926

Varicose veins

3577

34965

0.75

55.45

3.1

0.79

0.80

ug/l

0.16

2504

24249

Diseases of pulp and periapical tissues, including avohilmo

10654

47278

1.20

55.11

3.1

2.9

0.76

0.78

ug/l

0.52

7273

29874

Neurotic, stress-related and somatoform disorders

4856

43195

0.78

55.10

2.6

2.7

0.61

0.73

ug/l

18.06

3105

25648

Rotator cuff syndrome

6848

42221

1.26

54.78

3.0

2.9

0.67

0.79

ug/l

16.34

4661

27391

Other symptoms and signs involving the urinary system

1336

8924

1.73

54.75

4.3

3.0

0.79

0.78

ug/l

0.15

1068

6021

5656

61522

0.79

54.73

2.7

2.9

0.67

0.77

ug/l

8.19

3894

39182

Other heart diseases, wide

8481

44257

1.22

54.15

2.8

0.70

0.75

ug/l

3.77

5347

27078

Atherosclerosis, excluding cerebral and coronary sclerosis

3509

35729

0.74

54.01

2.8

3.3

0.81

ug/l

0.00

2478

25787

Schizophrenia or delusion, excluding more controls

1397

20679

0.64

53.90

2.3

2.6

0.54

0.73

ug/l

23.86

968

11613

In situ neoplasms

2500

18362

1.43

52.99

3.6

3.3

0.79

0.83

ug/l

0.84

1848

13357

Kela-code for severe mental illness

1766

25137

0.67

52.91

2.5

2.7

0.59

0.72

ug/l

11.44

1232

14814

Alcoholic liver disease

632

10768

0.51

52.71

2.6

3.0

0.72

0.76

ug/l

0.45

425

7179

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

916

14383

0.57

52.42

2.5

3.0

0.74

0.77

ug/l

0.30

625

9682

COPD

3850

39875

0.75

52.25

2.9

3.2

0.74

0.81

ug/l

3.09

2693

28289

Conductive and sensorineural hearing loss

8306

48708

1.22

52.16

3.3

3.0

0.77

0.78

ug/l

0.37

5800

32552

Cardiac arrhythmias

5309

28352

1.28

51.23

2.7

0.67

0.74

ug/l

4.18

3238

16529

Actinic keratosis

3618

26949

1.35

51.21

3.7

3.4

0.80

0.83

ug/l

0.94

2708

19836

Non-small cell lung cancer

901

14253

0.57

50.80

3.0

3.3

0.82

0.84

ug/l

0.13

625

10311

Peripheral artery disease

3770

38073

0.75

50.77

2.9

3.3

0.80

ug/l

0.02

2655

27254

Type 1 diabetes

1331

19653

0.64

50.26

2.4

2.8

0.72

0.73

ug/l

0.08

863

11987

Other diseases of upper respiratory tract

11296

50943

1.18

50.19

3.1

2.9

0.70

0.79

ug/l

14.34

7321

33065

Skin changes due to chronic exposure to nonionizing radiation

3667

27360

1.34

49.57

3.7

3.3

0.80

0.83

ug/l

0.81

2743

20119

Schizophrenia

668

11481

0.54

49.47

2.0

2.6

0.51

0.69

ug/l

11.14

466

6515

Chronic rhinitis, nasopharyngitis and pharyngitis

2397

17690

1.42

49.38

3.1

2.8

0.66

0.75

ug/l

2.40

1560

11154

Schizophrenia or delusion

1397

20490

0.65

49.28

2.3

2.6

0.54

0.71

ug/l

18.40

968

11763

Schizophrenia, schizotypal and delusional disorders

1410

20619

0.65

48.97

2.3

2.6

0.55

0.71

ug/l

17.19

980

11871

Sensorineural hearing loss

7946

47246

1.22

48.42

3.3

3.0

0.77

0.79

ug/l

0.33

5612

31899

GASTRO-related operations

7532

31645

1.22

47.95

2.9

2.6

0.76

0.73

ug/l

0.77

4850

18454

Any gastric operation

7532

31645

1.22

47.95

2.9

2.6

0.76

0.73

ug/l

0.77

4850

18454

Sulfonylureas

2979

30500

0.73

47.92

3.0

3.3

0.83

0.81

ug/l

0.35

2107

22068

Unspecified mental disorder

1958

26970

0.70

47.92

2.5

2.7

0.59

0.72

ug/l

11.55

1359

15884

Ill-defined and unknown causes of mortality

269

5887

0.39

47.00

2.4

3.2

1.01

0.84

ug/l

0.71

175

4135

Dermatitis and eczema

7790

60052

0.83

46.77

2.9

0.71

0.77

ug/l

4.27

5101

38331

Gonarthrosis [arthrosis of knee](FG)

8817

44500

1.21

46.68

3.1

2.9

0.71

0.79

ug/l

8.59

6002

28627

Disorders of choroid and retina

8321

51875

1.21

46.20

3.2

3.0

0.78

ug/l

0.07

5948

34466

Parasetamol

8822

38440

1.20

46.14

2.8

0.74

0.77

ug/l

1.13

5676

23558

Opioids

9740

44031

1.19

45.57

2.9

0.72

0.77

ug/l

3.17

6158

27890

3837

28918

1.32

45.18

3.6

3.3

0.79

0.83

ug/l

1.12

2852

21139

Other arrhythmias

5920

37822

1.24

43.45

3.2

2.9

0.74

0.76

ug/l

0.98

3983

24564

Diabetic retinopathy, strict definition

783

10893

0.58

42.93

2.5

2.9

0.78

0.76

ug/l

0.28

535

7350

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3969

15796

1.30

42.65

2.8

2.3

0.73

0.68

ug/l

1.46

2406

8456

Episodal and paroxysmal disorders

10422

46417

1.17

42.61

2.9

2.8

0.71

0.79

ug/l

8.87

6649

29489

Presbycusis

1290

8815

1.58

42.38

3.6

3.3

0.88

0.89

ug/l

0.11

860

6523

Any prescribed medicine buy

8.28

41.95

2.9

1.6

0.91

0.57

ug/l

2.22

Other dorsopathies, not elsewhere classified

10000

45826

1.18

41.78

2.9

0.71

0.79

ug/l

9.42

6467

28910

Insulin, fast-acting or short human

2446

31703

0.74

41.56

2.6

3.0

0.81

0.76

ug/l

0.73

1638

20587

Follow-up examination after treatment for conditions other than malignant neoplasms

2363

20457

0.73

41.52

2.9

0.72

0.78

ug/l

1.30

1714

13196

Diseases of the eye and adnexa

8422

36188

1.19

41.01

2.8

2.7

0.71

0.75

ug/l

2.71

5271

21643

Malignant neoplasm of digestive organs

2860

35554

0.75

40.74

2.9

3.2

0.78

0.81

ug/l

1.02

1972

25272

Type 1 diabetes, wide definition

1074

15862

0.64

40.31

2.3

2.8

0.75

0.74

ug/l

0.08

674

9541

Antihypertensive medication - note that there are other indications

4401

19441

1.27

40.27

2.6

2.5

0.68

0.72

ug/l

1.05

2584

10707

Dorsalgia

9720

45799

1.17

39.93

2.9

0.69

0.79

ug/l

12.31

6363

28903

Persons encountering health services for specific procedures and health care

10024

54245

1.17

39.67

3.0

2.8

0.81

0.74

ug/l

3.88

6819

34060

Diseases of oesophagus, stomach and duodenum

10353

55109

1.17

39.50

3.0

2.9

0.72

0.77

ug/l

4.02

7054

34830

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

5273

43238

1.24

39.45

2.9

2.8

0.67

0.77

ug/l

8.01

3321

27550

Acute alcohol intoxication, ICD10

1330

18599

0.67

39.41

2.6

2.8

0.66

0.73

ug/l

1.05

924

11554

All-cause Heart Failure

5010

43003

0.80

39.31

2.9

3.2

0.80

0.79

ug/l

0.17

3596

30305

Insulin, fast-acting

2432

31269

0.74

38.97

2.6

3.0

0.81

0.75

ug/l

0.87

1627

20259

Exposure to other specified factors

6610

52836

1.21

38.87

2.8

0.71

0.75

ug/l

1.73

4125

33046

Heart failure, strict

5106

43651

0.81

38.76

2.8

3.2

0.80

0.79

ug/l

0.14

3659

30710

Medical observation and evaluation for suspected diseases and conditions

7615

33423

1.20

38.54

2.9

2.8

0.72

0.79

ug/l

3.99

5050

20559

Other ill-defined and unspecified causes of mortality

243

5125

0.41

38.47

2.3

3.2

1.04

0.83

ug/l

0.76

157

3608

Any operation in hilmo

585

1651

1.93

37.95

2.4

1.8

0.76

0.70

ug/l

0.44

299

621

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

8723

51543

1.18

37.68

3.0

2.9

0.76

ug/l

0.09

6065

33042

Other chronic obstructive pulmonary disease, including avohilmo

4712

46657

0.80

37.39

3.0

3.2

0.73

0.80

ug/l

4.18

3301

32784

Polyarthropathies

6683

38012

1.20

37.20

3.0

2.8

0.76

0.80

ug/l

1.51

4608

24153

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

901

12594

0.62

36.78

3.0

2.9

0.82

0.76

ug/l

0.60

625

9029

Fitting and adjustment of other devices

3564

27022

1.29

35.98

3.4

3.2

0.83

0.80

ug/l

0.97

2411

19516

Peripheral artery operations in Hilmo

839

12441

0.62

35.64

2.7

3.2

0.80

0.83

ug/l

0.26

573

8868

Insulin, fast-acting (human)

548

9133

0.57

35.32

2.2

2.7

0.73

0.72

ug/l

0.04

340

5402

Benign neoplasm: Colon

5320

44230

1.23

35.26

3.2

0.76

0.79

ug/l

0.91

3939

30877

Arthropathies

8876

39381

1.17

34.91

2.9

2.8

0.71

0.79

ug/l

7.79

5593

24526

Other disorders of prostate

615

3941

2.04

34.69

3.6

2.6

0.91

0.79

ug/l

1.03

458

2551

Adjustment and management of implanted device

2088

16163

1.40

34.62

3.2

3.3

0.80

ug/l

0.04

1560

11691

Diseases of the ear and mastoid process

11223

50348

1.15

34.29

3.0

2.8

0.75

0.76

ug/l

0.62

7188

31587

Other disorders of penis

1446

10797

1.53

34.21

3.1

2.5

0.65

0.75

ug/l

4.71

955

6500

Heart failure,strict

4774

40662

0.81

34.06

2.8

3.2

0.78

ug/l

0.01

3428

28469

Symptoms and signs involving cognition, perception, emotional state and behaviour

9082

55943

1.16

33.98

3.1

2.9

0.74

0.77

ug/l

1.57

6331

36066

Persons encountering health services for other counselling and medical advice, not elsewhere classified

10690

54009

1.15

33.85

3.1

2.8

0.74

0.77

ug/l

1.72

6872

34348

Insulin, intermediate and long-acting

4634

53710

0.82

33.34

2.7

3.0

0.80

0.77

ug/l

0.71

3152

35569

Parodontitis or/and operation codes

5230

26230

1.22

32.73

3.1

2.9

0.73

0.72

ug/l

0.09

3510

16741

Carcinoma in situ of skin of other and unspecified parts of face

697

4468

1.75

32.66

3.6

2.9

0.77

0.78

ug/l

0.06

535

3255

Any mental disorder

9356

53083

0.87

32.53

2.8

2.9

0.69

0.78

ug/l

10.89

6362

33577

Non-small cell lung cancer, squamous, helper endpoint

224

4516

0.43

31.46

2.8

3.3

0.75

0.86

ug/l

1.42

149

3240

Non-small cell lung cancer, squamous

224

4516

0.43

31.46

2.8

3.3

0.75

0.86

ug/l

1.42

149

3240

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2307

17620

1.31

31.32

3.0

2.7

0.68

0.72

ug/l

0.86

1342

10371

Type 1 diabetes, wide definition, subgroup 1

1046

14764

0.68

30.75

2.3

2.8

0.75

0.73

ug/l

0.13

656

8787

Hypopituitarism

722

4750

1.70

30.50

3.1

2.7

0.57

0.70

ug/l

6.14

442

2757

Continuous positive airway pressure

2521

17470

1.33

30.37

3.2

3.0

0.79

0.78

ug/l

0.08

1629

11098

Exclusions for E4_PCOS_CONSORTIUM

1300

11333

0.71

30.15

2.9

2.7

0.66

0.72

ug/l

0.85

829

6665

Spermatocele

1276

9612

1.56

30.05

3.2

2.6

0.68

0.78

ug/l

4.46

860

6173

Hydrocele

1814

14206

1.42

30.02

3.1

2.7

0.78

0.79

ug/l

0.16

1276

9088

Cardiac arrest

475

6566

0.55

30.00

2.6

3.3

0.67

0.79

ug/l

3.19

326

4593

Symptoms and signs involving the circulatory and respiratory systems

9550

42366

1.15

29.86

2.8

0.71

0.78

ug/l

7.60

6006

26396

Other and unspecified tonsillitis

3016

20779

1.27

29.62

2.3

2.4

0.64

0.66

ug/l

0.66

1551

11097

Other hearing loss

2560

20204

1.31

29.60

3.4

3.2

0.85

0.84

ug/l

0.17

1774

14404

Psychiatric diseases

9180

51828

0.87

29.44

2.8

2.9

0.69

0.78

ug/l

9.68

6200

32681

ILD medications

10992

53991

1.14

29.31

2.9

0.75

0.76

ug/l

0.26

7147

34158

Other disorders of veins

2467

19599

1.30

29.26

3.1

3.0

0.69

0.76

ug/l

4.28

1707

13120

COPD-related respiratory insufficiency

761

11044

0.63

29.24

2.7

3.3

0.78

0.83

ug/l

0.40

491

7955

Allergic conjunctivitis

2397

18584

1.29

29.20

2.9

2.7

0.68

0.72

ug/l

0.92

1393

10965

Pain (limb, back, neck, head abdominally)

8477

37459

1.16

28.66

2.9

0.72

0.80

ug/l

7.50

5510

23589

Redundant prepuce, phimosis and paraphimosis

2850

23353

1.30

28.65

2.7

2.3

0.69

0.71

ug/l

0.58

1662

12750

ILD medications: prednisolone, methylprednisolone, prednisone

10650

53855

1.14

28.58

2.9

0.77

0.76

ug/l

0.29

6996

34127

Other heart diseases

4179

23124

1.23

28.55

2.6

0.66

0.71

ug/l

1.80

2497

12804

Diseases of the musculoskeletal system and connective tissue

5362

22944

1.20

28.03

2.9

2.7

0.72

0.82

ug/l

7.02

3327

14023

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1031

14474

0.69

27.93

2.5

2.7

0.61

0.74

ug/l

4.97

715

8205

Benzodiazepine use

7466

60273

0.86

27.86

3.0

2.9

0.69

0.77

ug/l

6.31

4992

38548

Hypertension, essential

7499

37592

1.16

27.57

2.8

0.72

0.73

ug/l

0.30

4825

22601

Lyme disease

1894

14765

1.34

27.47

3.3

3.0

0.72

0.76

ug/l

0.65

1278

9932

Diaphragmatic hernia

2846

23253

1.27

27.40

3.1

0.71

0.80

ug/l

3.00

2034

15852

Biguanides

9278

50983

1.14

27.33

2.8

2.9

0.76

ug/l

0.17

6139

32505

Degeneration of macula and posterior pole

4383

30764

1.22

27.33

3.4

3.3

0.80

0.83

ug/l

0.86

3289

22343

Deviated nasal septum

4267

36483

1.23

27.21

3.0

2.8

0.69

0.76

ug/l

3.60

2691

23324

Other spirochaetal diseases

1909

14953

1.33

26.66

3.3

3.0

0.72

0.76

ug/l

0.68

1288

10058

Degenerative diseases of the nervous system

2125

20014

0.77

26.58

2.9

3.4

0.89

0.86

ug/l

0.43

1521

14616

Coxarthrosis

5641

33230

1.19

26.42

3.3

3.0

0.73

0.82

ug/l

8.08

3999

22315

Amputation

624

9212

0.62

26.31

2.4

3.2

0.85

0.83

ug/l

0.07

430

6530

Any dementia, excluding more controls

2400

20534

0.78

26.29

2.9

3.5

0.84

0.86

ug/l

0.17

1701

15232

Other soft tissue disorders, not elsewhere classified

8262

45249

1.15

26.27

3.0

2.8

0.72

0.79

ug/l

6.24

5582

28564

Orchitis and epididymitis

1359

10454

1.46

26.00

3.3

2.5

0.78

0.77

ug/l

0.11

935

6420

Use of hypnotics and sedatives

10727

55912

1.13

25.75

3.0

2.9

0.69

0.78

ug/l

12.13

7118

35666

Melanocytic naevi

1904

14936

1.32

25.50

3.2

2.6

0.73

0.70

ug/l

0.80

1292

9584

Disorders of other endocrine glands

2665

21328

1.26

25.48

3.1

2.9

0.73

0.75

ug/l

0.60

1738

13560

Chronic diseases of tonsils and adenoids

4907

36123

0.84

25.34

2.6

2.7

0.67

0.73

ug/l

3.84

2801

21999

Carcinoma in situ of prostate

149

737

5.73

24.89

6.3

2.8

0.94

0.73

ug/l

3.30

136

516

Other external causes of accidental injury

8106

36023

1.15

24.52

2.9

0.75

0.79

ug/l

1.49

5315

22999

Suicide or other Intentional self-harm

1030

14099

0.71

24.44

2.5

2.6

0.61

0.71

ug/l

3.20

715

8216

Acute tubulo-interstitial nephritis

4885

37415

1.18

24.19

3.3

3.2

0.85

0.78

ug/l

3.26

3687

26083

Voice disturbances

1693

13190

1.33

24.11

3.3

3.1

0.69

0.78

ug/l

2.96

1201

9055

Progressive vascular leukoencephalopathy

310

1753

2.06

23.81

3.1

3.5

0.76

0.88

ug/l

1.15

245

1274

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1031

14101

0.71

23.77

2.5

2.6

0.61

0.71

ug/l

3.20

715

8216

Macular pucker

1436

11138

1.39

23.71

3.4

0.77

0.81

ug/l

0.79

1095

8237

Special screening examination for neoplasms

580

3902

1.71

23.39

3.8

3.1

1.02

0.83

ug/l

2.86

412

2665

Carcinoma in situ of skin of other and unspecified parts of face

697

4812

1.60

23.35

3.6

3.4

0.77

0.85

ug/l

1.09

535

3540

Anxiety (asthma-related co-morbidities)

2888

27470

0.81

23.28

2.5

2.6

0.57

0.71

ug/l

17.27

1841

14980

Chronic sinusitis

3233

27095

1.22

23.24

3.0

2.8

0.65

0.76

ug/l

11.28

2009

17171

Alcohol abuse, main dg, excluding more controls

1067

14200

0.71

23.22

2.6

2.8

0.63

0.75

ug/l

2.46

748

8586

Benign neoplasm: Colon, unspecified

2322

18941

1.28

23.02

3.2

2.8

0.79

0.73

ug/l

1.27

1679

13182

Persons encountering health services for examination and investigation

7512

33432

1.15

23.00

2.9

2.8

0.73

0.79

ug/l

3.30

4879

20562

Diseases of liver

2255

27534

0.79

22.96

2.8

3.0

0.71

0.76

ug/l

0.82

1513

18118

Gonarthrosis,primary

9348

53065

1.13

22.92

3.2

3.0

0.72

0.79

ug/l

6.54

6559

35199

Other intervertebral disc disorders

8262

45260

1.14

22.89

2.9

0.69

0.79

ug/l

12.68

5381

28714

Respiratory insufficiency

456

6999

0.60

22.87

2.5

3.3

0.71

0.87

ug/l

4.41

306

5067

COPD (mode)

2893

27288

0.80

22.86

2.9

3.2

0.74

0.81

ug/l

3.21

2027

19207

Dorsopathies

9961

45843

1.13

22.82

2.9

0.70

0.79

ug/l

10.69

6443

28919

Oxycodone

2697

31262

0.80

22.81

3.1

1.07

0.80

ug/l

6.63

1830

21636

Carcinoma in situ of skin of scalp and neck

297

1731

2.20

22.81

3.3

2.8

0.86

0.79

ug/l

0.23

210

1262

Insulin medication

4929

48246

0.85

22.55

2.7

3.0

0.80

0.77

ug/l

0.62

3361

31172

Myocardial infarction, strict

4887

40642

0.84

22.46

2.9

3.1

0.80

0.78

ug/l

0.34

3490

27724

Fentanyl

458

7085

0.61

22.40

3.1

1.32

0.84

ug/l

2.95

324

4950

Malignant neoplasm of pancreas

253

4481

0.51

22.39

2.6

3.3

0.71

0.80

ug/l

1.07

163

3154

Other special examinations and investigations of persons without complaint or reported diagnosis

7431

33432

1.15

22.27

2.9

2.8

0.70

0.79

ug/l

9.26

4788

20562

Covid-19 confirmed case

2348

19256

1.27

22.08

2.9

3.0

0.79

0.78

ug/l

0.19

1604

12832

Urolithiasis

3982

34490

1.21

21.98

3.1

0.77

0.78

ug/l

0.28

2768

23621

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

203

3763

0.48

21.89

2.4

3.3

0.71

0.81

ug/l

1.15

128

2662

Accidents

8051

36023

1.14

21.78

2.9

0.76

0.79

ug/l

1.34

5281

22999

Carcinoma in situ of skin

669

4642

1.58

21.67

3.6

2.8

0.85

0.76

ug/l

0.97

489

3314

Conduction disorders

3182

22407

1.23

21.65

3.2

0.80

0.81

ug/l

0.08

2275

15823

Organic, including symptomatic, mental disorders

3792

31809

0.83

21.62

3.0

3.3

0.78

0.82

ug/l

1.13

2720

22877

Hypertensive diseases

7476

37749

1.14

21.44

2.7

2.8

0.71

0.73

ug/l

0.83

4769

22642

Hypertension

7476

37747

1.14

21.38

2.7

2.8

0.71

0.73

ug/l

0.85

4770

22641

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

224

4028

0.50

21.31

2.8

0.75

0.78

ug/l

0.26

149

2878

Other and unspecified disorders of vitreous body

2901

24208

1.23

21.24

3.5

3.2

0.76

0.78

ug/l

0.34

2150

17189

Asthma (only as main-diagnosis)

5427

37296

0.86

21.21

2.9

0.67

0.78

ug/l

11.14

3446

23603

Benign neoplasm: Rectum, anus and anal canal

1833

14811

1.31

20.86

3.4

2.8

0.78

0.72

ug/l

0.96

1357

10209

Carcinoma in situ of prostate

149

799

5.01

20.78

6.3

3.2

0.94

0.75

ug/l

2.87

136

554

Any dementia

2536

21406

0.81

20.61

2.9

3.5

0.85

0.86

ug/l

0.06

1793

15877

Coronary artery bypass grafting

3278

28859

0.82

20.34

3.1

3.4

0.82

0.81

ug/l

0.10

2327

21035

Malignant melanoma, excluding all cancers (controls excluding all cancers)

1582

12606

1.33

20.33

3.6

2.8

0.79

0.74

ug/l

1.03

1178

8783

Abdominal and pelvic pain

10914

50044

1.11

20.24

2.9

0.72

0.77

ug/l

4.15

7121

31602

Small cell lung cancer, helper endpoint

1902

0.32

20.21

2.5

3.3

0.76

0.86

ug/l

0.35

1359

Small cell lung cancer

1902

0.32

20.21

2.5

3.3

0.76

0.86

ug/l

0.35

1359

Memory loss

805

5847

1.49

20.15

3.3

0.82

0.81

ug/l

0.02

566

4152

Other diseases of the respiratory system

1351

17140

0.75

20.14

2.8

3.2

0.76

0.82

ug/l

0.95

914

12135

Other respiratory disorders and diseases

1351

17140

0.75

20.14

2.8

3.2

0.76

0.82

ug/l

0.95

914

12135

Cardiovascular diseases (excluding rheumatic etc)

4725

23688

1.17

19.97

2.5

2.6

0.67

0.71

ug/l

1.55

2719

12948

Alcohol abuse, main dg

1067

13891

0.73

19.76

2.6

2.8

0.63

0.73

ug/l

1.85

748

8585

Influenza and pneumonia

9248

55157

1.12

19.76

2.7

2.9

0.73

0.76

ug/l

1.09

6032

34950

Other benign neoplasms of skin

2693

22149

1.23

19.68

3.2

2.7

0.76

0.72

ug/l

1.61

1852

14862

First line medication for Crohn's disease

10651

53009

1.11

19.63

2.9

0.77

0.75

ug/l

0.92

6929

33448

Other bacterial diseases

9029

56664

1.12

19.61

2.9

0.79

0.76

ug/l

1.56

6257

35856

Melanoma in situ

379

2397

1.81

19.57

3.8

2.7

0.83

0.75

ug/l

0.76

271

1682

Disorders of lens

7315

41521

1.14

19.33

3.2

3.0

0.77

ug/l

0.04

5312

27931

Cystitis

4916

34294

0.86

19.31

3.4

3.2

0.80

0.81

ug/l

0.11

3627

24010

Provisional assignment of new diseases of uncertain etiology

3252

27739

1.20

19.23

2.7

2.9

0.78

0.75

ug/l

0.48

2124

17790

Depression or dysthymia

6305

39550

0.87

19.21

2.8

2.9

0.66

0.80

ug/l

13.74

4123

25234

Sequelae of cerebrovascular disease

2797

28860

0.82

19.19

3.0

3.3

0.84

0.81

ug/l

0.47

1978

20390

Alcohol withdrawal state with delirium

561

7852

0.64

19.16

2.7

2.9

0.59

0.74

ug/l

3.52

409

5022

Heart failure, not strict

6528

50152

0.88

19.16

2.9

3.0

0.80

0.77

ug/l

1.06

4726

33488

Factors influencing health status and contact with health services

4611

20200

1.18

19.02

2.8

2.7

0.75

0.78

ug/l

0.62

2897

12071

Codes for special purposes

3253

27779

1.20

18.97

2.7

2.9

0.78

0.75

ug/l

0.49

2125

17817

Acute upper respiratory infections of multiple and unspecified sites

5981

39807

1.14

18.95

2.7

2.8

0.69

0.76

ug/l

6.24

3545

25251

Triptan medication for migraine, single purchase ok

3216

25609

0.84

18.91

2.6

2.5

0.65

0.68

ug/l

1.71

1790

14271

Migraine, single triptan purchase ok & required. ICD-code if available is included

3216

25609

0.84

18.91

2.6

2.5

0.65

0.68

ug/l

1.71

1790

14271

Benign neoplasm: Rectum

1645

13303

1.31

18.84

3.4

2.8

0.78

0.72

ug/l

0.94

1227

9179

Peripheral arterial reconstruction

1300

16307

0.75

18.61

2.7

3.3

0.84

0.83

ug/l

0.08

919

11912

Inflammatory bowel disease treatment related agents

10745

55876

1.11

18.61

2.9

0.76

ug/l

0.10

7049

35438

Nontraumatic intracranial haemmorrhage

1255

15931

0.75

18.58

3.0

3.2

0.87

0.81

ug/l

0.76

891

11143

Injuries to the knee and lower leg

10610

55597

1.11

18.33

2.9

0.72

0.77

ug/l

4.41

6825

35755

Unstable angina pectoris

3717

35233

0.84

18.28

3.0

3.3

0.78

0.80

ug/l

0.33

2616

25087

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

995

12970

0.73

18.26

3.1

2.8

1.04

0.72

ug/l

4.29

690

9004

Inguinal hernia, bilateral

1623

13392

1.34

18.20

3.1

0.76

0.80

ug/l

0.76

1135

9256

Tinnitus

1943

15974

1.27

18.18

3.1

2.9

0.66

0.75

ug/l

2.68

1338

10616

Inguinal or femoral hernia, bilateral

1632

13481

1.34

17.98

3.1

0.76

0.80

ug/l

0.82

1143

9317

Malignant neoplasm of liver and intrahepatic bile ducts

153

2878

0.46

17.97

2.2

3.3

0.75

0.83

ug/l

0.59

2049

Other septicaemia

2744

31550

0.83

17.84

3.0

3.2

0.84

0.79

ug/l

0.75

1952

21906

Symptoms and signs involving the skin and subcutaneous tissue

5306

46896

1.15

17.72

3.1

3.0

0.71

0.77

ug/l

4.67

3665

30880

Recurrent or chronic depression

2133

18625

0.81

17.69

2.6

0.64

0.73

ug/l

1.62

1368

10312

Asthma/COPD (KELA code 203)

7175

56005

0.89

17.68

2.8

2.9

0.67

0.78

ug/l

14.02

4563

35807

Myocardial infarction, with ST-elevation

1605

19536

0.77

17.67

3.0

3.2

0.85

0.81

ug/l

0.42

1174

13765

Cholelithiasis

5865

46023

0.88

17.59

3.1

0.79

ug/l

0.06

4095

31435

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1791

14552

1.26

17.55

3.0

2.9

0.72

0.74

ug/l

0.24

1179

9303

Wet age-related macular degeneration

1318

10238

1.33

17.48

3.4

0.85

0.87

ug/l

0.28

986

7560

Unspecified privation

898

6765

1.41

17.44

2.9

0.68

0.76

ug/l

2.04

612

4371

Non-ischemic cardiomyopathy

2300

22366

0.81

17.33

2.9

3.3

0.86

0.81

ug/l

0.94

1680

15675

Ptosis of eyelid

877

6601

1.42

17.31

3.4

3.2

0.74

0.79

ug/l

0.84

641

4675

Glucagon-like peptide-1 (GLP-1) analogues

5846

43173

1.15

17.20

3.0

3.1

0.83

0.78

ug/l

1.93

4167

29304

Cardiodefibrillation

4417

39176

1.17

17.17

3.2

0.76

0.79

ug/l

0.74

3124

27502

Abnormalities of heart beat

2555

21377

1.21

17.13

3.2

3.0

0.77

0.81

ug/l

0.58

1696

14375

Benign neoplasm: Sigmoid colon

1635

13346

1.29

17.07

3.4

2.8

0.74

0.72

ug/l

0.27

1249

9163

Need for other prophylactic measures

463

3132

1.61

16.98

3.4

2.9

0.81

0.73

ug/l

0.64

356

1986

Carcinoma in situ of skin of trunk

306

1917

1.86

16.92

3.6

2.8

0.81

0.80

ug/l

0.11

239

1384

Dementia

3046

24386

0.84

16.88

3.0

3.5

0.82

0.85

ug/l

0.44

2183

18147

Retinal breaks without detachment

1377

11037

1.32

16.86

3.4

3.1

0.75

0.77

ug/l

0.35

955

7653

Contraceptive management

1972

16801

0.81

16.85

2.4

2.3

0.64

0.63

ug/l

0.21

923

8376

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

1137

8932

1.36

16.72

3.3

2.9

0.86

0.78

ug/l

1.00

818

6537

Degeneration of nervous system due to alcohol

135

2500

0.44

16.63

2.5

3.1

0.65

0.74

ug/l

0.74

103

1701

Degeneration of the brain due to alcohol

135

2499

0.44

16.60

2.5

3.1

0.65

0.75

ug/l

0.79

103

1696

Cholelithiasis, broad definition with cholecystitis

6249

47593

0.89

16.58

3.1

0.79

ug/l

0.14

4357

32396

Excessive attrition of teeth

2874

13247

1.20

16.52

3.0

2.8

0.68

0.73

ug/l

1.71

1846

8487

Disturbances of skin sensation

1655

13447

1.26

16.46

3.0

2.8

0.62

0.74

ug/l

4.60

1091

8359

Other disorders of eyelid

3364

28184

1.18

16.43

3.3

3.2

0.79

0.81

ug/l

0.27

2441

20013

Carcinoma in situ of skin of scalp and neck

297

1900

1.94

16.38

3.3

3.4

0.86

0.83

ug/l

0.10

210

1384

Calculus of kidney and ureter

3572

31360

1.19

16.37

3.1

0.75

0.78

ug/l

0.65

2469

21404

Asthma (only as main-diagnosis), excluding more controls

5316

35524

0.88

16.30

2.9

0.66

0.77

ug/l

10.08

3371

22372

Myocardial infarction

5217

41712

0.87

16.30

2.9

3.1

0.79

0.78

ug/l

0.25

3729

28255

Implicit bacterial Sepsis

3341

35070

0.85

16.23

2.8

3.2

0.81

0.80

ug/l

0.23

2398

24502

Unknown and unspecified causes of morbidity

270

4392

0.58

16.22

3.3

3.0

0.72

0.79

ug/l

1.16

200

2844

Haemorrhage from respiratory passages

3625

29453

1.18

16.11

3.2

3.1

0.78

0.82

ug/l

1.35

2517

20271

Diabetic nephropathy

945

11979

0.74

16.06

2.6

3.0

0.95

0.77

ug/l

1.98

691

8256

Hallux valgus (acquired)

1094

10204

0.76

16.03

3.0

0.71

0.81

ug/l

1.93

777

7028

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

1729

0.36

16.02

2.5

2.8

0.76

0.81

ug/l

0.15

1233

Type 1 diabetes, wide definition, subgroup 2

999

0.19

16.01

2.0

3.2

0.74

0.86

ug/l

0.52

679

Carcinoma in situ of skin

669

4909

1.48

15.99

3.6

3.3

0.85

0.81

ug/l

0.25

489

3521

Type 2 diabetes, definitions combined, including avohilmo

8955

48519

1.11

15.95

2.8

2.9

0.75

0.76

ug/l

0.49

5865

30669

Carcinoma in situ of skin of ear and external auricular canal

194

1120

2.28

15.94

3.4

2.8

0.95

0.83

ug/l

0.30

147

792

Melanocytic naevi

1904

15765

1.24

15.90

3.2

3.0

0.73

0.76

ug/l

0.57

1292

10380

Retinal detachments and breaks

3401

29718

1.18

15.87

3.2

3.1

0.77

0.79

ug/l

0.57

2383

20690

Benign neoplasm: Ascending colon

1140

9025

1.34

15.81

3.4

2.8

0.78

0.73

ug/l

0.44

884

6341

All anxiety disorders

2888

27107

0.84

15.79

2.5

0.57

0.70

ug/l

13.91

1841

14977

Mouth breathing

4405

39150

1.16

15.78

3.0

2.8

0.67

0.73

ug/l

4.09

2750

24982

Diabetic nephropathy, excluding more controls

939

10063

0.73

15.77

2.6

3.0

0.95

0.75

ug/l

2.35

689

6849

Undefined dementia

510

6657

0.67

15.66

2.6

3.3

0.90

0.89

ug/l

0.04

339

4813

Ascites

304

4728

0.60

15.63

2.4

3.1

0.90

0.77

ug/l

0.48

203

3216

Other (not insulin) diabetes medications

9130

50483

1.11

15.61

2.8

2.9

0.75

0.76

ug/l

0.32

6018

32084

Unspecified dementia

511

6525

0.67

15.53

2.6

3.4

0.90

0.91

ug/l

0.07

340

4779

Heart failure and bmi 25plus

2994

23742

0.84

15.50

2.8

3.1

0.77

0.79

ug/l

0.48

2146

16244

Cardiovascular diseases

4277

20445

1.15

15.38

2.5

0.66

0.71

ug/l

1.64

2399

11001

Other disorders of fluid, electrolyte and acid-base balance

1839

21256

0.81

15.33

2.9

3.2

0.81

0.78

ug/l

0.30

1323

14633

Gout

3552

28585

1.18

15.15

3.1

0.82

0.83

ug/l

0.23

2589

19817

Benign lipomatous neoplasm

2260

19149

1.22

15.09

3.1

2.6

0.76

0.70

ug/l

1.45

1549

12260

Gastroduodenal ulcer

2058

24228

0.82

15.02

3.0

3.2

0.78

0.82

ug/l

1.06

1502

16979

Persons encountering health services in circumstances related to reproduction

3287

25605

0.86

14.88

2.3

0.63

0.65

ug/l

0.55

1637

13296

Later onset COPD, excluding more controls

1845

17068

0.80

14.87

3.1

3.5

0.75

0.85

ug/l

4.58

1329

12988

Hypertensive diseases (excluding secondary)

4501

23158

1.15

14.81

2.6

0.67

0.71

ug/l

1.34

2704

12814

Melanocytic naevi of trunk

844

6435

1.38

14.80

3.4

2.6

0.75

0.70

ug/l

0.84

604

4158

Septicaemia

3198

35114

0.85

14.71

3.0

3.2

0.83

0.79

ug/l

0.76

2263

24315

Other disorders of bladder

1405

11557

1.30

14.69

3.5

3.2

0.59

0.80

ug/l

24.25

1037

8116

Major coronary heart disease event excluding revascularizations

6461

48932

0.89

14.64

2.9

3.0

0.77

ug/l

0.11

4544

32879

Acute alcohol intoxication ICD-9

215

3479

0.55

14.64

2.8

3.0

0.58

0.76

ug/l

3.55

145

2278

Pneumonitis due to solids and liquids

481

6710

0.67

14.55

2.6

3.1

0.80

0.83

ug/l

0.15

326

4605

Substance use, excluding alcohol

1056

13343

0.76

14.55

2.4

2.6

0.52

0.71

ug/l

17.18

724

7634

Diseases of external ear

2850

24705

1.19

14.47

3.3

3.0

0.77

ug/l

0.03

1911

16520

Other and unspecified nonorganic psychotic disorders

749

9927

0.73

14.40

2.1

2.4

0.50

0.67

ug/l

10.60

511

5196

Autoimmune diseases related-to ILD

6147

59598

0.89

14.31

2.8

2.9

0.68

0.77

ug/l

9.78

4038

37940

Diseases of the skin and subcutaneous tissue

10188

47175

1.10

14.29

2.9

2.8

0.72

0.78

ug/l

3.83

6649

29764

Explicit Sepsis

3229

35276

0.86

14.24

3.0

3.2

0.82

0.80

ug/l

0.48

2298

24506

Dentofacial anomalies [including malocclusion]

1379

11011

1.26

14.23

2.8

2.6

0.63

0.73

ug/l

5.54

842

6498

Type 2 diabetes, strict (exclude DM1)

8956

49219

1.10

14.10

2.8

2.9

0.75

0.77

ug/l

0.62

5910

31169

Bacterial Sepsis

3863

38635

0.87

14.01

2.8

3.2

0.81

0.79

ug/l

0.21

2763

26774

Oesophageal varices

221

3525

0.56

13.97

2.2

3.0

0.74

0.75

ug/l

0.06

148

2341

Dementia in Alzheimer disease

915

10002

0.75

13.93

2.8

3.5

0.95

0.91

ug/l

0.24

605

7381

Other cataract

4216

29082

1.15

13.86

3.3

3.1

0.82

0.79

ug/l

0.70

3097

20171

7645

43807

1.11

13.85

2.8

3.0

0.74

0.78

ug/l

2.16

5115

28756

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7645

43807

1.11

13.85

2.8

3.0

0.74

0.78

ug/l

2.16

5115

28756

Type 2 diabetes, definitions combined

8927

49080

1.10

13.79

2.8

2.9

0.75

0.77

ug/l

0.62

5890

31072

Vasomotor and allergic rhinitis

2149

17911

1.20

13.78

2.8

2.6

0.67

0.72

ug/l

1.83

1238

10568

Melanoma in situ

379

2605

1.63

13.65

3.8

3.3

0.83

0.79

ug/l

0.36

271

1841

Internal derangement of knee

3634

32058

1.16

13.64

2.9

2.8

0.70

0.78

ug/l

4.36

2302

20272

Tonsillectomy and adenotomy

2380

19430

0.84

13.63

2.4

0.62

0.67

ug/l

2.38

1218

10332

Irritable bowel syndrome

1384

11240

1.26

13.62

3.1

2.8

0.63

0.76

ug/l

7.71

908

7134

Lumbar disc prolapse

5962

42982

1.12

13.62

2.8

2.9

0.68

0.78

ug/l

9.45

3827

27207

Special screening examination for infectious and parasitic diseases

2023

12728

1.22

13.60

2.6

2.4

0.61

0.70

ug/l

2.69

1193

6353

Special screening examination for other diseases and disorders

345

5124

0.64

13.59

3.0

0.82

0.80

ug/l

0.08

218

3373

Senile cataract

6748

38211

1.12

13.57

3.3

3.1

0.78

ug/l

0.00

4940

26409

Dental caries 2 and operation codes, only avohilmo

4287

29885

0.88

13.55

3.0

2.9

0.68

0.72

ug/l

2.11

2673

19494

Migraine with aura

760

5709

1.35

13.51

2.8

2.6

0.64

0.72

ug/l

1.75

493

3385

Adenocarcinoma and ductal carcinoma of pancreas

126

2334

0.48

13.47

2.5

3.3

0.62

0.79

ug/l

2.01

1650

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

410

5820

0.66

13.41

2.9

2.8

0.82

0.75

ug/l

0.30

276

4047

Use of biperiden

215

3482

0.57

13.34

2.3

2.8

0.52

0.70

ug/l

5.40

156

2165

Concussion

4175

32165

1.14

13.30

2.7

2.8

0.69

0.79

ug/l

6.66

2637

19978

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1299

10637

1.28

13.27

3.5

2.8

0.79

0.73

ug/l

0.99

973

7401

All pneumoniae

8812

56109

1.10

13.27

2.7

2.9

0.74

0.76

ug/l

0.63

5853

35518

Injury of muscle and tendon at lower leg level

1695

14308

1.25

13.17

3.0

2.8

0.73

0.74

ug/l

0.06

1073

8958

Pneumonias (Asthma/COPD co-morbidities)

8780

56131

1.10

13.17

2.7

2.9

0.74

0.76

ug/l

0.57

5832

35535

Coxarthrosis [arthrosis of hip](FG)

5753

37801

1.12

13.09

3.3

3.0

0.73

0.81

ug/l

7.12

4085

25608

Diseases of middle ear and mastoid

3118

29159

0.86

13.03

2.7

0.80

0.74

ug/l

1.09

1871

17560

Other diseases of anus and rectum

2438

21034

1.19

12.93

3.5

3.1

0.76

0.82

ug/l

2.40

1683

14256

Neurological diseases, wide definition

2460

10536

1.19

12.92

2.7

0.71

0.83

ug/l

4.78

1461

6092

Impacted cerumen

827

6449

1.36

12.92

3.6

3.2

0.85

0.80

ug/l

0.42

546

4519

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

339

4915

0.64

12.92

2.7

2.8

0.76

0.75

ug/l

0.05

229

3441

Impotence

802

6387

1.43

12.88

3.3

2.5

0.71

0.76

ug/l

0.69

542

3943

Hepatocellular carcinoma

106

1975

0.45

12.83

2.0

3.3

0.82

ug/l

0.00

1410

Myalgia

1252

10145

1.26

12.77

3.1

2.8

0.75

0.77

ug/l

0.12

797

6417

Seborrhoeic keratosis

1718

14458

1.23

12.74

3.4

3.2

0.83

0.80

ug/l

0.36

1235

10190

Injury of muscle and tendon at shoulder and upper arm level

4256

38374

1.15

12.71

3.0

0.69

0.76

ug/l

3.56

2837

25480

Other disorders of male genital organs

489

3598

1.54

12.70

2.7

2.4

0.66

0.69

ug/l

0.31

290

1986

Gastric ulcer

1223

14901

0.79

12.69

3.0

3.2

0.77

0.83

ug/l

1.09

881

10449

Diabetes medication

9144

51414

1.09

12.68

2.8

2.9

0.75

0.76

ug/l

0.42

6004

32322

Carcinoma in situ of skin of lower limb, including hip

155

861

2.06

12.67

3.8

2.8

0.76

0.82

ug/l

0.37

119

609

Epilepsy

1990

23255

0.83

12.65

2.6

2.9

0.72

0.80

ug/l

1.52

1340

15142

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

681

8907

0.74

12.44

2.6

2.8

0.74

0.75

ug/l

0.04

436

5522

Carcinoma in situ, bladder

424

3095

1.61

12.39

3.5

2.8

0.75

0.76

ug/l

0.14

323

2212

Alzheimer disease

1828

16233

0.82

12.39

2.9

3.5

0.90

0.88

ug/l

0.21

1292

12028

Symptoms and signs involving speech and voice

2168

18591

1.19

12.34

3.3

3.1

0.71

0.79

ug/l

3.46

1557

12824

Focal epilepsy

1185

14491

0.79

12.33

2.7

3.0

0.75

0.77

ug/l

0.14

825

9540

Lung diseases due to external agents

964

11967

0.77

12.27

2.8

3.2

0.81

0.82

ug/l

0.13

673

8354

AV-block

1997

15572

1.22

12.27

3.2

3.4

0.80

0.83

ug/l

0.41

1439

11372

Anoxic brain damage

1159

0.33

12.21

2.6

3.0

0.60

0.82

ug/l

1.40

773

Other retinal disorders

5895

43223

1.12

12.19

3.2

3.1

0.78

0.79

ug/l

0.51

4297

29446

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

1500

12631

1.26

12.16

3.2

2.9

0.77

0.76

ug/l

0.20

1102

9112

714

5441

1.35

12.12

2.9

2.8

0.66

0.73

ug/l

1.27

523

3356

Presence of other devices

2050

17593

1.20

12.08

3.5

3.3

0.81

0.84

ug/l

0.65

1503

12790

Symptoms and signs involving the digestive system and abdomen

10718

50044

1.09

12.06

2.9

0.72

0.77

ug/l

4.33

6977

31602

Blepharochalasis

1798

15217

1.21

12.04

3.5

3.2

0.79

ug/l

0.03

1317

10921

Carcinoma in situ of skin of trunk

306

2080

1.68

12.03

3.6

3.4

0.81

0.82

ug/l

0.08

239

1496

Neurological diseases

7951

36845

1.10

11.99

2.8

0.70

0.79

ug/l

8.35

5033

23061

Amputation of thigh

103

1963

0.47

11.99

2.2

3.4

1.16

0.84

ug/l

0.32

1385

Abdominal aortic aneurysm (AAA)

985

11954

0.77

11.84

2.9

3.4

0.83

0.88

ug/l

0.50

715

8780

Subjective visual disturbances

1487

12391

1.23

11.79

3.1

3.0

0.68

0.76

ug/l

3.20

1058

8207

Diabetic neuropathy

665

8510

0.73

11.78

2.6

3.0

0.76

0.78

ug/l

0.07

473

5847

Benign neoplasm of other and unspecified endocrine glands

918

7306

1.31

11.76

3.2

2.7

0.78

0.70

ug/l

0.83

657

4788

Any event in hilmo or specialist outpatient

119

317

2.25

11.65

2.6

1.7

0.77

0.70

ug/l

0.37

127

Subarachnoid haemorrhage

533

7105

0.71

11.58

2.9

3.1

0.83

0.79

ug/l

0.29

373

4868

Dementia, including avohilmo

3354

25970

0.87

11.56

3.0

3.5

0.80

0.84

ug/l

1.24

2410

19265

Amputation of toe

475

6347

0.69

11.54

2.5

3.2

0.78

0.80

ug/l

0.11

331

4452

Disorders of vitreous body

3628

31718

1.14

11.49

3.4

3.1

0.76

0.78

ug/l

0.21

2672

22245

Benign neoplasm: Caecum

844

6709

1.33

11.46

3.2

2.8

0.81

0.73

ug/l

0.60

655

4719

Adenocarcinoma of pancreas

1837

0.47

11.44

2.6

3.3

0.57

0.80

ug/l

3.80

1304

Cardiomyopathy (excluding other)

1199

14357

0.79

11.43

2.7

3.2

0.79

ug/l

0.03

851

9873

Infections with a predominantly sexual mode of transmission

1218

9924

1.25

11.41

2.5

2.4

0.62

0.68

ug/l

1.11

718

5339

Smoking dependency

427

5856

0.69

11.39

2.7

2.9

0.62

0.74

ug/l

2.86

299

3777

Fracture of femur

1503

16311

0.82

11.35

2.9

3.2

0.82

0.84

ug/l

0.20

1016

11409

Atrial fibrillation and flutter

3591

20932

1.15

11.29

2.7

0.68

0.72

ug/l

1.38

2286

12228

Mental and behavioural disorders due to tobacco

427

5847

0.69

11.28

2.7

2.9

0.62

0.74

ug/l

2.92

299

3775

Carcinoma in situ of other and unspecified sites

442

3292

1.55

11.25

3.5

2.8

0.74

0.76

ug/l

0.21

335

2340

Intracerebral haemorrhage

787

9900

0.76

11.17

2.9

3.2

0.90

0.83

ug/l

0.57

567

7029

Exclusions for E4_PCOS_BROAD

1104

8986

1.27

11.17

3.1

2.8

0.74

0.73

ug/l

0.10

713

5551

Gastrointestinal diseases

5138

23293

1.12

11.12

2.8

2.7

0.71

0.78

ug/l

4.38

3194

13832

Hallux rigidus

977

7870

1.29

11.10

3.0

0.62

0.81

ug/l

13.22

701

5405

Benign neoplasm: Skin of eyelid, including canthus

966

7772

1.29

11.03

3.3

2.8

0.77

0.72

ug/l

0.60

675

5332

Diseases of appendix

6559

55018

1.10

11.00

2.8

0.74

0.75

ug/l

0.20

4056

34755

Benign neoplasm: Rectum, anus and anal canal

1833

15770

1.21

10.95

3.4

3.2

0.78

ug/l

0.04

1357

11093

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

946

7621

1.29

10.87

3.1

2.5

0.80

0.69

ug/l

1.31

628

4767

Pain associated with micturition

683

5272

1.34

10.83

3.4

3.0

0.67

0.78

ug/l

3.00

468

3497

Constipation

7627

50575

1.09

10.81

3.3

3.0

0.74

0.79

ug/l

2.17

5352

34118

Appendicitis, broad definition

6520

54909

1.10

10.81

2.8

0.74

0.75

ug/l

0.19

4030

34675

Other headache syndromes

2248

19473

1.17

10.80

2.9

2.8

0.62

0.76

ug/l

14.27

1440

12308

Urethral stricture

818

6641

1.37

10.79

3.4

3.1

0.63

0.81

ug/l

8.78

565

4591

Acute peritonitis

330

4663

0.66

10.76

2.5

3.1

0.71

0.77

ug/l

0.82

239

3111

Melanoma in situ of trunk

162

987

2.02

10.74

3.7

2.7

0.79

0.77

ug/l

0.11

115

673

Carcinoma in situ of skin of ear and external auricular canal

194

1255

1.96

10.71

3.4

0.95

0.83

ug/l

0.28

147

893

Status epilepticus

140

2380

0.54

10.70

2.5

3.0

0.63

0.77

ug/l

1.70

1570

Occupational exposure to risk-factors

195

2990

0.58

10.56

2.7

3.1

0.75

ug/l

0.01

122

2023

Amputation of ankle bones

1805

0.48

10.56

2.2

3.2

0.70

0.78

ug/l

0.48

1221

Malignant neoplasm of oesophagus

147

2374

0.54

10.45

2.7

3.2

0.69

0.77

ug/l

0.93

102

1655

Acute appendicitis

6126

53198

1.10

10.41

2.8

0.74

ug/l

0.10

3767

33389

Stroke, including SAH

5641

45388

0.90

10.39

3.0

3.1

0.83

0.78

ug/l

1.55

4042

31104

Aneurysms, operations, SAH

872

10802

0.78

10.38

2.9

3.1

0.79

0.78

ug/l

0.00

590

7335

Disorders of vitreous body and globe

3735

32782

1.13

10.37

3.4

3.1

0.77

0.78

ug/l

0.20

2754

22964

Adenocarcinoma and papillary adenocarcinoma of stomach

128

2183

0.53

10.36

2.4

3.3

0.76

0.83

ug/l

0.63

1523

Type 1 diabetes, strict (exclude DM2)

308

4440

0.67

10.28

2.1

2.3

0.61

0.65

ug/l

0.44

176

2191

Asthma (mode)

6279

37479

0.91

10.26

2.9

0.67

0.78

ug/l

12.36

4052

23730

Enthesopathies of lower limb, excluding foot

1580

13428

1.21

10.22

3.1

2.8

0.67

0.75

ug/l

3.58

989

8388

Stroke, excluding SAH

5383

43520

0.90

10.17

3.0

3.1

0.83

0.79

ug/l

1.22

3858

30082

Focal epilepsy, strict definition

1123

13522

0.81

10.10

2.7

3.0

0.76

0.78

ug/l

0.11

782

8925

Type 1 diabetes, definitions combined

315

4506

0.68

10.09

2.1

2.3

0.61

0.65

ug/l

0.47

179

2228

Acute and transient psychotic disorders

486

6463

0.73

9.99

2.4

2.5

0.52

0.70

ug/l

9.72

355

3574

2374

18488

1.17

9.97

3.4

0.83

0.85

ug/l

0.42

1769

13643

Persons with potential health hazards related to communicable diseases

1944

16621

1.18

9.97

3.0

2.6

0.74

0.69

ug/l

0.95

1228

9443

Ischaemic Stroke, excluding all haemorrhages

5049

41598

0.90

9.96

3.0

3.2

0.83

0.79

ug/l

1.23

3607

28947

Benign neoplasm: Transverse colon

925

7573

1.30

9.96

3.2

2.8

0.74

0.72

ug/l

0.11

701

5266

Personality disorders, excluding more controls

1204

14455

0.82

9.91

2.5

2.6

0.55

0.71

ug/l

11.31

828

7880

Other and unspecified nerve root and plexus disorders, also in other diseases

1093

13166

0.80

9.89

2.8

0.66

0.73

ug/l

2.18

664

8228

Acute sinusitis

3553

29734

1.13

9.88

2.6

2.7

0.65

0.73

ug/l

4.45

2053

17930

Benign neoplasm: Rectum

1645

14168

1.21

9.87

3.4

3.2

0.78

ug/l

0.05

1227

9932

Other predominantly sexually transmitted diseases, not elsewhere classified

595

4535

1.34

9.83

2.4

0.60

0.65

ug/l

0.52

326

2361

Focal epilepsy, mode (most common among epilepsy diagnosis)

1049

12677

0.80

9.81

2.7

3.0

0.76

0.78

ug/l

0.11

733

8364

Benign neoplasm: Ascending colon

1140

9525

1.26

9.79

3.4

3.2

0.78

0.79

ug/l

0.09

884

6757

Oral corticosteroids

9809

55609

1.08

9.74

3.0

2.9

0.78

0.76

ug/l

0.41

6549

35367

Thoracic aortic aneurysm

1852

16265

1.21

9.73

3.2

0.79

0.78

ug/l

0.10

1312

11470

Temporomandibular joint disorders, including avohilmo

1424

11952

1.20

9.72

3.0

2.7

0.64

0.73

ug/l

2.48

863

7288

Malignant neoplasm of stomach

286

4050

0.66

9.71

2.6

3.2

0.79

0.81

ug/l

0.18

205

2838

Visual disturbances and blindness

3600

32429

1.13

9.71

3.0

0.74

0.78

ug/l

0.83

2502

21651

Melanocytic naevi of trunk

844

6805

1.29

9.70

3.4

3.0

0.75

ug/l

0.02

604

4509

182

2865

0.61

9.67

2.5

3.1

0.86

ug/l

0.01

115

1986

Cirrhosis of liver, NAS

286

4027

0.65

9.66

2.3

3.1

0.72

0.76

ug/l

0.31

201

2735

Carcinoma in situ of skin of lower limb, including hip

155

936

1.87

9.66

3.8

3.2

0.76

0.81

ug/l

0.33

119

650

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

126

2130

0.54

9.65

2.5

2.8

0.62

0.75

ug/l

1.44

1492

Hyperlipidaemia, other/unspecified

4208

36349

1.12

9.54

3.2

3.1

0.81

0.78

ug/l

0.58

2986

25108

Nasal polyp

2112

18574

1.18

9.54

3.1

2.9

0.68

0.78

ug/l

5.90

1387

12280

Specific personality disorders

944

11563

0.80

9.54

2.5

2.6

0.55

0.69

ug/l

8.12

639

6553

Accidental poisoning by and exposure to alcohol

992

0.36

9.53

2.3

2.8

0.61

0.75

ug/l

0.90

593

Cough

2968

25398

1.14

9.48

3.2

3.0

0.69

0.80

ug/l

8.19

2019

17120

Pneumonia, organism unspecified

8145

54968

1.08

9.44

2.8

2.9

0.76

ug/l

0.05

5440

34897

Amputation of foot

150

2352

0.56

9.40

2.1

3.3

0.75

0.79

ug/l

0.18

1641

Rheumatoid arthritis

1708

18018

0.85

9.40

3.0

0.74

0.82

ug/l

1.37

1183

12231

Dissocial personality disorder

1358

0.45

9.37

2.0

2.4

0.62

0.68

ug/l

0.17

694

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

8599

56479

1.08

9.36

2.8

2.9

0.74

0.76

ug/l

0.40

5733

35797

Cardiomyopathies, Primary/intrinsic

1179

13879

0.81

9.34

2.7

3.2

0.79

ug/l

0.03

841

9558

Umbilical hernia

3020

27181

1.15

9.31

3.0

2.9

0.69

0.76

ug/l

3.34

2021

17531

Suppurative and necrotic conditions of lower respiratory tract

370

4955

0.69

9.28

2.8

3.1

0.69

0.76

ug/l

1.12

261

3338

Diseases of peritoneum

480

6294

0.73

9.24

2.7

3.1

0.70

0.78

ug/l

1.68

346

4227

Benign neoplasm: Colon, unspecified

2322

20572

1.17

9.22

3.2

0.79

ug/l

0.07

1679

14582

Dental caries 1 and operation codes, only avohilmo

1998

8690

1.18

9.22

3.1

2.8

0.71

0.74

ug/l

0.67

1324

5602

Spirochaetal infections, other/unspecified

592

4617

1.35

9.17

3.4

3.0

0.71

0.74

ug/l

0.43

417

3096

Chronic ulcer of skin, not elsewhere classified

352

4789

0.69

9.15

2.6

3.1

0.67

0.78

ug/l

2.69

248

3263

Bleeding

8098

55083

1.08

9.11

3.1

2.9

0.76

0.77

ug/l

0.12

5630

35962

Arterial embolism and thrombosis

331

4527

0.69

9.04

2.7

3.3

0.76

0.85

ug/l

0.87

234

3202

Mental retardation, excluding more controls

1645

0.51

9.01

2.2

2.6

0.73

0.74

ug/l

0.04

915

Condition for Implicit Sepsis (Organ dysfunction codes)

7950

53972

1.08

8.96

2.9

0.76

ug/l

0.13

5542

34730

Poisoning by drugs, medicaments and biological substances

1014

12237

0.81

8.88

2.4

2.6

0.57

0.69

ug/l

4.73

682

6928

Overexertion and strenuous or repetitive movements

801

6504

1.29

8.86

2.8

2.7

0.60

0.71

ug/l

4.80

517

3909

Cerebral cysts

203

3053

0.63

8.85

2.7

3.0

0.62

0.77

ug/l

2.39

133

1957

Hepatic failure, not elsewhere classified

162

2518

0.59

8.83

2.6

3.0

0.73

0.76

ug/l

0.14

114

1654

Diabetes, varying definitions

8943

50083

1.08

8.79

2.8

2.9

0.73

0.76

ug/l

1.24

5841

31338

L01XE Protein kinase inhibitors

267

3770

0.66

8.78

2.6

3.2

0.89

0.76

ug/l

0.98

192

2640

Enterocolitis due to Clostridium difficile

490

6364

0.74

8.75

2.8

3.1

0.86

0.81

ug/l

0.39

336

4396

Gastro-oesophageal reflux disease

6050

49678

1.09

8.75

3.2

2.9

0.68

0.78

ug/l

9.55

4050

32402

Pyothorax

284

3910

0.66

8.72

2.8

3.1

0.71

0.77

ug/l

0.55

199

2617

Visual disturbances

3307

29842

1.13

8.71

2.9

3.0

0.74

0.77

ug/l

0.59

2290

19900

Non-small cell lung cancer, adenocarcinoma, helper endpoint

362

4846

0.70

8.71

3.0

3.3

0.83

0.82

ug/l

0.01

254

3486

Non-small cell lung cancer, adenocarcinoma

362

4846

0.70

8.71

3.0

3.3

0.83

0.82

ug/l

0.01

254

3486

Persistent delusional disorders

298

4159

0.69

8.62

2.3

2.8

0.58

0.72

ug/l

3.93

209

2495

Asthma, including avohilmo

9504

58709

0.93

8.60

2.9

0.68

0.78

ug/l

11.85

6087

37587

Type 1 diabetes, strict definition

193

2945

0.64

8.59

1.7

2.0

0.58

0.59

ug/l

0.07

1232

Malignant melanoma

1281

10934

1.22

8.58

3.4

3.2

0.80

ug/l

0.04

952

7703

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1686

0.52

8.53

2.6

2.8

0.57

0.77

ug/l

3.24

1191

Headache

3923

36017

0.90

8.50

2.8

0.66

0.75

ug/l

6.74

2511

22227

Benign neoplasm of other and ill-defined parts of digestive system

1156

9741

1.22

8.48

3.2

2.8

0.76

0.72

ug/l

0.70

854

6683

Restless leg syndrome

723

5811

1.29

8.47

3.5

3.0

0.69

0.75

ug/l

0.49

495

3876

Diabetes mellitus

8944

50094

1.08

8.44

2.8

2.9

0.73

0.76

ug/l

1.21

5843

31345

Convulsions, not elsewhere classified

1633

18555

0.85

8.43

2.8

2.9

0.68

0.75

ug/l

1.40

1108

11612

Acute appendicitis, no complications

4585

41990

1.10

8.41

2.7

0.73

0.72

ug/l

0.08

2766

25518

Schizoaffective disorder

264

3754

0.68

8.37

2.3

2.6

0.49

0.68

ug/l

9.98

194

2158

Disorders of adult personality and behaviour

1265

14884

0.84

8.31

2.4

2.5

0.54

0.69

ug/l

9.65

860

8335

Mental retardation, wide definition

101

1772

0.54

8.31

2.2

2.6

0.73

0.72

ug/l

0.07

1014

Fibrosis and cirrhosis of liver

375

4983

0.71

8.31

2.4

3.1

0.73

0.75

ug/l

0.25

259

3387

Osteomyelitis

411

5357

0.72

8.28

2.7

3.1

0.75

ug/l

0.02

275

3605

Alzheimer’s disease (Atypical or mixed), excluding more controls

428

4844

0.73

8.28

2.8

3.6

1.03

0.95

ug/l

0.28

309

3617

Other antidepressants

10429

51337

1.07

8.27

2.9

0.68

0.79

ug/l

15.26

6887

32702

Erosion of teeth, including avohilmo

1247

10211

1.21

8.26

3.0

2.8

0.70

0.72

ug/l

0.30

798

6517

Personality disorders

1204

14211

0.83

8.24

2.5

0.55

0.68

ug/l

8.22

828

8011

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

246

3428

0.65

8.22

2.8

2.7

0.70

0.72

ug/l

0.22

173

2317

Poisoning by medicine

897

10863

0.81

8.20

2.4

2.6

0.58

0.70

ug/l

3.76

605

6130

Benign neoplasm: Sigmoid colon

1635

14271

1.19

8.19

3.4

3.1

0.74

0.78

ug/l

0.65

1249

9982

Drug-induced neutropenia

246

3515

0.67

8.19

2.6

3.1

0.89

0.74

ug/l

0.92

170

2369

Other diseases of pleura

4267

41061

0.90

8.18

3.1

3.2

0.77

0.81

ug/l

0.96

3028

29064

Other and unspecified glaucoma

491

3802

1.36

8.10

3.4

3.3

0.83

0.81

ug/l

0.14

356

2670

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

601

7575

0.78

8.01

2.4

2.5

0.55

0.68

ug/l

3.56

408

4144

Melanoma in situ of trunk

162

1068

1.83

7.98

3.7

3.2

0.79

0.80

ug/l

0.02

115

736

Systemic atrophies primarily affecting the central nervous system

198

2891

0.64

7.97

2.7

3.2

0.81

0.78

ug/l

0.22

138

1967

Secondary malignant neoplasm of respiratory and digestive organs

903

0.39

7.96

1.8

3.1

0.93

0.82

ug/l

0.31

624

Alzheimer’s disease (Early onset), excluding more controls

159

2321

0.61

7.95

2.7

3.3

1.03

0.94

ug/l

0.17

109

1663

Falls/tendency to fall

10262

48488

1.07

7.93

2.9

0.72

0.77

ug/l

4.48

6626

30736

Calculus of lower urinary tract

677

5566

1.33

7.89

3.3

3.2

0.86

0.80

ug/l

0.70

493

3931

Glomerular diseases

1331

15399

0.84

7.88

2.6

3.0

0.97

0.76

ug/l

3.18

981

10294

Other disorders of patella

1104

9305

1.21

7.87

2.8

2.6

0.66

0.74

ug/l

2.72

633

5417

Mental retardation

1605

0.53

7.86

2.2

2.6

0.73

0.72

ug/l

0.04

908

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1956

17231

1.16

7.84

2.6

2.7

0.69

0.71

ug/l

0.18

1177

10217

Other benign neoplasms of skin

2693

24199

1.13

7.83

3.2

3.1

0.76

0.79

ug/l

0.61

1852

16591

Type 1 diabetes, strict definition, subgroup 1

173

2648

0.63

7.83

1.7

2.0

0.57

0.59

ug/l

0.10

1072

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

170

2509

0.61

7.82

2.5

2.7

0.88

0.76

ug/l

0.82

110

1748

Male infertility

473

3687

1.37

7.79

2.3

1.9

0.56

0.59

ug/l

0.29

217

1570

Squamous cell neoplasms and carcinomas of the skin

1137

9708

1.22

7.76

3.3

3.4

0.86

0.84

ug/l

0.15

818

7085

Asthma (diagnoses ohter than nonallergic)

5979

54913

0.92

7.71

2.9

3.0

0.67

0.78

ug/l

13.61

3936

35914

Glomerular disorders in diseases classified elsewhere

823

9865

0.80

7.69

2.6

3.0

0.98

0.76

ug/l

2.43

609

6612

Decubitus ulcer and pressure area

309

4163

0.70

7.66

2.5

3.2

0.77

0.81

ug/l

0.19

207

2883

Emphysema

535

6667

0.76

7.65

2.6

3.2

0.74

0.84

ug/l

1.28

369

4735

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

128

2025

0.58

7.62

2.4

2.7

0.76

0.77

ug/l

0.11

1389

Abnormalities of gait and mobility

1031

8738

1.23

7.62

3.0

3.2

0.74

0.82

ug/l

1.25

773

6224

Agranulocytosis

434

5629

0.75

7.62

2.6

3.1

0.82

0.75

ug/l

0.51

299

3793

Presence of other functional implants

5311

34886

1.09

7.60

3.4

3.2

0.77

0.80

ug/l

1.61

3857

24563

Dental caries 3 and operation codes, only avohilmo

2219

9850

1.15

7.59

3.1

2.8

0.73

0.74

ug/l

0.10

1467

6299

Disorders of vestibular function (Vertigo)

3090

27806

1.12

7.57

3.2

3.1

0.78

ug/l

0.08

2108

19035

Benign neoplasm of other and unspecified endocrine glands

918

7677

1.24

7.55

3.2

3.0

0.78

0.75

ug/l

0.24

657

5145

1497

12310

1.18

7.54

3.4

0.85

0.87

ug/l

0.27

1114

9086

Acquired absence of limb

782

0.37

7.42

3.2

3.0

0.85

0.75

ug/l

0.54

527

Primary open-angle glaucoma, strict

1951

17253

1.16

7.41

3.3

0.80

0.82

ug/l

0.34

1395

12460

Nutritional anaemias

2975

31919

0.89

7.41

3.1

3.2

0.90

0.81

ug/l

2.03

2110

22321

Unspecific neurodegenerative disorder

2943

22371

0.89

7.40

3.0

3.5

0.84

0.85

ug/l

0.16

2104

16684

Malaise and fatigue

4182

32052

1.10

7.38

2.9

3.1

0.82

0.79

ug/l

0.49

2879

21646

Glaucoma-related operations

388

2953

1.39

7.37

3.6

3.3

0.79

ug/l

0.00

286

2080

Persons encountering health services for specific procedures, not carried out

545

4326

1.31

7.33

2.8

0.54

0.71

ug/l

8.68

406

2663

Benign neoplasm: Pituitary gland, craniopharyngeal duct

353

2648

1.41

7.31

3.2

2.5

0.79

0.70

ug/l

0.34

249

1648

Coxarthrosis, primary, with hip surgery

4090

35730

1.11

7.28

3.3

3.2

0.73

0.81

ug/l

5.60

2903

25350

Mild mental retardation

1106

0.47

7.21

2.1

2.6

0.69

0.71

ug/l

0.06

648

Carcinoma in situ of skin of upper limb, including shoulder

192

1320

1.62

7.12

3.4

2.8

0.84

0.78

ug/l

0.21

138

948

Type 2 diabetes

8860

49656

1.07

7.10

2.8

2.9

0.74

0.76

ug/l

1.20

5820

31219

Tuberculosis

360

4706

0.73

7.10

3.0

3.2

0.85

ug/l

0.02

245

3303

Other extrapyramidal and movement disorders in other diseases

1582

13868

1.17

7.09

3.3

3.1

0.73

0.79

ug/l

0.94

1107

9524

Disorders of gallbladder, biliary tract and pancreas

8146

55659

0.93

7.09

3.1

3.0

0.76

0.77

ug/l

0.81

5649

36531

Melanoma in situ of other and unspecified parts of face

100

592

1.95

7.00

3.9

2.8

0.94

0.81

ug/l

0.36

430

Carcinoma in situ, bladder

424

3380

1.42

6.99

3.5

3.3

0.75

0.78

ug/l

0.41

323

2438

Disorders of lacrimal system

2145

19113

1.14

6.99

3.2

3.0

0.74

0.77

ug/l

0.70

1515

12821

Alzheimer disease, including avohilmo

2313

18584

0.88

6.97

3.0

3.5

0.88

0.87

ug/l

0.16

1669

13823

Alzheimer disease, excluding more controls

1316

10115

0.84

6.95

3.0

3.6

0.89

ug/l

0.01

945

7615

Complications following myocardial infarction

696

0.36

6.94

2.6

3.2

1.17

0.80

ug/l

0.42

486

Hypo-osmolality and hyponatraemia

900

10637

0.82

6.92

2.9

3.1

0.81

0.79

ug/l

0.13

635

7346

Unspecified jaundice

283

3802

0.70

6.92

2.7

3.1

0.81

ug/l

0.01

188

2582

Other inflammation of eyelid

783

6488

1.24

6.92

3.5

3.0

0.72

0.78

ug/l

0.84

568

4333

Testicular dysfunction, other/unspecified

406

2.48

6.91

2.8

2.7

0.68

0.69

ug/l

0.03

233

Use of anticholinesterases

2141

19339

0.88

6.90

3.0

3.5

0.83

0.87

ug/l

0.71

1538

14362

N06DA Anticholinesterases

2141

19339

0.88

6.90

3.0

3.5

0.83

0.87

ug/l

0.71

1538

14362

Haemorrhoids and perianal venous thrombosis

2429

21884

1.13

6.84

3.3

3.1

0.78

0.82

ug/l

0.54

1734

15046

Anogenital herpesviral [herpes simplex] infection

254

1807

1.45

6.84

2.9

2.5

0.70

0.69

ug/l

0.06

159

1007

Other degenerative diseases of the nervous system

1930

16443

0.87

6.83

2.9

3.3

0.83

0.84

ug/l

0.13

1381

11650

Respiratory tuberculosis

311

4115

0.72

6.76

2.9

3.2

0.88

0.84

ug/l

0.16

209

2887

Respiratory tuberculosis, confirmed and not-confirmed

311

4115

0.72

6.76

2.9

3.2

0.88

0.84

ug/l

0.16

209

2887

Chronic gastritis

2177

19521

1.14

6.76

3.4

3.2

0.77

0.82

ug/l

1.09

1614

13759

Alzheimer’s disease, wide definition

1404

13438

0.85

6.75

2.9

3.4

0.88

0.89

ug/l

0.13

998

9874

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

946

8015

1.22

6.73

3.1

2.9

0.80

0.74

ug/l

0.53

628

5154

ILD medications: immunosuppressive drugs

4228

43845

0.91

6.73

2.7

2.8

0.70

0.74

ug/l

1.40

2852

27555

Unattended death

642

0.34

6.73

2.7

3.2

1.17

0.80

ug/l

0.49

424

Alzheimer’s disease (Early onset)

159

2370

0.64

6.70

2.7

3.3

1.03

0.85

ug/l

0.39

109

1659

Degenerative macular diseases

895

7559

1.23

6.70

3.4

3.3

0.80

0.83

ug/l

0.42

669

5404

Dizziness and giddiness

6205

47179

1.08

6.68

3.1

3.0

0.74

0.79

ug/l

2.26

4375

31713

Primary open-angle glaucoma

2398

21081

1.13

6.66

3.4

3.3

0.80

0.82

ug/l

0.45

1729

15219

Benign neoplasm: Caecum

844

7123

1.24

6.66

3.2

0.81

0.80

ug/l

0.08

655

5076

Adult respiratory distress syndrome

971

0.45

6.63

2.7

3.1

0.58

0.81

ug/l

1.41

648

Other/unspecified seropositive rheumatoid arthritis

1129

13140

0.84

6.63

2.9

3.1

0.71

0.79

ug/l

1.15

765

9058

Soft tissue disorders related to use, overuse and pressure

2041

18253

1.14

6.62

3.0

2.9

0.65

0.78

ug/l

13.38

1358

11752

Benign neoplasm of eye and adnexa

640

5234

1.27

6.61

3.4

2.7

0.75

0.72

ug/l

0.20

433

3495

Spinal stenosis

5141

37583

1.09

6.60

3.1

0.71

0.81

ug/l

7.00

3672

25791

Unspecified chronic bronchitis

178

2565

0.65

6.58

3.2

0.76

0.85

ug/l

0.77

124

1748

Benign lipomatous neoplasm

2260

20343

1.13

6.58

3.1

3.0

0.76

ug/l

0.03

1549

13427

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

132

2033

0.62

6.57

1.9

2.2

0.60

0.61

ug/l

0.03

984

Seropositive rheumatoid arthritis, wide

1147

13323

0.85

6.56

3.0

3.1

0.71

0.79

ug/l

1.16

779

9187

GI-bleeding

2689

29503

0.89

6.55

3.0

3.2

0.81

0.80

ug/l

0.09

1844

20471

Trigger finger

900

7596

1.22

6.52

3.2

2.9

0.65

0.77

ug/l

4.97

617

4927

Malignant neoplasm of eye, brain and central nervous system

198

2793

0.67

6.52

2.4

2.9

0.76

ug/l

0.02

119

1801

Depression medications

2251

10107

1.13

6.48

2.4

2.2

0.59

0.69

ug/l

2.93

1247

4631

Melanocytic naevi of other and unspecified parts of face

286

2104

1.41

6.46

3.0

2.6

0.71

0.73

ug/l

0.10

183

1312

Carcinoma in situ of other and unspecified sites

442

3568

1.38

6.44

3.5

3.3

0.74

0.78

ug/l

0.43

335

2576

Acute myeloid leukaemia and myelodysplastic syndromes

1132

0.50

6.43

3.0

3.3

0.87

0.85

ug/l

0.05

794

Diagnoses used for exclusion with ILD

1881

21015

0.88

6.40

2.8

3.1

0.79

ug/l

0.04

1247

14150

Retinal detachment with retinal break

1264

11060

1.19

6.39

3.1

0.81

0.79

ug/l

0.21

872

7615

Arterial embolism and thrombosis of lower extremity artery

185

2613

0.66

6.35

2.5

3.3

0.79

0.81

ug/l

0.11

132

1858

Gout, idiopatic and unspecified

3044

28049

1.12

6.35

3.1

3.2

0.82

0.79

ug/l

0.60

2228

19697

Benign neoplasm: Skin of eyelid, including canthus

966

8233

1.21

6.33

3.3

3.2

0.77

0.80

ug/l

0.24

675

5716

Pain in joint

4833

34376

0.92

6.32

2.9

2.8

0.65

0.78

ug/l

9.80

3095

21414

Benign paroxysmal vertigo

1642

14514

1.15

6.32

3.3

3.1

0.78

0.77

ug/l

0.02

1110

10001

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

357

4581

0.74

6.31

2.8

2.7

0.76

ug/l

0.05

249

3183

Benign neoplasm of brain and other parts of central nervous system

438

3456

1.32

6.30

3.1

2.6

0.79

0.71

ug/l

0.52

299

2221

Malignant neoplasm of brain

144

2138

0.63

6.29

2.2

2.9

0.73

0.76

ug/l

0.18

1344

Duodenal ulcer

897

10471

0.82

6.28

3.0

3.1

0.81

0.83

ug/l

0.16

667

7334

Malignant neoplasm, without specification of site

134

2017

0.62

6.27

2.6

3.3

0.64

0.85

ug/l

3.67

1423

Fibroblastic disorders

2390

21691

1.13

6.25

3.3

3.1

0.75

0.82

ug/l

2.74

1666

14957

Exposure to excessive natural cold

779

0.42

6.24

1.9

2.9

0.80

0.78

ug/l

0.05

497

Motor neuron disease

1481

0.56

6.22

2.5

3.3

0.83

0.87

ug/l

0.16

1029

Secondary uncertain malignant neoplasm

835

9812

0.82

6.14

2.7

3.2

0.85

0.80

ug/l

0.52

575

6840

Cardiomyopathy

1659

18543

0.87

6.14

2.7

3.1

0.79

ug/l

0.01

1176

12708

Syncope and collapse

4200

34548

1.09

6.12

3.1

0.77

0.79

ug/l

0.35

2905

23412

Entropion and trichiasis of eyelid

712

5962

1.25

6.10

3.3

0.86

0.84

ug/l

0.20

532

4346

Motor neuron disease (with DMD)

1489

0.57

6.09

2.5

3.3

0.82

0.87

ug/l

0.20

1033

Tuberculosis, IBD comorbidity

413

5201

0.76

6.07

2.9

3.2

0.80

0.84

ug/l

0.25

281

3628

Gout, unspecified

2482

22727

1.13

6.05

3.1

3.2

0.83

0.79

ug/l

0.57

1817

15995

Fissure and fistula of anal and rectal regions

2095

18883

1.13

6.05

3.2

2.9

0.69

0.77

ug/l

4.97

1352

12221

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1112

12852

0.85

6.00

2.9

3.1

0.71

0.79

ug/l

1.05

754

8846

Other disorders of glucose regulation and pancreatic internal secretion

407

5140

0.76

6.00

2.7

3.0

0.66

0.75

ug/l

1.51

279

3330

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

403

3192

1.34

6.00

3.1

2.8

0.84

0.77

ug/l

0.58

293

2245

Schizotypal disorder

1176

0.53

5.98

2.3

0.38

0.66

ug/l

6.98

590

Hernia of abdominal wall, postoperative

1665

14848

1.15

5.97

3.0

2.9

0.72

0.75

ug/l

0.84

1151

9550

Polypectomy (DHB20)

759

6456

1.25

5.90

3.0

2.9

0.71

0.74

ug/l

0.43

508

4215

Other specified and unspecified disorders of eye and adnexa

231

1676

1.45

5.90

3.1

3.0

0.63

0.75

ug/l

1.71

170

1079

Personality and behavioural disorders due to brain disease, damage and dysfunction

1140

0.52

5.88

2.4

2.9

0.64

0.79

ug/l

1.27

734

Other acute lower respiratory infections

3804

39168

0.92

5.86

2.8

2.9

0.72

0.78

ug/l

1.84

2435

24959

Gout, strict definition

2205

20129

1.14

5.85

3.1

3.2

0.84

0.79

ug/l

0.90

1643

14263

Macular cyst

205

1479

1.51

5.83

3.1

3.2

0.77

0.78

ug/l

0.07

155

1044

Benign neoplasm: Transverse colon

925

7976

1.21

5.83

3.2

0.74

0.79

ug/l

0.60

701

5633

Valvular heart disease excluding rheumatic fever

4873

33304

1.09

5.82

3.1

3.0

0.79

0.78

ug/l

0.21

3457

22572

Tuberculosis, wide

422

5276

0.77

5.82

2.9

3.2

0.80

0.84

ug/l

0.27

287

3680

Non-rheumatic valve diseases

4861

33189

1.09

5.81

3.1

0.79

0.78

ug/l

0.22

3448

22512

Other blood glucose lowering drugs, excl. Insulins

1191

13578

0.85

5.80

3.0

3.2

0.73

0.77

ug/l

0.74

815

9445

Chronic pancreatitis

1055

12070

0.84

5.80

2.8

2.9

0.66

0.75

ug/l

3.78

744

7872

Diabetes, insulin treatment (Kela reimbursement)

9195

53484

1.06

5.77

2.8

2.9

0.75

0.76

ug/l

0.49

6101

33702

COPD/asthma related infections

8292

43807

0.94

5.77

2.9

3.0

0.73

0.78

ug/l

4.07

5383

28756

COPD/asthma/ILD related infections

8292

43807

0.94

5.77

2.9

3.0

0.73

0.78

ug/l

4.07

5383

28756

Toxic effect of ethanol

188

2621

0.68

5.73

2.2

2.7

0.59

0.72

ug/l

1.81

126

1550

Nonorganic sleeping disorders

1042

8986

1.18

5.73

2.7

0.63

0.73

ug/l

2.31

668

5434

Charcot foot

1524

0.58

5.71

2.6

3.1

0.69

0.73

ug/l

0.21

1029

Myelodysplastic syndrome

578

0.36

5.68

3.0

3.2

0.86

0.90

ug/l

0.08

402

Atrial fibrillation and flutter with reimbursement

3081

18186

1.11

5.64

2.9

0.71

0.74

ug/l

0.83

2138

11335

Cyst of kidney

621

5195

1.26

5.63

3.4

3.2

0.77

0.76

ug/l

0.07

421

3653

Pain in limb

6453

43993

1.07

5.63

3.0

2.9

0.71

0.79

ug/l

7.68

4443

28143

Extreme obesity with alveolar hypoventilation

177

2477

0.68

5.61

2.6

3.0

0.62

0.75

ug/l

1.65

114

1603

Persons encountering health services in other circumstances

2584

23552

1.11

5.61

3.3

2.9

0.74

0.76

ug/l

0.54

1945

15118

Alcohol-induced chronic pancreatitis

604

7150

0.79

5.59

2.6

2.8

0.61

0.73

ug/l

3.93

428

4480

Non-selective monoamine reuptake inhibitors

2229

23835

0.90

5.57

2.9

3.0

0.63

0.78

ug/l

14.27

1483

15710

Asthma, hospital admissions , main diagnosis only

5511

52511

0.93

5.56

2.9

0.67

0.77

ug/l

11.53

3498

33773

Injury, poisoning and certain other consequences of external causes

4854

22685

1.08

5.53

2.9

0.76

0.81

ug/l

1.60

3124

14558

Diseases of the digestive system

3559

38261

0.91

5.52

3.0

3.1

0.80

0.79

ug/l

0.04

2417

26189

Benign neoplasm: Adrenal gland

525

4307

1.27

5.52

3.2

2.7

0.76

0.71

ug/l

0.48

385

2876

Ectropion of eyelid

357

2819

1.35

5.50

3.2

3.3

0.82

0.85

ug/l

0.17

264

2024

Crushed, pushed or stepped on by crowd or human stampede

414

3288

1.30

5.50

2.4

2.5

0.61

0.67

ug/l

0.86

229

1775

Paroxysmal tachycardia

1904

14488

1.13

5.48

3.0

0.75

0.76

ug/l

0.05

1322

9325

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

204

2784

0.70

5.47

2.9

2.7

0.71

0.77

ug/l

0.39

151

1926

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

362

4546

0.76

5.43

3.0

2.8

0.83

0.76

ug/l

0.70

254

3242

Insomnia

858

7323

1.20

5.43

2.7

0.56

0.72

ug/l

8.63

537

4384

Complications of surgical and medical care, not elsewhere classified

8421

57428

1.06

5.41

3.0

2.9

0.75

0.77

ug/l

1.23

5784

37128

Benign neoplasm: Descending colon

569

4736

1.27

5.40

3.3

2.7

0.80

0.73

ug/l

0.47

430

3258

Sleep disorders

1271

11172

1.16

5.40

2.7

2.8

0.64

0.74

ug/l

2.50

805

6890

Focal brain injury

510

6163

0.79

5.39

3.1

3.0

0.68

0.82

ug/l

3.75

358

3972

Allergic rhinitis

1341

11683

1.15

5.38

2.7

2.5

0.61

0.69

ug/l

2.60

742

6560

119

1757

0.62

5.37

2.9

3.3

0.63

0.82

ug/l

2.21

1249

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

8610

50016

1.06

5.37

2.8

2.9

0.75

0.76

ug/l

0.57

5686

31320

Hypoglycaemia, other or unspecified

313

4020

0.75

5.36

2.6

2.9

0.66

0.75

ug/l

1.14

208

2585

Injury of muscle and tendon at hip and thigh level

802

6864

1.21

5.36

3.0

2.9

0.76

0.74

ug/l

0.18

491

4447

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1999

17996

1.12

5.36

2.6

2.5

0.62

0.69

ug/l

3.65

1119

10114

Suppurative and unspecified otitis media

1564

15576

0.88

5.36

2.5

2.6

0.76

0.71

ug/l

0.54

901

8797

Coxarthrosis, primary

5401

44146

1.08

5.32

3.3

3.2

0.72

0.80

ug/l

9.00

3839

30905

Obesity related asthma

2543

23289

1.11

5.29

3.0

2.9

0.60

0.75

ug/l

24.16

1674

15142

Pulmonary oedema

1141

0.55

5.27

2.3

3.2

1.09

0.85

ug/l

0.54

784

Respiratory tuberculosis, not confirmed

226

3006

0.71

5.23

2.7

3.3

0.92

0.84

ug/l

0.31

153

2115

Ulcer of oesophagus

536

6413

0.80

5.22

3.1

0.84

0.81

ug/l

0.18

386

4453

Achilles tendinitis

876

7558

1.20

5.22

3.3

2.9

0.68

0.76

ug/l

2.37

578

4833

Osteopathies and chondropathies

3226

33080

0.91

5.22

2.9

0.73

0.76

ug/l

0.69

2087

21355

Type1 diabetes, definitions combined, early onset

108

1667

0.63

5.22

1.7

1.8

0.53

0.52

ug/l

0.09

653

Preparation and fitting of bite rail to mouth

747

6330

1.21

5.21

2.6

2.7

0.60

0.70

ug/l

4.09

426

3782

Contact with and exposure to communicable diseases

1280

11205

1.15

5.21

3.0

2.4

0.68

0.67

ug/l

0.21

726

6050

Left bundle-branch block

608

5099

1.24

5.20

3.3

3.2

0.82

0.81

ug/l

0.08

439

3576

Other diseases of the digestive system

2675

29035

0.90

5.20

3.1

3.2

0.81

0.80

ug/l

0.11

1841

20161

Intestinal stricture

2148

23564

0.90

5.18

2.8

3.1

0.77

0.79

ug/l

0.21

1483

16276

Dialysis

235

3087

0.72

5.16

2.4

2.9

0.91

0.72

ug/l

2.97

198

1952

Schizoid personality disorder

1302

0.58

5.16

2.5

2.6

0.56

0.70

ug/l

1.42

756

Nontoxic goitre/thyroid nodule

942

8107

1.17

5.14

3.4

3.2

0.80

0.79

ug/l

0.12

693

5657

External causes of morbidity and mortality

6048

28545

1.07

5.11

2.9

0.77

0.79

ug/l

0.61

3947

18224

Benign neoplasm: Skin of ear and external auricular canal

296

2295

1.36

5.11

3.4

2.7

0.73

0.77

ug/l

0.27

204

1566

Malignant neoplasm of other and unspecified parts of biliary tract

896

0.50

5.10

2.9

3.1

0.56

0.81

ug/l

3.19

621

Dialysis, with operation codes

1024

11645

0.85

5.10

2.3

3.0

0.90

0.75

ug/l

4.04

797

7684

Macular hole

367

2923

1.32

5.08

3.3

0.82

0.79

ug/l

0.21

281

2118

Endovascular or surgical operations to intracerebral aneurysms

285

3673

0.75

5.06

2.4

3.0

0.85

0.74

ug/l

0.38

190

2415

Other postsurgical states

293

3759

0.75

5.06

2.6

3.0

0.63

0.74

ug/l

0.87

208

2498

Somnolence, stupor and coma

201

2713

0.71

5.03

2.7

3.0

0.90

0.77

ug/l

0.35

143

1776

Melanoma in situ of other and unspecified parts of face

100

649

1.75

5.03

3.9

3.2

0.94

0.84

ug/l

0.26

458

Infective dermatitis

699

8202

0.83

5.02

2.9

3.0

0.76

0.77

ug/l

0.04

462

5466

Hydrocephalus

387

4799

0.78

5.01

2.7

3.3

0.67

0.82

ug/l

3.37

274

3403

Azathioprine

736

8634

0.84

5.01

2.6

2.8

0.73

0.72

ug/l

0.07

492

5223

Other disorders of lacrimal gland

1670

14980

1.13

5.01

3.2

3.0

0.73

0.77

ug/l

1.02

1191

10002

Oedema, not elsewhere classified

2383

21699

1.11

4.99

3.2

3.1

0.76

0.79

ug/l

0.65

1667

14799

Benign neoplasm: Cranial nerves

206

1522

1.44

4.98

3.4

2.7

0.71

0.73

ug/l

0.11

139

997

Benign neoplasm: Stomach

561

4664

1.24

4.98

3.2

2.7

0.80

0.73

ug/l

0.61

419

3180

Diabetic retinopathy, excluding more controls

1733

10822

0.88

4.93

2.9

3.0

0.76

0.74

ug/l

0.37

1210

7278

ILD medications: azathioprine

736

8622

0.84

4.93

2.6

2.7

0.73

0.71

ug/l

0.10

492

5204

Gonarthrosis, primary, with knee surgery

4443

38642

0.93

4.90

3.2

0.70

0.81

ug/l

12.08

3195

27399

Iron deficiency anaemia secondary to blood loss (chronic)

812

9423

0.84

4.89

2.9

3.2

0.90

0.81

ug/l

0.66

547

6536

Polymyalgia rheumatica

880

7623

1.19

4.88

3.3

0.72

0.83

ug/l

2.56

626

5500

Migraine with aura and triptan purchases

280

2129

1.33

4.88

2.7

2.5

0.56

0.66

ug/l

1.91

177

1157

Asthma

6587

37296

0.94

4.87

2.8

2.9

0.67

0.78

ug/l

11.18

4248

23603

Alzheimer’s disease (Atypical or mixed)

428

5224

0.79

4.84

2.8

3.4

1.03

0.91

ug/l

0.50

309

3863

Dementia in other diseases classified elsewhere

230

3012

0.73

4.82

2.7

3.4

0.70

0.82

ug/l

0.66

158

2167

Other other unspecified disorders of the circulatory system

154

2148

0.68

4.81

3.2

3.1

0.73

0.78

ug/l

0.36

109

1482

Acute renal failure

1696

18696

0.88

4.81

2.7

3.2

0.93

0.78

ug/l

2.68

1266

12960

Brain glioblastoma and astrocytoma

1085

0.56

4.81

2.2

2.9

0.62

0.72

ug/l

0.87

691

Epileptic seizures related to alcohol

633

0.43

4.79

2.4

2.8

0.55

0.70

ug/l

1.19

402

Localized swelling, mass and lump of skin and subcutaneous tissue

2287

20942

1.11

4.79

3.1

3.0

0.74

0.77

ug/l

0.58

1599

13930

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1313

0.61

4.68

2.4

2.7

0.65

0.75

ug/l

0.51

753

Alzheimer’s disease (Late onset)

1271

12217

0.87

4.61

3.0

3.4

0.88

0.90

ug/l

0.26

906

9018

Fever of other and unknown origin

4687

40904

1.07

4.59

3.0

0.78

ug/l

0.10

3268

26874

Myocardial infarction, without ST-elevation

4044

39650

0.92

4.59

3.0

3.2

0.80

ug/l

0.10

2913

28007

Primary coxarthrosis, bilateral

2274

20895

1.11

4.58

3.4

3.2

0.74

0.81

ug/l

2.72

1626

14773

Seropositive rheumatoid arthritis

1147

12933

0.87

4.56

3.0

3.1

0.71

0.80

ug/l

1.59

779

8824

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

276

3535

0.76

4.55

2.1

2.2

0.40

0.65

ug/l

13.24

176

1693

Dysphagia

1947

17760

1.12

4.55

3.1

3.2

0.67

0.81

ug/l

6.88

1361

12314

Brain glioblastoma

925

0.54

4.55

2.2

2.9

0.60

0.72

ug/l

1.13

607

Diseases of inner ear

3962

36354

1.08

4.50

3.2

3.0

0.78

0.77

ug/l

0.07

2646

24657

Palmar fascial fibromatosis [Dupuytren]

1932

17724

1.12

4.50

3.4

3.2

0.77

0.83

ug/l

1.57

1363

12445

TMD related operations

860

7460

1.17

4.48

2.6

2.7

0.61

0.71

ug/l

4.51

496

4471

Toxic effect of alcohol

122

1729

0.65

4.48

2.5

2.7

0.65

0.74

ug/l

0.79

1037

Other infectious diseases

435

5261

0.80

4.48

2.7

3.1

0.77

0.79

ug/l

0.17

308

3553

Universal erythroderma, KELA reimbursement

1106

0.58

4.46

2.9

0.56

0.76

ug/l

2.50

710

Hypothyroidism (congenital or acquired)

1877

9762

1.12

4.45

2.7

2.2

0.62

0.69

ug/l

3.41

1096

4568

Benign neoplasm: Pituitary gland, craniopharyngeal duct

353

2843

1.29

4.44

3.2

2.9

0.79

0.74

ug/l

0.17

249

1805

Varicose veins of other sites

620

5299

1.22

4.43

2.9

2.8

0.82

0.72

ug/l

0.41

384

3205

Other disorders of skin and subcutaneous tissue

4809

46673

0.93

4.42

3.1

0.77

0.79

ug/l

0.45

3350

31659

Malignant neoplasm of head and neck

636

7385

0.83

4.42

2.8

3.1

0.73

0.79

ug/l

0.99

440

5108

Benign neoplasm: Appendix

553

1.73

4.41

3.5

2.6

0.77

ug/l

0.01

362

Non-Hodgkin lymphoma, all

243

3101

0.74

4.38

2.8

3.3

0.77

0.82

ug/l

0.25

162

2191

Benign neoplasm of other and ill-defined parts of digestive system

1156

10274

1.15

4.37

3.2

3.1

0.76

0.78

ug/l

0.22

854

7131

Transient global amnesia

593

5030

1.22

4.37

3.4

3.2

0.72

0.79

ug/l

0.82

433

3576

Problems related to social environment

1119

0.59

4.37

2.9

2.8

0.74

0.80

ug/l

0.18

714

Nephropathy related operations

974

10986

0.86

4.33

2.3

3.0

0.87

0.76

ug/l

2.89

756

7264

Other specified disorders of external ear

439

3687

1.29

4.32

3.5

3.1

0.79

0.76

ug/l

0.14

296

2527

Melanocytic naevi of other and unspecified parts of face

286

2242

1.31

4.30

3.0

2.9

0.71

0.75

ug/l

0.24

183

1430

Nerve, nerve root and plexus disorders

8921

58470

0.95

4.29

2.9

0.70

0.77

ug/l

6.34

5889

37539

Disorders of sclera, cornea, iris and ciliary body

4135

38881

1.07

4.28

2.9

2.8

0.70

0.75

ug/l

3.80

2676

24518

Striking against or struck by other objects

2772

25721

1.09

4.28

2.9

2.7

0.72

0.71

ug/l

0.05

1682

15508

Chalazion

767

6644

1.18

4.27

3.0

2.9

0.69

0.74

ug/l

1.18

518

4219

Other disorders of urethra and urinary system

4000

31953

0.93

4.26

3.3

3.2

0.85

0.81

ug/l

0.87

3005

22447

Abnormal findings on diagnostic imaging of lung

4216

43511

0.93

4.25

3.1

3.2

0.77

0.80

ug/l

0.57

2914

30429

Other diseases of lip and oral mucosa

1067

9450

1.15

4.25

2.9

0.69

0.77

ug/l

2.81

715

6130

Use of antiglaucoma preparations and miotics

523

4396

1.23

4.25

3.5

3.3

0.78

0.84

ug/l

0.81

384

3116

Carcinoma in situ of skin of upper limb, including shoulder

192

1456

1.43

4.22

3.4

0.84

0.83

ug/l

0.01

138

1037

Secondary parkinsonism+Parkinsonism in other disease

135

1868

0.68

4.21

2.9

3.2

0.63

0.79

ug/l

2.06

1280

ILD, hospital admissions 3, with pneumonia sepsis

571

6669

0.82

4.17

2.7

3.3

0.73

0.83

ug/l

1.35

406

4783

Benign neoplasm: Anus and anal canal

203

1542

1.40

4.16

3.7

2.7

0.79

0.75

ug/l

0.25

144

1049

Other specified/unspecified diseases of inner ear

262

2.08

4.15

3.9

2.8

0.85

0.71

ug/l

0.51

172

Nontoxic single thyroid nodule

265

2062

1.31

4.14

3.5

3.1

0.85

0.77

ug/l

0.32

187

1413

Hypothyroidism, levothyroxine purchases

1863

9741

1.11

4.10

2.7

2.2

0.62

0.69

ug/l

3.74

1088

4564

Hypothyroidism and >3 levothyroxin purchases

1863

9741

1.11

4.10

2.7

2.2

0.62

0.69

ug/l

3.74

1088

4564

Morphin

1175

0.61

4.10

3.1

3.2

0.67

0.89

ug/l

2.07

822

Secondary parkinsonism, excluding more controls

133

1833

0.68

4.07

3.0

3.2

0.63

0.84

ug/l

3.06

1235

ILD-related respiratory insufficiency

192

2490

0.72

4.05

2.4

3.3

0.68

0.79

ug/l

0.60

124

1778

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

545

4645

1.22

4.02

3.0

2.6

0.75

0.70

ug/l

0.85

378

2978

Other and unspecified visual disturbances

549

4654

1.21

4.01

2.7

3.0

0.79

0.74

ug/l

0.28

371

3057

Pacemaker

3166

28826

1.09

4.01

3.2

3.3

0.82

ug/l

0.10

2301

20819

Other diseases of urinary system

9065

48920

1.05

4.01

3.4

3.0

0.79

0.78

ug/l

0.18

6663

32711

Other respiratory diseases principally affecting the interstitium

1339

14791

0.88

4.00

2.9

3.2

0.73

0.82

ug/l

2.49

958

10542

Other nutritional deficiencies

3875

40264

0.93

4.00

2.8

2.9

0.67

0.74

ug/l

3.30

2560

25702

Alzheimer’s disease, wide definition, excluding more controls

1169

8873

0.88

3.99

3.0

3.6

0.87

0.90

ug/l

0.26

844

6672

Carcinoma in situ of other and unspecified digestive organs

220

1716

1.38

3.97

3.6

2.7

0.73

0.75

ug/l

0.13

155

1170

Laparoscopic left hemicolectomy

160

1196

1.47

3.96

2.9

3.1

0.82

0.75

ug/l

0.38

113

817

Carpal tunnel syndrome

3849

36933

0.93

3.95

3.0

2.9

0.69

0.76

ug/l

4.54

2545

23990

Blood alcohol or alcohol intoxication level

112

1584

0.67

3.92

2.5

2.6

0.77

0.70

ug/l

0.17

913

Alcohol induced polyneuropathy

1080

0.59

3.92

2.7

3.1

0.61

0.77

ug/l

1.26

721

Generalized epilepsy

127

1777

0.69

3.89

2.6

2.7

0.69

0.75

ug/l

0.33

1030

Behavioural syndromes associated with physiological disturbances and physical factors

1628

14788

1.11

3.88

2.7

2.8

0.65

0.73

ug/l

2.67

1038

9081

Total colectomy operation

200

2590

0.74

3.87

2.9

2.8

0.76

0.73

ug/l

0.21

132

1595

Total colectomy

200

2590

0.74

3.87

2.9

2.8

0.76

0.73

ug/l

0.21

132

1595

Tobacco use

269

3359

0.77

3.87

2.3

2.9

0.60

0.72

ug/l

3.08

180

2132

Encephalopathy

723

0.52

3.87

2.5

3.0

0.47

0.76

ug/l

7.06

494

Thyrotoxicosis

913

8029

1.15

3.84

2.9

3.0

0.75

0.78

ug/l

0.34

605

5357

Secondary parkinsonism

133

1815

0.69

3.84

3.0

3.2

0.63

0.77

ug/l

1.71

1237

Other or ill-defined heart diseases

324

3958

0.79

3.83

2.7

2.9

0.78

ug/l

0.01

200

2523

Heartburn

661

5711

1.18

3.82

3.1

3.0

0.65

0.75

ug/l

3.19

447

3740

Recurrent dislocation and subluxation of joint

394

3250

1.24

3.82

2.4

2.3

0.61

0.70

ug/l

1.61

215

1666

Temporomandibular joint disorders

579

4924

1.19

3.81

2.9

2.8

0.63

0.76

ug/l

4.22

348

3017

Alcoholic gastritis

116

1584

0.66

3.80

3.2

2.9

0.73

0.75

ug/l

0.06

1028

Chronic laryngitis and laryngotracheitis

965

8565

1.15

3.80

3.5

3.0

0.67

0.79

ug/l

5.09

665

5815

Injuries to the elbow and forearm

3850

36961

0.93

3.80

2.9

2.8

0.74

ug/l

0.07

2510

23178

Benign neoplasm of eye and adnexa

640

5528

1.19

3.79

3.4

3.1

0.75

0.78

ug/l

0.15

433

3772

Pollen allergy

582

4899

1.19

3.79

2.6

2.4

0.61

0.64

ug/l

0.32

306

2542

Malignant neoplasm of rectum

706

8049

0.85

3.79

3.0

3.2

0.69

0.80

ug/l

2.75

486

5704

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

464

3891

1.22

3.79

2.4

0.61

0.70

ug/l

1.80

257

2053

Endocrine, nutritional and metabolic diseases

7447

36220

1.05

3.78

2.8

0.71

0.76

ug/l

2.80

4683

21807

Nonorganic sleeping disorders, excluding more controls

1042

9272

1.14

3.78

2.7

2.8

0.63

0.76

ug/l

3.71

668

5505

Benign neoplasm: Conjunctiva

206

1587

1.36

3.78

3.3

2.6

0.86

0.75

ug/l

0.27

142

1015

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

1023

0.60

3.78

2.2

2.5

0.62

0.73

ug/l

0.90

645

Melanocytic naevi of lower limb, including hip

204

1561

1.35

3.76

3.4

2.6

0.70

0.73

ug/l

0.31

149

970

Iron deficiency anaemia

2383

25439

0.92

3.75

3.0

3.2

0.92

0.80

ug/l

2.35

1696

17770

Alcoholic cardiomyopathy

530

0.45

3.75

2.3

3.1

0.65

0.80

ug/l

0.75

364

Other disorders of the genitourinary system

366

2991

1.24

3.73

3.2

3.3

0.87

0.81

ug/l

0.18

244

2133

General examination and investigation of persons without complaint and reported diagnosis

6567

33350

1.06

3.73

2.9

2.8

0.72

0.79

ug/l

6.82

3976

20512

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1059

6967

1.15

3.72

3.0

3.1

0.69

0.88

ug/l

8.25

750

4745

Sequelae of other accidents

960

0.59

3.72

2.5

3.0

0.61

0.79

ug/l

1.73

617

ILD, hospital admission 2, with pulmonary infections

697

7951

0.85

3.72

2.7

3.3

0.71

0.83

ug/l

2.23

493

5644

Nonischemic cardiomyopathy

494

5745

0.82

3.71

2.6

3.0

0.84

0.77

ug/l

0.42

363

3764

Benign neoplasm of brain and other parts of central nervous system

438

3678

1.23

3.71

3.1

3.0

0.79

0.75

ug/l

0.20

299

2424

773

0.55

3.71

2.3

2.7

0.63

0.75

ug/l

0.51

469

Vascular dementia (multiple infarctions)

818

0.56

3.69

3.0

3.3

0.86

0.95

ug/l

0.34

581

Extracorporeal dialysis

427

5038

0.81

3.68

2.3

3.0

0.99

0.76

ug/l

4.34

345

3337

Use of pramipexole

1408

12785

1.12

3.65

3.1

0.69

0.78

ug/l

3.55

979

8795

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

802

0.56

3.65

2.8

2.7

0.69

0.81

ug/l

0.52

551

Asthma, excluding more controls

6360

35524

0.95

3.65

2.8

2.9

0.66

0.77

ug/l

12.20

4078

22372

Otitis externa

1496

13623

1.12

3.65

3.2

2.9

0.75

0.76

ug/l

0.03

1014

8878

Faecal incontinence

234

1820

1.31

3.64

3.6

3.2

0.82

0.78

ug/l

0.09

167

1257

Other specified and unspecified personality disorders

380

4578

0.81

3.64

2.5

2.6

0.53

0.70

ug/l

6.38

278

2632

Acute upper respiratory infections

7999

52218

0.95

3.64

2.9

3.0

0.71

0.78

ug/l

8.24

5022

34597

Melanocytic naevi of upper limb, including shoulder

124

886

1.47

3.63

3.2

2.6

0.61

0.74

ug/l

1.49

578

Other and unspecified intracranial injuries

154

2040

0.72

3.62

2.7

3.0

0.72

0.77

ug/l

0.22

106

1307

Dependence on enabling machines and devices, not elsewhere classified

666

0.52

3.61

1.7

3.1

0.57

0.75

ug/l

1.23

438

Laparoscopic right hemicolectomy

421

3548

1.24

3.61

3.4

3.3

0.71

0.78

ug/l

1.47

313

2505

Bronchitis

8927

56289

1.05

3.60

2.8

2.9

0.72

0.78

ug/l

4.36

5560

36723

Other specified/unspecified hearing loss

599

5180

1.19

3.59

3.2

3.1

0.85

0.82

ug/l

0.17

476

3608

Other or unspecified ileus, impaction or obstruction

1311

14424

0.89

3.58

2.9

3.1

0.80

0.82

ug/l

0.24

900

9940

Methotrexate

590

6849

0.85

3.58

2.8

3.0

0.64

0.76

ug/l

3.46

412

4517

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

152

2016

0.72

3.58

2.8

3.3

0.93

0.84

ug/l

0.27

110

1421

Kela-code for behavioural disturbances in mental retardation

535

0.48

3.57

2.2

2.9

0.62

0.73

ug/l

0.25

345

Other pleural conditions

785

8858

0.86

3.57

3.1

3.3

0.82

0.84

ug/l

0.14

571

6336

Second line medication for Crohn's disease

3425

36394

0.93

3.56

2.7

2.9

0.68

0.74

ug/l

2.26

2263

23095

Collagenous colitis

455

3835

1.21

3.56

2.9

3.0

0.70

0.75

ug/l

0.44

318

2514

Gastrojejunal ulcer

882

0.58

3.54

2.1

2.9

0.67

0.80

ug/l

1.02

592

Carcinoma in situ of rectum

550

1.68

3.54

3.7

2.6

0.70

0.76

ug/l

0.26

377

Other disorders of eye and adnexa

649

5623

1.17

3.53

3.1

2.9

0.63

0.73

ug/l

3.01

448

3559

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

1243

0.65

3.52

2.7

0.59

0.76

ug/l

2.76

861

Pneumonia due to Streptococcus pneumoniae

253

3136

0.77

3.51

2.5

3.0

0.78

0.76

ug/l

0.09

164

2015

Other diseases of biliary tract

426

5043

0.82

3.51

2.9

3.1

0.70

0.79

ug/l

1.26

288

3433

Malignant melanoma of skin

940

8405

1.15

3.51

3.4

3.2

0.80

0.79

ug/l

0.12

707

5903

Asthma and allergy

462

3836

1.20

3.50

2.7

2.5

0.54

0.69

ug/l

5.36

261

2088

Benign neoplasm: Rectosigmoid junction

307

2517

1.28

3.50

3.7

2.7

0.95

0.74

ug/l

0.75

236

1695

Other specified/unspecified arthritis

1869

17217

1.10

3.50

3.0

2.9

0.74

0.79

ug/l

1.01

1269

11252

Colorectal cancer

1843

19937

0.91

3.50

3.1

3.2

0.79

0.81

ug/l

0.18

1293

14205

Other systemic involvement of connective tissue (FG)

1203

10759

1.12

3.49

3.2

3.1

0.72

0.82

ug/l

3.34

838

7421

Other shoulder lesions

566

4869

1.19

3.49

2.7

0.67

0.75

ug/l

0.38

356

2962

Psychotic depression

253

3161

0.78

3.49

2.8

2.9

0.76

0.77

ug/l

0.05

159

1987

Adverse effects, not elsewhere classified

880

7785

1.14

3.48

2.9

0.66

0.74

ug/l

1.84

581

4955

Colonic or urogenital fistula

2173

20172

1.09

3.48

3.2

2.9

0.69

0.76

ug/l

3.71

1410

13273

Bicipital tendinitis

427

3618

1.23

3.47

2.9

2.8

0.66

0.74

ug/l

0.95

282

2293

Other disorders of skin and subcutaneous tissue, not elsewhere classified

808

9126

0.87

3.47

3.1

0.69

0.79

ug/l

3.59

570

6234

1277

0.66

3.47

2.4

2.5

0.71

0.70

ug/l

0.03

719

Emotionally unstable personality disorder

295

3643

0.80

3.46

2.3

2.4

0.46

0.65

ug/l

8.78

201

1901

Injuries to the hip and thigh

3462

33599

0.93

3.46

2.9

3.1

0.79

0.80

ug/l

0.02

2272

22649

General symptoms and signs

10173

49151

1.04

3.46

2.8

2.9

0.73

0.76

ug/l

1.62

6681

30739

Occlusion and stenosis of arteries, not leading to stroke

965

0.61

3.44

2.5

3.3

0.91

0.86

ug/l

0.12

686

Urticaria

1323

11980

1.11

3.43

2.8

0.74

ug/l

0.05

846

7478

Open wound of thorax

1150

0.64

3.43

2.6

0.59

0.74

ug/l

1.33

651

Cardiomyopathies, Secondary/extrinsic

553

0.49

3.43

2.4

3.0

0.60

0.78

ug/l

0.93

375

Plantar fascial fibromatosis

473

4009

1.20

3.43

3.0

2.8

0.68

0.77

ug/l

1.60

321

2583

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

458

3883

1.21

3.42

3.3

2.6

0.72

0.69

ug/l

0.34

308

2453

Melanoma in situ of upper limb, including shoulder

308

1.85

3.41

3.7

2.7

0.82

0.78

ug/l

0.09

206

Thyrotoxicosis, other and/or unspecified

755

6618

1.15

3.41

2.8

3.0

0.76

0.78

ug/l

0.23

492

4378

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

3484

28869

1.07

3.40

3.5

2.7

1.24

0.71

ug/l

22.59

2559

19519

Benign neoplasm: Kidney

203

1585

1.34

3.40

3.0

2.8

1.00

0.76

ug/l

0.76

141

1088

Other pulmonary heart/vessel disease

228

2852

0.77

3.39

2.9

3.2

0.93

0.82

ug/l

0.35

145

1989

Ethmoidectomy

954

8537

1.14

3.38

3.2

2.8

0.69

0.72

ug/l

0.61

576

5357

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

858

0.59

3.36

2.2

2.6

0.60

0.73

ug/l

1.26

555

Asthma and allergy, excluding more controls

462

3852

1.20

3.36

2.7

2.5

0.54

0.69

ug/l

5.49

261

2103

severe traumatic brain injury, does not include concussion

1875

20220

0.91

3.35

3.1

0.78

0.80

ug/l

0.27

1331

13777

Benign neoplasm of meninges

381

3172

1.22

3.34

3.4

2.7

0.90

0.74

ug/l

1.04

277

2159

Normotensive glaucoma

473

4033

1.20

3.34

3.4

3.3

0.78

0.81

ug/l

0.27

338

2898

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2503

23399

1.08

3.34

2.9

2.8

0.66

0.73

ug/l

3.86

1555

14375

Other disorders of conjunctiva

1031

9277

1.14

3.34

3.4

3.1

0.71

0.80

ug/l

2.16

723

6474

Rheumatoid arthritis, including avohilmo

1885

20414

0.91

3.33

3.0

3.1

0.74

0.78

ug/l

0.62

1291

13890

Chronic viral hepatitis

244

3034

0.78

3.33

2.2

2.3

0.46

0.65

ug/l

6.14

164

1528

L04AX Other immunosuppressants

3347

35505

0.93

3.33

2.7

2.9

0.68

0.74

ug/l

2.27

2219

22573

Lung transplant status

525

1.67

3.32

1.5

2.8

0.50

0.74

ug/l

3.55

337

Lung transplantation

525

1.67

3.32

1.5

2.8

0.50

0.74

ug/l

3.55

337

Phlebitis and thrombophlebitis (not including DVT)

1603

14724

1.11

3.31

3.0

0.80

0.76

ug/l

0.57

1118

9763

Inhalation and ingestion of food causing obstruction of respiratory tract

562

0.51

3.31

2.9

3.1

0.66

0.79

ug/l

0.38

379

Disorders of tooth development and eruption

243

1881

1.29

3.31

2.7

2.5

0.64

0.71

ug/l

0.72

147

995

Benign neoplasm: Adrenal gland

525

4532

1.20

3.31

3.2

3.1

0.76

0.74

ug/l

0.15

385

3104

Benign neoplasm: Parotid gland

578

5025

1.19

3.29

3.0

2.7

0.71

0.72

ug/l

0.05

397

3350

Autoimmune diseases excluding thyroid diseases

9440

54301

0.96

3.29

2.8

2.9

0.73

0.77

ug/l

1.86

6250

34435

Exposure to excessive heat of man-made origin

517

0.49

3.29

2.8

2.9

0.68

0.77

ug/l

0.39

332

Hyperaldosteronism

222

1773

1.33

3.28

3.5

3.1

0.77

0.74

ug/l

0.20

158

1161

Other anxiety disorders

1932

18550

0.92

3.28

2.5

0.56

0.70

ug/l

9.40

1262

10174

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

130

988

1.51

3.25

3.2

2.7

0.79

0.74

ug/l

0.29

105

673

Benign neoplasm of male genital organs

278

2317

1.32

3.24

3.6

2.7

0.67

0.74

ug/l

0.88

201

1527

Toxic effects of substances chiefly nonmedicinal as to source

616

7047

0.86

3.23

2.6

2.8

0.67

0.72

ug/l

0.81

413

4286

Benign neoplasm: Choroid

350

2919

1.24

3.23

3.7

2.7

0.71

0.73

ug/l

0.31

239

1976

Other arterial embolism and thrombosis

160

2065

0.74

3.20

3.0

3.3

0.69

0.82

ug/l

1.27

114

1437

Other specific joint derangements/joint disorders

5856

37527

1.05

3.20

2.9

2.8

0.66

0.78

ug/l

11.72

3711

23322

Benign neoplasm of major salivary glands

708

6251

1.16

3.19

3.0

2.7

0.72

ug/l

0.00

489

4183

Benign neoplasm: Cranial nerves

206

1632

1.33

3.19

3.4

3.0

0.71

0.76

ug/l

0.35

139

1079

Acute pancreatitis (for exclusion)

1662

17962

0.91

3.15

2.8

3.0

0.69

0.77

ug/l

2.90

1123

11896

Infectious mononucleosis

326

2688

1.23

3.14

2.2

2.3

0.64

0.63

ug/l

0.11

155

1344

Medicines for HER+ breast cancer

105

716

1.43

3.14

3.1

2.4

1.16

0.76

ug/l

0.43

371

Benign neoplasm: Appendix

600

1.57

3.14

3.5

3.0

0.77

0.81

ug/l

0.12

398

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

245

3017

0.79

3.13

2.3

2.5

0.75

0.72

ug/l

0.31

159

1879

Other peripheral vascular diseases

329

3949

0.81

3.12

2.8

3.1

0.67

0.79

ug/l

2.45

233

2667

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

415

0.45

3.11

2.9

2.05

0.73

ug/l

0.40

270

Complications peculiar to reattachment and amputation

480

0.49

3.11

1.8

3.1

0.44

0.83

ug/l

2.54

317

Injuries to unspecified part of trunk, limb or body region

657

5778

1.16

3.10

2.7

3.0

0.72

0.75

ug/l

0.26

433

3779

Metatarsalgia

392

3299

1.21

3.09

3.1

2.9

0.65

0.76

ug/l

3.17

269

2130

Thyrotoxicosis with toxic multinodular goitre

189

1469

1.31

3.08

3.6

3.1

0.65

0.79

ug/l

2.31

142

1008

Angina pectoris

6021

42354

0.95

3.07

2.9

3.1

0.74

0.78

ug/l

2.38

4134

28601

Hypotension

1348

12358

1.11

3.07

3.3

0.79

0.84

ug/l

0.56

969

8863

Secondary right heart disease

199

2496

0.77

3.06

2.8

3.2

0.93

0.81

ug/l

0.32

126

1743

Complications of procedures, not elsewhere classified

6561

54430

1.05

3.06

3.0

0.75

0.77

ug/l

0.83

4466

35709

Corns and callosities

345

4102

0.82

3.06

2.7

3.0

0.65

0.76

ug/l

2.68

237

2659

UC patients in KELA-register (code 208), prior to 1994

264

3204

0.79

3.06

3.0

0.72

0.73

ug/l

0.04

172

2088

Pain in thoracic spine

818

7279

1.14

3.06

2.8

0.68

0.76

ug/l

0.77

547

4474

Seropositive rheumatoid arthritis, strict definition

628

7158

0.86

3.04

2.9

3.1

0.76

0.78

ug/l

0.12

424

4862

Trochanteric bursitis

410

3462

1.20

3.04

2.9

3.0

0.60

0.79

ug/l

9.23

291

2314

Abscess of lung

1230

0.67

3.03

2.6

2.9

0.59

0.78

ug/l

1.88

777

Pleural effusion

1294

14085

0.90

3.00

3.2

3.3

0.74

0.83

ug/l

2.19

959

10061

Problems related to lifestyle

617

7015

0.86

3.00

2.5

2.7

0.59

0.73

ug/l

4.58

427

4237

Reimbursement for rheumatic diseases

3280

34628

0.94

2.99

2.8

2.9

0.69

0.76

ug/l

3.50

2205

22568

Dementia due to Parkinsons disease, excluding more controls

130

1699

0.72

2.99

2.7

3.5

0.70

0.94

ug/l

1.41

1259

Thiamine deficiency

479

0.49

2.98

3.5

2.9

0.65

0.74

ug/l

0.27

317

Functional dyspepsia

1465

13451

1.10

2.97

3.2

2.9

0.65

0.78

ug/l

5.83

945

8829

Benign neoplasm: Cerebral meninges

334

2782

1.22

2.96

3.3

2.7

0.88

0.74

ug/l

0.79

245

1889

Pain, not elsewhere classified

1757

16263

1.09

2.96

2.9

0.68

0.76

ug/l

2.35

1171

10423

Other/unspecified soft tissue disorders related to use, overuse and pressure

162

1250

1.34

2.95

2.9

2.7

0.64

0.75

ug/l

1.34

102

759

Vascular diseases of the intestine

197

2456

0.77

2.94

2.9

3.3

0.86

0.83

ug/l

0.10

135

1718

Migraine without aura and triptan purchases

259

2093

1.25

2.94

2.5

2.4

0.58

0.67

ug/l

1.86

147

1096

Autoimmune diseases excluding thyroid diseases, strict definition

9308

53637

0.96

2.93

2.8

2.9

0.73

0.77

ug/l

1.85

6157

33948

Cervicalgia

1259

11499

1.11

2.92

3.2

2.9

0.71

0.78

ug/l

0.92

864

7460

Parkinson's disease, excluding more controls

1190

12654

0.90

2.92

3.0

3.4

0.74

0.86

ug/l

4.44

858

9215

Benign neoplasm: Descending colon

569

5007

1.18

2.92

3.3

3.2

0.80

0.77

ug/l

0.17

430

3487

Dementia due to Parkinson's disease

130

1693

0.72

2.92

2.7

3.4

0.70

0.82

ug/l

0.57

1233

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

8521

57415

0.96

2.90

3.0

2.9

0.78

0.77

ug/l

0.19

5819

37197

Ganglion

1093

9911

1.11

2.88

2.8

0.68

0.76

ug/l

2.64

676

6194

Obesity

3701

38600

0.94

2.87

2.8

2.9

0.67

0.74

ug/l

3.06

2434

24617

Vocal cord dysfunction

1005

8445

1.12

2.85

3.0

0.67

0.78

ug/l

4.66

649

5402

Frostbite

777

0.61

2.85

2.1

2.9

0.65

0.77

ug/l

0.61

474

Anorexia (incl.atypical)

118

1590

0.73

2.85

2.5

2.7

0.70

0.76

ug/l

0.35

949

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

185

2314

0.77

2.84

3.2

2.7

0.76

0.77

ug/l

0.07

117

1651

Obesity and other hyperalimentation

3720

38756

0.94

2.84

2.8

2.9

0.67

0.74

ug/l

3.06

2447

24714

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

382

4470

0.83

2.84

2.6

0.74

0.72

ug/l

0.17

259

2871

Diseases of salivary glands

1160

10570

1.11

2.84

2.9

2.8

0.74

0.76

ug/l

0.24

760

6744

Carbimazole or st.post thyroidectomy, condition for graves disease

716

6339

1.14

2.84

2.8

2.9

0.72

0.75

ug/l

0.48

479

4116

Glaucoma, exfoliation

672

5952

1.15

2.84

3.5

3.3

0.78

0.86

ug/l

1.63

503

4333

Multiple myeloma

122

1602

0.72

2.82

2.8

3.3

0.87

0.79

ug/l

0.33

1136

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

122

1602

0.72

2.82

2.8

3.3

0.87

0.79

ug/l

0.33

1136

Acute bronchitis

2728

28361

0.93

2.82

2.9

3.0

0.74

0.80

ug/l

2.48

1803

18602

Colorectal adenocarcinoma

1577

16990

0.91

2.82

3.1

3.3

0.79

0.81

ug/l

0.30

1108

12156

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3587

21555

1.06

2.82

2.8

2.7

0.73

0.72

ug/l

0.07

2279

12399

Melanoma in situ of scalp and neck

179

2.24

2.81

4.3

2.6

0.74

0.83

ug/l

0.28

126

Conjunctivitis (acute, non atopic)

1594

14682

1.09

2.79

2.9

2.8

0.72

0.73

ug/l

0.14

1037

9153

Open wound of lower leg

975

8829

1.12

2.79

2.8

2.9

0.73

0.76

ug/l

0.38

633

5594

Other abnormal findings of blood chemistry

297

2482

1.24

2.79

3.1

2.9

0.76

0.71

ug/l

0.43

161

1617

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

763

8477

0.87

2.79

3.0

3.2

0.73

0.80

ug/l

0.79

528

6030

Spondylosis

4972

40830

1.05

2.78

3.1

3.0

0.68

0.79

ug/l

10.56

3447

26885

Colitis, primary sclerosing, strict definition

536

0.54

2.78

2.3

2.5

0.88

0.68

ug/l

0.30

289

Exposure to other and unspecified inanimate mechanical forces

497

4334

1.18

2.75

2.7

0.73

0.70

ug/l

0.13

321

2636

Benign neoplasm of urinary organs

287

2391

1.24

2.75

3.3

2.8

0.93

0.75

ug/l

0.83

207

1650

Accidental poisoning by and exposure to other gases and vapours

321

0.42

2.75

1.5

2.8

0.80

0.78

ug/l

—

202

Complications of cardiac and vascular prosthetic devices, implants and grafts

127

1641

0.73

2.75

2.4

3.2

0.79

0.81

ug/l

0.11

1136

Inflammatory bowel disease, strict (require KELA)

1420

15390

0.91

2.72

2.7

0.68

0.71

ug/l

0.90

886

9247

Other/unspecified rheumatoid arthritis

479

5512

0.86

2.71

3.0

3.2

0.68

0.79

ug/l

2.94

332

3812

Ductal carcinoma of pancreas

517

0.53

2.71

2.1

3.1

0.77

0.76

ug/l

0.01

349

Normal-pressure hydrocephalus

268

3206

0.81

2.70

2.7

3.4

0.69

0.82

ug/l

1.86

189

2334

Evidence of alcohol involvement determined by blood alcohol level

1029

0.67

2.69

2.5

2.7

0.81

0.71

ug/l

0.15

607

Acute pancreatitis

1662

17839

0.92

2.69

2.8

3.0

0.69

0.77

ug/l

2.82

1123

11769

Benign neoplasm: Stomach

561

4933

1.16

2.68

3.2

0.80

0.78

ug/l

0.13

419

3407

Alzheimer’s disease (Late onset), excluding more controls

1090

7957

0.90

2.66

3.0

3.6

0.86

0.91

ug/l

0.66

788

6062

Ulcerative colitis, NAS

765

8523

0.88

2.65

2.8

0.68

0.73

ug/l

0.95

506

5248

Disorders of refraction and accommodation

1333

12206

1.10

2.65

2.8

0.70

0.73

ug/l

0.21

827

7503

Alcohol-induced acute pancreatitis

331

3841

0.82

2.64

2.9

2.8

0.60

0.72

ug/l

2.83

220

2405

Colitis, primary sclerosing

677

0.60

2.64

2.2

2.5

0.79

0.68

ug/l

0.17

370

Generalized anxiety disorder

541

4728

1.16

2.64

2.6

2.5

0.49

0.69

ug/l

12.30

342

2576

Other systemic involvement of connective tissue

1236

11325

1.10

2.63

3.2

0.72

0.80

ug/l

2.23

858

7903

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2381

21691

1.08

2.63

3.1

2.8

0.82

0.72

ug/l

2.67

1688

15045

IBD patients in KELA-register

1420

15365

0.91

2.63

2.7

0.68

0.72

ug/l

0.99

886

9260

FESS (DNB20)

896

8116

1.13

2.63

3.2

2.8

0.68

0.72

ug/l

0.84

544

5068

Carcinoma in situ of rectum

587

1.55

2.62

3.7

3.2

0.70

0.76

ug/l

0.28

397

Disorders of oesophagus in diseases classified elsewhere

100

1334

0.71

2.62

3.0

3.1

0.94

0.79

ug/l

0.31

919

Migraine without aura

406

3468

1.18

2.62

2.5

0.58

0.67

ug/l

2.34

233

1900

Injury of unspecified body region

480

4188

1.17

2.61

2.8

3.0

0.71

0.76

ug/l

0.38

312

2750

Hypokalaemia

549

6232

0.87

2.61

2.9

3.1

0.76

0.78

ug/l

0.10

388

4229

Other and unspecified urticaria

855

7698

1.12

2.61

2.8

0.75

0.74

ug/l

0.02

557

4807

Delirium, not induced by alcohol and other psychoactive substances

756

8378

0.88

2.59

2.8

3.2

0.80

0.84

ug/l

0.23

513

5877

Other diseases of pericardium

300

3530

0.82

2.59

2.9

3.1

0.77

0.80

ug/l

0.21

210

2392

Multiple myeloma and malignant plasma cell neoplasms

277

3285

0.81

2.59

2.9

3.2

0.97

0.78

ug/l

1.25

205

2309

Diffuse brain injury

244

2931

0.80

2.58

2.7

2.9

0.66

0.78

ug/l

1.86

177

1845

Benign neoplasm: Prostate

750

1.54

2.58

4.6

2.8

0.74

0.80

ug/l

0.43

534

Hyperosmolality and hypernatraemia

799

0.63

2.58

2.3

3.1

0.73

0.82

ug/l

0.36

560

Melanocytic naevi of upper limb, including shoulder

124

943

1.37

2.57

3.2

3.0

0.61

0.76

ug/l

1.84

621

Dissociative [conversion] disorders

807

0.65

2.57

2.4

2.6

0.59

0.71

ug/l

0.74

474

Other epidermal thickening

205

2511

0.79

2.57

3.0

3.1

0.70

0.77

ug/l

0.89

146

1680

Panic disorder

549

4815

1.15

2.56

2.5

0.54

0.69

ug/l

4.91

336

2602

Carcinoma in situ of skin, other sites/unspecified

668

1.47

2.55

3.6

2.8

0.73

0.84

ug/l

0.89

484

Other enthesopathy of foot (+metatarsalgia)

416

3583

1.18

2.55

3.1

2.8

0.65

0.76

ug/l

3.52

286

2307

Glucosamine medication

3148

26468

0.94

2.54

3.6

3.3

0.73

0.81

ug/l

3.35

2259

19029

Acidosis

134

1696

0.74

2.53

2.4

3.1

0.81

0.73

ug/l

0.69

1163

Complications of internal orthopaedic prosthetic devices, implants and grafts

1594

14829

1.09

2.53

3.2

0.69

0.80

ug/l

5.65

1136

10496

Postprocedural disorders of ear and mastoid process, not elsewhere classified

515

0.55

2.52

3.1

3.0

0.71

0.76

ug/l

0.27

351

Myeloid leukaemia

128

1644

0.74

2.52

2.8

3.1

0.73

0.78

ug/l

0.43

1109

Oral leukoplakia and related diseases, including avohilmo

594

5276

1.15

2.52

3.1

3.0

0.63

0.75

ug/l

3.28

396

3456

Sulfasalazine

1785

19117

0.92

2.51

2.7

2.9

0.71

0.74

ug/l

0.46

1176

12262

Adenocarcinoma and papilloma adenocarcinoma of rectum

731

8087

0.88

2.50

3.0

3.2

0.73

0.80

ug/l

0.73

507

5744

Other disorders affecting eyelid function

514

0.56

2.50

1.9

3.0

0.69

0.76

ug/l

0.22

340

Care involving dialysis

615

6867

0.87

2.50

2.4

3.0

1.07

0.75

ug/l

7.38

498

4567

Hypertensive Heart Disease

2229

19329

0.93

2.49

3.1

3.3

0.80

0.79

ug/l

0.17

1590

13732

Other diseases of arteries and capillaries

529

5983

0.86

2.49

3.1

3.2

0.90

0.82

ug/l

0.36

350

4160

Hereditary ataxia

826

0.65

2.48

2.6

3.0

0.70

0.79

ug/l

0.39

553

Conjunctivitis

3876

32192

1.05

2.47

2.9

2.7

0.69

0.73

ug/l

0.66

2357

19483

Melanoma in situ of upper limb, including shoulder

337

1.67

2.47

3.7

3.1

0.82

0.76

ug/l

0.15

228

L01XX Other antineoplastic agents

310

3632

0.83

2.47

2.9

3.3

0.78

ug/l

0.01

215

2587

Other dialysis

190

2316

0.78

2.47

2.5

2.9

1.00

0.73

ug/l

4.05

161

1468

Selective serotonin reuptake inhibitors

9466

51362

0.97

2.46

2.9

0.66

0.79

ug/l

28.57

6227

32712

Autoimmune diseases

10342

54363

0.97

2.45

2.8

2.9

0.72

0.77

ug/l

4.86

6732

34475

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

336

1.64

2.45

3.3

2.5

0.59

0.72

ug/l

1.02

212

Eating disorders

167

2101

0.79

2.43

2.5

2.7

0.66

0.73

ug/l

0.61

108

1225

Pathological resorption of teeth

205

1677

1.27

2.43

3.0

2.8

0.69

0.77

ug/l

0.66

136

1028

Benign neoplasm: Pancreas

174

1403

1.30

2.42

3.4

2.8

0.78

0.75

ug/l

0.16

124

956

Shock, not elsewhere classified

688

0.62

2.42

2.7

3.1

0.59

0.78

ug/l

1.74

463

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

151

1888

0.76

2.41

3.3

2.8

0.72

0.78

ug/l

0.41

1347

Sexual dysfunction

155

1245

1.34

2.41

2.5

2.7

0.67

0.73

ug/l

0.36

724

Abnormal involuntary movements

893

8126

1.12

2.40

3.1

3.0

0.72

0.78

ug/l

0.93

654

5453

Nontoxic multinodular goitre

561

4949

1.14

2.40

3.4

3.2

0.78

ug/l

0.03

423

3512

Melanocytic naevi of lower limb, including hip

204

1663

1.26

2.39

3.4

3.0

0.70

0.74

ug/l

0.44

149

1076

Zoster [herpes zoster]

1109

10189

1.10

2.38

3.2

0.78

0.81

ug/l

0.28

780

7100

Benign neoplasm of bone and articular cartilage

471

4129

1.16

2.38

3.1

2.5

0.73

0.69

ug/l

0.36

306

2467

Superficial injury of wrist and hand

1082

9918

1.10

2.37

2.7

0.67

0.71

ug/l

1.32

662

5924

Use of memantine

1619

15091

0.92

2.37

3.0

3.4

0.91

0.89

ug/l

0.19

1138

11178

Use of other anti-dementia drugs

1619

15091

0.92

2.37

3.0

3.4

0.91

0.89

ug/l

0.19

1138

11178

Major coronary heart disease event

7287

50179

0.96

2.37

2.9

3.0

0.76

0.77

ug/l

0.19

5016

33440

Other ulcerative colitis

282

3328

0.83

2.36

2.9

2.8

0.68

0.71

ug/l

0.28

197

2028

Other maltreatment syndromes

222

1837

1.25

2.36

2.0

2.3

0.57

0.66

ug/l

0.43

151

928

Recurring oral aphthae, including avohilmo

668

5981

1.13

2.35

2.9

3.0

0.63

0.77

ug/l

3.77

439

3972

Late syphilis

1008

0.68

2.35

2.7

2.8

0.65

0.73

ug/l

0.51

636

Otitis externa, unspecified

648

5800

1.14

2.35

3.2

2.9

0.83

0.73

ug/l

0.49

441

3690

Benign neoplasm: Skin of ear and external auricular canal

296

2521

1.22

2.35

3.4

3.2

0.73

0.81

ug/l

0.82

204

1751

Benign neoplasm: Liver/bile ducts

113

859

1.36

2.34

3.0

2.5

0.84

0.72

ug/l

0.62

556

Extrapyramidal and movement disorders

2826

26838

1.06

2.34

3.1

3.2

0.73

0.80

ug/l

1.94

2005

18760

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

192

1.90

2.34

1.9

2.3

0.49

0.63

ug/l

0.73

Intermittent heterotropia

207

1688

1.25

2.34

3.1

2.7

1.03

0.72

ug/l

0.69

125

1006

Cerebral aneurysm, nonruptured

399

4584

0.85

2.34

2.8

3.0

0.80

0.76

ug/l

0.17

261

3052

Other and unspecified degenerative diseases of nervous system

124

1577

0.75

2.32

3.3

3.4

0.68

0.83

ug/l

1.22

1117

Benign neoplasm: Anus and anal canal

203

1672

1.27

2.32

3.7

3.1

0.79

ug/l

0.01

144

1143

Dental caries 2, only avohilmo

4424

36397

0.95

2.31

2.9

2.7

0.68

0.72

ug/l

2.43

2748

21930

Use of disulfiram, acamprosate or naltrexone

731

8050

0.88

2.31

2.6

0.58

0.69

ug/l

2.99

513

4525

Hypothermia

111

1424

0.73

2.30

2.4

3.1

0.73

0.77

ug/l

0.19

937

Benign neoplasm: Conjunctiva

206

1697

1.26

2.30

3.3

3.0

0.86

0.78

ug/l

0.17

142

1114

Other and unspecified coagulation defects

228

1888

1.24

2.30

2.8

2.9

0.75

0.72

ug/l

0.13

148

1178

Adenocarcinoma and Papillary adenocarcinoma of kidney

130

1042

1.40

2.30

3.2

3.1

0.79

0.76

ug/l

0.15

105

713

Loose body in joint

233

1956

1.25

2.30

2.8

0.89

0.77

ug/l

0.35

158

1257

Pure hyperglyceridaemia

148

1834

0.76

2.29

2.9

3.0

1.10

0.75

ug/l

0.60

1213

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

968

10566

0.90

2.29

2.8

2.7

0.71

0.72

ug/l

0.12

620

6380

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1102

10184

1.11

2.29

3.2

2.8

0.87

0.74

ug/l

3.23

814

7083

Communicating hydrocephalus

1164

0.72

2.28

2.4

3.1

0.62

0.77

ug/l

1.16

769

Migraine

1625

12861

1.08

2.28

2.7

2.6

0.68

0.73

ug/l

0.71

981

7544

Rash and other nonspecific skin eruption

504

4449

1.15

2.28

2.9

3.0

0.72

0.76

ug/l

0.41

366

2930

Other and unspecified dermatitis

3447

32892

1.06

2.27

2.9

3.0

0.70

0.77

ug/l

2.57

2346

21607

Fibromyalgia

115

872

1.33

2.26

2.3

2.5

0.76

0.72

ug/l

0.12

474

Foreign body in genitourinary tract

306

0.47

2.26

3.7

2.9

0.97

0.76

ug/l

—

204

Desensitization to allergens

155

1228

1.28

2.25

2.4

2.2

0.62

0.64

ug/l

0.12

586

Aplastic and other anaemias

3577

35443

0.95

2.24

3.1

3.2

0.88

0.81

ug/l

1.98

2586

24983

Asthma-related pneumonia or sepsis

2307

24366

0.94

2.24

2.8

3.1

0.67

0.82

ug/l

9.18

1552

16574

Asthma, hospital admissions 3, pneumonia

2307

24366

0.94

2.24

2.8

3.1

0.67

0.82

ug/l

9.18

1552

16574

Disorders of ocular muscles, binocular movement, accommodation and refraction

2735

25724

1.06

2.24

2.8

0.75

0.74

ug/l

0.15

1747

16132

Acne vulgaris

225

1856

1.23

2.24

2.3

2.1

0.55

0.61

ug/l

0.91

117

880

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

801

8770

0.89

2.24

2.8

2.7

0.72

ug/l

0.10

557

5925

Primary_lymphoid and hematopoietic malignant neoplasms

1893

20097

0.93

2.24

2.9

3.2

0.77

0.79

ug/l

0.50

1308

14097

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1116

12093

0.91

2.23

2.8

2.7

0.70

0.71

ug/l

0.13

704

7331

Vascular syndromes of brain in cerebrovascular disorders

284

3314

0.83

2.23

2.7

3.3

0.87

0.81

ug/l

0.29

198

2351

Intestinal infectious diseases

7141

57388

0.96

2.23

2.7

2.9

0.73

0.77

ug/l

1.42

4312

36590

Rheumatic fever incl heart disease

155

1922

0.78

2.23

3.0

3.1

0.79

0.82

ug/l

0.20

110

1325

Fungal Sepsis

209

2505

0.80

2.23

3.1

3.2

0.76

0.77

ug/l

0.05

164

1714

Exposure to smoke, fire and flames

151

1865

0.77

2.23

2.7

0.68

0.73

ug/l

0.42

1117

Left ventricular outflow tract obstruction (LVOTO), broad definition

797

8727

0.89

2.23

2.5

2.7

0.69

0.70

ug/l

0.11

512

5303

Undetermined asthma

820

7450

1.12

2.22

3.3

3.0

0.67

0.81

ug/l

4.82

546

5008

Paranoid personality disorder

1055

0.71

2.21

2.6

2.8

0.67

0.72

ug/l

0.20

638

Acute posthaemorrhagic anaemia

174

2126

0.79

2.20

2.8

3.2

0.88

0.80

ug/l

0.29

134

1497

Paralytic ileus and intestinal obstruction

1837

19520

0.93

2.19

2.8

3.1

0.76

0.81

ug/l

0.92

1263

13346

Keratitis

2492

23623

1.06

2.19

2.9

2.8

0.71

0.75

ug/l

1.32

1599

14829

Asthma-related pneumonia

2305

24325

0.94

2.19

2.8

3.1

0.67

0.82

ug/l

9.13

1550

16551

Ulcerative colitis (strict definition, require KELA)

1016

11040

0.91

2.18

2.8

2.7

0.70

0.72

ug/l

0.24

650

6673

Aortic valve malfunction, age under 60 years

764

8368

0.89

2.18

2.5

2.7

0.66

0.70

ug/l

0.79

495

5082

Speech disturbances, not elsewhere classified

494

5557

0.87

2.18

3.4

3.1

0.75

0.79

ug/l

0.36

369

3813

Hypertensive heart and/or renal disease

2537

20686

0.94

2.17

3.0

3.2

0.82

0.78

ug/l

0.68

1822

14616

Diarrhoea and gastroenteritis of presumed infectious origin

5509

48272

1.04

2.17

2.6

2.8

0.72

0.76

ug/l

1.15

3281

29845

Carcinoma in situ of other and unspecified digestive organs

220

1852

1.26

2.17

3.6

3.2

0.73

0.78

ug/l

0.43

155

1278

Idiopathic pulmonary fibrosis

565

6279

0.87

2.16

2.9

3.3

0.68

0.84

ug/l

3.66

407

4561

Hyperkinetic disorders

237

1945

1.21

2.16

1.8

0.43

0.54

ug/l

3.61

133

772

Assault by sharp object

1214

0.73

2.15

2.1

2.4

0.43

0.65

ug/l

7.00

613

Other viral hepatitis

307

3569

0.84

2.15

2.2

2.4

0.52

0.64

ug/l

3.21

205

1874

Oral lichen ruber planus, including avohilmo

218

1808

1.23

2.15

3.6

2.9

0.61

0.72

ug/l

2.16

137

1157

Other diseases of blood and blood-forming organs, wide

1314

14121

0.92

2.15

2.8

3.0

0.75

0.77

ug/l

0.30

895

9527

Fall on same level involving ice and snow

3873

37112

1.05

2.15

2.9

0.72

0.76

ug/l

1.01

2538

23940

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

246

2919

0.83

2.15

2.5

2.7

0.67

0.72

ug/l

0.40

165

1749

Crohn's disease NAS

286

3345

0.84

2.14

2.7

2.8

0.64

0.72

ug/l

1.39

184

2013

L04AA Selective immunosuppressants

1127

12191

0.91

2.14

2.5

2.8

0.70

0.72

ug/l

0.34

818

7629

Dronedarone medication

273

2345

1.22

2.13

3.5

3.2

0.70

0.79

ug/l

0.95

199

1656

Vitamin B12 deficiency anaemia

634

7027

0.89

2.13

3.1

3.3

0.83

ug/l

0.00

446

5025

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

103

1321

0.74

2.13

2.8

0.82

0.77

ug/l

0.25

931

Other enthesopathies

1924

18112

1.07

2.12

2.9

2.8

0.66

0.77

ug/l

5.50

1233

11397

Other and unspecified myopathies

573

6368

0.88

2.12

2.7

3.1

0.69

0.79

ug/l

2.10

394

4303

Respiratory conditions due to other external agents

991

0.71

2.12

2.6

3.1

0.90

0.78

ug/l

0.36

669

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

178

1455

1.26

2.12

2.8

2.9

0.63

0.72

ug/l

0.99

117

922

Fall on and from ladder

891

8227

1.12

2.11

3.2

3.0

0.78

0.76

ug/l

0.14

587

5540

Acute laryngitis and tracheitis

465

4031

1.15

2.11

2.3

2.2

0.72

0.65

ug/l

0.21

208

2012

Benign neoplasm of mouth and pharynx

727

6604

1.12

2.09

2.9

2.6

0.68

0.70

ug/l

0.39

474

4295

L02BG Aromatase inhibitors

348

1.50

2.08

2.5

2.1

0.64

0.69

ug/l

0.16

142

Right hemicolectomy

342

3918

0.85

2.07

2.9

3.2

0.76

0.81

ug/l

0.53

232

2734

Erectile dysfunction

1181

11076

1.11

2.07

3.8

3.2

0.72

0.80

ug/l

1.68

721

7984

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8214

57182

1.03

2.07

3.0

2.9

0.84

0.76

ug/l

4.64

5660

36970

Vitamin deficiency

200

2401

0.81

2.06

2.9

3.0

0.77

ug/l

0.01

141

1566

Vitamin deficiency, wide

200

2401

0.81

2.06

2.9

3.0

0.77

ug/l

0.01

141

1566

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

196

1643

1.27

2.06

2.6

2.4

0.67

0.71

ug/l

0.41

123

932

Biological medication for rheuma

670

7409

0.89

2.05

2.4

2.5

0.64

0.68

ug/l

0.85

387

4164

Acute pharyngitis

990

9052

1.10

2.05

2.5

2.4

0.61

0.65

ug/l

1.35

542

4803

Bacterial intestinal infections, IBD co-morbidities

1069

11554

0.91

2.05

2.9

3.1

0.83

0.80

ug/l

0.21

729

7817

Haemangioma, any site

428

3771

1.15

2.05

3.1

2.6

0.70

0.71

ug/l

0.08

290

2405

Malignant neoplasm of other and ill-defined digestive organs

449

0.58

2.04

3.7

3.1

0.84

0.86

ug/l

0.04

309

Other sleep disorders

908

8354

1.11

2.04

2.9

0.77

ug/l

0.05

568

5522

Other neurological diseases

6358

49506

1.04

2.04

3.0

3.1

0.77

0.79

ug/l

0.34

4442

33658

Thyrotoxicosis with diffuse goitre

382

3327

1.16

2.03

2.8

2.9

0.74

0.73

ug/l

0.07

238

2126

Circumscribed brain atrophy

104

1326

0.75

2.03

2.4

3.1

1.04

0.83

ug/l

0.39

919

Other and unspecified medical devices associated with adverse incidents

323

1.63

2.03

3.1

3.0

0.64

0.78

ug/l

0.80

226

Benign neoplasm: Vertebral column

131

2.02

2.03

4.7

2.3

0.84

0.79

ug/l

0.13

Manic episode

128

1604

0.77

2.02

2.1

2.7

0.69

0.74

ug/l

0.12

934

Fracture of forearm

2412

23816

0.94

2.02

3.0

2.9

0.74

ug/l

0.01

1577

15117

Cytomegalovirus infection, IBD co-morbidity

104

1328

0.75

2.02

2.8

2.9

0.85

0.73

ug/l

0.60

837

Erysipelas

5384

50778

0.96

2.01

2.9

3.0

0.74

0.76

ug/l

0.91

3695

33305

Assault by bodily force

370

4223

0.86

2.01

2.4

0.64

0.66

ug/l

0.11

220

2188

Bell's palsy

811

7421

1.11

2.01

2.9

3.0

0.82

0.76

ug/l

0.44

538

4834

Contact with sharp object, undetermined intent

179

1484

1.26

2.01

2.8

2.7

0.63

0.73

ug/l

0.75

112

857

Other/unspecified enthesopathies of lower limb, excluding foot

351

3053

1.17

2.01

2.7

0.65

0.73

ug/l

1.20

209

1845

Reactive arthropathies

609

5494

1.13

2.01

2.9

2.8

0.71

0.79

ug/l

0.73

393

3443

Other infective otitis externa

398

3505

1.16

2.01

3.4

3.0

0.76

0.75

ug/l

0.06

299

2309

Hyperkinetic disorders, excluding more controls

237

1934

1.20

2.00

1.8

1.9

0.43

0.60

ug/l

6.88

133

689

Other and unspecified psoriasis

398

4503

0.86

2.00

2.9

3.0

0.67

0.77

ug/l

1.51

269

2983

Sudden idiopathic hearing loss

765

6994

1.12

2.00

3.2

3.1

0.81

0.78

ug/l

0.17

519

4802

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

545

4907

1.14

2.00

3.0

0.75

0.73

ug/l

0.17

378

3228

Other sexually transmitted chlamydial diseases

197

1627

1.23

1.99

2.3

2.0

0.63

0.60

ug/l

0.10

110

688

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

886

0.70

1.99

2.9

2.7

0.96

0.76

ug/l

0.42

605

Other benign neoplasms of connective and other soft tissue

568

5103

1.13

1.99

3.2

2.6

0.74

0.70

ug/l

0.43

357

3248

Embolic stroke

336

3829

0.85

1.99

3.0

3.3

0.85

0.84

ug/l

0.04

223

2761

Open wound of wrist and hand

4302

41033

1.05

1.98

2.9

2.8

0.72

0.74

ug/l

0.29

2700

25243

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1930

20391

0.93

1.97

2.7

2.9

0.71

0.72

ug/l

0.08

1250

13035

Infections, IBD-co-morbidities

1312

8904

1.09

1.97

2.9

0.77

0.85

ug/l

1.16

891

5617

conjunctival haemorrhage

508

4551

1.14

1.97

3.5

3.1

0.65

0.77

ug/l

3.77

349

3141

Hereditary corneal dystrophies

166

1360

1.26

1.97

3.0

3.1

0.77

0.79

ug/l

0.15

126

920

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

477

0.59

1.97

2.1

2.8

0.77

0.73

ug/l

0.06

320

Malignant neoplasm of heart, mediastinum and pleura

1030

0.71

1.96

2.7

3.3

0.85

0.81

ug/l

0.15

731

Cholangitis (primary sclerosing, PSC)

335

3832

0.85

1.96

2.7

3.1

0.79

0.78

ug/l

0.05

212

2536

Melanoma in situ of lower limb, including hip

175

1.77

1.96

3.7

2.5

0.77

0.68

ug/l

0.29

116

Occupant of special vehicle mainly used on industrial premises injured in transport accident

502

0.59

1.96

3.1

2.9

0.81

0.71

ug/l

0.37

319

Other inflammatory liver diseases

326

3738

0.85

1.95

2.8

2.9

0.57

0.73

ug/l

6.47

211

2404

Cholangitis (primary sclerosing, PSC), with reimbursement 202

750

0.68

1.95

2.7

2.5

0.77

0.70

ug/l

0.17

411

Carcinoma in situ of colon

118

944

1.34

1.95

3.8

2.7

0.75

0.77

ug/l

0.12

652

Colitis due to radiation

106

841

1.37

1.94

4.1

3.2

0.78

0.82

ug/l

0.12

575

Parkinson's disease

1190

12741

0.92

1.93

3.0

3.3

0.74

0.82

ug/l

2.07

858

9258

Anaemia in chronic diseases classified elsewhere

148

1798

0.79

1.93

2.8

3.1

1.20

0.78

ug/l

2.24

122

1219

Other interventions on the root canals of the tooth

107

836

1.33

1.93

2.7

0.75

0.73

ug/l

0.11

496

Other disorders of kidney and ureter

1030

9558

1.10

1.93

3.1

0.80

0.78

ug/l

0.23

731

6543

Malignant neoplasm of oropharynx

120

1476

0.76

1.92

3.0

3.1

0.64

0.73

ug/l

1.13

981

Acute gastritis

439

4931

0.87

1.92

3.1

3.0

0.86

0.78

ug/l

0.35

306

3257

Cutaneous abscess, furuncle and carbuncle

1761

18659

0.93

1.92

2.7

2.8

0.65

0.74

ug/l

5.40

1159

11624

Exposure to uncontrolled fire in building or structure

558

0.63

1.92

2.2

2.8

0.65

0.70

ug/l

0.19

332

Superficial frostbite

465

0.60

1.91

1.9

2.8

0.68

0.80

ug/l

0.41

274

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

186

1544

1.24

1.91

2.6

2.7

0.64

0.72

ug/l

0.65

108

887

Use of tolcapone

0.00

1.91

0.0

3.3

—

0.75

—

Inflammatory bowel disease

2084

21986

0.94

1.91

2.7

2.8

0.68

0.73

ug/l

1.86

1334

13612

Ulcer of lower limb, not elsewhere classified

1070

11493

0.91

1.91

2.7

3.1

0.77

0.80

ug/l

0.21

734

7997

Undetermined asthma, excluding more controls

820

7513

1.10

1.91

3.3

3.1

0.67

0.81

ug/l

5.04

546

5076

Dental caries 2

4622

37674

0.96

1.91

2.9

2.7

0.68

0.72

ug/l

1.95

2904

22716

Haemangioma and lymphangioma, any site

453

4026

1.14

1.91

3.1

2.6

0.70

ug/l

0.03

302

2547

Otitis media, unspecified

303

3230

0.86

1.91

3.0

2.7

0.77

0.71

ug/l

0.13

183

1959

Benign neoplasm: salivary glands, exclude unknown (D119)

649

5905

1.12

1.90

3.0

3.1

0.71

0.76

ug/l

1.16

446

3998

Melanocytic naevi of scalp and neck

127

1014

1.29

1.90

3.0

2.6

0.71

0.73

ug/l

0.12

630

Lichen simplex chronicus

171

2057

0.81

1.90

2.6

3.0

0.65

0.76

ug/l

1.04

104

1325

Diplopia

905

8349

1.10

1.90

2.8

3.0

0.76

0.78

ug/l

0.10

624

5638

Other bursitis of elbow

731

1.41

1.89

3.2

2.9

0.67

0.80

ug/l

0.93

485

Other arthritis (FG)

2174

20630

1.06

1.89

3.0

0.74

0.78

ug/l

0.85

1479

13440

Systemic connective tissue disorders

1709

16089

1.07

1.89

3.1

0.69

0.79

ug/l

4.44

1201

11126

Cytomegaloviral disease

109

1371

0.76

1.88

2.8

2.9

0.83

0.72

ug/l

0.56

856

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

381

4314

0.87

1.88

3.2

3.1

0.71

0.74

ug/l

0.35

274

3034

Disorders of skin appendages

2902

27706

1.05

1.88

2.9

2.8

0.72

0.73

ug/l

0.34

1858

17337

Parkinson's disease, including avohilmo

1246

13301

0.92

1.87

3.1

3.3

0.74

0.82

ug/l

2.28

901

9672

Osteoporosis

789

8221

0.91

1.86

3.1

0.72

0.81

ug/l

1.47

562

5704

Malignant neoplasm of larynx

134

1622

0.77

1.85

3.1

3.2

0.72

0.80

ug/l

0.64

1137

Acute myeloid leukaemia

560

0.64

1.85

3.0

3.1

0.88

0.85

ug/l

0.06

382

Congenital malformations of trachea and bronchus

346

0.55

1.85

2.6

3.0

0.79

0.72

ug/l

0.09

230

Cervicocranial syndrome

525

4712

1.13

1.85

3.1

2.9

0.66

0.79

ug/l

2.79

357

3067

Other and unspecified hydrocephalus

889

0.71

1.85

2.3

2.9

0.75

0.81

ug/l

0.19

583

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

458

4088

1.14

1.85

3.3

3.0

0.72

0.73

ug/l

0.09

308

2632

Nausea and vomiting

1264

13314

0.93

1.85

3.0

0.85

0.80

ug/l

0.38

856

8862

Use of levodopa decarbox-comt-inhibitor

221

2574

0.82

1.84

2.9

3.3

0.71

0.79

ug/l

0.49

159

1832

Gout, FINNGEN

3552

34234

1.05

1.83

3.1

3.2

0.82

0.80

ug/l

0.39

2589

24060

Sleep disorders, other/unspecified

130

1042

1.27

1.83

2.4

2.6

0.48

0.69

ug/l

5.58

599

Mental and behavioural disorders due to opioids

131

1620

0.79

1.82

2.1

0.42

0.65

ug/l

5.42

743

Acne

289

2489

1.17

1.82

2.4

2.3

0.57

0.64

ug/l

1.07

150

1262

Vasomotor rhinitis (mode)

401

3555

1.15

1.81

3.5

3.0

0.73

0.75

ug/l

0.13

264

2324

Other and unspecified mental retardation

469

0.62

1.80

2.7

2.4

0.67

0.68

ug/l

0.03

248

Peripheral retinal degeneration

188

1577

1.23

1.80

3.1

3.0

0.73

0.77

ug/l

0.33

124

1017

Tumor necrosis factor alpha inhibitors

578

6388

0.90

1.79

2.4

2.5

0.62

0.67

ug/l

1.28

332

3582

Injuries to the abdomen, lower back, lumbar spine and pelvis

2789

26488

1.05

1.79

2.9

3.0

0.70

0.78

ug/l

3.07

1852

17318

Oral leukoplakia and related diseases

365

3227

1.16

1.79

2.9

3.0

0.67

0.75

ug/l

0.97

245

2159

Other/unspecified dorsalgia

2462

23344

1.06

1.79

2.9

0.71

0.79

ug/l

2.28

1655

14877

Psoriasis (vulgaris), strict definition

197

2318

0.82

1.79

2.2

2.8

0.53

0.71

ug/l

6.12

119

1380

Toxic effect of carbon monoxide

1093

0.74

1.79

2.6

2.8

0.63

0.75

ug/l

1.18

676

Somatoform disorder

766

7017

1.10

1.79

3.0

2.8

0.60

0.75

ug/l

8.29

518

4353

Sacrococcygeal disorders, not elsewhere classified

110

866

1.30

1.79

3.4

2.7

0.52

0.75

ug/l

4.12

524

Senility

365

1.48

1.78

2.8

3.4

0.74

0.88

ug/l

0.69

249

Evidence of alcohol involvement determined by level of intoxication

581

0.66

1.78

2.4

2.6

0.67

0.71

ug/l

0.09

340

Other Crohn's disease

305

3494

0.86

1.78

2.4

2.7

0.64

0.68

ug/l

0.68

199

2047

Use of entacapone

541

0.64

1.78

2.8

3.1

0.63

0.88

ug/l

1.92

377

Short Achilles tendon (acquired)

832

0.72

1.77

2.1

2.8

0.77

0.75

ug/l

0.10

513

Portal vein thrombosis

1097

0.74

1.77

2.8

3.0

0.60

0.74

ug/l

1.72

703

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

110

885

1.33

1.77

3.2

2.8

0.99

0.80

ug/l

0.55

602

Olecranon bursitis

739

6830

1.12

1.76

3.0

2.9

0.66

0.78

ug/l

4.16

484

4428

Suggestive for eosinophilic asthma

732

6728

1.11

1.76

3.2

3.0

0.62

0.78

ug/l

6.97

500

4453

Open wound of forearm

677

6195

1.11

1.75

2.9

2.8

0.76

0.74

ug/l

0.10

447

3876

Pneumonia derived septicemia

182

2157

0.82

1.75

2.5

3.1

0.68

0.77

ug/l

0.93

121

1426

Hyperkalaemia

360

4053

0.86

1.75

2.7

3.2

0.90

0.83

ug/l

0.49

269

2849

Abnormal findings in nipple discharge synovial fluid wound secretions

627

1.36

1.75

3.2

2.7

0.77

0.72

ug/l

0.21

387

Family history of malignant neoplasm

275

2370

1.17

1.75

3.0

2.8

0.75

0.71

ug/l

0.29

179

1479

Emergency coronary revascularization (for ACS)

6617

46260

1.04

1.75

3.1

3.2

0.81

0.79

ug/l

0.43

4599

32489

Injury of eye and orbit

1220

11432

1.08

1.74

2.6

2.7

0.68

0.73

ug/l

0.87

707

6731

All influenza

1935

20369

0.94

1.74

2.7

2.9

0.74

0.77

ug/l

0.64

1229

13152

Alcohol abuse counselling and surveillance

160

1339

1.26

1.74

2.9

2.6

0.77

0.70

ug/l

0.51

780

Crohn disease

670

7330

0.90

1.74

2.6

2.7

0.62

0.72

ug/l

3.97

425

4411

Secondary malignant neoplasm of other and unspecified sites

980

0.73

1.74

2.8

3.3

1.63

0.78

ug/l

2.83

700

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

557

0.66

1.74

3.2

2.6

0.66

0.70

ug/l

0.13

313

Tick-borne viral encephalitis

209

1.70

1.73

3.4

2.9

0.53

0.67

ug/l

1.14

136

Vestibular neuronitis

613

5588

1.12

1.73

3.0

0.78

0.75

ug/l

0.28

423

3733

Renal cell carcinoma of kidney

218

2535

0.83

1.73

3.2

3.3

0.85

0.81

ug/l

0.20

167

1784

Pseudomembranous colitis

327

0.55

1.73

2.4

2.8

0.81

0.84

ug/l

—

196

Other mental disorders due to brain damage and dysfunction and to physical disease

720

7830

0.90

1.73

3.1

3.2

0.69

0.83

ug/l

4.45

526

5471

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

160

0.40

1.73

5.3

2.6

1.05

0.88

ug/l

—

114

Peritonsillar abscess

1465

13789

1.07

1.72

2.7

2.6

0.72

0.73

ug/l

0.11

878

8165

Melanoma in situ of lower limb, including hip

182

1.69

1.72

3.7

3.0

0.77

0.73

ug/l

0.11

129

Noise effects on inner ear

439

4842

0.87

1.72

3.0

2.9

0.70

0.74

ug/l

0.53

266

3128

Intentional self-harm by sharp object

861

0.73

1.71

2.1

2.5

0.47

0.72

ug/l

3.66

449

Diseases of the myoneural junction and muscle

788

8534

0.91

1.71

2.7

3.0

0.68

0.78

ug/l

3.05

545

5727

Assault

768

8341

0.91

1.71

2.3

2.4

0.57

0.66

ug/l

1.43

476

4291

Melanoma in situ of scalp and neck

208

1.83

1.71

4.3

3.2

0.74

0.80

ug/l

0.18

149

Aphakia

123

997

1.29

1.71

3.0

0.83

ug/l

0.03

665

Chondrocostal junction syndrome [Tietze]

132

1069

1.26

1.71

2.9

0.53

0.75

ug/l

4.01

668

Brain meningioma, excluding all cancers (controls excluding all cancers)

186

1560

1.21

1.70

3.1

2.7

0.82

0.75

ug/l

0.51

129

1047

Benign neoplasm: Skin of lip

596

1.37

1.70

2.8

2.6

0.75

0.73

ug/l

0.04

384

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

394

0.58

1.70

3.4

2.9

0.80

0.69

ug/l

0.27

241

Pneumonia due to other infectious organisms, not elsewhere classified

185

2179

0.82

1.70

2.4

3.1

0.72

0.75

ug/l

0.21

119

1415

Benign neoplasm: Liver/bile ducts

113

903

1.29

1.69

3.0

2.9

0.84

0.71

ug/l

0.66

591

Other and unspecified vascular occlusions

700

6433

1.11

1.69

3.3

3.2

0.78

0.83

ug/l

0.67

515

4590

Other abnormalities of plasma proteins

110

885

1.31

1.69

3.8

3.0

0.87

0.72

ug/l

0.97

597

Implicit fungal Sepsis

190

2231

0.82

1.68

3.0

3.2

0.76

0.78

ug/l

0.07

147

1518

Other coagulation defects

351

3100

1.15

1.68

2.9

3.0

0.74

0.75

ug/l

0.13

233

2011

IBD (strict) with PSC

456

0.63

1.67

2.4

2.5

0.92

0.71

ug/l

0.27

231

Chronic lower respiratory diseases

10157

56214

0.97

1.67

2.8

2.9

0.69

0.78

ug/l

11.36

6474

35875

Simple and mucopurulent chronic bronchitis

259

2972

0.85

1.67

3.2

0.77

0.85

ug/l

0.60

182

2051

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

383

1.53

1.66

3.1

2.7

0.71

0.79

ug/l

0.42

257

Benign neoplasm: Kidney

203

1730

1.21

1.66

3.0

3.3

1.00

0.80

ug/l

0.61

141

1203

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

3658

29582

0.96

1.66

3.0

2.7

0.81

0.71

ug/l

4.14

2552

19974

Parkinson's disease, strict definition, excluding more controls

1126

11766

0.92

1.66

3.1

3.4

0.75

0.87

ug/l

3.73

809

8605

Kidney transplant status

336

3781

0.87

1.65

2.4

2.9

0.90

0.69

ug/l

3.65

279

2367

Assault by unspecified means

1107

0.76

1.65

2.6

2.3

0.58

0.66

ug/l

0.50

556

Rheumatic valve diseases

112

1383

0.78

1.65

2.8

3.2

0.81

0.83

ug/l

0.11

951

Volvulus

122

1492

0.79

1.64

2.6

3.0

0.73

0.83

ug/l

0.50

1008

Complications of medical and surgical care

5599

51584

1.04

1.64

3.1

3.0

0.74

0.78

ug/l

1.87

3845

34714

Transient acantholytic dermatosis [Grover]

171

1.96

1.64

3.3

0.64

0.76

ug/l

0.63

118

Obesity due to excess calories

2725

28439

0.95

1.63

2.8

2.9

0.67

0.73

ug/l

2.87

1808

18204

Other diseases of spinal cord

161

1912

0.82

1.62

3.1

3.0

0.80

0.74

ug/l

0.34

114

1257

Respiratory tuberculosis, clinically confirmed

929

0.74

1.61

2.6

3.1

0.90

0.89

ug/l

0.03

633

Other disorders of nervous system

426

4724

0.88

1.60

2.8

3.1

0.66

0.75

ug/l

1.78

288

3159

Benign neoplasm: Liver

722

1.31

1.60

3.1

2.5

0.89

0.74

ug/l

0.65

468

Bipolar affective disorders

903

9727

0.92

1.60

2.6

0.58

0.71

ug/l

5.66

627

5583

Other symptoms and signs involving general sensations and perceptions

134

1625

0.81

1.59

2.8

2.9

0.62

0.78

ug/l

1.51

1045

Disturbance of activity and attention

211

1771

1.18

1.59

1.8

0.43

0.54

ug/l

2.82

110

689

Separation of retinal layers (serosa)

386

3471

1.15

1.58

2.8

0.72

0.70

ug/l

0.14

262

2139

Lesion of sciatic nerve

251

2874

0.85

1.57

2.8

3.3

0.79

0.84

ug/l

0.36

190

2058

Other bacterial intestinal infections

1093

11666

0.93

1.57

2.9

3.1

0.81

0.80

ug/l

0.10

735

7898

Other symptoms and signs involving the nervous and musculoskeletal systems

2517

26279

0.95

1.57

2.9

3.0

0.69

0.76

ug/l

4.39

1504

17417

Wilms' tumor

407

0.62

1.56

2.7

3.2

0.72

0.83

ug/l

0.38

287

Rosacea

512

4640

1.12

1.56

3.1

3.0

0.75

0.76

ug/l

0.07

338

3089

Respiratory tuberculosis, confirmed

106

1303

0.78

1.56

3.3

3.1

0.76

0.82

ug/l

0.36

891

Moderate visual impairment, binocular

155

1295

1.23

1.56

3.3

3.2

0.91

0.85

ug/l

0.23

122

881

Melanocytic naevi, other sites/unspecified

435

3916

1.13

1.55

3.0

2.6

0.73

0.70

ug/l

0.35

281

2472

Familial hypercholesterolemia, with ischemic heart disease

905

9670

0.92

1.55

3.0

3.4

0.78

0.83

ug/l

0.81

616

7007

Reactive arthropathies, FINNGEN

465

4205

1.13

1.55

2.8

0.72

0.76

ug/l

0.22

304

2586

Malignant neoplasm of nasal cavity and sinuses

452

0.64

1.55

2.5

3.1

0.82

0.83

ug/l

0.02

302

Nummular dermatitis

573

6249

0.90

1.54

3.0

3.1

0.82

0.78

ug/l

0.18

405

4240

Urticaria and erythema

1696

16072

1.06

1.54

2.9

2.8

0.75

0.74

ug/l

0.08

1097

10185

Viral infections characterized by skin and mucous membrane lesions

3067

29486

1.05

1.54

2.8

0.71

0.74

ug/l

0.75

1900

18204

Sequelae of injuries of head

353

3943

0.87

1.54

2.8

0.61

0.73

ug/l

2.27

247

2440

Use of amantadine

670

0.71

1.54

3.2

2.9

0.72

0.78

ug/l

0.25

440

Pneumothorax

581

6321

0.90

1.54

2.9

3.1

0.77

0.80

ug/l

0.31

397

4284

Other symptoms and signs involving the digestive system and abdomen

534

4845

1.11

1.54

3.3

3.1

0.75

0.77

ug/l

0.26

372

3287

Shoulder region

756

0.72

1.53

2.8

2.9

0.65

0.75

ug/l

0.52

480

Presbyopia

377

3374

1.14

1.53

2.8

0.66

0.72

ug/l

0.85

218

2057

Hyperprolactinaemia

759

1.28

1.53

3.0

2.6

0.63

0.70

ug/l

0.58

454

Pulmonary heart disease, diseases of pulmonary circulation

2274

23750

0.95

1.52

3.1

0.82

0.80

ug/l

0.38

1579

16411

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

374

1.45

1.52

3.3

3.0

0.59

0.73

ug/l

1.17

247

Disturbances of smell and taste

211

1815

1.19

1.52

3.0

2.9

0.73

0.75

ug/l

0.06

132

1191

Other diseases of intestine

980

9170

1.09

1.52

3.2

3.1

0.80

ug/l

0.01

713

6284

Other vitreous opacities

244

2128

1.18

1.52

3.5

3.2

0.69

0.77

ug/l

1.29

196

1471

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

131

1082

1.25

1.51

3.0

2.5

0.64

0.75

ug/l

1.35

695

Anosmia

144

1185

1.23

1.51

3.1

2.7

0.79

0.75

ug/l

0.10

774

Arthropathies in other diseases classified elsewhere

184

2149

0.83

1.51

2.7

2.8

0.64

0.79

ug/l

2.19

120

1369

Erythema multiforme

996

0.76

1.51

3.3

3.0

0.78

ug/l

0.00

642

Scleritis and episcleritis

278

2438

1.16

1.51

2.7

2.8

0.66

0.71

ug/l

0.70

186

1479

Somnolence

597

0.69

1.51

2.7

2.9

0.58

0.79

ug/l

1.40

359

Hydronephrosis

885

8254

1.09

1.50

3.4

3.2

1.17

0.79

ug/l

6.35

633

5713

Viral hepatitis

391

4349

0.88

1.50

2.4

2.5

0.54

0.67

ug/l

3.99

262

2392

Embedded and impacted teeth

691

6390

0.91

1.50

2.2

2.3

0.62

0.65

ug/l

0.19

355

3278

Presence of cardiac and vascular implants and grafts

5274

38816

1.04

1.50

3.1

0.82

0.80

ug/l

0.48

3753

26991

Graves ophthalmopathy, strict

499

1.35

1.49

2.6

2.9

0.71

0.75

ug/l

0.19

308

Impingement syndrome of shoulder

2168

20748

1.06

1.49

3.1

2.9

0.69

0.76

ug/l

2.01

1469

13669

Benign neoplasm: Rectosigmoid junction

307

2731

1.16

1.48

3.7

3.2

0.95

0.78

ug/l

0.58

236

1901

Dislocation of lens

105

853

1.29

1.48

3.0

3.1

0.59

0.81

ug/l

3.75

586

Benign neoplasm: Short bones of lower limb

452

1.39

1.48

3.2

2.4

0.75

0.72

ug/l

0.14

274

Respiratory tuberculosis, bacteriologically and histologically confirmed

112

1360

0.79

1.48

3.2

3.1

0.75

0.83

ug/l

0.49

930

Malignant neoplasm of tonsil

110

1323

0.78

1.48

3.1

3.0

0.65

0.74

ug/l

0.89

869

Endocarditis

292

3275

0.86

1.48

3.0

3.1

0.91

0.80

ug/l

0.41

207

2214

Paget disease

364

1.49

1.47

4.0

3.1

0.73

0.77

ug/l

0.19

262

Polyarthrosis

832

7400

1.09

1.47

3.2

3.1

0.72

0.82

ug/l

1.52

583

5109

Hernia of abdominal wall

4414

42826

1.04

1.47

3.0

0.71

0.76

ug/l

3.53

2986

28380

Benign neoplasm of male genital organs

278

2488

1.19

1.47

3.6

3.1

0.67

0.77

ug/l

1.65

201

1655

therapeutic use

195

1679

1.20

1.47

3.7

3.3

0.74

0.76

ug/l

0.24

156

1182

Personal history of other diseases and conditions

247

2134

1.16

1.47

3.1

2.7

0.72

ug/l

0.01

172

1302

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

448

1.37

1.47

2.7

0.76

0.66

ug/l

0.41

272

Ulcerative colitis

1614

16993

0.94

1.47

2.8

0.70

0.73

ug/l

0.75

1053

10563

Symptoms and signs involving the nervous and musculoskeletal systems

4231

40958

1.04

1.47

3.0

0.71

0.78

ug/l

4.51

2775

27484

Other and unspecified acquired haemolytic anaemias

554

0.68

1.46

2.3

3.0

0.53

0.80

ug/l

2.76

368

Fracture of lumbar spine and pelvis

1387

13100

1.07

1.46

2.9

3.1

0.73

0.80

ug/l

2.18

960

8964

Other crystal arthropathies

134

1120

1.25

1.46

3.5

3.0

0.67

0.86

ug/l

2.87

763

Benign neoplasm of thyroid gland

118

964

1.25

1.46

3.7

2.6

0.78

0.74

ug/l

0.15

628

Sequelae of injuries of neck and trunk

172

2008

0.83

1.46

2.6

2.9

0.61

0.70

ug/l

1.30

120

1231

Ulcerative ileocolitis

205

2369

0.85

1.46

2.8

2.7

0.64

0.72

ug/l

0.76

130

1384

Dyspnoea

7478

55893

1.03

1.46

3.0

0.72

0.78

ug/l

5.29

5110

36844

Malignant neoplasm of testis

168

1441

1.23

1.46

2.5

2.6

0.67

0.70

ug/l

0.18

109

822

Malignant neoplasm of oral cavity

228

2599

0.85

1.46

2.7

3.0

0.81

0.74

ug/l

0.43

151

1742

Pneumococcal septicemia

178

2074

0.83

1.46

2.5

3.1

0.69

0.77

ug/l

0.79

118

1381

Synovial hypertrophy, not elsewhere classified

476

0.66

1.45

2.7

0.51

0.69

ug/l

1.57

279

Transient ischemic attack

4803

38654

1.04

1.45

3.1

3.2

0.79

ug/l

0.08

3405

27114

Benign neoplasm: Vertebral column

146

1.78

1.45

4.7

2.9

0.84

0.82

ug/l

0.06

104

Other neurotic disorders

280

3163

0.87

1.45

2.8

2.9

0.71

0.75

ug/l

0.40

192

2026

Filling of root of tooth

188

1614

1.20

1.45

2.7

2.8

0.67

0.73

ug/l

0.53

115

997

Streptococcal septicaemia

641

6930

0.91

1.44

2.8

3.2

0.78

0.79

ug/l

0.07

438

4767

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1492

14160

1.07

1.44

3.1

2.8

0.84

0.74

ug/l

2.05

1068

9928

Pustular psoriasis

157

1856

0.83

1.44

3.0

2.9

0.64

0.73

ug/l

1.35

100

1196

Benign neoplasm: Spinal cord

739

1.30

1.44

3.3

2.6

0.63

0.70

ug/l

0.60

463

Synovial cyst of popliteal space [Baker]

421

3805

1.12

1.43

3.1

3.0

0.67

0.78

ug/l

2.83

309

2573

Effects of air pressure and water pressure

321

1.49

1.43

2.5

0.60

0.73

ug/l

0.43

179

Other bursopathies

976

9149

1.08

1.42

3.2

3.0

0.67

0.79

ug/l

5.98

682

6062

Cerebrovascular diseases

6866

50384

0.97

1.42

3.0

3.1

0.80

0.77

ug/l

0.97

4888

34046

Other demyelinating diseases of the central nervous system

1180

0.79

1.42

2.9

2.5

0.66

0.69

ug/l

0.17

671

Invasive ventilation

493

5387

0.90

1.42

2.6

3.1

0.73

0.76

ug/l

0.20

330

3601

Dislocation, sprain and strain of joints and ligaments of thorax

214

1860

1.18

1.42

3.1

2.8

0.60

0.74

ug/l

3.19

142

1145

Valvular operations

1502

15771

0.94

1.42

2.9

3.2

0.82

0.79

ug/l

0.29

1054

10986

Other fall from one level to another

1655

17370

0.94

1.41

2.8

2.9

0.72

0.74

ug/l

0.47

1074

11201

Vascular disorders of the intestines

423

4656

0.89

1.41

3.0

3.2

0.88

0.85

ug/l

0.14

309

3303

Other injuries of spine and trunk, level unspecified

492

0.67

1.40

2.5

2.9

0.64

0.73

ug/l

0.38

311

Dyshidrosis [pompholyx]

602

0.71

1.40

3.2

2.8

0.86

0.70

ug/l

0.68

369

Other anaemias

3342

33353

0.96

1.39

3.1

3.2

0.86

0.81

ug/l

1.15

2398

23568

Other and unspecified injuries of head

377

3396

1.13

1.39

2.7

2.9

0.79

0.75

ug/l

0.12

256

2116

Rare circulating lymphoid malignancy

188

2167

0.84

1.39

3.3

3.1

0.72

0.77

ug/l

0.47

129

1494

Disorders of eyelid in diseases classified elsewhere

154

1301

1.21

1.39

3.2

2.8

0.73

0.79

ug/l

0.46

106

833

Acute otitis externa, noninfective

814

0.75

1.39

3.0

2.8

0.65

0.75

ug/l

0.53

516

Benign neoplasm: Choroid

350

3143

1.14

1.39

3.7

3.2

0.71

0.76

ug/l

0.78

239

2172

Benign neoplasm: Parotid gland

578

5325

1.11

1.38

3.0

3.1

0.71

0.76

ug/l

0.93

397

3591

Covid-19 suspected case

980

9175

1.08

1.38

2.4

2.7

0.76

0.73

ug/l

0.22

579

5476

Amputation of ankle

112

0.38

1.38

2.0

3.2

0.37

0.73

ug/l

—

Adrenocortical insufficiency

121

1457

0.81

1.38

3.2

2.9

0.95

0.76

ug/l

0.31

925

Visual field defects

508

5543

0.90

1.38

3.0

3.1

0.78

0.79

ug/l

0.06

354

3804

Inflammation of lacrimal passages (chronic)

561

1.32

1.38

2.9

3.0

0.78

0.82

ug/l

0.13

363

Other and unspecified epidermal thickening

118

1419

0.81

1.38

3.2

3.0

0.73

0.77

ug/l

0.21

927

Epidural haemorrhage

814

0.74

1.37

2.4

2.7

0.72

0.74

ug/l

0.07

493

L02BA Anti-estrogens

424

1.35

1.37

3.6

2.7

1.41

0.74

ug/l

0.53

247

Benign neoplasm: Brain, infratentorial

227

1.54

1.37

2.8

2.5

1.02

0.74

ug/l

0.88

140

Pain and other conditions associated with female genital organs and menstrual cycle

3.00

1.37

1.2

1.1

—

Explicit fungal Sepsis

463

0.66

1.37

3.2

3.0

0.78

0.82

ug/l

0.07

295

Urethritis and urethral syndrome

113

929

1.25

1.37

3.3

2.7

0.63

0.70

ug/l

0.50

562

Chronic periodontitis, complicated

748

8015

0.92

1.37

2.7

3.0

0.77

0.75

ug/l

0.17

573

5314

Postprocedural musculoskeletal disorders, not elsewhere classified

360

3994

0.88

1.37

3.3

3.1

0.68

0.76

ug/l

1.05

237

2695

9337

50362

0.98

1.36

2.9

3.0

0.73

0.79

ug/l

6.66

6037

33301

Drug-induced hypoglycaemia without coma

1062

0.78

1.36

2.8

0.66

0.79

ug/l

1.00

668

Other and unspecified anaemias

3315

33159

0.96

1.36

3.1

3.2

0.86

0.81

ug/l

1.16

2378

23433

Other disorders of cornea

546

5012

1.10

1.36

2.9

0.68

0.73

ug/l

0.93

376

3155

Diphtheria

2.02

1.36

3.9

2.8

0.65

0.73

ug/l

—

Carrier of infectious disease

959

0.77

1.36

2.7

2.9

0.86

0.73

ug/l

0.53

603

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

173

2002

0.84

1.35

3.2

2.8

0.92

0.77

ug/l

0.46

130

1387

Cramp and spasm

287

2552

1.15

1.35

2.9

0.58

0.74

ug/l

4.39

208

1613

Patellar tendinitis

119

989

1.25

1.35

2.2

2.3

0.58

0.70

ug/l

1.07

514

Cholera

128

1063

1.22

1.35

3.8

3.1

0.71

0.77

ug/l

0.39

728

Acute and subacute iridocyclitis

1315

12456

1.07

1.35

2.9

0.69

0.75

ug/l

1.92

885

7904

Other congenital malformations of urinary system

162

1.63

1.35

3.6

2.5

0.47

0.74

ug/l

2.11

Other and specified injuries of hip and thigh

143

1210

1.22

1.35

3.3

3.0

0.66

0.81

ug/l

1.30

798

Other and/or unspecified nontoxic goitre

228

1986

1.16

1.34

3.3

3.2

0.87

0.79

ug/l

0.23

167

1370

Mesothelioma

1191

0.78

1.34

3.0

3.3

0.83

0.82

ug/l

0.04

849

Delayed puberty

2.00

1.34

1.4

1.2

0.30

0.32

ug/l

—

Crohn's disease of large intestine

229

2611

0.86

1.34

2.6

2.7

0.64

0.70

ug/l

0.86

149

1534

Combinations of oral blood glucose lowering drugs

2971

30720

0.96

1.34

2.8

3.1

0.74

0.76

ug/l

0.35

1902

20800

Other diseases of pancreas

523

5680

0.90

1.34

2.8

3.0

0.72

0.78

ug/l

0.47

380

3822

Hyperhidrosis

105

856

1.25

1.34

3.2

2.8

0.60

0.75

ug/l

1.94

519

Other noninfective gastroenteritis and colitis

1394

13206

1.06

1.33

2.9

3.0

0.72

0.78

ug/l

1.16

926

8627

Nontoxic diffuse goitre

685

1.28

1.33

3.2

3.1

1.02

0.79

ug/l

0.29

447

Other/unspecified cytomegaloviral diseases

1136

0.79

1.33

2.8

0.83

0.73

ug/l

0.42

705

Transport accidents

3648

31301

1.04

1.33

2.8

0.67

0.77

ug/l

10.16

2238

19410

Obstructive hydrocephalus

763

0.75

1.33

2.9

0.65

0.79

ug/l

1.03

481

Other viral diseases

1719

16344

1.06

1.32

2.5

2.6

0.67

0.71

ug/l

0.93

991

9440

Mixed conductive and sensorineural hearing loss

864

8092

1.08

1.32

3.2

3.1

0.74

0.80

ug/l

0.79

614

5687

Other disorders of adrenal gland

153

1797

0.84

1.32

3.2

3.0

0.94

0.76

ug/l

0.40

112

1153

Autoimmune hyperthyroidism

174

1487

1.18

1.32

2.6

2.9

0.79

0.73

ug/l

0.40

100

942

Benign neoplasm: Tongue

170

1462

1.20

1.32

2.7

2.6

0.67

0.72

ug/l

0.42

116

943

Inflammation of lacrimal passages (acute and unspecified)

502

1.33

1.31

2.6

2.8

0.79

0.73

ug/l

0.18

306

Other condition

778

8337

0.92

1.31

2.6

2.8

0.68

0.74

ug/l

0.96

471

5092

Disease of hard tissues of teeth, NOS

470

1.35

1.31

4.0

2.6

0.69

0.77

ug/l

0.38

273

Acquired haemolytic anaemia

113

1354

0.81

1.31

2.8

3.1

0.92

0.78

ug/l

0.49

911

Erythema intertrigo

108

1300

0.81

1.31

2.6

3.1

0.60

0.78

ug/l

1.64

855

Disorders of lacrimal system and orbit in diseases classified elsewhere

563

1.30

1.31

2.7

2.8

0.70

0.76

ug/l

0.31

342

Acute nephritic syndrome

138

1618

0.82

1.30

2.5

2.9

0.77

0.76

ug/l

0.06

1038

Dental caries 2 and operation codes

4497

36782

0.97

1.30

2.9

2.7

0.68

0.72

ug/l

1.95

2827

22191

Other problems related to primary support group, including family circumstances

230

2562

0.87

1.30

2.4

2.6

0.80

0.68

ug/l

0.23

144

1419

Injury of muscle and tendon at forearm level

160

1377

1.21

1.30

2.7

2.6

0.71

0.73

ug/l

0.09

109

795

Crystal arthropathies, rheuma endpoint

134

1135

1.23

1.30

3.5

3.1

0.67

0.82

ug/l

2.09

770

Benign neoplasm of meninges

381

3440

1.12

1.30

3.4

3.2

0.90

0.76

ug/l

0.83

277

2384

Explicit bacterial Sepsis

754

8067

0.92

1.30

2.8

3.1

0.74

0.79

ug/l

0.49

514

5526

Necrotizing fasciitis

306

0.60

1.29

2.5

3.1

0.38

0.89

ug/l

4.37

195

Mixed hyperlipidaemia

332

3666

0.88

1.29

3.2

3.1

0.97

0.76

ug/l

0.68

230

2493

Causalgia

672

0.74

1.28

2.1

2.6

0.67

0.71

ug/l

0.17

407

Diabetic retinopathy

2341

15367

0.95

1.28

3.0

2.9

0.77

ug/l

0.10

1675

10509

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

339

3044

1.13

1.28

3.1

2.6

0.76

0.71

ug/l

0.47

237

1935

Kyphosis

568

0.71

1.28

3.0

2.7

0.74

0.82

ug/l

0.24

371

Heart failure and antihypertensive medication

2185

15028

0.95

1.28

2.6

2.8

0.72

0.75

ug/l

0.58

1545

9414

Moderate mental retardation

250

0.57

1.28

1.7

2.5

0.92

0.64

ug/l

—

138

Ménière disease

522

4797

1.10

1.28

3.1

0.80

0.78

ug/l

0.11

345

3288

Adalimumab

373

4123

0.89

1.28

2.3

2.6

0.63

0.66

ug/l

0.37

216

2317

Volume depletion

591

6381

0.91

1.27

2.8

3.2

0.93

0.84

ug/l

0.51

411

4486

Flatback syndrome

0.00

1.27

0.0

2.5

—

0.67

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

625

5805

1.10

1.27

3.0

2.8

0.91

0.75

ug/l

2.15

457

4101

Viral agents as the cause of diseases classified to other chapters

124

1041

1.23

1.27

2.8

2.9

0.81

0.76

ug/l

0.19

655

Unspecified acute lower respiratory infection

1162

12263

0.94

1.27

2.5

2.7

0.68

0.74

ug/l

0.55

695

7367

Mental and behavioural disorders due to use of other stimulants, including caffeine

101

1225

0.81

1.26

1.8

1.9

0.32

0.59

ug/l

10.67

489

Stenosis and insufficiency of lacrimal passages

384

3475

1.12

1.26

3.1

0.81

0.77

ug/l

0.28

264

2339

Benign neoplasm: Cerebral meninges

334

3000

1.13

1.26

3.3

3.1

0.88

0.77

ug/l

0.59

245

2070

Benign neoplasm: Pancreas

174

1509

1.19

1.26

3.4

3.3

0.78

0.76

ug/l

0.10

124

1064

Excluding asthma or asthma-COPD overlap

7348

37652

0.97

1.26

2.8

2.9

0.70

0.78

ug/l

6.43

4640

23782

Malignant neoplasm of gallbladder

185

0.51

1.25

2.2

3.0

0.95

0.72

ug/l

—

123

Lagophthalmos

682

1.29

1.25

3.6

3.1

1.05

0.81

ug/l

1.03

463

Iridocyclitis

1549

14771

1.06

1.25

2.9

0.68

0.75

ug/l

2.59

1043

9428

Non-allergic asthma (mode), excluding more controls

1217

12721

0.94

1.25

2.7

3.1

0.65

0.81

ug/l

6.06

808

8656

Foreign body in respiratory tract

269

2393

1.14

1.24

2.8

3.0

0.88

0.74

ug/l

0.51

171

1519

Malignant neoplasm of hypopharynx

422

0.65

1.24

2.3

3.1

0.66

0.86

ug/l

1.01

291

Ankylosing spondylitis, ICD10

659

6132

1.09

1.24

2.8

2.7

0.66

0.71

ug/l

1.01

453

3696

Paralytic ileus

248

2783

0.87

1.24

2.6

3.1

0.59

0.83

ug/l

8.23

174

1881

Other diseases of gallbladder

234

2065

1.15

1.24

3.1

3.2

0.67

0.77

ug/l

1.33

159

1393

Myeloproliferative diseases

498

5405

0.91

1.23

2.8

3.1

0.76

0.79

ug/l

0.22

340

3719

Benign neoplasm of major salivary glands

708

6610

1.09

1.23

3.0

3.1

0.72

0.76

ug/l

0.82

489

4496

Sequelae of tuberculosis

1031

0.79

1.23

3.5

3.3

0.80

0.89

ug/l

0.55

736

Other and unspecified types of non-Hodgkin lymphoma, hilmo

253

2834

0.87

1.23

2.7

3.2

0.70

0.78

ug/l

0.96

164

1977

Other surgical follow-up care

182

1581

1.18

1.22

3.0

2.9

0.62

0.73

ug/l

1.86

125

1002

Myeloid leukaemia

128

1504

0.83

1.21

2.8

2.7

0.73

0.74

ug/l

0.05

991

Adhesive capsulitis of shoulder

1159

10983

1.07

1.21

3.0

0.71

0.79

ug/l

1.91

809

7278

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

1.21

0.0

2.3

—

0.84

—

Gluteal tendinitis

118

986

1.21

1.20

3.6

3.0

0.70

0.75

ug/l

0.47

661

Mandibular retrognathia

230

2020

1.15

1.20

2.7

2.6

0.65

0.70

ug/l

0.36

115

1144

Lichen ruber planus, wide definition including periferal and oral lichen planus

1097

10375

1.07

1.20

3.0

0.75

ug/l

0.03

693

6890

Other lack of coordination

991

0.79

1.20

3.3

3.0

0.80

ug/l

0.01

655

Glaucoma suspect

2320

22341

1.04

1.19

3.2

0.77

0.79

ug/l

0.32

1624

15575

Personal history of malignant neoplasm

650

1.26

1.19

2.9

3.0

0.71

0.76

ug/l

0.28

431

Generalized epilepsy, strict definition

822

0.77

1.19

1.9

2.5

0.78

0.73

ug/l

0.15

454

Contusion of ankle

152

1767

0.85

1.19

2.9

2.7

0.71

0.69

ug/l

0.09

107

1055

Ulcerative colitis (strict) with PSC

375

0.66

1.19

2.2

2.4

1.05

0.73

ug/l

0.33

187

Other specified transport accidents

255

0.59

1.19

3.1

2.6

0.72

0.74

ug/l

—

148

Conductive hearing loss, unspecified

497

4578

1.10

1.19

2.9

3.0

0.66

0.77

ug/l

2.20

308

3022

Injury of nerves at shoulder and upper arm level

679

0.75

1.18

2.4

2.7

0.56

0.73

ug/l

1.45

420

Foreign body on external eye

1509

15760

0.94

1.18

2.6

2.7

0.71

0.70

ug/l

0.17

884

9411

Chronic tubulo-interstitial nephritis

110

1315

0.82

1.18

2.6

3.0

0.74

0.78

ug/l

0.24

853

Benign neoplasm of middle ear and respiratory system

629

5863

1.09

1.18

2.9

2.6

0.76

0.72

ug/l

0.54

415

3848

Benign neoplasm of urinary organs

287

2578

1.14

1.18

3.3

0.93

0.78

ug/l

0.67

207

1827

Pterygium

258

2315

1.15

1.18

3.8

3.2

0.82

0.80

ug/l

0.13

186

1647

Other deformities of toe(s)

131

1109

1.20

1.18

2.8

2.9

0.67

0.80

ug/l

1.68

720

Pustulosis palmaris et plantaris

137

1605

0.84

1.18

3.0

2.9

0.64

0.74

ug/l

1.31

1026

Nonsuppurative otitis media

841

7752

0.93

1.17

3.0

2.8

0.80

0.73

ug/l

0.60

535

4701

Mechanical strabismus

1.84

1.17

1.8

3.1

0.79

0.73

ug/l

—

Assault by blunt object

933

0.78

1.17

2.5

2.4

0.64

0.67

ug/l

0.21

492

Lesion of radial nerve

205

2322

0.86

1.17

2.9

0.83

0.74

ug/l

0.17

131

1433

Other injuries of lower limb, level unspecified

464

1.34

1.17

2.2

3.0

0.80

0.74

ug/l

0.15

298

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

570

6138

0.92

1.17

3.2

3.1

0.76

0.78

ug/l

0.14

383

4187

Campylobacter enteritis

182

1592

1.18

1.17

2.9

0.73

0.75

ug/l

0.08

121

1017

Benign neoplasm: other/unspecified salivary gland

163

1413

1.18

1.16

2.9

2.7

0.78

0.74

ug/l

0.17

109

960

395

0.68

1.16

2.3

3.1

0.82

0.84

ug/l

0.04

269

Haemorrhagic and haematological disorders of fetus and newborn

0.00

1.16

0.0

2.2

—

0.78

—

Peroneal tendinitis

567

1.29

1.16

3.0

2.6

0.65

0.72

ug/l

0.39

348

Graves ophthalmopathy

565

1.28

1.15

2.7

2.9

0.72

0.75

ug/l

0.20

345

Malignant neoplasm of mesothelium and soft tissue

275

3051

0.88

1.15

3.0

3.3

0.76

0.79

ug/l

0.33

211

2140

Benign neoplasm: Liver

757

1.24

1.14

3.1

2.8

0.89

0.71

ug/l

0.84

484

Carcinoma in situ of skin, other sites/unspecified

756

1.27

1.14

3.6

3.2

0.73

0.82

ug/l

0.61

525

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

170

1931

0.85

1.14

2.9

2.8

0.76

ug/l

0.01

122

1347

Scissor bite

430

1.31

1.14

2.8

2.4

0.61

0.67

ug/l

0.24

245

Fracture of lower leg, including ankle

3657

37493

0.97

1.14

2.8

0.72

0.74

ug/l

0.96

2391

23457

Dermatographic urticaria

199

1743

1.15

1.14

2.8

0.84

0.73

ug/l

0.29

127

1081

Dislocation, sprain and strain of joint and ligaments of hip

223

1980

1.15

1.13

2.7

3.1

0.67

0.78

ug/l

1.10

144

1314

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

508

0.72

1.13

3.0

2.7

0.88

0.81

ug/l

0.18

359

Acute myeloid leukaemia, helper endpoint

508

0.72

1.13

3.0

2.7

0.88

0.81

ug/l

0.18

359

Injuries to the neck

1474

14079

1.05

1.13

2.8

0.70

0.73

ug/l

0.36

932

8757

Toxic effect of other gases, fumes and vapours

367

0.67

1.13

2.4

2.6

0.55

0.69

ug/l

0.41

215

Ulcerative enterocolitis

158

1817

0.85

1.12

2.9

2.8

0.72

0.74

ug/l

0.13

1088

Crohn disease (strict definition, all UC cases excluded)

217

2448

0.87

1.12

2.6

2.7

0.61

0.69

ug/l

1.22

133

1424

Burn and corrosion of shoulder and upper limb, except wrist and hand

111

1309

0.82

1.12

2.8

0.64

0.73

ug/l

0.79

794

Ulcerative colitis (strict definition, all Crohn cases excluded)

887

9403

0.93

1.12

2.8

2.7

0.70

0.73

ug/l

0.32

560

5679

Pyoderma

1158

0.81

1.12

3.2

3.0

0.63

0.79

ug/l

1.94

748

Maltreatment syndromes

173

1984

0.86

1.12

2.2

2.3

0.50

0.66

ug/l

4.35

100

1002

Viral Sepsis

1343

14071

0.95

1.12

2.9

3.1

0.74

0.80

ug/l

1.25

938

9652

Calcific aortic valvular stenosis, including rheumatic fever

2669

26945

0.96

1.12

3.0

3.3

0.80

0.83

ug/l

0.44

1888

19546

Calcific aortic valvular stenosis

2660

26878

0.96

1.11

3.0

3.3

0.80

0.83

ug/l

0.43

1880

19499

Calcific aortic valvular stenosis, operated

2660

26878

0.96

1.11

3.0

3.3

0.80

0.83

ug/l

0.43

1880

19499

Psoriasis

2042

21207

0.96

1.11

2.8

2.9

0.64

0.75

ug/l

5.11

1340

13692

Malignant neoplasm of rectosigmoid junction

102

1204

0.81

1.11

2.9

3.2

1.11

0.82

ug/l

0.53

824

Appendectomy

4326

40558

1.03

1.11

2.7

0.72

0.73

ug/l

0.05

2590

24497

Contact with other hot metals

1024

0.80

1.11

2.6

2.8

0.72

0.75

ug/l

0.10

639

Heterophoria

307

2768

1.12

1.11

2.8

2.9

0.84

0.72

ug/l

0.91

193

1699

DVT of lower extremities

1477

14129

1.06

1.11

3.0

3.1

0.83

0.78

ug/l

0.50

1074

9597

Lichen simplex chronicus and prurigo

330

3630

0.89

1.11

2.8

3.0

0.67

0.75

ug/l

0.97

224

2376

Exfoliative dermatitis

877

0.78

1.11

2.9

3.1

0.53

0.80

ug/l

6.24

574

Operations 2 for CAVS

2659

26864

0.96

1.11

3.0

3.3

0.80

0.83

ug/l

0.43

1880

19489

Calcific aortic valvular stenosis, diagnosis (helper)

2659

26864

0.96

1.11

3.0

3.3

0.80

0.83

ug/l

0.43

1880

19489

Chronic lymphocytic leukaemia, helper endpoint

228

2039

1.15

1.11

2.8

0.79

0.77

ug/l

0.09

170

1428

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

228

2039

1.15

1.11

2.8

0.79

0.77

ug/l

0.09

170

1428

Erectile dysfunction, exclusion

370

0.66

1.11

2.4

3.2

0.60

0.79

ug/l

1.03

243

Rickettsioses

125

1.74

1.11

3.3

2.9

0.64

0.71

ug/l

0.29

Foreign body entering into or through eye or natural orifice

670

6277

1.08

1.11

2.8

0.65

0.72

ug/l

1.40

426

3843

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

282

2546

1.13

1.10

3.0

2.6

0.82

0.73

ug/l

0.82

188

1622

Oral leukoplakia

1046

0.80

1.10

2.7

3.0

0.65

0.74

ug/l

0.81

688

Other and unspecified injuries of shoulder and upper arm

187

1645

1.16

1.10

2.7

2.8

0.94

0.74

ug/l

0.37

114

1031

Dental caries

2001

20579

0.96

1.10

2.6

2.8

0.77

0.76

ug/l

0.04

1418

12799

Car occupant injured in noncollision transport accident

164

1879

0.86

1.10

2.5

2.7

0.58

0.74

ug/l

3.28

107

1101

Benign neoplasm: Prostate

841

1.29

1.10

4.6

3.2

0.74

0.83

ug/l

0.61

597

Any reimbursement code in KELA

4274

22019

0.97

1.09

2.6

0.69

0.70

ug/l

0.28

2553

12029

Right side

375

0.67

1.09

2.4

3.0

0.98

0.75

ug/l

1.42

264

Other and unspecified iron deficiency

1824

18981

0.96

1.09

3.0

3.2

0.96

0.80

ug/l

2.74

1312

13322

Anisometropia and aniseikonia

155

1344

1.18

1.09

2.8

3.0

0.72

0.77

ug/l

0.38

100

883

Primary biliary cholangitis (PBC)

544

0.74

1.09

2.9

0.86

0.75

ug/l

0.33

356

Episcleritis

228

2027

1.14

1.09

2.8

2.7

0.63

0.71

ug/l

1.61

151

1206

Benign neoplasm: Connective and other soft tissue of head, face and neck

829

1.23

1.08

3.1

2.5

0.81

0.76

ug/l

0.17

521

Exposure to ignition or melting of other clothing and apparel

218

0.57

1.08

1.7

2.8

0.53

0.78

ug/l

—

137

Other diseases of blood and blood-forming organs

481

4455

1.10

1.08

2.9

3.0

0.67

0.75

ug/l

1.70

323

2936

Secondary hypertension

599

6348

0.92

1.08

2.7

3.1

0.91

0.76

ug/l

1.89

442

4131

Frostbite with tissue necrosis

255

0.61

1.08

2.5

2.9

0.73

0.75

ug/l

0.04

167

Other skin changes

1135

10796

1.06

1.08

3.1

3.2

0.76

0.80

ug/l

0.53

807

7533

Ischaemic heart disease, wide definition

7491

47790

0.98

1.07

2.8

2.9

0.71

0.77

ug/l

3.02

5035

30750

Thrombotic microangiopathy

307

0.65

1.07

2.0

3.1

0.79

0.73

ug/l

0.13

203

Fasciculation

613

1.27

1.07

2.8

0.68

0.73

ug/l

0.12

381

Allergic colitis

194

1.45

1.07

2.6

2.5

0.60

0.65

ug/l

0.20

106

Oral leukoplakia, including avohilmo

147

1687

0.85

1.07

2.7

3.0

0.61

0.72

ug/l

1.67

1081

Degenerative conditions of globe

340

0.66

1.07

2.5

2.9

0.84

0.80

ug/l

0.11

227

Other and unspecified diseases of blood and blood-forming organs

158

1379

1.18

1.07

2.8

3.0

0.63

0.76

ug/l

1.60

116

923

Other and unspecified spinal muscular atrophies

588

0.74

1.06

3.1

0.95

0.78

ug/l

0.95

392

Procedures for purposes other than remedying health state

446

1.30

1.06

2.8

0.68

0.72

ug/l

0.18

281

Xerosis cutis

888

0.79

1.06

2.7

3.1

0.52

0.78

ug/l

4.78

596

Melanocytic naevi of scalp and neck

127

1088

1.19

1.06

3.0

2.9

0.71

0.76

ug/l

0.36

693

Osteonecrosis

388

3565

1.11

1.06

3.2

3.0

0.96

0.74

ug/l

1.30

279

2343

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

924

8764

1.07

1.06

3.2

2.8

0.87

0.73

ug/l

4.45

698

6067

Chronic suppurative otitis media, including avohilmo

398

4331

0.91

1.05

3.0

0.92

0.76

ug/l

0.91

280

2834

Implicit viral Sepsis

1342

14036

0.95

1.05

2.9

3.1

0.74

0.80

ug/l

1.22

937

9631

Benign neoplasm: Testis

443

1.37

1.05

3.1

2.6

0.68

0.81

ug/l

0.55

288

Myeloproliferative diseases (CML excluded)

449

4852

0.91

1.05

2.8

3.1

0.76

0.77

ug/l

0.07

309

3337

Benign neoplasm: Extrahepatic bile ducts

150

1.60

1.05

2.3

2.4

0.62

0.80

ug/l

1.00

Use of selegiline

316

3460

0.89

1.05

2.9

3.3

0.67

0.79

ug/l

3.47

234

2447

Gilbert syndrome

445

1.33

1.05

2.4

2.8

0.84

0.70

ug/l

0.41

286

Other CVD (FINNGEN)

1055

7895

1.07

1.04

3.2

3.3

0.74

0.79

ug/l

0.84

761

5592

Other and unspecified polyneuropathies, also in other diseases

1801

17352

1.05

1.04

3.1

0.69

0.78

ug/l

2.91

1348

12009

Benign lipomatous neoplasm of other sites/unspecified

542

5044

1.09

1.04

3.0

2.7

0.74

0.73

ug/l

0.08

384

3358

Pilonidal cyst

654

6130

1.08

1.04

2.3

2.4

0.61

0.67

ug/l

1.01

327

3217

Other congenital malformations of circulatory system

157

1372

1.17

1.04

3.1

2.9

0.66

0.74

ug/l

0.74

108

874

Corneal degeneration

641

1.26

1.04

3.2

0.68

0.78

ug/l

0.80

414

Benign neoplasm: Skin of trunk

232

2076

1.14

1.04

3.0

2.6

0.71

0.73

ug/l

0.17

163

1322

Neuromuscular dysfunction of bladder

686

6446

1.08

1.04

3.0

3.1

0.59

0.78

ug/l

8.07

507

4412

ILD differential diagnosis

7335

37479

0.98

1.04

2.8

2.9

0.71

0.78

ug/l

5.28

4628

23730

Obesity, other/unspecified

1631

17001

0.95

1.03

2.6

2.8

0.61

0.73

ug/l

2.81

1074

10640

Other bacterial agents as the cause of diseases classified to other chapters

444

0.72

1.03

3.2

3.0

1.59

0.74

ug/l

0.36

301

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

441

4752

0.91

1.03

2.8

3.3

0.80

0.83

ug/l

0.22

302

3374

Other symptoms and signs involving cognitive functions and awareness

3712

33897

1.03

3.1

0.73

0.81

ug/l

3.85

2627

23228

Other CVD

1493

14317

1.05

1.03

3.3

3.2

0.79

0.83

ug/l

0.73

1072

10216

L04AC Interleukin inhibitors

223

2493

0.88

1.03

2.3

2.6

0.67

0.68

ug/l

0.06

126

1391

Burn and corrosion of ankle and foot

959

0.80

1.02

2.8

2.9

0.69

0.76

ug/l

0.35

605

Chronic myeloproliferative disease

882

0.79

1.02

2.5

3.2

0.85

0.77

ug/l

0.34

623

Seminoma of testis, excluding all cancers (controls excluding all cancers)

101

862

1.24

1.02

2.5

2.2

0.70

ug/l

0.00

472

Other and unspecified abdominal hernia

202

2267

0.87

1.02

3.1

0.65

0.80

ug/l

2.35

143

1553

Benign neoplasm: Connective and other soft tissue, unspecified

525

1.28

1.02

3.1

2.6

0.81

0.77

ug/l

0.09

336

Lichen striatus

0.00

1.02

0.0

2.6

—

0.85

—

Secondary thrombocytopenia

719

0.78

1.02

2.2

3.0

0.80

0.73

ug/l

0.24

469

Cardiomyopathy, Hypertrophic obstructive

126

1451

0.84

1.01

3.0

3.1

0.59

0.74

ug/l

2.07

1005

Lumbosacral root disorders, not elsewhere classified

698

0.77

1.01

2.1

2.9

0.60

0.74

ug/l

1.05

467

Certain zoonotic bacterial diseases

1090

0.82

1.01

2.4

3.0

0.60

0.77

ug/l

1.89

692

Chronic nephritic syndrome

270

2972

0.89

1.01

2.6

3.0

0.98

0.75

ug/l

1.86

211

1940

Myositis ossificans

177

1.54

1.00

3.5

2.9

0.95

0.79

ug/l

0.25

122

Oesophagitis, drug-induced

144

1.62

1.00

3.1

0.55

0.77

ug/l

1.44

103

Disorder of lipoprotein metabolism, unspecified

1284

12298

1.06

1.00

3.0

3.2

0.74

0.78

ug/l

0.75

943

8700

Other diseases of peritoneum

152

1740

0.86

1.00

3.1

0.67

0.78

ug/l

1.35

109

1177

Left hemicolectomy

139

1590

0.85

1.00

3.1

3.2

0.80

ug/l

0.02

101

1092

Dependent personality disorder

800

0.79

1.00

2.8

2.7

0.53

0.72

ug/l

1.43

486

Other interstitial pulmonary diseases

1191

12454

0.95

1.00

3.0

3.2

0.71

0.81

ug/l

2.78

853

8899

Superficial injury of shoulder and upper arm

715

6730

1.07

1.00

3.2

2.9

0.72

0.75

ug/l

0.24

461

4289

Acquired stenosis of external ear canal

101

867

1.24

0.99

3.0

2.9

0.75

0.71

ug/l

0.17

558

Brain astrocytoma

183

0.57

0.99

2.3

2.7

0.76

0.77

ug/l

—

111

Other and unspecified hereditary haemolytic anaemias

0.00

0.99

0.0

2.5

—

0.67

—

Non-allergic asthma (mode)

1217

12627

0.95

0.99

2.7

3.1

0.65

0.81

ug/l

5.94

808

8554

Occupant of pick-up truck or van injured in other and unspecified transport accidents

357

0.69

0.99

2.5

2.7

0.57

0.68

ug/l

0.81

202

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

617

0.76

0.99

2.7

2.6

0.71

0.78

ug/l

0.29

420

Maze procedure for atrial fibrillation

410

1.36

0.99

2.8

3.1

0.65

0.77

ug/l

0.55

271

Carcinoma in situ of skin of lip

196

1.52

0.99

5.0

2.7

0.61

0.79

ug/l

0.56

139

Benign neoplasm of bone and articular cartilage

471

4370

1.09

0.99

3.1

2.8

0.73

0.72

ug/l

0.06

306

2729

6-mercaptopurine

103

1213

0.84

0.99

2.8

2.5

0.67

0.71

ug/l

0.29

639

Undescended testicle

364

1.33

0.98

2.9

2.7

0.61

0.75

ug/l

0.87

203

Drug-induced gout

354

0.68

0.98

3.0

3.2

0.88

ug/l

0.01

242

Folate deficiency anaemia

581

0.75

0.98

3.0

3.1

0.88

0.78

ug/l

0.38

395

Collapsed vertebra, not elsewhere classified

287

1.38

0.98

3.1

3.0

0.73

0.85

ug/l

0.40

201

Flatulence and related conditions

501

1.28

0.98

3.2

3.1

0.58

0.79

ug/l

2.56

330

Oesophageal obstruction

253

2787

0.89

0.98

2.9

3.2

0.81

0.78

ug/l

0.07

176

1917

Radial styloid tenosynovitis [de Quervain]

162

1417

1.15

0.98

2.8

2.7

0.66

0.73

ug/l

0.33

103

847

243

1.40

0.98

3.0

2.5

0.67

0.70

ug/l

0.11

146

Primary gonarthrosis, bilateral

3938

35319

0.97

0.98

3.3

3.2

0.74

0.80

ug/l

2.59

2791

24767

Behavioural disorders, excluding more controls

667

0.78

0.98

1.5

2.0

0.51

0.66

ug/l

1.58

278

Cerebral palsy

511

0.75

0.98

1.9

2.5

0.93

0.75

ug/l

0.18

260

Other and unspecified acne

427

1.29

0.98

2.5

2.6

0.58

0.70

ug/l

0.61

234

Additional codes for the location of defect, injury or illness

265

2924

0.89

0.98

2.9

3.0

0.73

0.75

ug/l

0.19

183

1905

Certain conditions originating in the perinatal period

665

0.80

0.97

1.8

2.1

0.56

0.71

ug/l

0.74

297

Viral pneumonia (unknown virus, not influenza)

459

4263

1.09

0.97

2.6

2.8

0.73

ug/l

0.01

320

2652

Poisoning by medicine, drug-induced

652

0.77

0.97

2.4

2.5

0.38

0.68

ug/l

5.87

347

Background retinopathy and retinal vascular changes

112

1300

0.84

0.97

2.9

3.0

0.83

0.78

ug/l

0.33

847

Neovascular glaucoma

241

2666

0.89

0.97

3.1

0.88

0.80

ug/l

0.36

175

1806

Interstitial lung disease

1191

12445

0.95

0.97

3.0

3.2

0.71

0.81

ug/l

2.79

853

8893

Interstitial lung disease endpoints

1191

12445

0.95

0.97

3.0

3.2

0.71

0.81

ug/l

2.79

853

8893

Retinal vascular occlusion

933

8870

1.06

0.97

3.2

3.3

0.77

0.82

ug/l

0.85

677

6333

Deep bite that required surgery

419

1.30

0.97

2.8

2.3

0.61

0.65

ug/l

0.16

216

Parapsoriasis

123

1063

1.19

0.97

3.0

2.9

0.62

0.77

ug/l

1.73

683

Burns and corrosions of external body surface, specified by site

698

7406

0.93

0.97

2.8

2.7

0.69

0.73

ug/l

0.68

439

4534

Viral infections of central nervous system, not elsewhere classified/unspecified

518

0.75

0.97

3.1

2.7

0.55

0.69

ug/l

0.99

284

COPD differential diagnosis

7342

37482

0.98

0.97

2.8

2.9

0.71

0.78

ug/l

5.26

4633

23731

Other symptoms and signs involving the circulatory and respiratory systems

430

3982

1.09

0.97

3.4

3.0

0.67

0.77

ug/l

1.92

317

2671

Drug-induced cataract

107

1248

0.84

0.97

2.9

3.0

0.73

0.74

ug/l

0.06

811

Rheumatic fever without mention of heart involvement

204

0.59

0.97

3.6

2.9

0.88

0.81

ug/l

—

135

Follicular lymphoma, hilmo

253

2788

0.89

0.96

2.9

3.2

0.68

0.76

ug/l

1.10

171

1924

Chromophobe cell carcinoma of kidney

420

1.35

0.96

3.1

3.0

0.71

0.79

ug/l

0.47

273

Benign neoplasm: Skin of other and unspecified parts of face

629

5903

1.08

0.96

3.2

2.7

0.79

0.74

ug/l

0.79

437

3985

Routine general health check-up of defined subpopulation

216

1.40

0.96

2.0

2.2

0.69

0.71

ug/l

0.04

103

Unspecified renal colic

407

1.33

0.96

3.2

2.9

0.57

0.73

ug/l

1.47

265

Benign neoplasm: Nasopharynx

477

1.29

0.96

3.2

2.6

0.76

0.77

ug/l

0.02

300

Spinal enthesopathy

138

1581

0.86

0.96

3.1

1.06

0.96

ug/l

0.16

1118

Cerebral palsy and other paralytic syndromes

628

6686

0.93

0.96

2.6

3.0

0.72

0.78

ug/l

0.51

449

4346

Idiopathic gout

1013

9685

1.07

0.96

3.1

3.2

0.82

0.79

ug/l

0.32

743

6800

Leisure time condition

1096

10450

1.06

0.96

2.9

0.76

ug/l

0.02

690

6712

Other viral diseases, not elsewhere classified

1065

10115

1.06

0.96

2.6

2.7

0.66

0.72

ug/l

1.38

630

6021

Opening and dilatation of root channel of tooth

352

3233

1.10

0.95

2.9

2.8

0.65

0.70

ug/l

0.78

209

1945

Use of donepezil

1187

11939

0.95

3.0

3.4

0.85

0.88

ug/l

0.28

820

8835

Drug-induced osteoporosis

461

0.74

0.95

2.5

2.9

0.53

0.73

ug/l

1.48

306

Etanercept

220

2452

0.89

0.95

2.6

2.7

0.54

0.69

ug/l

5.11

136

1429

Benign neoplasm: Hypopharynx

338

1.37

0.95

2.5

2.6

0.82

0.80

ug/l

0.05

219

Benign neoplasm: Connective and other soft tissue of thorax

239

1.43

0.94

3.1

2.5

0.57

0.69

ug/l

0.39

161

Other and unspecified effects of external causes

1398

13398

1.05

0.94

2.7

2.8

0.64

0.73

ug/l

3.71

875

8177

Postzoster neuralgia

751

1.22

0.94

3.3

3.1

0.82

0.85

ug/l

0.05

523

Dislocation, sprain and strain of joints and ligaments at neck level

757

7145

1.07

0.94

2.9

2.7

0.73

0.71

ug/l

0.11

459

4244

Unspecified nephritic syndrome

138

1571

0.85

0.94

2.8

2.9

0.72

0.75

ug/l

0.18

111

1010

Missing teeth due to accident, extraction or parodontitis

816

7733

1.07

0.94

2.7

2.9

0.71

0.77

ug/l

0.67

554

5113

Osteonecrosis due to drugs

792

1.23

0.94

4.6

3.1

1.69

0.75

ug/l

1.61

519

Contact with nonpowered hand tool

439

4094

1.10

0.94

3.1

2.8

0.77

0.71

ug/l

0.30

284

2568

Mental and behavioural disorders due to cannabinoids

101

1185

0.84

0.93

1.7

1.9

0.43

0.60

ug/l

3.15

489

Carcinoma in situ of colon

118

1028

1.20

0.93

3.8

3.1

0.75

0.80

ug/l

0.30

703

Disorders of continuity of bone

386

4182

0.91

0.93

2.7

2.8

0.70

0.72

ug/l

0.14

243

2554

Wilms' tumor, excluding all cancers (controls excluding all cancers)

365

0.70

0.93

2.7

2.6

0.72

0.77

ug/l

0.16

254

Benign neoplasm: Parathyroid gland

378

1.31

0.93

3.1

2.6

0.75

ug/l

0.01

250

Vitamin D deficiency

628

0.78

0.93

2.7

2.8

0.64

0.72

ug/l

0.38

389

Graves disease, strict definition

226

2026

1.12

0.93

2.6

2.8

0.68

0.72

ug/l

0.37

126

1210

Parkinson's disease, strict definition

1126

11762

0.95

0.93

3.1

3.3

0.75

0.82

ug/l

1.70

809

8555

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

305

3320

0.90

0.92

2.7

2.6

0.75

0.71

ug/l

0.24

204

2172

Fracture at wrist and hand level

2753

26729

1.03

0.92

2.7

0.70

0.72

ug/l

0.35

1683

15962

Congenital malformations of the respiratory system

594

0.77

0.92

2.3

2.8

0.66

0.72

ug/l

0.18

375

Parodontitis, under 40 years, or operation codes

124

1437

0.86

0.92

1.3

1.5

0.40

0.43

ug/l

0.33

441

Drug-induced obesity

265

0.66

0.92

2.7

2.8

0.56

0.75

ug/l

0.80

165

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

403

0.72

0.92

2.0

2.9

0.60

0.69

ug/l

0.20

247

Neuroendocrine tumor and carcinoma of lung

366

0.71

0.92

2.7

3.1

0.48

0.76

ug/l

3.57

246

5-aminosalicylic acid

1385

14430

0.95

0.92

2.7

0.69

0.72

ug/l

0.45

863

8727

Disorders of brain, other and unspecified

567

0.76

0.92

3.0

1.09

0.77

ug/l

0.30

371

Intermittent hydrarthrosis

121

1.62

0.92

3.3

2.6

0.59

0.70

ug/l

—

Malignant neoplasm of eye and adnexa

510

0.75

0.92

3.1

3.0

0.99

0.76

ug/l

0.67

334

Parodontitis, under 40 years

124

1436

0.86

0.92

1.3

1.5

0.40

0.43

ug/l

0.33

441

Multiple myeloma and malignant plasma cell neoplasms

277

3030

0.90

0.91

2.9

2.7

0.97

0.75

ug/l

1.59

205

2104

Examination and encounter for administrative purposes

393

3649

1.10

0.91

3.0

0.73

0.78

ug/l

0.75

258

2397

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

388

3605

1.10

0.91

3.1

2.7

0.90

0.71

ug/l

3.00

293

2427

Guttate psoriasis

646

0.78

0.91

2.7

2.8

0.64

0.71

ug/l

0.29

393

Wegener granulomatosis

905

0.81

0.90

2.5

3.0

0.71

0.76

ug/l

0.25

595

Right bundle-branch block

316

2910

1.11

0.90

3.2

0.77

0.82

ug/l

0.45

222

2036

Other birth injuries to central nervous system

0.00

0.90

0.0

3.3

—

0.69

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

284

2587

1.11

0.90

3.1

2.6

0.74

0.71

ug/l

0.34

200

1648

Other specified and unspecified retinal disorders

219

1977

1.13

0.90

2.8

3.0

0.69

0.76

ug/l

0.63

150

1304

Diseases of tongue

303

2772

1.11

0.90

3.3

2.9

0.71

0.79

ug/l

0.60

214

1805

Autoimmune hepatitis

204

0.62

0.90

2.2

3.0

0.41

0.82

ug/l

—

130

Other complications of surgical and medical care, not elsewhere classified

492

4591

1.08

0.90

3.0

0.72

0.74

ug/l

0.14

339

3020

Chondropathies

947

9016

1.06

0.89

2.9

2.7

0.62

0.72

ug/l

4.00

562

5466

Lower back pain or/and sciatica

8364

58974

0.98

0.89

2.8

2.9

0.67

0.77

ug/l

12.81

5508

37662

Lymphoid leukaemia

413

3842

1.09

0.89

3.0

2.7

0.77

0.75

ug/l

0.17

296

2649

Demyelinating diseases of the central nervous system

262

2884

0.90

0.89

2.6

2.7

0.60

0.70

ug/l

1.85

173

1698

Disorders of synovium and tendon

3673

33904

0.97

0.89

2.9

2.8

0.67

0.77

ug/l

10.03

2317

21519

Open wound of head

5052

48748

1.03

0.88

2.9

0.75

0.77

ug/l

0.60

3314

31104

Benign neoplasm: Long bones of lower limb

176

1568

1.14

0.88

2.9

2.4

0.68

0.67

ug/l

0.04

106

886

Leukaemia of unspecified cell type

475

0.75

0.88

2.6

2.9

0.63

0.81

ug/l

0.99

297

Herpesviral keratitis and keratoconjunctivitis

266

2426

1.12

0.88

2.8

3.0

0.81

0.76

ug/l

0.32

166

1574

Other contact dermatitis

363

3931

0.91

0.88

3.1

2.9

0.68

0.75

ug/l

1.18

221

2467

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

654

0.77

0.88

2.4

2.6

0.68

0.77

ug/l

0.67

438

Other and unspecified acantholytic disorders

0.00

0.88

0.0

2.5

—

0.59

—

Conduct disorder

669

0.79

0.88

1.5

2.1

0.55

0.62

ug/l

0.40

290

Abnormal reflex

259

0.66

0.88

2.2

2.8

0.63

0.76

ug/l

—

163

Toxic effect of contact with venomous animals

210

1891

1.13

0.88

2.8

2.9

0.80

0.74

ug/l

0.40

143

1197

Biomechanical lesions, not elsewhere classified

286

2618

1.11

0.88

3.2

3.0

0.80

0.76

ug/l

0.12

213

1717

Postprocedural disorders of nervous system

216

1941

1.12

0.88

2.5

0.59

0.70

ug/l

1.81

124

1090

Congenital malformations of eye, ear, face and neck

255

2314

1.11

0.88

2.8

0.72

ug/l

0.02

150

1386

Labyrinthine fistula

243

0.64

0.87

3.4

3.0

0.71

0.74

ug/l

0.12

163

Abnormal findings on diagnostic imaging of other body structures

632

5953

1.07

0.87

3.2

3.1

0.82

0.76

ug/l

0.64

461

4088

Viral haemorrhagic fevers, not elsewhere classified/unspecified

571

6062

0.93

0.87

2.8

2.9

0.73

0.72

ug/l

0.08

365

3848

Choroidal haemorrhage and rupture

200

1.46

0.87

2.6

2.9

1.90

0.77

ug/l

0.66

133

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

164

1828

0.87

2.9

2.7

0.71

ug/l

0.01

112

1183

Eustachian salpingitis and obstruction

357

3293

1.09

0.87

2.3

2.2

0.64

0.62

ug/l

0.11

167

1553

Multiple myeloma, excluding all cancers (controls excluding all cancers)

280

3052

0.90

0.87

2.9

2.7

0.97

0.75

ug/l

1.61

206

2125

Malignant neoplasm of colon

1068

11155

0.95

0.87

3.2

3.3

0.83

ug/l

0.04

754

7988

Keratoconus

130

1479

0.86

0.87

2.6

2.5

0.72

0.70

ug/l

0.08

832

Contact with machinery

1249

12966

0.95

0.87

2.9

0.69

0.74

ug/l

1.02

787

8391

Contact with heat and hot substances

294

3202

0.90

0.86

2.9

2.8

0.76

0.72

ug/l

0.30

175

1987

Trachoma

0.00

0.86

0.0

2.5

—

0.85

—

Obsessive-compulsive disorder

213

1915

1.12

0.86

2.2

2.4

0.55

0.69

ug/l

2.07

125

993

Other congenital malformations of face and neck

141

1240

1.16

0.86

2.5

2.7

0.65

0.72

ug/l

0.57

731

Glomerulonephritis

700

7387

0.94

0.86

2.7

3.0

0.92

0.75

ug/l

1.47

519

4845

Anterior Iridocyclitis

1359

13064

1.05

0.86

2.9

0.69

0.75

ug/l

2.05

914

8332

Postprocedural disorders of digestive system, not elsewhere classified

159

1785

0.87

0.86

2.9

3.1

0.78

0.77

ug/l

0.06

104

1206

Otalgia

272

2479

1.11

0.86

3.3

2.9

0.56

0.76

ug/l

7.12

187

1577

Paraplegia, diplegia of upper limbs

126

1433

0.86

2.8

2.9

0.63

0.77

ug/l

1.24

936

Motorcycle rider injured in noncollision transport accidents

231

2100

1.12

0.85

2.7

2.5

0.71

0.67

ug/l

0.23

126

1170

Malignant neoplasm of meninges

0.00

0.85

0.0

3.7

—

0.68

—

Retinal vascular disorders

948

9055

1.06

0.85

3.2

3.3

0.77

0.82

ug/l

0.85

687

6468

Mixed disorder of acid-base balance

0.00

0.85

0.0

2.7

—

0.71

—

Other rupture of muscle

350

1.32

0.85

3.4

2.8

0.69

0.71

ug/l

0.07

223

Iridocyclitis in diseases classified elsewhere

113

983

1.18

0.85

3.3

2.9

0.67

0.78

ug/l

0.69

614

Hard cardiovascular diseases

7532

49128

0.98

0.85

2.8

2.9

0.74

0.76

ug/l

0.42

5139

31592

Coronary revascularization (ANGIO or CABG)

5500

39068

0.98

0.84

3.0

3.1

0.80

0.79

ug/l

0.17

3782

27046

Benign neoplasm: Short bones of lower limb

494

1.26

0.84

3.2

2.9

0.75

ug/l

0.02

319

Human immunodeficiency virus [HIV] disease

151

1688

0.87

0.84

2.3

2.4

0.69

0.67

ug/l

0.07

111

886

Anomalies of pupillary function

628

1.22

0.83

3.3

2.7

0.70

0.78

ug/l

0.42

366

Parodontitis, operation under 40 years and operation codes

115

1327

0.86

0.83

1.3

1.4

0.40

0.43

ug/l

0.24

405

Senile degeneration of the brain, not elsewhere classified

243

0.66

0.83

2.5

3.3

0.75

0.78

ug/l

0.07

166

Other hereditary haemolytic anaemias

279

1.35

0.83

2.6

0.59

0.75

ug/l

0.80

174

Bitten or struck by other mammals

452

4217

1.08

0.83

2.9

2.7

0.76

0.70

ug/l

0.33

290

2551

Panniculitis affecting regions of neck and back

214

1937

1.12

0.82

2.8

0.61

0.75

ug/l

2.99

131

1229

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

226

2047

1.11

0.82

3.0

2.6

0.74

0.70

ug/l

0.30

160

1284

Parodontitis, under 40 years and operation codes

115

1325

0.86

0.82

1.3

1.4

0.40

0.43

ug/l

0.24

405

Chronic suppurative otitis media

351

3787

0.92

0.82

3.0

0.96

0.76

ug/l

0.97

246

2483

Vascular dementia

511

5255

0.93

0.82

2.9

3.4

0.80

0.91

ug/l

2.19

361

3869

Cluster headache, wide,, including avohilmo

273

2501

1.11

0.82

2.6

0.68

0.71

ug/l

0.22

162

1464

Ulcer of oesophagus, drug-induced

398

0.73

0.82

3.0

3.1

0.74

0.77

ug/l

0.06

272

Viral and other specified intestinal infections

834

8566

0.95

0.82

2.3

2.5

0.71

0.70

ug/l

0.01

421

4565

Superficial injury of lower leg

1257

12072

1.05

0.81

2.9

2.8

0.69

0.74

ug/l

0.76

816

7535

Benign neoplasm of thyroid gland

118

1029

1.16

0.81

3.7

3.1

0.78

0.77

ug/l

0.02

679

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

423

0.75

0.81

2.5

2.6

0.71

0.76

ug/l

0.15

285

Other protozoal intestinal diseases

642

1.22

0.81

2.9

0.50

0.72

ug/l

3.94

405

Periodontal disease, other/unspecified

252

0.67

0.81

3.3

2.8

0.54

0.77

ug/l

1.83

170

Ankylosing spondylitis

692

6566

1.07

0.81

2.8

0.67

0.76

ug/l

2.60

481

4021

Certain infectious and parasitic diseases

8893

43848

1.02

0.80

2.9

0.73

0.77

ug/l

2.13

5813

27921

Mature T/NK-cell lymphomas, hilmo

1027

0.83

0.80

2.8

3.1

0.64

0.78

ug/l

1.31

687

Other nutritional anaemias

545

0.78

0.80

3.1

3.2

0.72

0.78

ug/l

0.23

361

Benign neoplasm: Orbit, unspecified

236

1.37

0.80

2.7

2.4

0.94

0.76

ug/l

0.34

144

Mental and behavioural disorders due to use of volatile solvents

131

0.58

0.80

2.8

2.1

0.38

0.64

ug/l

—

Disorders of muscles

680

6448

1.06

0.80

2.8

0.67

0.77

ug/l

2.39

442

4054

Arthropod-borne viral fevers and viral haemorrhagic fevers

740

7772

0.94

0.80

2.8

2.9

0.71

0.75

ug/l

0.37

470

4965

TMD related pain

420

1.25

0.79

3.5

2.8

0.52

0.77

ug/l

3.56

247

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

660

0.80

0.79

3.6

2.6

0.65

0.77

ug/l

0.65

440

Contusion of other and unspecified parts of foot

211

1911

1.12

0.79

2.6

2.7

0.61

0.70

ug/l

1.54

114

1119

Torsion of testis

123

1082

1.16

0.79

2.1

2.0

0.66

0.64

ug/l

0.06

462

Exposure to unspecified smoke, fire and flames

619

0.79

2.8

2.7

0.72

0.76

ug/l

0.19

367

Non-allergic asthma

460

4904

0.93

0.78

2.8

3.0

0.65

0.76

ug/l

3.16

307

3264

Acute suppurative otitis media

992

9688

0.95

0.78

2.3

0.70

0.64

ug/l

0.50

517

4922

Nystagmus and other irregular eye movements

546

0.79

0.78

3.3

2.7

0.64

0.73

ug/l

0.42

327

Benign neoplasm: Brain, infratentorial

255

1.35

0.78

2.8

2.9

1.02

0.75

ug/l

0.82

163

Conotruncal defects

302

0.72

0.78

2.1

2.3

0.41

0.68

ug/l

2.44

157

Use of levodopa decarboxylase inhibitor

1027

10697

0.95

0.78

3.0

3.3

0.73

0.82

ug/l

2.64

748

7846

Other injuries of upper limb, level unspecified

582

1.23

0.78

2.7

2.8

0.64

0.70

ug/l

0.43

348

305

1.29

0.78

2.2

2.6

0.78

0.69

ug/l

0.10

182

Disorder of external ear, unspecified

213

1940

1.12

0.78

2.8

3.0

0.77

0.75

ug/l

0.06

139

1245

Cholecystectomy

4643

41871

0.98

0.78

3.1

0.77

0.79

ug/l

0.84

3194

28727

Mandibular prognathia AND surgery (LeFortI or BSSRO)

160

0.60

0.78

2.7

2.3

0.53

0.67

ug/l

—

Orthopaedic devices associated with adverse incidents

107

936

1.18

0.78

4.1

3.2

0.75

0.76

ug/l

0.05

648

Juvenile arthritis (FINNGEN)

995

0.85

0.77

2.3

2.4

0.66

0.71

ug/l

0.37

532

Impetigo

168

1871

0.89

0.77

2.8

2.7

0.63

0.71

ug/l

0.75

1082

Visual impairment including blindness (binocular or monocular)

362

3367

1.09

0.77

3.3

3.1

0.79

0.78

ug/l

0.05

262

2292

Sequelae of injuries of lower limb

607

5746

1.07

0.77

2.8

2.7

0.62

0.71

ug/l

2.22

388

3476

Benign neoplasm: Endocrine pancreas

412

1.28

0.76

3.8

2.7

0.86

0.77

ug/l

0.36

272

Abnormal blood-pressure reading, without diagnosis

210

1907

1.11

0.76

3.5

2.8

0.70

0.75

ug/l

0.36

134

1210

Arthropathy in Crohn disease

400

0.75

0.76

2.4

2.6

0.69

0.71

ug/l

0.07

215

Hypotony of eye

1.82

0.76

4.2

2.9

0.85

0.75

ug/l

—

Haemangioma, any site

428

4007

1.08

0.76

3.1

3.0

0.70

0.74

ug/l

0.55

290

2601

Sequelae of injuries of upper limb

600

6333

0.94

0.76

2.8

2.7

0.60

0.71

ug/l

4.18

367

3802

Scabies

282

3050

0.91

0.76

2.8

2.7

0.65

0.71

ug/l

0.68

171

1814

Herpesviral [herpes simplex] infections

559

5276

1.07

0.75

2.9

0.73

0.77

ug/l

0.47

382

3378

Colon adenocarcinoma

867

9057

0.95

0.75

3.2

3.3

0.84

0.83

ug/l

0.04

617

6509

Other appendicitis

519

4893

1.07

0.75

3.0

2.8

0.72

ug/l

0.08

336

3063

Use of ropinirole

250

2710

0.90

0.75

3.0

3.2

0.65

0.76

ug/l

2.49

166

1884

Other strabismus

1031

9853

1.05

0.75

2.8

0.81

0.73

ug/l

0.59

646

5991

Defects in the complement system

171

0.63

0.75

2.3

2.6

0.27

0.66

ug/l

—

104

Pulmonary embolism

2100

21597

0.97

0.75

3.1

0.81

0.79

ug/l

0.28

1469

14871

Benign neoplasm: Other and unspecified parts of small intestine

722

1.19

0.75

2.7

0.76

ug/l

0.01

485

Lichen sclerosus et atrophicus

178

1599

1.12

0.75

2.8

0.70

0.71

ug/l

0.04

123

945

Benign neoplasm: Extrahepatic bile ducts

162

1.46

0.75

2.3

2.8

0.62

0.74

ug/l

0.72

108

Benign neoplasm: Skin of scalp and neck

143

1276

1.14

0.75

3.4

2.6

0.72

0.74

ug/l

0.14

102

817

Other and unspecified injuries of ankle and foot

178

1604

1.12

0.75

2.7

0.73

0.70

ug/l

0.14

108

949

Renal failure

4244

39540

0.98

0.74

2.9

3.2

0.98

0.79

ug/l

10.55

3177

27531

Pedestrian injured in collision with pedal cycle

193

1752

1.12

0.74

2.4

2.8

0.74

0.75

ug/l

0.07

125

1070

Other pulmonary diagnosis

7399

37652

0.98

0.74

2.8

2.9

0.70

0.78

ug/l

6.55

4685

23782

Malignant neoplasm of bladder

696

7291

0.94

0.74

2.9

3.3

0.78

0.85

ug/l

0.54

480

5306

Dislocation, sprain and strain of joints and ligaments of elbow

263

2416

1.10

0.74

2.4

2.7

0.68

0.69

ug/l

0.04

145

1372

Acute drug-induced interstitial lung disorder

450

0.77

0.74

3.3

3.2

0.97

0.80

ug/l

0.43

313

Superficial injury of head

1373

13242

1.04

0.74

2.7

2.9

0.76

0.77

ug/l

0.07

907

8304

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

251

0.69

0.74

2.2

2.5

1.02

0.76

ug/l

0.65

171

Thyrotoxicosis with toxic single thyroid nodule

194

1.37

0.74

2.0

3.0

0.69

0.70

ug/l

0.04

131

Coeliac disease

519

5505

0.94

0.74

2.8

3.0

0.76

ug/l

0.01

347

3609

Benign neoplasm: Pharynx, unspecified

347

1.28

0.74

2.7

2.5

0.68

0.74

ug/l

0.32

215

Other and unspecified iridocyclitis

230

2105

1.11

0.74

2.9

0.68

0.75

ug/l

0.63

156

1271

Effects of foreign body entering through natural orifice

2158

22174

0.97

0.74

2.7

2.8

0.73

0.72

ug/l

0.11

1323

13613

Monoamine oxidase A inhibitors

781

7451

1.06

0.74

3.1

2.9

0.63

0.76

ug/l

4.19

548

4873

Other disorders of bone

1274

12279

1.04

0.74

2.8

2.7

0.65

0.72

ug/l

2.51

758

7468

Other mycoses, not elsewhere classified/unspecified

201

0.65

0.73

2.2

2.9

0.90

0.77

ug/l

—

135

Pneumocystosis

1084

0.85

0.73

2.1

3.1

0.67

0.75

ug/l

0.41

734

Speech therapy

1718

16647

1.04

0.73

2.9

3.1

0.70

0.78

ug/l

2.42

1332

11259

Glaucoma secondary to other eye disorders

243

2641

0.91

0.73

3.1

0.88

0.79

ug/l

0.38

176

1780

Molar incisor enamel hypoplasia

147

1.41

0.73

1.7

2.1

0.43

0.62

ug/l

1.58

Malignant neoplasm of lip

589

0.80

0.73

3.0

3.2

0.76

0.86

ug/l

0.60

416

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

177

0.63

0.73

3.2

2.8

0.49

0.80

ug/l

—

106

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

168

0.63

0.73

2.3

2.4

0.76

0.79

ug/l

—

Strabismus

1449

13971

1.04

0.73

2.8

2.9

0.79

0.75

ug/l

0.39

940

8872

Cauda equina syndrome

594

0.80

0.73

3.1

2.8

0.62

0.73

ug/l

0.70

378

Inhalation and ingestion of other objects causing obstruction of respiratory tract

294

1.31

0.72

4.2

3.0

0.69

0.78

ug/l

0.26

193

Other overlap syndromes

542

0.80

0.72

2.2

2.9

1.02

0.78

ug/l

0.35

359

Benign neoplasm: Scapula and long bones of upper limb

503

1.23

0.72

3.1

2.4

0.77

0.76

ug/l

0.02

289

Benign neoplasm: Spinal cord

801

1.18

0.72

3.3

2.9

0.63

0.72

ug/l

0.82

502

Use of rivastigmine

770

8047

0.95

0.72

2.9

3.4

0.73

0.87

ug/l

5.10

543

5924

Chorioretinal scars

171

1.42

0.72

2.7

2.8

0.75

ug/l

0.00

105

Fall on and from stairs and steps

1603

15521

1.04

0.72

2.9

0.66

0.76

ug/l

5.28

1086

10090

Contact with other and unspecified heat and hot substances

415

0.76

0.72

2.9

0.73

0.80

ug/l

0.23

242

Other rickettsioses

2.16

0.72

2.2

2.8

0.64

0.67

ug/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

131

1166

1.15

0.72

3.0

0.64

0.77

ug/l

1.70

749

Hypothyroidism, drug reimbursement

721

5419

0.95

0.72

3.0

2.5

0.69

0.73

ug/l

1.04

503

3151

Mycoses

1733

17868

0.96

0.72

2.9

3.0

0.73

0.77

ug/l

0.51

1190

11891

Behavioural disorders

640

0.82

0.71

1.5

2.1

0.51

0.61

ug/l

0.92

274

Other/unspecified reactive arthropathies

387

3623

1.08

0.71

2.9

0.74

ug/l

0.00

258

2276

Type 2 diabetes, wide definition

7422

47646

1.02

0.71

2.9

0.78

0.77

ug/l

0.15

5122

30468

Idiopathic thrombocytopenic purpura

148

1646

0.88

0.71

2.8

3.0

0.74

0.76

ug/l

0.16

101

1076

Benign neoplasm: Testis

466

1.28

0.71

3.1

3.0

0.68

0.84

ug/l

0.67

298

Brain meningioma

176

1590

1.12

0.71

3.1

3.2

0.82

0.78

ug/l

0.25

122

1094

Other and unspecified injuries of neck

330

1.28

0.71

3.0

2.6

0.69

0.75

ug/l

0.14

181

Benign neoplasm: Bronchus and lung

870

1.18

0.71

2.7

2.6

0.61

0.74

ug/l

1.45

576

Traumatic amputation of wrist and hand

445

4702

0.93

0.71

3.1

3.0

0.68

0.75

ug/l

1.45

294

3071

Polyarteritis nodosa

360

0.75

0.71

2.4

3.0

0.60

0.75

ug/l

0.99

234

Benign neoplasm: Skin of lip

671

1.19

0.71

2.8

2.9

0.75

ug/l

0.02

446

Malignant neoplasm of other and unspecified parts of mouth

336

0.74

0.71

2.2

3.3

0.99

0.83

ug/l

0.13

243

Congenital malformations of the musculoskeletal system, not elsewhere classified

195

1.35

0.71

3.5

2.7

0.49

0.75

ug/l

1.68

110

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1051

10905

0.95

0.71

3.0

3.2

0.85

0.77

ug/l

1.05

755

7670

Other and unspecified rosacea

394

3689

1.08

0.70

3.3

3.0

0.72

0.75

ug/l

0.14

260

2441

Sequelae of external causes of morbidity and mortality

1628

16795

0.96

0.70

3.0

3.1

0.71

0.78

ug/l

2.20

1147

11436

Other and unspecified parapsoriasis

372

1.29

0.70

3.3

3.2

0.52

0.79

ug/l

3.21

251

Asymptomatic human immunodeficiency virus [HIV] infection status

530

0.79

0.70

2.5

2.3

0.99

0.62

ug/l

0.52

265

Chronic conjunctivitis

114

1005

1.15

0.70

3.5

2.8

0.58

0.76

ug/l

2.75

619

Juvenile rheumatoid arthirtis

475

0.79

0.70

2.6

2.2

0.62

0.65

ug/l

0.12

234

Foreign body in alimentary tract

321

3443

0.92

0.70

3.0

0.65

0.75

ug/l

1.73

219

2275

Mesial bite

192

0.67

0.70

2.7

2.5

0.62

0.71

ug/l

—

104

Lateral epicondylitis

832

7961

1.05

0.70

2.8

2.7

0.62

0.73

ug/l

4.83

521

4790

Hypoplasia of dental enamel , including avohilmo

133

1.42

0.70

1.7

2.0

0.41

0.62

ug/l

1.61

Other functional intestinal disorders

2948

27419

1.03

0.70

3.1

0.77

0.82

ug/l

1.13

2089

18649

Benign neoplasm of mouth and pharynx

727

6941

1.06

0.69

2.9

3.0

0.68

0.75

ug/l

1.86

474

4617

Lupus erythematosus

734

0.83

0.69

3.1

2.9

0.54

0.73

ug/l

2.17

468

Benign neoplasm: Other and unspecified parts of mouth

202

1847

1.11

0.69

2.8

2.7

0.58

0.71

ug/l

2.08

141

1195

Carcinoma in situ of skin of lip

210

1.40

0.69

5.0

3.3

0.61

0.75

ug/l

0.41

144

Pulmonary heart disease

2100

21562

0.97

0.69

3.1

0.81

0.79

ug/l

0.27

1469

14841

Impacted maxillary molar

797

1.16

0.69

2.2

0.56

0.67

ug/l

1.15

386

Other chondrocalcinosis

760

1.19

0.69

3.0

3.1

0.66

0.84

ug/l

1.99

521

Organ-limited amyloidosis

272

1.33

0.69

2.4

3.1

0.64

0.82

ug/l

0.83

187

Other haemoglobinopathies

122

1.52

0.69

2.2

2.6

0.49

0.71

ug/l

1.43

Congenital malformations and deformations of the musculoskeletal system

245

2239

1.09

0.68

2.9

2.6

0.66

0.71

ug/l

0.43

146

1254

Other and unspecified injuries of lower leg

319

2967

1.08

0.68

2.7

2.8

0.74

0.70

ug/l

0.21

195

1806

Panniculitis, unspecified

432

1.24

0.68

2.6

3.0

0.60

0.77

ug/l

1.39

280

Cluster headache, strict, including avohilmo

252

2325

1.10

0.68

2.6

0.67

0.70

ug/l

0.16

150

1341

Cardiomyopathy, other and unspecified

661

6922

0.94

0.68

2.7

3.1

0.82

0.78

ug/l

0.26

469

4686

Chronic myeloid leukaemia [CML], BCR/ABL-positive

586

0.81

0.68

2.5

3.1

0.75

0.82

ug/l

0.28

385

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4599

44986

1.02

0.68

3.1

0.75

0.78

ug/l

1.33

3137

30595

Exposure to controlled fire, not in building or structure

209

0.67

0.68

2.9

2.5

0.98

0.75

ug/l

—

124

Hidradenitis suppurativa

116

1308

0.88

0.68

2.3

2.6

0.61

0.70

ug/l

0.68

733

Chronic hepatitis, not elsewhere classified

133

1485

0.88

0.68

2.5

2.9

0.70

0.75

ug/l

0.26

947

Other otitis externa (chronic)

380

3565

1.08

0.67

3.3

3.0

0.70

0.75

ug/l

0.61

238

2314

Benign neoplasm: Skin, unspecified

218

2002

1.10

0.67

3.3

2.6

0.84

0.73

ug/l

0.86

147

1270

Other benign neoplasms of connective and other soft tissue

568

5392

1.06

0.67

3.2

3.0

0.74

0.75

ug/l

0.08

357

3508

Autism spe, excluding more controls

428

0.79

0.67

2.1

2.0

0.53

0.60

ug/l

0.25

163

Cellulitis

1609

16578

0.96

0.67

2.8

2.9

0.70

0.75

ug/l

0.91

1043

10597

Lichen planus, including avohilmo

959

9215

1.05

0.67

2.9

3.0

0.77

0.76

ug/l

0.06

599

6134

Injury of muscle and tendon at ankle and foot level

167

1518

1.12

0.66

2.8

0.87

0.72

ug/l

0.36

107

936

Toxic effect of other and unspecified substances

545

0.81

0.66

2.0

2.4

0.56

0.64

ug/l

0.44

286

Other and unspecified immunodeficiencies with predominantly antibody defects

433

1.23

0.66

2.5

2.8

0.53

0.73

ug/l

2.70

261

Benign neoplasm: Peripheral nerves and autonomic nervous system

769

1.17

0.66

3.5

2.5

0.71

0.74

ug/l

0.16

486

Tubulo-interstitial nephritis, not specified as acute or chronic

367

3439

1.08

0.66

2.9

3.2

0.84

0.77

ug/l

0.36

257

2335

Unspecified misadventure during surgical and medical care

314

3360

0.92

0.66

3.1

0.64

0.76

ug/l

3.10

232

2251

Liver disorders in diseases classified elsewhere

104

0.55

0.66

2.8

2.6

0.48

0.69

ug/l

—

Melanoma in situ, other sites/unspecified

175

1.41

0.66

4.7

2.6

0.98

0.74

ug/l

0.51

120

Other conjunctival vascular disorders and cysts

124

1108

1.14

0.66

3.2

3.0

0.82

0.79

ug/l

0.08

734

Syndrome of inappropriate secretion of antidiuretic hormone

288

0.73

0.66

2.4

2.9

0.59

0.74

ug/l

0.85

190

Haemangioma and lymphangioma, any site

453

4275

1.07

0.65

3.1

3.0

0.70

0.74

ug/l

0.54

302

2767

Mandibular hypoplasia

208

1.34

0.65

2.5

2.6

0.53

0.69

ug/l

1.14

118

Hypertension, portal

207

0.68

0.65

1.9

2.8

0.53

0.77

ug/l

—

130

Diseases of pulp and periapical tissues

3004

29399

1.03

0.65

2.9

2.8

0.76

ug/l

0.07

2026

18427

Unspecified event, undetermined intent

113

1269

0.88

0.65

2.7

2.8

0.60

0.72

ug/l

0.81

761

Other acantholytic disorders

213

1.39

0.65

3.3

3.1

0.70

0.77

ug/l

0.28

150

Benign neoplasm: Bones of skull and face

302

0.74

0.65

2.7

2.9

0.46

0.75

ug/l

2.42

203

Human immunodeficiency virus [HIV] disease resulting in other conditions

138

1523

0.88

0.65

2.2

2.4

0.69

0.67

ug/l

0.04

102

778

Psoriasis vulgaris

1398

14425

0.96

0.65

2.9

0.65

0.75

ug/l

2.66

924

9262

Benign neoplasm: Spinal meninges

343

1.26

0.65

2.9

2.7

1.17

0.77

ug/l

0.38

228

Viral pneumonia

883

9187

0.95

0.65

2.7

3.0

0.72

0.78

ug/l

1.18

608

5987

Cardiomyopathy in other diseases

375

1.27

0.65

2.8

3.1

0.78

0.80

ug/l

0.05

272

Other keratitis

658

6277

1.06

0.65

2.8

0.71

0.72

ug/l

0.17

427

3815

Convalescence

211

2297

0.91

0.65

3.2

3.0

0.78

0.74

ug/l

0.21

159

1515

Benign neoplasm: Penis

206

1.42

0.65

2.5

0.43

0.73

ug/l

3.18

135

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

839

1.17

0.65

3.0

2.7

0.78

0.76

ug/l

0.10

570

Follow-up examination after treatment for malignant neoplasms

671

6406

1.06

0.65

3.3

3.2

0.86

0.84

ug/l

0.12

481

4596

Other localized connective tissue disorders

479

1.21

0.65

3.0

2.7

0.88

0.71

ug/l

0.33

287

Other congenital malformations of peripheral vascular system

425

1.22

0.64

2.1

2.7

0.58

0.72

ug/l

1.13

257

Acute bronchiolitis

870

0.86

0.64

2.8

0.75

ug/l

0.01

520

Bruxism

369

1.23

0.64

2.2

2.5

0.69

0.73

ug/l

0.10

214

Sequelae of other and unspecified infectious and parasitic diseases

352

3302

1.08

0.64

2.7

2.6

0.66

0.70

ug/l

0.36

208

1861

Congenital malformations of the urinary system

297

2767

1.08

0.64

3.0

2.9

1.02

0.74

ug/l

1.75

214

1767

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

138

1519

0.88

0.64

3.0

2.7

0.69

0.71

ug/l

0.10

980

Other specified/unspecified nutritional deficiencies

311

0.75

0.64

2.4

2.8

0.55

0.85

ug/l

1.63

199

Vitreous haemorrhage

679

7097

0.95

0.63

2.9

3.1

0.85

0.78

ug/l

0.53

474

4795

Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)

340

0.75

0.63

2.4

2.5

0.61

0.74

ug/l

0.64

217

Moderate visual impairment, monocular

220

1.34

0.63

3.8

3.0

0.56

0.72

ug/l

1.06

152

Disorders of speech understanding and production

118

1030

1.13

0.63

2.7

2.8

0.70

0.75

ug/l

0.19

643

Vertical strabismus

176

1606

1.11

0.63

2.9

0.69

0.75

ug/l

0.54

124

1036

Enlarged lymph nodes

1132

10932

1.04

0.63

2.8

3.0

0.68

0.75

ug/l

2.34

753

7100

Postdysenteric arthropathy

521

1.21

0.63

2.9

2.7

0.61

0.74

ug/l

0.83

319

Other disorders of gingiva or/and edentulous alveolar ridge

250

2695

0.92

0.63

2.9

0.72

0.78

ug/l

0.74

188

1749

Benign neoplasm: Ill-defined sites within the digestive system

255

1.30

0.63

2.7

2.6

0.76

0.74

ug/l

0.03

178

Other aneurysm

450

4743

0.93

0.63

2.9

3.2

0.79

0.83

ug/l

0.20

298

3349

Blindness or visual impairment, binocular

219

0.70

0.63

2.8

1.05

0.72

ug/l

—

145

Other specified/unspecified bacterial intestinal infections

377

3547

1.07

0.63

3.2

3.1

0.87

0.76

ug/l

0.52

264

2353

Other meningitis

638

0.83

0.63

2.7

2.8

0.73

0.72

ug/l

0.07

388

Anxious personality disorder

629

0.83

0.62

2.3

0.52

0.66

ug/l

0.48

312

Disorders of porphyrin and bilirubin metabolism

728

1.17

0.62

2.7

2.9

0.90

0.71

ug/l

0.72

465

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

1.55

0.62

2.8

2.4

0.62

0.65

ug/l

—

Other (seronegative) rheumatoid arthritis, wide

878

9137

0.96

0.62

3.0

3.1

0.72

0.79

ug/l

0.88

620

6261

Congenital malformations of genital organs

818

1.15

0.62

2.7

0.62

0.77

ug/l

1.08

470

ILD, hospital admissions

1183

12218

0.96

0.62

3.0

3.2

0.71

0.81

ug/l

2.83

848

8724

Disorders of orbit

177

1615

1.11

0.62

2.8

0.62

0.74

ug/l

1.79

112

993

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

414

0.78

0.62

2.1

2.6

0.84

0.76

ug/l

0.19

277

Other psoriatic arthropathies

614

6432

0.95

0.62

2.8

0.58

0.73

ug/l

7.85

379

4025

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

342

0.76

0.62

2.7

2.6

0.48

0.75

ug/l

3.22

223

Autism spe

423

0.80

0.62

2.1

1.9

0.53

0.57

ug/l

0.13

167

Crohn disease (strict definition, require KELA)

276

2964

0.92

0.62

2.5

2.7

0.56

0.69

ug/l

3.96

169

1721

Granulomatous disorders of skin and subcutaneous tissue

800

0.85

0.62

3.2

2.9

0.78

0.74

ug/l

0.16

498

Injuries to the ankle and foot

4552

42173

0.98

0.61

2.6

2.7

0.66

0.73

ug/l

5.41

2708

25401

Actinomycosis

228

0.71

0.61

2.7

0.45

0.74

ug/l

—

140

Gonococcal infection

109

969

1.14

0.61

2.2

2.3

0.69

0.64

ug/l

0.13

488

Other erythematous conditions

158

1437

1.11

0.61

3.0

0.75

0.78

ug/l

0.11

103

950

Cholecystitis

1014

10500

0.96

0.61

3.0

3.2

0.80

0.82

ug/l

0.27

709

7346

Other factor of the environment

666

0.84

0.60

3.0

2.9

0.77

0.74

ug/l

0.11

410

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

105

938

1.15

0.60

2.9

2.7

0.80

0.75

ug/l

0.23

623

Prepatellar bursitis

493

4700

1.07

0.60

3.0

2.8

0.67

0.75

ug/l

1.96

319

2953

Pruritus

430

4062

1.06

0.60

3.1

0.72

0.80

ug/l

0.44

302

2710

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

316

2968

1.08

0.60

2.7

0.82

0.74

ug/l

0.67

220

2038

Diffuse large B-cell lymphoma, helper endpoint

316

2968

1.08

0.60

2.7

0.82

0.74

ug/l

0.67

220

2038

Atypical mycobacterium lung infection

569

0.82

0.60

3.3

3.1

1.00

0.84

ug/l

0.19

388

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1993

20438

0.97

0.60

2.8

0.74

ug/l

0.08

1241

12888

Hyperkinetic disorders (excl. ADHD)

360

1.22

0.60

1.5

1.7

0.39

0.59

ug/l

2.96

126

Haemolytic anaemias

172

1876

0.90

0.59

2.7

3.0

0.82

0.76

ug/l

0.26

126

1236

Psoriatic arthropathies, ICD10

631

6597

0.95

0.59

2.8

0.58

0.73

ug/l

8.14

391

4140

Toxic effect of organic solvents

271

0.74

0.59

3.0

2.9

0.55

0.66

ug/l

0.60

167

Benign neoplasm: Carotid body

116

1.45

0.59

2.0

2.5

0.79

0.80

ug/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

673

1.17

0.59

2.8

0.66

0.72

ug/l

0.35

389

Vascular dementia (other)

341

1.25

0.59

3.8

3.2

0.73

0.95

ug/l

1.02

244

Nail disorders

437

4139

1.06

0.58

2.8

0.66

0.72

ug/l

1.08

279

2503

Erosion of teeth

701

1.16

0.58

2.6

0.75

ug/l

0.01

426

Benign neoplasm: Tongue

170

1559

1.11

0.58

2.7

2.9

0.67

0.75

ug/l

0.71

116

1022

Temporal arteritis

195

1798

1.10

0.58

3.3

0.62

0.79

ug/l

3.96

143

1261

Bicuspidal aortic valve syndrome

306

2878

1.08

0.58

2.9

2.8

0.70

ug/l

0.03

185

1770

Overjet

281

1.25

0.58

3.1

2.6

0.65

0.73

ug/l

0.37

157

Other disorders of iris and ciliary body

164

1502

1.11

0.58

2.6

3.0

0.65

0.78

ug/l

1.28

955

Benign neoplasm: Scrotum

449

1.25

0.58

2.7

2.5

0.55

0.70

ug/l

1.28

283

Hypotension due to drugs

106

952

1.15

0.58

2.9

3.1

0.63

0.83

ug/l

1.97

641

Short stature, not elsewhere classified

1.57

0.58

1.4

1.2

0.54

0.45

ug/l

—

Complications following infusion, transfusion and therapeutic injection

749

0.85

0.58

2.6

3.0

0.81

0.80

ug/l

0.03

487

Infections of the skin and subcutaneous tissue

4665

47184

0.98

0.58

2.7

2.8

0.68

0.74

ug/l

4.96

2916

29178

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

388

1.23

0.57

2.8

2.0

0.58

0.66

ug/l

0.35

186

Polyneuropathies and other disorders of the peripheral nervous system

2027

19806

1.03

0.57

3.1

0.70

0.79

ug/l

2.56

1510

13636

Intentional self-harm by unspecified means

373

0.79

0.57

2.3

1.17

0.73

ug/l

0.37

196

Pervasive developmental disorders excl. Autism + Asperger

123

1.39

0.57

1.8

1.9

0.35

0.61

ug/l

—

Syphilis

189

2042

0.91

0.57

2.6

2.7

0.63

0.72

ug/l

0.92

130

1222

Benign neoplasm: Eye, unspecified

178

1.34

0.57

3.2

2.7

0.83

0.73

ug/l

0.15

121

Discharge from other and unspecified firearms

290

0.75

0.57

2.3

2.4

0.73

ug/l

0.02

159

Chorioretinal inflammation

131

1444

0.89

0.57

2.5

2.9

0.75

0.74

ug/l

0.06

912

Allergic urticaria

292

2731

1.08

0.57

3.0

2.8

0.68

0.73

ug/l

0.24

173

1669

Bullous pemphigoid

140

1276

1.12

0.57

2.7

3.2

1.10

0.80

ug/l

0.49

880

Valgus deformity, not elsewhere classified

249

1.27

0.57

2.7

2.5

0.75

0.78

ug/l

0.05

153

Other arthrosis

4854

35256

0.98

0.57

3.0

2.9

0.68

0.80

ug/l

9.42

3256

22856

Tibial collateral bursitis [Pellegrini-Stieda]

414

1.21

0.56

2.7

2.6

0.61

0.70

ug/l

0.45

256

Pneumonia due to Haemophilus influenzae

191

0.70

0.56

3.4

3.0

0.99

0.79

ug/l

—

109

Congenital malformations of aortic and mitral valves

318

2996

1.08

0.56

2.9

2.8

0.70

ug/l

0.06

191

1835

Congenital malformations of the circulatory system

844

7873

1.04

0.56

2.8

0.71

0.72

ug/l

0.15

520

4878

Familial erythrocytosis

325

1.26

0.56

2.7

2.8

0.73

0.76

ug/l

0.10

191

Other/unspecified synovitis and tenosynovitis

656

6285

1.05

0.56

2.8

2.9

0.70

0.77

ug/l

0.91

406

4013

Defect, injury or illness of neck

196

1.32

0.56

2.9

2.8

1.26

0.76

ug/l

0.49

121

Suppurative otitis media, unspecified

1077

0.88

0.56

3.1

0.74

0.75

ug/l

0.09

696

Recurrent dislocation of patella

101

898

1.13

0.56

1.9

2.1

0.82

0.69

ug/l

0.22

436

Benign neoplasm: Connective and other soft tissue of thorax

261

1.28

0.56

3.1

2.9

0.57

0.70

ug/l

0.46

174

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

402

0.80

0.56

2.6

2.4

0.42

0.78

ug/l

5.97

255

Other articular cartilage disorders

184

1700

1.10

0.56

3.1

2.8

0.64

0.80

ug/l

1.56

115

1074

Enteropathic arthropathies

1044

0.88

0.55

2.7

2.6

0.64

0.77

ug/l

1.07

617

Acute appendicitis, with complications

1541

15825

0.97

0.55

2.9

0.77

0.76

ug/l

0.10

1001

10193

Gangrene, not elsewhere classified

571

0.83

0.55

2.0

3.1

0.97

0.81

ug/l

0.16

403

Viral pneumonia (known virus, not influenza)

130

1428

0.89

0.55

2.8

3.0

0.74

0.77

ug/l

0.20

954

Malignant neoplasm of penis

424

0.78

0.55

2.9

3.1

0.82

0.84

ug/l

0.05

281

Personal history of risk-factors, not elsewhere classified

533

0.83

0.55

2.0

2.6

0.82

0.68

ug/l

0.26

312

Hyperfunction of pituitary gland

154

1405

1.10

0.55

2.7

2.8

0.60

0.73

ug/l

2.15

101

833

Muscle strain

176

1620

1.10

0.55

2.9

2.8

0.74

0.73

ug/l

0.07

106

1000

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

626

1.18

0.55

2.5

2.7

0.66

0.76

ug/l

0.60

443

Epiphora

780

1.14

0.55

3.2

3.0

0.73

0.81

ug/l

0.38

518

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

205

2198

0.91

0.55

2.9

2.6

0.70

ug/l

0.01

143

1400

Helminthiases

781

1.15

0.55

3.0

2.9

0.65

0.78

ug/l

1.00

503

Traumatic subarachnoid haemorrhage

265

2823

0.92

0.55

2.8

3.0

0.70

0.82

ug/l

1.58

183

1888

Dacryoadenitis

278

1.25

0.54

3.1

2.8

0.64

0.86

ug/l

0.97

188

Dentinal caries

1790

18249

0.97

0.54

2.6

2.8

0.78

0.75

ug/l

0.25

1273

11382

Drug-induced myopathy

211

0.71

0.54

1.9

2.9

1.00

0.92

ug/l

—

137

Childhood asthma (age<16), excluding more controls

321

2712

0.94

0.54

1.6

1.7

0.48

0.54

ug/l

1.22

108

968

Injury of nerves and spinal cord at neck level

152

1653

0.90

0.54

2.4

3.0

0.57

0.73

ug/l

2.43

105

1056

Vascular dementia (undefined)

196

2097

0.92

0.54

2.8

3.4

0.76

0.93

ug/l

2.70

127

1521

Benign neoplasm: Duodenum

146

1592

0.90

0.54

3.1

3.2

0.63

0.77

ug/l

1.83

111

1104

Nail dystrophy

316

1.24

0.54

4.1

2.9

0.63

0.76

ug/l

0.85

198

Ocular pain

299

2806

1.07

0.54

3.0

2.8

0.63

0.73

ug/l

1.74

199

1742

Other autoimmune haemolytic anaemias

668

0.85

0.54

2.8

3.1

1.27

0.80

ug/l

0.98

454

Intracranial and intraspinal abscess and granuloma

796

1.15

0.54

2.9

0.57

0.72

ug/l

1.98

512

Mixed disorders of conduct and emotions, excluding more controls

160

1.32

0.54

1.3

1.5

0.32

0.57

ug/l

—

Fracture of rib(s), sternum and thoracic spine

2806

27537

1.02

0.53

3.1

3.0

0.71

0.78

ug/l

2.22

1907

18218

Psoriatic and enteropathic arthropathies

731

7595

0.96

0.53

2.8

0.59

0.75

ug/l

9.15

448

4722

Crohn's disease of small intestine

328

3477

0.94

0.53

2.7

0.60

0.71

ug/l

2.50

209

2087

Other drug-induced secondary parkinsonism

570

0.83

0.53

2.8

2.9

0.68

0.77

ug/l

0.37

375

Biological medicines for asthma

576

1.17

0.53

2.4

2.5

0.48

0.66

ug/l

2.75

329

Acute mastoiditis

493

1.19

0.53

2.2

2.5

0.76

0.72

ug/l

0.16

268

Chondromalacia

171

1577

1.10

0.53

3.4

2.8

0.67

0.72

ug/l

0.71

103

972

Care involving use of rehabilitation procedures

4933

47514

0.98

0.53

2.9

0.69

0.75

ug/l

3.74

3311

30821

Sequelae of injuries, of poisoning and of other consequences of external causes

1702

17443

0.97

0.53

2.8

2.7

0.62

0.72

ug/l

7.92

1091

10661

Tetraplegia

494

0.82

0.53

2.5

2.9

0.67

0.78

ug/l

0.52

318

Benign neoplasm: Brain, supratentorial

727

1.15

0.53

2.7

2.6

0.82

0.73

ug/l

0.36

449

Deforming dorsopathies

1526

14857

1.03

0.52

2.9

0.65

0.76

ug/l

2.82

1003

9459

Giant cell arteritis with polymyalgia rheumatica

195

1809

1.09

0.52

3.3

0.62

0.79

ug/l

4.00

143

1268

Benign neoplasm: Connective and other soft tissue, unspecified

568

1.17

0.52

3.1

3.0

0.81

0.76

ug/l

0.11

372

Misadventures to patients during surgical and medical care

797

8264

0.96

0.52

3.0

3.1

0.73

0.78

ug/l

0.87

569

5680

Bus occupant injured in other and unspecified transport accidents

189

1.30

0.52

2.7

2.9

0.74

0.70

ug/l

0.09

121

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

1052

10204

1.04

0.52

2.8

0.74

0.73

ug/l

0.29

720

7032

Childhood asthma (age<16)

321

2707

0.94

0.52

1.6

1.7

0.48

0.54

ug/l

1.27

108

971

Other and unspecified heterotropia

137

1.38

0.52

2.6

3.0

1.21

0.73

ug/l

0.36

Ingrowing nail

289

2718

1.07

0.52

2.7

2.6

0.62

0.71

ug/l

1.39

170

1536

Localized scleroderma [morphea]

297

1.23

0.52

3.2

2.7

0.95

0.73

ug/l

0.26

172

Polycythaemia vera

198

2128

0.92

0.52

2.8

2.7

0.77

0.74

ug/l

0.07

140

1434

Hyperchylomicronaemia

185

0.70

0.52

2.5

3.0

0.64

0.70

ug/l

0.24

120

Other congenital malformations of skin

155

1422

1.10

0.51

2.5

2.8

0.62

0.73

ug/l

0.99

880

Mucosal proctocolitis

774

8027

0.96

0.51

2.6

2.7

0.68

0.72

ug/l

0.55

498

4765

Other immunodeficiencies

356

0.80

0.51

2.4

2.7

0.58

0.74

ug/l

0.32

219

Injury of blood vessels at lower leg level

298

0.77

0.51

2.4

2.7

0.74

0.81

ug/l

0.16

178

Contact with other sharp object(s)

395

3752

1.06

0.51

2.9

2.7

0.72

0.69

ug/l

0.43

220

2184

Disorders of male genital organs in diseases classified elsewhere

613

1.18

0.51

3.1

2.4

0.58

0.70

ug/l

1.25

342

Seminoma of testis

101

916

1.14

0.51

2.5

2.6

0.70

0.71

ug/l

0.06

520

Acute generalized exanthematous pustulosis

197

1828

1.09

0.51

3.4

3.1

0.79

0.78

ug/l

0.04

145

1216

Malaria

310

1.24

0.51

2.6

3.1

0.68

0.76

ug/l

0.45

196

Traumatic amputation of ankle and foot

229

0.73

0.51

1.4

2.9

0.48

0.72

ug/l

—

149

Lower leg

199

1.29

0.51

3.5

2.8

0.59

0.80

ug/l

1.36

120

Complications of other internal prosthetic devices, implants and grafts

205

1908

1.09

0.50

2.7

3.1

0.65

0.79

ug/l

2.26

148

1303

Nonalcoholic fatty liver disease

536

5132

1.05

0.50

2.8

2.7

0.70

ug/l

0.00

345

3107

Exposure to other specified electric current

588

1.16

0.50

2.5

2.3

0.65

0.64

ug/l

0.03

291

Infection due to other mycobacteria

834

0.87

0.50

3.4

3.2

0.85

0.81

ug/l

0.08

558

Other renal tubulo-interstitial diseases

671

1.14

0.50

3.2

3.0

1.12

0.78

ug/l

0.31

432

Chronic mastoiditis

189

1758

1.09

0.50

3.2

0.87

0.79

ug/l

0.48

120

1188

Benign neoplasm: Carotid body

120

1.40

0.50

2.0

3.1

0.79

0.70

ug/l

—

Pedestrian injured in other and unspecified transport accidents

537

0.84

0.50

2.9

0.77

0.78

ug/l

0.03

330

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

686

1.16

0.50

3.5

2.7

0.86

0.74

ug/l

0.79

466

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

510

0.83

0.50

2.1

2.6

0.50

0.68

ug/l

2.57

288

Mucinous and mucinous cystic tumor of rectum

381

0.80

0.50

2.3

3.1

0.74

0.76

ug/l

0.04

274

Lactose intolerance

117

1061

1.11

0.50

3.1

2.9

0.73

0.71

ug/l

0.08

664

Correction of physiology of bite - very demanding therapy visit

690

1.14

0.50

2.6

2.8

0.50

0.71

ug/l

3.21

427

Melanoma of uvea

672

0.85

0.50

3.4

3.0

0.71

0.80

ug/l

0.50

445

Cerebral atherosclerosis

745

0.86

0.50

2.6

3.1

0.94

0.85

ug/l

0.13

515

Urticaria due to cold and heat

199

1.28

0.49

2.8

2.3

0.63

0.66

ug/l

0.07

113

Superficial injury of neck

863

1.13

0.49

2.7

2.5

0.61

0.71

ug/l

0.99

472

Asthma, unspecified (mode)

4076

32806

0.98

0.49

3.0

0.69

0.79

ug/l

8.70

2773

21588

Other mosquito-borne viral fevers

130

1.39

0.49

2.4

2.7

0.63

0.71

ug/l

—

Cerebrovascular diseases (FINNGEN)

2841

19953

1.02

0.49

2.7

2.8

0.71

0.73

ug/l

0.26

1919

11898

Retinoschisis and retinal cysts

174

1616

1.10

0.49

3.1

3.2

0.66

0.79

ug/l

1.48

115

1116

Nonalcoholic steatohepatitis

394

1.20

0.49

2.5

2.7

0.56

0.71

ug/l

1.23

247

Immunodeficiency following hereditary defective response to Epstein-Barr virus

0.00

0.49

0.0

2.3

—

0.66

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

218

2328

0.92

0.49

3.2

2.7

0.85

0.77

ug/l

0.52

167

1627

Crohn disease (strict definition, require KELA, min 2 HDR)

272

2891

0.93

0.49

2.5

2.7

0.56

0.69

ug/l

3.84

168

1680

ILD and respiratory illness in diseases classified elsewhere

264

0.77

0.49

3.2

0.58

0.77

ug/l

0.95

167

Unspecified human immunodeficiency virus [HIV] disease

921

0.87

0.49

2.2

2.4

0.71

0.66

ug/l

0.10

481

Asthma, hospital admission 2, infections

3811

38082

0.98

0.49

2.7

2.9

0.66

0.78

ug/l

13.36

2442

24426

Asthma-related infections

3811

38082

0.98

0.49

2.7

2.9

0.66

0.78

ug/l

13.36

2442

24426

Spontaneous rupture of synovium and tendon

539

5168

1.05

0.49

3.1

2.9

0.70

0.78

ug/l

1.17

342

3440

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

393

1.20

0.49

3.8

2.6

0.77

0.75

ug/l

0.05

253

Atrophic disorders of skin

329

3107

1.06

0.49

3.0

2.8

0.76

0.72

ug/l

0.17

224

1899

Golimumab

110

1213

0.90

0.49

2.2

2.4

0.65

0.66

ug/l

0.07

632

Carcinoma in situ of middle ear and respiratory system

402

0.81

0.49

3.4

3.2

0.85

0.76

ug/l

0.34

285

Dermatophytosis

1021

10513

0.96

0.49

2.8

3.0

0.73

0.77

ug/l

0.33

677

7055

Leukaemia of unspecified cell type

438

0.82

0.48

2.6

2.5

0.63

0.78

ug/l

0.84

274

Spondylopathies in diseases classified elsewhere

787

0.87

0.48

3.9

3.0

0.89

0.83

ug/l

0.21

562

Intracranial injury

4505

44144

0.98

0.48

2.9

3.0

0.73

0.78

ug/l

1.57

3018

28695

Spondylopathies (FG)

891

8624

1.04

0.48

2.8

2.7

0.66

0.75

ug/l

2.93

584

5173

Fibrosis of liver

404

0.81

0.48

2.6

2.9

0.88

0.74

ug/l

0.42

263

Malignant neoplasm of other and unspecified parts of tongue

965

0.88

0.48

2.9

3.1

0.84

0.75

ug/l

0.35

649

Hyphaema and other vascular disorders of iris and ciliary body

132

1212

1.11

0.48

2.6

3.0

0.69

0.78

ug/l

0.62

780

Combined immunodeficiencies

492

0.84

0.48

2.7

3.0

1.22

0.73

ug/l

0.31

311

Perioral dermatitis

281

1.22

0.48

2.5

2.6

0.41

0.75

ug/l

3.33

167

Other disorders of choroid

791

1.14

0.48

2.8

3.0

1.08

0.79

ug/l

0.48

511

Benign neoplasm: Hypopharynx

370

1.22

0.48

2.5

3.1

0.82

0.79

ug/l

0.06

240

Hereditary spherocytosis

112

1.40

0.48

2.8

2.3

0.85

0.66

ug/l

—

Psoas tendinitis

165

1.31

0.48

3.4

2.8

1.02

0.75

ug/l

0.30

107

Transplanted organ and tissue status

725

7503

0.96

0.48

2.4

2.8

0.76

0.72

ug/l

0.61

561

4724

Other diseases of hard tissues of teeth

5091

38464

0.98

0.48

3.0

2.8

0.69

0.76

ug/l

6.44

3376

24095

Papulosquamous disorders

2756

28060

0.98

0.48

2.8

2.9

0.67

0.75

ug/l

3.14

1796

18246

MS-disease / Multiple Sclerosis

209

2241

0.93

0.48

2.4

2.6

0.56

0.71

ug/l

3.21

140

1273

Burn and corrosion of other internal organs

174

0.72

0.47

2.6

0.71

0.77

ug/l

—

Deaf mutism, not elsewhere classified

274

0.78

0.47

2.4

2.7

0.83

0.86

ug/l

0.05

176

Other infiltrative disorders of skin and subcutaneous tissue

241

0.76

0.47

3.5

2.9

0.57

0.71

ug/l

0.46

145

Burn and corrosion confined to eye and adnexa

167

1550

1.10

0.47

2.6

0.55

0.70

ug/l

3.58

100

860

Perforation of oesophagus

380

0.81

0.47

3.0

3.1

0.60

0.73

ug/l

0.76

255

Chronic kidney disease

2847

27858

1.02

0.47

2.9

3.3

1.01

0.80

ug/l

9.46

2158

19535

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

121

1317

0.90

0.47

2.5

2.6

0.77

0.69

ug/l

0.48

733

Alopecia areata

627

1.14

0.47

2.6

2.8

0.59

0.72

ug/l

1.28

370

Dermatitis due to substances taken internally

252

2368

1.07

0.47

3.3

3.0

0.75

0.77

ug/l

0.09

180

1523

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

254

0.78

0.47

2.2

2.6

0.56

0.69

ug/l

—

141

Disorders of other and unspecified cranial nerves

294

1.23

0.47

2.8

3.1

0.97

0.86

ug/l

0.23

192

Carcinoma in situ of larynx

170

0.70

0.47

3.2

0.75

0.71

ug/l

—

126

Benign neoplasm: Skin of trunk

232

2177

1.08

0.47

3.0

0.71

0.75

ug/l

0.41

163

1415

Other necrotizing vasculopathies (FG)

352

3345

1.06

0.47

3.0

3.1

0.66

0.82

ug/l

3.93

266

2271

Non-seminoma of testis

397

1.20

0.47

2.8

2.3

0.58

0.68

ug/l

0.51

201

Benign neoplasm: Epididymis

355

1.24

0.47

3.4

2.4

0.74

0.70

ug/l

0.13

222

Seronegative rheumatoid arthritis

554

5316

1.05

0.47

3.0

0.70

0.80

ug/l

2.06

398

3585

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

215

2296

0.93

0.47

3.1

2.9

0.77

0.75

ug/l

0.13

130

1434

Other degenerative diseases of the basal ganglia

134

1238

1.11

0.47

2.8

3.3

0.54

0.78

ug/l

4.29

102

880

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

294

0.79

0.46

2.9

2.6

0.67

0.77

ug/l

0.38

198

Melanocytic naevi of lip

201

1.26

0.46

3.2

2.5

0.69

0.71

ug/l

0.05

119

Contact with blunt object, undetermined intent

341

1.21

0.46

3.2

2.7

0.67

0.75

ug/l

0.26

202

Intentional self-harm by jumping from a high place

208

0.75

0.46

1.6

2.1

0.59

0.63

ug/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

139

1.34

0.46

2.8

2.3

0.51

0.81

ug/l

1.56

Muscle wasting and atrophy, not elsewhere classified

391

0.82

0.46

2.3

2.9

0.78

0.81

ug/l

0.09

256

Injury of urinary and pelvic organs

158

1467

1.10

0.46

3.0

2.9

0.67

0.76

ug/l

0.93

103

914

Mantle cell lymphoma

831

0.87

0.46

3.5

3.0

0.73

0.78

ug/l

0.21

563

Disorder of the sleep-wake schedule

773

1.13

0.46

2.6

2.7

0.63

0.72

ug/l

0.71

467

Benign neoplasm: Connective and other soft tissue of head, face and neck

898

1.12

0.46

3.1

3.0

0.81

0.75

ug/l

0.25

569

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

804

8293

0.96

0.46

3.0

2.8

0.74

0.73

ug/l

0.07

561

5803

Candidiasis

553

5757

0.96

0.45

2.9

3.0

0.76

0.75

ug/l

0.09

398

3773

Burn and corrosion, body region unspecified

361

1.21

0.45

2.6

2.7

0.80

0.74

ug/l

0.22

222

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

434

0.83

0.45

2.2

2.6

0.69

0.76

ug/l

0.33

277

Injury of nerves at forearm level

843

1.13

0.45

2.5

2.7

0.71

0.68

ug/l

0.09

513

Benign neoplasm: Nasopharynx

520

1.17

0.45

3.2

2.9

0.76

0.82

ug/l

0.18

329

Vascular dementia (subcortical)

174

1620

1.09

0.45

2.8

3.5

0.76

0.88

ug/l

1.18

136

1165

Disorders of puberty

103

1.37

0.45

1.9

1.5

0.31

0.46

ug/l

—

Renal agenesis and other reduction defects of kidney

261

0.78

0.45

3.2

2.8

0.52

0.73

ug/l

1.65

162

Generalized skin eruption due to drugs and medicaments

169

1569

1.09

0.45

3.4

3.1

0.78

ug/l

0.00

124

1051

Pneumoconiosis due to asbestos and other mineral fibres

214

2270

0.92

0.45

3.2

3.4

0.88

0.86

ug/l

0.08

159

1660

Pedestrian injured in collision with car, pick-up truck or van

103

1132

0.90

0.45

3.1

2.8

0.80

0.74

ug/l

0.23

695

Injury of cranial nerves

369

0.82

0.45

3.0

2.7

0.67

0.73

ug/l

0.24

216

Benign neoplasm: Skin of lower limb, including hip

130

1195

1.10

0.45

3.0

2.6

0.73

0.76

ug/l

0.13

752

Deposits [accretions] on teeth

405

4093

0.95

0.45

2.7

2.8

0.72

0.76

ug/l

0.48

289

2554

Acquired pure red cell aplasia [erythroblastopenia]

222

1.26

0.45

3.2

2.9

1.21

0.80

ug/l

0.31

153

Mixed connective tissue disease

159

1717

0.92

0.45

2.7

3.0

0.70

0.76

ug/l

0.32

107

1120

Fall involving bed

147

1587

0.91

0.45

3.0

3.2

0.85

0.83

ug/l

0.04

109

1102

Congenital malformation of vitreous humour

0.00

0.44

0.0

2.9

—

0.75

—

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

0.44

0.0

2.8

—

0.71

—

Other specified and unspecified disorders of conjunctiva

492

1.17

0.44

2.2

2.7

0.56

0.76

ug/l

2.22

305

Contusion of toe(s) without damage to nail

821

1.12

0.44

2.9

2.7

0.67

0.72

ug/l

0.24

476

Typhus fever

0.00

0.44

0.0

3.0

—

0.74

—

Mandibular prognathia

521

0.85

0.44

2.7

0.73

0.72

ug/l

0.02

307

Other bursitis, not elsewhere classified

603

0.86

0.44

2.9

0.64

0.80

ug/l

0.95

384

Hepatomegaly and splenomegaly, not elsewhere classified

634

0.86

0.44

3.0

2.8

0.87

0.76

ug/l

0.40

414

Other disorders of electrolyte and fluid balance, not elsewhere classified

391

0.83

0.44

2.9

3.1

0.66

0.74

ug/l

0.23

255

Use of interferon beta-1a

522

0.85

0.44

1.7

2.3

0.55

0.63

ug/l

0.52

248

Restrictive cardiomyopathy

226

0.76

0.44

3.2

3.0

0.92

0.71

ug/l

0.41

143

Nezelof syndrome

227

0.76

0.44

2.2

3.0

0.57

0.72

ug/l

0.78

154

2583

25165

1.02

0.44

2.7

2.8

0.63

0.76

ug/l

12.34

1603

15380

Acute poliomyelitis

541

0.85

0.44

2.6

2.8

0.56

0.79

ug/l

1.47

318

Mesothelioma, excluding all cancers (controls excluding all cancers)

1081

0.89

0.44

3.0

2.9

0.83

0.79

ug/l

0.23

771

All influenza (not pneumonia)

1164

11941

0.97

0.43

2.7

2.8

0.74

0.75

ug/l

0.10

708

7345

Cholesteatoma of external ear

514

1.17

0.43

3.6

3.0

0.69

0.74

ug/l

0.17

343

Tularaemia

802

0.88

0.43

2.2

3.0

0.60

0.79

ug/l

1.72

521

Exclusion endpoint for supernumerary teeth

313

1.20

0.43

2.4

0.52

0.75

ug/l

1.76

160

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

961

9031

1.03

0.43

2.9

2.8

0.81

0.72

ug/l

1.16

619

5609

Myositis

168

1566

1.09

0.43

2.9

0.69

0.76

ug/l

0.57

117

1020

Operations for atrial fibrillation

160

1498

1.10

0.43

2.7

3.1

0.70

0.75

ug/l

0.36

1015

Infective bursitis

276

2622

1.07

0.43

3.2

2.8

0.70

0.74

ug/l

0.59

181

1672

Acquired absence of organs, not elsewhere classified

801

0.88

0.43

2.1

3.0

1.04

0.75

ug/l

0.65

526

Fracture of skull and facial bones

1643

16786

0.97

0.43

2.7

0.67

0.73

ug/l

2.03

1067

10052

Carcinoma in situ of oral cavity, oesophagus and stomach

373

1.20

0.43

1.8

2.6

0.66

0.79

ug/l

0.37

257

Other melanin hyperpigmentation

961

0.89

0.43

3.5

3.1

0.84

0.78

ug/l

0.27

654

Open bite

840

1.11

0.43

3.2

2.4

0.68

0.69

ug/l

0.06

447

Heart failure and hypertrophic cardiomyopathy

123

1330

0.90

0.43

2.6

3.1

0.62

0.78

ug/l

1.77

894

Intestinal adhesions without obstruction

543

5228

1.05

0.43

2.9

3.1

0.80

0.81

ug/l

0.06

368

3579

ILD medications: nintedanib

585

0.85

0.43

2.4

3.2

0.58

0.79

ug/l

1.90

418

Other acute viral hepatitis

664

1.14

0.43

2.4

2.6

0.68

0.72

ug/l

0.20

367

Ulcerative rectosigmoiditis

509

5293

0.96

0.43

2.7

2.8

0.75

0.72

ug/l

0.29

322

3210

Burn and corrosion of trunk

186

1984

0.92

0.43

2.9

0.66

0.72

ug/l

0.73

128

1261

Chronic hepatitis NAS

550

0.86

0.43

2.7

2.9

0.75

0.73

ug/l

0.03

348

Other and unspecified myoneural disorders

187

1.28

0.42

2.3

2.9

0.69

0.78

ug/l

0.27

121

Rheumatism, unspecified

252

2374

1.06

0.42

3.2

2.9

0.80

0.74

ug/l

0.19

164

1531

Retinoblastoma

0.00

0.42

0.0

1.5

—

0.55

—

Other disorders of binocular movement

710

0.88

0.42

2.8

2.9

0.58

0.72

ug/l

1.15

441

Magnesium deficiency

213

0.76

0.42

2.5

2.8

0.39

0.77

ug/l

3.98

139

Arthropathy in ulcerative colitis

539

0.86

0.42

2.9

2.6

0.67

0.70

ug/l

0.10

326

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

867

8421

1.04

0.42

3.2

2.8

0.84

0.75

ug/l

1.80

617

5968

Convergent concomitant strabismus

197

2103

0.93

0.42

2.4

2.5

0.52

0.70

ug/l

3.29

101

1139

Benign neoplasm: Pharynx, unspecified

372

1.19

0.42

2.7

2.9

0.68

0.73

ug/l

0.29

241

Striae atrophicae

222

1.23

0.42

2.9

2.8

0.54

0.78

ug/l

1.82

115

Other salmonella infections

227

2140

1.07

0.42

3.3

2.9

0.74

0.75

ug/l

0.08

161

1364

Acute nasopharyngitis (common cold)

1205

11693

1.03

0.42

2.2

2.3

0.66

0.63

ug/l

0.43

572

5922

hereditary angioödema type 3

0.00

0.42

0.0

2.0

—

0.41

—

Abnormal results of function studies

518

4985

1.05

0.42

3.0

2.9

0.73

0.74

ug/l

0.14

352

3215

Ankylosis of joint

323

0.81

0.42

3.6

2.8

0.96

0.95

ug/l

0.02

211

Hemiplegia

265

2797

0.94

0.42

2.6

3.1

0.72

0.80

ug/l

0.32

195

1866

Other bursitis of knee

117

1080

1.11

0.42

2.9

2.7

0.76

ug/l

0.01

665

Exposure to ignition of highly flammable material

374

0.82

0.42

3.6

2.6

0.75

0.78

ug/l

0.10

220

Purpura and other haemorrhagic conditions

824

8490

0.97

0.42

2.8

3.1

0.79

0.78

ug/l

0.06

565

5728

Postprocedural endocrine and metabolic disorders, not elsewhere classified

330

3138

1.06

0.41

2.9

0.66

0.73

ug/l

1.08

231

1993

Thyroiditis

193

1806

1.07

0.41

3.3

2.9

0.68

0.75

ug/l

1.01

133

1151

Other diseases of liver

1058

10862

0.97

0.41

2.9

0.74

0.75

ug/l

0.06

697

6984

Other and unspecified erythematous conditions

140

1297

1.09

0.41

3.1

2.9

0.77

ug/l

0.01

858

Other/unspecified disorders of vestibular function

195

1830

1.08

0.41

3.0

3.1

0.72

0.77

ug/l

0.26

125

1232

Small plaque parapsoriasis

189

1.29

0.41

3.2

3.1

0.68

0.69

ug/l

0.01

118

Early syphilis

105

966

1.11

0.41

2.6

2.5

0.59

0.70

ug/l

0.98

519

Benign neoplasm: Small intestine

230

2172

1.07

0.41

2.9

2.7

0.67

0.74

ug/l

0.57

177

1471

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

536

1.16

0.41

2.9

2.7

0.61

0.76

ug/l

1.36

368

Iodine-deficiency-related thyroid disorders and allied conditions

0.00

0.41

0.0

3.3

—

0.86

—

Disorders of optic nerve and visual pathways

439

4210

1.05

0.41

3.0

0.74

ug/l

0.03

286

2699

Drug-induced osteoporosis with pathological fracture

548

0.86

0.41

2.6

3.0

0.48

0.75

ug/l

2.70

367

Disorders of puberty, all

114

1.32

0.41

1.8

1.5

0.31

0.47

ug/l

—

Barrett oesophagus

455

4382

1.05

0.41

3.4

3.0

0.74

0.76

ug/l

0.08

313

2906

Other disorders of binocular vision

303

0.82

0.41

2.6

0.72

0.70

ug/l

—

179

Other abnormal auditory perceptions

344

1.18

0.41

3.5

2.8

1.33

0.75

ug/l

0.40

212

Other general symptoms and signs

199

1847

1.07

0.40

3.3

3.0

0.74

0.76

ug/l

0.11

126

1175

LSIL lesion of the cervix uteri

0.00

0.40

0.0

1.1

—

Persistent mood disorders

1016

10437

0.97

0.40

2.6

2.8

0.59

0.76

ug/l

10.90

726

6529

Drug-induced tremor

343

0.82

0.40

2.4

3.1

0.77

0.75

ug/l

0.05

236

Cardiac murmurs and other cardiac sounds

325

3057

1.05

0.40

3.2

3.0

0.81

0.78

ug/l

0.12

224

2030

Mixed disorders of conduct and emotions

168

1.26

0.40

1.3

1.4

0.32

0.52

ug/l

—

Hereditary deficiency of other clotting factors

298

1.20

0.40

3.1

2.9

0.68

0.77

ug/l

0.20

200

Asthma mixed form (mode), excluding more controls

275

2896

0.94

0.40

2.9

3.1

0.72

0.84

ug/l

1.26

162

1948

Hypertrophy of bone

152

1.30

0.40

2.9

2.7

0.62

0.71

ug/l

0.42

Sequelae of intentional self-harm, assault and events of undetermined intent

290

0.81

0.40

3.0

2.4

0.46

0.69

ug/l

2.87

156

Coronary atherosclerosis

7009

45627

0.99

0.40

2.8

3.0

0.73

0.77

ug/l

1.85

4795

29980

Melanocytic naevi, other sites/unspecified

435

4176

1.05

0.40

3.0

0.73

ug/l

0.00

281

2698

Other encephalitis

144

1339

1.09

0.40

2.8

2.9

0.77

ug/l

0.01

831

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.40

0.0

1.1

—

Pedal cyclist injured in noncollision transport accidents

692

6703

1.04

0.40

2.8

0.66

0.72

ug/l

1.45

454

4069

Endometriosis of pelvic peritoneum

0.00

0.40

0.0

1.1

—

Systemic disorders of connective tissue in diseases classified elsewhere

198

1.26

0.39

2.5

2.7

0.69

0.75

ug/l

0.21

126

Other peripheral vertigo

490

4717

1.05

0.39

3.2

3.1

0.77

ug/l

0.05

358

3245

Triptan medication for migraine, min. 3 purchases

1478

11931

0.98

0.39

2.6

2.5

0.64

0.67

ug/l

0.76

796

6524

Hereditary motor and sensory neuropathy

469

1.16

0.39

2.8

3.0

0.76

0.74

ug/l

0.06

288

Non-follicular lymphoma, hilmo, excluding all cancers

735

7135

1.04

0.39

2.8

2.7

0.76

0.72

ug/l

0.52

509

4912

Melanoma in situ, other sites/unspecified

190

1.27

0.39

4.7

3.0

0.98

0.78

ug/l

0.41

118

Benign neoplasm: Pelvic bones, sacrum and coccyx

143

1.30

0.39

2.8

2.6

0.51

0.76

ug/l

1.36

Burns and corrosions

958

9835

0.97

0.39

2.8

2.7

0.67

0.72

ug/l

1.29

604

5973

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

306

3212

0.95

0.39

2.5

2.7

0.57

0.69

ug/l

3.66

181

1881

Medial epicondylitis

194

1824

1.07

0.39

2.8

2.7

0.74

0.72

ug/l

0.15

123

1125

Dystonia

217

2046

1.07

0.39

2.6

2.9

0.72

0.75

ug/l

0.08

150

1305

Burn and corrosion of hip and lower limb, except ankle and foot

132

1420

0.92

0.39

2.8

0.69

0.75

ug/l

0.33

865

Viral hepatitis, IBD co-morbidity

322

3374

0.95

0.39

2.3

2.4

0.53

0.80

ug/l

7.00

213

1692

Childhood allergy (age < 16)

109

821

1.09

0.39

1.3

0.40

ug/l

0.05

239

Anuria and oliguria

437

0.84

0.39

3.8

3.0

0.73

0.77

ug/l

0.14

285

Myopia

465

4469

1.04

0.39

2.7

0.64

0.69

ug/l

1.14

286

2610

Contact with other specified venomous animals

319

1.19

0.39

2.8

0.67

0.73

ug/l

0.19

202

ILD, hospital admissions 1, main diag only

1049

10746

0.97

0.39

2.9

3.3

0.71

0.82

ug/l

2.62

752

7703

D07AA Corticosteroids, weak (group I)

664

6419

1.04

0.39

2.7

2.8

0.63

0.74

ug/l

3.17

412

3996

Sequelae of other external causes

308

2938

1.06

0.38

2.7

3.0

0.63

0.75

ug/l

1.27

220

1910

Giant cell arteritis

217

2051

1.07

0.38

3.4

3.3

0.61

0.79

ug/l

4.97

162

1443

Monoplegia

794

1.11

0.38

2.6

2.9

0.68

0.78

ug/l

0.55

512

Malignant neoplasm of kidney, except renal pelvis

760

7814

0.96

0.38

3.1

3.2

0.86

0.80

ug/l

0.95

581

5469

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4199

41449

1.01

0.38

3.1

0.74

0.78

ug/l

1.35

2870

28220

Benign neoplasm of other and unspecified intrathoracic organs

606

0.87

0.38

3.0

1.41

0.80

ug/l

0.94

395

Artificial joint re-operation

377

3615

1.05

0.38

3.3

3.2

0.65

0.77

ug/l

2.82

274

2528

Ankylosing spondylitis, strict definition

283

2696

1.06

0.38

2.5

0.70

0.67

ug/l

0.30

183

1477

Pemphigus

415

0.84

0.38

3.4

3.1

0.81

0.75

ug/l

0.08

259

Drug-induced thyroiditis

192

1.28

0.38

2.5

2.7

0.74

0.73

ug/l

0.03

127

Malnutrition

817

0.89

0.38

2.2

3.0

1.46

0.79

ug/l

0.91

538

Personal history of allergy to analgesic agent

217

1.23

0.38

3.1

2.6

0.45

0.75

ug/l

2.61

129

Injury of blood vessels at shoulder and upper arm level

146

1.32

0.38

3.2

3.0

1.29

0.73

ug/l

0.53

Beningn neoplasm: Meninges, unspecified

469

1.14

0.37

3.7

2.6

0.78

0.77

ug/l

0.03

319

Implicit Sepsis

6645

51143

1.01

0.37

2.9

3.0

0.78

0.77

ug/l

0.21

4686

33881

Lactose intolerance, other/unspecified

103

946

1.10

0.37

3.2

2.8

0.78

0.72

ug/l

0.21

579

ILD medications: pirfenidone

1005

0.89

0.37

2.6

3.3

0.60

0.74

ug/l

0.87

716

Other dermatomyositis

168

0.76

0.37

2.4

2.8

0.72

0.75

ug/l

—

111

Benign neoplasm: Penis

222

1.28

0.37

2.5

2.9

0.43

0.72

ug/l

3.44

150

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

265

1.21

0.37

2.3

2.8

0.90

0.78

ug/l

0.15

172

Carcinoma in situ of lip, oral cavity and pharynx

192

1.27

0.37

1.7

2.6

0.50

0.81

ug/l

1.44

127

Budesonide

750

7283

1.03

0.37

3.1

2.8

0.66

0.75

ug/l

1.98

480

4538

Contact with lifting and transmission devices, not elsewhere classified

183

1730

1.08

0.37

3.0

2.8

0.69

0.72

ug/l

0.30

129

1065

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

569

1.14

0.37

2.7

2.8

1.11

0.80

ug/l

0.30

410

Non-follicular lymphoma

735

7559

0.97

0.37

2.8

3.2

0.76

0.79

ug/l

0.35

509

5306

Radiculopathy

1123

11495

0.97

0.37

3.1

3.0

0.70

0.83

ug/l

5.03

778

7805

Other juvenile arthritis

735

0.89

0.37

2.0

2.4

0.64

0.72

ug/l

0.54

391

Other disorders of Eustachian tube

138

1286

1.08

0.37

3.1

2.9

0.64

0.72

ug/l

1.03

101

813

Follow-up care involving plastic surgery

104

1130

0.91

0.37

3.5

3.1

0.70

0.73

ug/l

0.22

763

Benign neoplasm: Bones of skull and face

277

0.82

0.37

2.7

2.4

0.46

0.71

ug/l

1.94

175

Cluster headache, wide

216

2044

1.07

0.37

2.5

2.6

0.67

0.72

ug/l

0.31

128

1232

Disorders of synovium and tendon in diseases classified elsewhere

153

1435

1.08

0.37

3.1

2.8

0.58

0.74

ug/l

2.72

102

910

Benign neoplasm: Ribs, sternum and clavicle

118

1.33

0.37

3.1

2.6

0.54

0.80

ug/l

—

Acute lymphadenitis

265

2785

0.95

0.36

2.5

2.7

0.66

0.72

ug/l

0.35

138

1626

Guillain-Barre syndrome

113

1048

1.10

0.36

3.4

2.9

0.71

0.76

ug/l

0.31

684

Other primary thrombocytopenia

163

1.27

0.36

3.0

0.74

0.71

ug/l

0.07

113

Central retinal artery occlusion

152

1618

0.92

0.36

2.9

3.4

0.70

0.84

ug/l

1.17

105

1151

Exposure to other and unspecified animate mechanical forces

106

977

1.09

0.36

2.6

0.73

0.69

ug/l

0.13

550

Arthropathic psoriasis

701

7217

0.97

0.36

2.9

0.59

0.74

ug/l

8.65

442

4563

Melanocytic naevi of ear and external auricular canal

209

1.22

0.36

3.0

2.6

0.67

0.85

ug/l

0.45

139

Corneal ulcer

1186

11597

1.03

0.36

2.8

0.71

0.73

ug/l

0.39

730

7154

Distal bite

532

1.13

0.36

2.5

0.76

0.68

ug/l

0.31

303

Other/unspecified crystal arthropathies

360

1.17

0.36

4.0

3.2

0.62

0.86

ug/l

1.44

245

Benign neoplasm: Oesophagus

718

0.89

0.36

2.7

2.9

0.54

0.77

ug/l

2.44

473

Lifestyle-related condition

614

0.88

0.36

3.0

2.9

0.75

0.73

ug/l

0.06

377

Use of rotigotine

655

0.88

0.36

3.4

3.0

0.67

0.73

ug/l

0.45

446

Other congenital malformations of intestine

387

1.16

0.36

2.5

2.8

0.57

0.83

ug/l

1.83

245

Spinal osteochondrosis

625

1.12

0.36

3.1

2.5

0.46

0.77

ug/l

4.66

357

Phobic anxiety disorders

446

4631

0.96

0.36

2.5

2.4

0.53

0.67

ug/l

4.53

283

2400

Other and unspecified mononeuropathies of lower limb

126

1172

1.09

0.35

2.9

0.64

0.75

ug/l

1.04

758

Hypersomnia

769

1.11

0.35

2.9

0.83

0.72

ug/l

0.22

488

Malignant neoplasm of tongue

140

1492

0.92

0.35

2.7

3.0

0.81

0.74

ug/l

0.48

1003

Malignant neoplasm of nasopharynx

229

0.79

0.35

2.5

2.9

0.66

0.80

ug/l

0.54

141

Dissection of aorta

275

2873

0.94

0.35

2.9

3.2

0.89

0.81

ug/l

0.20

195

1990

Blindness, monocular

455

0.86

0.35

3.0

0.75

0.84

ug/l

0.30

295

Pedal cyclist injured in collision with pedestrian or animal

446

1.15

0.35

2.8

0.60

0.70

ug/l

0.71

274

Residual foreign body in soft tissue

375

3607

1.05

0.35

2.9

2.7

0.60

0.72

ug/l

3.49

239

2194

Chloasma

1.37

0.35

3.1

2.8

0.73

0.67

ug/l

—

Nonspecific lymphadenitis

288

2750

1.05

0.35

2.4

2.6

0.81

0.70

ug/l

0.33

154

1590

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

188

1986

0.94

0.35

3.3

2.7

0.72

0.75

ug/l

0.24

129

1331

Polyarteritis nodosa and related conditions

624

0.88

0.35

2.5

3.0

0.67

0.74

ug/l

0.49

405

Xanthelasma of eyelid

369

1.16

0.35

2.7

2.8

0.66

0.77

ug/l

0.43

243

Embolic stroke with flimmer

175

1851

0.93

0.35

2.9

3.3

0.83

ug/l

0.01

113

1317

Hypermobility syndrome

341

0.85

0.35

2.1

2.3

0.90

0.67

ug/l

0.22

168

Benign neoplasm: Spinal meninges

369

1.16

0.34

2.9

3.1

1.17

0.73

ug/l

0.44

251

Traumatic subdural haemorrhage

1224

12281

0.97

0.34

3.1

3.3

0.84

0.85

ug/l

0.08

882

8674

Other specified/unspecified deforming dorsopathies

644

1.11

0.34

3.2

2.6

0.62

0.80

ug/l

1.66

380

KRA_PSY_EATING, excluding more controls

719

0.90

0.34

2.5

0.45

0.70

ug/l

3.49

383

Malignant neoplasm of urinary organs

835

8556

0.97

0.34

3.1

3.2

0.86

0.80

ug/l

0.92

627

6026

Neuroendocrine tumor and carcinoma of pancreas

410

0.85

0.34

2.5

3.1

0.87

0.77

ug/l

0.27

265

Osteitis due to dental implant

295

1.18

0.34

2.4

2.9

0.76

0.77

ug/l

0.05

189

Autism

425

0.87

0.34

2.0

1.9

0.50

0.57

ug/l

0.29

166

Toxic liver disease

779

0.90

0.34

2.8

3.0

0.66

0.74

ug/l

0.36

490

Perforation of tympanic membrane

549

5667

0.96

0.34

3.0

0.89

0.77

ug/l

0.69

386

3738

Drug-induced polyneuropathy

485

1.14

0.34

3.1

3.0

0.96

0.75

ug/l

0.30

312

Corneal scars and opacities

164

1546

1.07

0.34

3.2

3.0

0.66

0.76

ug/l

1.22

120

1009

Respiratory disorders in diseases classified elsewhere

695

0.89

0.34

3.0

3.1

0.66

0.76

ug/l

0.69

460

Other secondary coxarthrosis

197

1867

1.07

0.34

3.0

2.9

0.71

0.78

ug/l

0.66

134

1193

Astigmatism

291

2780

1.05

0.34

2.7

2.9

0.76

0.75

ug/l

0.03

189

1752

Other and unspecified corneal deformities and disorders

172

1623

1.07

0.33

3.1

2.8

0.66

0.74

ug/l

1.02

123

961

Scleritis

455

1.14

0.33

2.7

0.80

0.73

ug/l

0.36

274

Villonodular synovitis (pigmented)

380

1.15

0.33

2.6

2.5

0.54

0.74

ug/l

1.76

221

Hypertension, Pulmonary Arterial

348

0.85

0.33

2.3

2.8

0.60

0.79

ug/l

0.79

225

Unspecified kidney failure

828

8080

1.03

0.33

2.8

3.2

0.89

0.83

ug/l

0.74

617

5698

Benign neoplasm: Larynx

255

2438

1.06

0.33

2.9

2.6

0.71

0.74

ug/l

0.30

164

1571

Benign neoplasm: Other and unspecified parts of small intestine

772

1.10

0.33

2.7

3.1

0.76

0.78

ug/l

0.07

525

Artificial opening status

393

3791

1.05

0.33

2.9

3.1

0.83

0.78

ug/l

0.22

270

2597

Sequelae with surgical and medical care as external cause

1265

12907

0.98

0.33

3.1

0.73

0.78

ug/l

1.09

895

8883

Asthma mixed form (mode)

275

2876

0.95

0.33

2.9

3.1

0.72

0.83

ug/l

1.22

162

1920

Dislocation, sprain and strain of joints and ligaments of head

129

1381

0.93

0.33

2.4

2.7

0.57

0.73

ug/l

2.30

772

Primary angle-closure glaucoma

234

2229

1.06

0.33

3.4

3.2

0.76

0.79

ug/l

0.24

173

1542

Encephalitis

151

1420

1.07

0.33

2.7

2.8

0.77

0.76

ug/l

0.03

104

882

Venous thromboembolism

4295

42137

0.99

0.33

3.1

0.81

0.79

ug/l

0.38

3015

28637

Otosclerosis

424

4092

1.04

0.33

3.2

3.1

0.78

0.75

ug/l

0.29

273

2764

Iliotibial band syndrome

323

1.16

0.33

2.8

2.5

0.77

0.73

ug/l

0.11

192

Other endocrine disorders

153

1566

0.94

0.33

3.3

2.8

0.71

0.76

ug/l

0.42

106

982

Recurring oral aphthae

187

1975

0.94

0.33

2.8

3.0

0.63

0.76

ug/l

1.72

121

1272

Hereditary retinal dystrophy

744

1.10

0.33

2.7

2.8

0.59

0.73

ug/l

1.54

454

Drug-induced interstitial lung disorders, unspecified

1.40

0.32

2.2

3.0

0.33

0.65

ug/l

—

Anomalies of dental arch relationship, including avohilmo

734

6412

1.03

0.32

2.9

2.7

0.64

0.70

ug/l

1.28

413

3810

Previous suicide attempt

379

0.86

0.32

1.8

2.6

0.81

0.73

ug/l

0.11

213

Open bite that required surgery (Lefort1 or BSSRO)

154

0.77

0.32

2.2

2.3

0.50

0.70

ug/l

—

Neuralgic amyotrophy

149

1.29

0.32

3.5

2.8

0.51

0.69

ug/l

0.80

104

Cicatricial alopecia [scarring hair loss]

230

1.19

0.32

2.0

3.0

1.11

0.73

ug/l

0.36

149

Other acquired deformities of musculoskeletal system and connective tissue

280

2922

0.95

0.32

3.0

2.8

0.83

0.71

ug/l

0.46

189

1791

Noninfectious colitis NAS

693

6742

1.03

0.32

2.9

0.72

0.75

ug/l

0.26

469

4288

Melanocytic naevi of eyelid, including canthus

389

0.86

0.32

2.3

3.0

1.03

0.72

ug/l

0.33

253

Use of cabergoline

610

1.11

0.32

2.5

2.8

0.70

0.79

ug/l

0.44

373

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

781

7999

0.97

0.32

3.0

2.8

0.74

0.73

ug/l

0.05

545

5605

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

411

4255

0.96

0.32

3.1

2.7

0.76

0.74

ug/l

0.26

297

2910

Anankastic personality disorder

132

1409

0.93

0.32

2.9

2.6

0.49

0.70

ug/l

5.19

820

Other disorders of teeth and supporting structures

1538

15654

0.98

0.32

2.8

2.9

0.78

0.77

ug/l

0.14

1055

10130

Other and unspecified disorders of white blood cells

233

2441

0.95

0.32

2.9

3.1

0.75

0.76

ug/l

0.06

157

1618

Motorcycle rider injured in other and unspecified transport accidents

429

4147

1.04

0.32

2.6

2.5

0.60

0.67

ug/l

1.59

239

2328

Scoliosis

213

2022

1.06

0.32

3.2

2.9

0.72

0.77

ug/l

0.32

149

1303

Lesion of ulnar nerve

1122

11450

0.98

0.32

2.9

0.67

0.75

ug/l

1.06

783

7297

Specific development disorders of scholastic skills

743

1.10

0.32

1.9

2.0

0.38

0.59

ug/l

3.81

302

Neuralgia and neuritis, unspecified

232

2433

0.95

0.32

3.0

2.8

0.80

0.74

ug/l

0.20

152

1539

Benign neoplasm: Retina

250

1.19

0.32

2.9

2.5

0.73

ug/l

0.02

166

Isolated proteinuria

209

1991

1.06

0.32

3.0

0.94

0.76

ug/l

0.88

157

1308

Amblyopia ex anopsia

137

1460

0.93

0.32

2.6

2.9

0.86

0.75

ug/l

0.31

909

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

236

0.80

0.32

2.8

2.7

0.52

0.70

ug/l

0.77

121

Inflammatory disorders of male genital organs, not elsewhere classified

141

1332

1.08

0.31

3.0

2.5

0.96

0.72

ug/l

0.60

781

Sciatica+with lumbago

3634

34892

0.99

0.31

2.7

2.8

0.65

0.77

ug/l

9.33

2427

22086

Effects of other external causes

142

1509

0.93

0.31

2.5

0.60

0.68

ug/l

0.82

815

Other specified disorders of kidney and ureter

181

1908

0.94

0.31

2.7

3.0

0.76

0.74

ug/l

0.12

126

1262

Benign neoplasm: Floor of mouth

204

1.22

0.31

3.4

2.3

0.74

0.76

ug/l

0.06

123

Hodgkin lymphoma, hilmo

168

1774

0.94

0.31

2.8

3.0

0.73

0.74

ug/l

0.06

113

1119

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

344

1.15

0.31

3.3

2.7

0.71

0.76

ug/l

0.21

230

Osteoporosis with pathological fracture (FG)

538

0.89

0.31

2.6

2.9

0.48

0.85

ug/l

3.50

355

Allergic asthma (mode)

1167

11219

1.02

0.31

2.7

0.64

0.75

ug/l

2.55

692

6679

Chronic iridocyclitis

228

2390

0.95

0.31

3.0

2.9

0.74

0.75

ug/l

0.07

158

1474

Severe visual impairment, binocular

238

0.82

0.31

3.7

2.8

0.66

0.87

ug/l

0.60

156

Scarlet fever

292

0.84

0.31

1.8

2.2

0.66

0.62

ug/l

—

134

Polymyositis

402

1.14

0.31

2.8

3.0

0.69

0.76

ug/l

0.36

264

Disorders of eyelid, lacrimal system and orbit

6549

50924

1.01

0.31

3.2

3.0

0.76

0.78

ug/l

1.18

4611

34261

Meralgia paraesthetica

197

1874

1.06

0.31

2.8

2.9

0.58

0.72

ug/l

3.49

131

1202

Disorders of parathyroid gland

776

7469

1.03

0.31

3.1

0.80

0.81

ug/l

0.07

572

5115

Car occupant injured in other and unspecified transport accidents

972

9938

0.98

0.31

2.9

2.7

0.69

0.74

ug/l

1.04

609

6023

Atopic dermatitis

2704

22755

1.01

0.31

2.7

0.66

0.72

ug/l

2.45

1651

13219

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

282

2708

1.05

0.31

3.0

0.82

0.75

ug/l

0.57

188

1782

Spinal instabilities

134

1425

0.93

0.30

2.6

2.7

0.59

0.73

ug/l

2.36

868

Immunodeficiencies

192

2021

0.94

0.30

2.8

2.9

0.77

0.76

ug/l

0.03

138

1264

Fracture of foot, except ankle

1393

13677

1.02

0.30

2.6

2.7

0.64

0.72

ug/l

3.66

857

8305

Pemphigoid

161

1524

1.07

0.30

2.8

3.3

1.03

0.81

ug/l

0.39

111

1056

Injury of muscle and tendon at wrist and hand level

1196

11736

1.02

0.30

2.8

0.69

0.72

ug/l

0.23

749

7266

Secondary and unspecified malignant neoplasm of lymph nodes

597

6134

0.97

0.30

2.8

3.1

0.78

0.77

ug/l

0.10

398

4191

Retinal haemorrhage

141

1329

1.07

0.30

3.4

3.1

0.78

0.81

ug/l

0.17

882

Lesion of plantar nerve

184

1744

1.06

0.30

3.5

3.1

0.71

0.76

ug/l

0.39

121

1155

Other congenital malformations, not elsewhere classified

194

1.20

0.30

2.8

0.66

0.76

ug/l

0.29

113

Traumatic ischaemia of muscle

824

0.91

0.30

2.4

2.6

0.58

0.71

ug/l

1.15

492

Subacute thyroiditis

101

938

1.08

0.30

3.1

3.0

0.67

0.74

ug/l

0.53

611

Fracture of neck

453

4671

0.96

0.30

2.7

3.1

0.65

0.77

ug/l

1.91

304

3096

Injury of nerves at ankle and foot level

365

0.86

0.30

3.2

2.6

0.66

ug/l

0.02

222

Other noninfective disorders of lymphatic vessels and lymph nodes

154

1454

1.07

0.30

3.0

2.9

0.79

0.75

ug/l

0.15

915

Malignant neoplasm of gum

289

0.83

0.30

2.5

2.9

0.62

0.74

ug/l

0.55

197

Hyperparathyroidism

697

6708

1.03

0.30

3.1

0.80

0.81

ug/l

0.10

512

4601

Benign neoplasm: Parathyroid gland

431

1.13

0.30

3.1

0.76

0.75

ug/l

0.03

290

Congenital malformations of the nervous system

514

0.89

0.30

2.0

2.5

0.52

0.67

ug/l

1.90

275

Other and unspecified disorders of pigmentation

259

0.84

0.30

3.5

2.7

0.59

0.71

ug/l

0.54

151

Certolizumab pegol

392

1.13

0.30

2.1

2.5

0.55

0.69

ug/l

0.71

216

Postinfectious hypothyroidism

108

0.73

0.30

3.1

2.6

0.49

0.88

ug/l

—

Other metabolic disorders

395

3813

1.04

0.30

2.8

2.9

0.66

0.73

ug/l

1.59

266

2437

Speech and linguistic disorders

212

1936

1.05

0.29

2.3

2.4

0.58

0.70

ug/l

1.01

135

1032

Burn and corrosion of wrist and hand

208

2180

0.95

0.29

2.5

2.7

0.67

0.71

ug/l

0.32

126

1273

Dental pulpitis 3

462

0.90

0.29

1.1

1.3

0.32

0.39

ug/l

1.40

131

Spondylolisthesis/Spondylolysis

1077

10554

1.02

0.29

2.8

2.9

0.66

0.76

ug/l

1.56

709

6776

Motor- or nonmotor-vehicle accident in traffic area

301

0.85

0.29

2.7

2.5

0.85

0.73

ug/l

0.26

175

Injury of blood vessels at wrist and hand level

520

1.13

0.29

2.7

2.9

0.78

0.77

ug/l

0.02

327

Optic atrophy

958

0.92

0.29

2.9

0.71

0.73

ug/l

0.07

612

Other orthopaedic follow-up care

322

3101

1.04

0.29

2.7

2.9

0.60

0.72

ug/l

1.98

235

1989

Fourth [trochlear] nerve palsy

154

1459

1.07

0.29

2.9

3.2

0.70

0.78

ug/l

0.67

110

994

Malignant immunoproliferative diseases

674

1.11

0.29

2.9

2.8

0.66

0.75

ug/l

0.58

466

L04AD Calcineurin inhibitors

686

7032

0.97

0.29

2.2

2.8

0.77

0.70

ug/l

1.10

531

4314

Monoarthritis, not elsewhere classified

245

2346

1.05

0.29

2.7

2.8

0.74

0.79

ug/l

0.42

165

1454

Benign neoplasm: Peripheral nerves and autonomic nervous system

817

1.09

0.29

3.5

2.9

0.71

0.74

ug/l

0.17

522

Cysts of oral region, not elsewhere classified

340

3282

1.04

0.29

3.0

2.8

0.92

0.77

ug/l

0.60

212

2070

Hypermetropia

298

2863

1.05

0.29

3.1

2.9

0.70

0.73

ug/l

0.38

196

1833

Injury of nerves at wrist and hand level

285

2742

1.05

0.29

2.7

0.73

0.71

ug/l

0.06

182

1649

Contact with sharp glass

187

1965

0.95

0.29

2.5

0.75

0.70

ug/l

0.25

103

1079

Benign neoplasm: Eye, unspecified

196

1.20

0.29

3.2

3.0

0.83

0.70

ug/l

0.22

136

Benign neoplasm: Ciliary body

150

1.25

0.29

2.4

2.6

0.77

0.79

ug/l

—

Viral encephalitis, not elsewhere classified/unspecified

105

1122

0.93

0.29

3.7

2.9

0.66

0.77

ug/l

0.77

722

Brachial plexus disorders

377

3640

1.04

0.29

2.8

2.7

0.61

0.68

ug/l

1.73

240

2152

Personal history of medical treatment

471

1.12

0.29

2.8

3.0

0.87

0.77

ug/l

0.35

317

Oher contracture of tendon (sheath)

225

1.20

0.29

3.4

2.9

0.63

0.92

ug/l

1.18

149

Benign neoplasm: Endocrine pancreas

454

1.13

0.29

3.8

3.3

0.86

0.79

ug/l

0.27

309

Contact with venomous snakes and lizards

500

0.89

0.29

2.7

3.0

0.75

0.77

ug/l

0.03

325

Vitiligo

490

0.89

0.29

2.7

2.6

0.67

0.71

ug/l

0.18

291

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

489

0.88

0.29

2.7

3.2

0.77

ug/l

0.00

331

Unspecified threat to breathing

322

0.86

0.29

2.9

2.8

0.53

0.76

ug/l

2.77

197

Osteomyelitis of vertebra

266

0.83

0.29

2.2

3.0

0.66

0.85

ug/l

0.81

180

Sicca syndrome [Sjögren]

176

1669

1.06

0.29

2.9

3.0

0.69

0.75

ug/l

0.62

116

1088

Malignant neoplasm of endocrine gland

275

2640

1.05

0.28

3.1

3.0

0.77

0.74

ug/l

0.23

192

1728

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

478

0.88

0.28

2.3

2.6

0.82

0.76

ug/l

0.08

324

Benign neoplasm: Larynx

255

2652

0.95

0.28

2.9

3.1

0.71

0.76

ug/l

0.61

164

1759

Dermatopolymyositis, unspecified

299

0.85

0.28

2.8

3.0

0.68

0.75

ug/l

0.37

205

Varicella [chickenpox]

380

3924

0.96

0.28

2.5

2.4

0.65

0.67

ug/l

0.15

187

2105

Disorders resulting from impaired renal tubular function

230

2399

0.95

0.28

2.5

3.0

0.91

0.73

ug/l

3.12

188

1571

Horner syndrome

693

1.10

0.28

2.6

2.8

0.71

0.77

ug/l

0.26

451

Other and unspecified injuries of forearm

321

0.86

0.28

3.3

2.6

0.83

0.69

ug/l

0.38

185

Amyloidosis

138

1305

1.07

0.28

2.9

3.2

0.71

0.78

ug/l

0.62

106

938

Mental disorders, not otherwise specified

286

2976

0.96

0.28

2.5

2.6

0.55

0.68

ug/l

2.34

197

1663

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

936

0.92

0.28

2.0

0.51

0.63

ug/l

1.33

397

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

768

0.91

0.28

3.2

2.8

0.73

0.80

ug/l

0.50

544

Benign neoplasm: Long bones of lower limb

176

1674

1.06

0.28

2.9

2.7

0.68

0.72

ug/l

0.43

106

982

Malignant neoplasm of other connective and soft tissue

146

1540

0.94

0.28

3.1

3.2

0.74

0.79

ug/l

0.44

112

1046

Emotional disorders and disorders of social functioning with onset specific to childhood

402

0.88

0.28

1.6

1.7

0.36

0.54

ug/l

2.48

132

Frontotemporal dementia, wide, incl. Pick's disease

445

0.88

0.28

2.4

3.2

0.92

0.83

ug/l

0.09

309

Benign neoplasm: Mediastinum

192

0.81

0.28

2.4

2.7

1.10

0.75

ug/l

0.27

123

Peptic ulcer

592

0.90

0.28

2.8

2.9

0.63

0.82

ug/l

1.37

386

Noninfective enteritis and colitis

3111

31423

0.99

0.28

2.8

2.9

0.70

0.75

ug/l

2.09

2015

19860

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

347

3593

0.96

0.28

2.8

3.2

0.79

0.77

ug/l

0.20

243

2455

Spondyloarthritis

1221

12428

0.98

0.28

2.8

2.9

0.72

0.78

ug/l

0.96

808

7871

Follicular cysts of skin and subcutaneous tissue

1316

12938

1.02

0.27

2.9

0.76

0.74

ug/l

0.13

867

8313

Superficial injury of thorax

1042

10621

0.98

0.27

3.0

2.9

0.68

0.77

ug/l

1.36

698

6774

Pedal cyclist injured in collision with motor vehicle

148

1562

0.94

0.27

3.2

2.7

0.68

0.73

ug/l

0.50

921

Immunodeficiency with predominantly antibody defects

104

973

1.08

0.27

3.0

2.8

0.63

0.71

ug/l

0.51

587

Other/unspecified mastoiditis and related conditions

273

1.17

0.27

2.6

2.8

0.69

0.72

ug/l

0.12

169

Melanocytic naevi of lip

215

1.18

0.27

3.2

2.8

0.69

0.77

ug/l

0.26

131

Dermatitis

4349

43077

1.01

0.27

2.9

3.0

0.72

0.77

ug/l

1.30

2932

28396

289

0.86

0.27

2.3

2.5

0.80

0.72

ug/l

0.12

165

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1860

18857

0.98

0.27

4.0

2.8

1.57

0.72

ug/l

20.13

1442

13247

Abnormal findings on diagnostic imaging of central nervous system

219

2096

1.05

0.27

2.8

2.9

0.72

0.74

ug/l

0.21

138

1340

Open wound of neck

580

0.90

0.27

2.5

2.6

0.47

0.70

ug/l

3.75

325

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.66

0.27

2.7

3.0

1.25

0.83

ug/l

—

Donors of organs and tissues

644

0.91

0.27

2.6

0.77

0.69

ug/l

0.47

377

Other disorders of optic [2nd] nerve and visual pathways

340

3285

1.04

0.27

3.1

3.0

0.76

0.75

ug/l

0.03

228

2163

Pulmonary eosinophilia, not elsewhere classified

602

0.90

0.27

2.9

3.0

0.70

0.81

ug/l

0.50

391

Other specified and unspecified disorders of choroid

198

1.20

0.27

3.2

2.8

0.62

0.70

ug/l

0.24

120

Papillary adenocarcinoma of thyroid gland

174

1655

1.06

0.27

2.9

3.0

0.71

0.73

ug/l

0.20

125

1067

Contact with other hot fluids

142

1499

0.94

0.27

3.1

2.7

0.72

0.71

ug/l

0.06

904

Open wound of shoulder and upper arm

127

1200

1.07

0.27

2.2

2.7

0.57

0.72

ug/l

2.12

709

Chronic Coagulation defects

635

1.09

0.27

2.9

2.7

0.68

0.74

ug/l

0.24

388

Struck by thrown, projected or falling objec

363

3516

1.04

0.27

2.7

2.8

0.70

0.72

ug/l

0.15

215

2143

Chronic myeloid leukaemia

286

0.85

0.27

2.6

2.9

0.69

0.67

ug/l

0.04

181

Exposure to other and unspecified forces of nature

287

0.85

0.27

2.6

2.9

0.53

0.73

ug/l

1.20

192

Other reaction to severe stress, and adjustment disorders

1563

15880

0.98

0.27

2.6

2.5

0.63

0.70

ug/l

2.22

987

8628

Superficial injury of abdomen, lower back and pelvis

879

8609

1.02

0.27

2.9

0.71

0.76

ug/l

0.40

564

5462

Findings of drugs and other substances, not normally found in blood

274

1.16

0.27

3.9

2.7

0.62

0.71

ug/l

0.45

166

Superficial injury of forearm

476

4625

1.03

0.27

2.8

0.69

0.72

ug/l

0.27

320

2883

Colorectal neuroendocrine tumor and carcinoma

622

0.91

0.26

2.6

3.0

0.67

0.76

ug/l

0.70

404

Other superficial injuries of ankle and foot

287

0.86

0.26

2.0

2.7

0.73

0.69

ug/l

0.06

167

Other specified/unspecified disorders of bone/cartilage

222

2132

1.05

0.26

2.9

2.7

0.68

0.70

ug/l

0.10

133

1302

Onycholysis

207

1.18

0.26

2.8

3.0

0.93

0.73

ug/l

0.76

119

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

630

0.90

0.26

2.9

0.73

0.80

ug/l

0.29

393

Sequelae of poliomyelitis

516

0.89

0.26

2.6

3.2

0.96

0.80

ug/l

0.65

374

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

143

1504

0.94

0.26

2.9

2.6

0.72

ug/l

0.02

990

Lumbosacral plexus disorders

161

1.21

0.26

3.5

3.0

0.64

0.73

ug/l

0.28

118

Use of rasagiline

181

1891

0.95

0.26

3.2

0.63

0.77

ug/l

2.70

132

1330

Other gastritis (incl. Duodenitis)

1792

17675

1.02

0.26

3.1

0.73

0.80

ug/l

1.58

1330

12013

Abscess of tendon sheath

293

1.15

0.26

2.4

3.1

0.48

0.77

ug/l

2.90

183

Migraine without aura, drug-induced

192

0.83

0.26

2.1

2.2

0.68

0.66

ug/l

—

Other prurigo

486

0.89

0.26

2.9

3.1

0.52

0.84

ug/l

3.25

312

Superficial injury of ankle and foot

550

5358

1.03

0.26

2.7

0.66

0.71

ug/l

0.96

333

3194

Rhinophyma

663

1.11

0.26

3.3

3.1

1.00

0.84

ug/l

0.59

457

Malignant neoplasm of anus and anal canal

233

0.84

0.26

1.5

3.0

0.42

0.75

ug/l

—

163

Attention to artificial openings

319

3088

1.04

0.26

3.1

3.2

1.00

0.81

ug/l

0.83

231

2148

Ventral hernia

1630

16537

0.98

0.26

3.1

0.74

0.80

ug/l

1.73

1132

11223

Mixed and other personality disorders

376

3880

0.97

0.26

2.3

2.5

0.50

0.67

ug/l

4.94

279

2132

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

163

1552

1.06

0.25

3.2

3.0

0.67

0.79

ug/l

1.38

115

992

Benign neoplasm: Lip

125

1320

0.94

0.25

3.3

3.0

0.80

0.78

ug/l

0.10

877

Nephropathy induced by other drugs, medicaments and biological substances

125

1.27

0.25

2.7

0.71

0.76

ug/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

5417

49795

1.01

0.25

3.1

0.77

0.79

ug/l

0.42

3742

34056

Benign neoplasm of other and unspecified sites

164

1720

0.95

0.25

3.3

2.9

0.71

0.76

ug/l

0.42

112

1099

Benign neoplasm: other/unspecified salivary gland

163

1554

1.06

0.25

2.9

3.1

0.78

0.80

ug/l

0.08

109

1071

Benign neoplasm: Tonsil

620

0.91

0.25

2.5

3.0

0.65

0.72

ug/l

0.52

411

Other congenital malformations

277

2666

1.04

0.25

2.5

2.7

0.64

0.72

ug/l

0.90

170

1618

Viral infections of the central nervous system

328

3391

0.96

0.25

2.9

2.7

0.64

0.72

ug/l

1.16

206

2025

Carcinoma in situ of larynx

156

0.79

0.25

3.2

2.9

0.75

0.82

ug/l

—

115

Benign neoplasm: Scrotum

480

1.13

0.25

2.7

2.9

0.55

0.75

ug/l

2.03

319

Ischemic heart diseases

7589

47826

0.99

0.25

2.8

2.9

0.72

0.77

ug/l

2.72

5066

30772

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

826

0.92

0.25

2.9

2.6

0.69

0.74

ug/l

0.22

468

Disorders of optic nerve, not elsewhere classified

132

1253

1.07

0.25

3.2

3.0

0.78

0.79

ug/l

0.02

848

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

546

0.90

0.25

2.4

2.5

0.75

ug/l

0.01

352

Glaucoma secondary to eye trauma

487

1.11

0.25

3.3

3.0

0.80

0.79

ug/l

0.04

314

Trigeminal neuralgia

240

2308

1.04

0.25

3.3

3.0

0.71

0.77

ug/l

0.41

171

1526

Other congenital malformations of digestive system

106

1.27

0.25

3.6

2.6

0.81

0.69

ug/l

—

Atopic dermatitis, strict definition

1012

9734

1.02

0.24

2.5

0.64

0.68

ug/l

0.95

576

5343

Carcinoma in situ of lip, oral cavity and pharynx

201

1.20

0.24

1.7

2.8

0.50

0.77

ug/l

1.26

135

Seborrhoeic dermatitis

779

7637

1.03

0.24

2.9

3.0

0.76

0.78

ug/l

0.14

524

5055

Dietary selenium deficiency

0.00

0.24

0.0

3.1

—

0.81

—

Burns and corrosions confined to eye and internal organs

187

1792

1.05

0.24

2.5

2.6

0.56

0.70

ug/l

3.48

110

996

Vascular dementia (mixed)

907

0.93

0.24

2.9

3.4

0.85

0.89

ug/l

0.15

650

Other specified/unspecified systemic involvement of connective tissue

150

1577

0.95

0.24

2.9

3.0

0.67

0.76

ug/l

0.53

105

1019

Idiopathic peripheral autonomic neuropathy

189

0.82

0.24

3.6

3.0

0.79

0.94

ug/l

0.24

113

Primary_lymphoid and hematopoietic malignant neoplasms

1893

18683

1.02

0.24

2.9

2.8

0.77

0.73

ug/l

1.21

1308

12823

Thrombocytopenia, unspecified

463

4752

0.97

0.24

2.9

3.1

0.82

0.77

ug/l

0.42

320

3224

Assault by other specified means

442

0.89

0.24

2.4

2.3

0.52

0.72

ug/l

1.93

225

Malignant neoplasm of parotid gland

482

0.90

0.24

2.7

3.0

0.73

0.74

ug/l

0.04

312

Asthma, unspecified (mode), excluding more controls

3984

31551

0.99

0.24

3.0

0.69

0.78

ug/l

7.43

2706

20676

Injury of blood vessels at hip and thigh level

209

0.83

0.24

2.8

3.1

0.55

0.73

ug/l

0.73

142

Other and unspecified mood [affective] disorders

222

2310

0.96

0.24

2.3

2.5

0.48

0.71

ug/l

10.04

150

1226

Viral conjunctivitis

776

1.08

0.24

2.8

2.7

0.69

0.70

ug/l

0.06

454

Other follicular disorders

369

3800

0.97

0.23

2.6

2.8

0.65

0.71

ug/l

0.93

233

2319

Cluster headache, strict

195

1871

1.05

0.23

2.5

2.6

0.67

0.70

ug/l

0.17

116

1114

Drug-induced adrenocortical insufficiency

680

0.92

0.23

3.5

3.0

1.11

0.79

ug/l

0.27

444

Burns classified according to extent of body surface involved

643

1.09

0.23

2.5

2.8

0.66

0.71

ug/l

0.24

397

Eating disorder

702

0.92

0.23

2.5

2.4

0.45

0.65

ug/l

2.72

378

Other acute disseminated demyelination

285

1.13

0.23

2.4

2.7

0.71

0.72

ug/l

0.01

157

Mandibular retrognathia AND surgery (BSSRO)

815

1.07

0.23

2.8

2.5

0.66

0.65

ug/l

0.07

448

Mental and behavioural disorders due to hallucinogens

210

0.84

0.23

1.5

2.1

0.41

0.59

ug/l

0.78

Atypical virus infections of central nervous system

482

0.90

0.23

2.8

0.60

0.75

ug/l

0.86

277

Familial hypercholesterolemia

1466

14463

1.02

0.23

3.1

3.3

0.77

0.79

ug/l

0.41

1013

10290

Other and unspecified nail disorders

865

0.93

0.23

2.9

0.68

0.76

ug/l

0.41

556

Post-traumatic stress disorder

168

1604

1.05

0.23

2.7

2.5

0.54

0.68

ug/l

2.95

111

843

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

294

0.87

0.23

3.3

3.0

0.83

0.81

ug/l

0.05

190

Benign lipomatous neoplasm of other sites/unspecified

542

5294

1.03

0.23

3.0

3.1

0.74

0.79

ug/l

0.46

384

3591

Allergic asthma (mode), excluding more controls

1167

11268

1.02

0.23

2.7

0.64

0.76

ug/l

2.55

692

6720

Kela reimbursement Agammaglobulinemia (D80-84)

324

1.13

0.23

2.8

2.6

0.70

0.69

ug/l

0.03

181

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

194

2016

0.95

0.23

2.8

2.6

0.73

0.71

ug/l

0.12

129

1315

Congenital malformations of oesophagus

239

1.15

0.23

2.1

3.1

0.66

0.74

ug/l

0.37

162

Oral lichen ruber planus

719

1.08

0.23

3.1

3.0

0.65

0.74

ug/l

0.70

474

Pediculosis and phthiriasis

271

0.86

0.23

1.7

2.5

0.61

0.70

ug/l

0.25

150

Post-traumatic wound infection, not elsewhere classified

173

1659

1.05

0.23

2.8

0.65

0.74

ug/l

1.03

113

1011

Thromboangiitis obliterans

261

0.86

0.23

2.7

3.1

0.74

0.82

ug/l

0.16

185

Varus deformity, not elsewhere classified

263

0.87

0.23

2.3

2.7

0.55

0.95

ug/l

1.78

166

Traction detachment of retina

522

0.90

0.23

3.0

2.8

0.68

0.74

ug/l

0.34

317

Gout due to impairment of renal function

921

0.93

0.22

2.9

3.1

1.02

0.80

ug/l

0.80

629

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

0.00

0.22

0.0

2.0

—

0.70

—

Chronic inflammatory disorders of orbit

145

1.21

0.22

1.9

2.8

0.61

0.69

ug/l

—

Tooth agenesis EXCLUDE clefts and syndromes

554

1.09

0.22

2.3

2.4

0.70

0.69

ug/l

0.02

283

Disorders of calcium metabolism

330

3399

0.97

0.22

3.0

3.1

0.88

0.76

ug/l

1.06

244

2327

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

302

0.87

0.22

2.9

3.3

0.65

0.83

ug/l

0.77

211

Deficiency of other B group vitamins

101

1068

0.94

0.22

2.9

3.1

0.79

0.82

ug/l

0.09

727

Diseases of arteries, arterioles and capillaries (FINNGEN)

2557

18046

0.99

0.22

2.7

2.9

0.70

0.74

ug/l

0.81

1747

11217

Migraine, unspecified, drug-induced

163

1.18

0.22

2.2

2.5

0.65

0.73

ug/l

—

Family history of certain disabilities and chronic diseases leading to disablement

138

1314

1.05

0.22

2.6

0.66

0.70

ug/l

0.26

744

Disorder of pancreatic internal secretion, other and/or unspecified

293

0.87

0.22

2.7

0.59

0.71

ug/l

0.48

178

Discitis, unspecified

130

1241

1.06

0.22

3.0

0.69

0.80

ug/l

0.89

857

Bursitis of shoulder

131

1248

1.06

0.22

3.5

2.8

0.72

0.73

ug/l

0.05

789

Malignant neoplasm of other and unspecified major salivary glands

218

0.84

0.22

2.3

2.9

0.56

0.73

ug/l

1.62

148

Chondrolysis

0.00

0.22

0.0

2.6

—

0.75

—

Contact with hot air and gases

442

1.11

0.22

2.7

2.8

0.90

0.71

ug/l

0.37

275

Other disorders of central nervous system

522

0.91

0.22

3.3

2.8

0.87

0.79

ug/l

0.27

337

Other superficial mycoses

122

1161

1.06

0.22

2.9

2.7

0.59

0.72

ug/l

1.59

702

Acute inflammation of orbit

297

1.13

0.22

2.8

2.6

0.47

0.75

ug/l

3.03

187

Other and unspecified disorders of adult personality and behaviour

177

0.84

0.22

2.9

2.3

0.59

0.74

ug/l

—

Lichen planus

637

6239

1.02

0.22

2.9

3.0

0.76

ug/l

0.01

405

4160

Benign neoplasm: Orbit, unspecified

278

1.13

0.22

2.7

3.1

0.94

0.78

ug/l

0.29

181

Other and unspecified mononeuropathies, also in other diseases

165

1720

0.95

0.21

2.9

3.0

1.04

0.77

ug/l

0.52

104

1144

Ulcerative proctitis

342

3324

1.03

0.21

2.8

0.66

0.72

ug/l

0.63

223

2040

Benign neoplasm: Rectum/anal canal icd-9

428

0.90

0.21

3.8

3.2

0.86

0.88

ug/l

0.03

303

Other papulosquamous disorders

552

0.91

0.21

3.4

3.0

0.64

0.77

ug/l

0.55

362

Protozoal diseases

163

1698

0.95

0.21

2.2

3.1

0.64

0.75

ug/l

1.15

116

1118

Ankylosing hyperostosis [Forestier]

114

1086

1.07

0.21

3.1

2.9

0.58

0.76

ug/l

3.24

741

Labour and delivery complicated by umbilical cord complications

0.00

0.21

0.0

1.1

—

Inflammatory disorders of breast

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.0

—

Other puerperal infections

0.00

0.21

0.0

1.1

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.21

0.0

1.1

—

Lesion of femoral nerve

261

0.87

0.21

3.3

2.9

0.63

0.67

ug/l

0.12

179

Examination and observation for other reasons

5364

32835

0.99

0.21

2.7

2.8

0.65

0.78

ug/l

15.40

3832

20255

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.21

0.0

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

1175

11579

1.02

0.21

2.9

3.0

0.78

ug/l

0.02

799

7741

Elevated blood glucose level

510

5215

0.97

0.21

2.8

0.68

0.70

ug/l

0.20

354

3365

Adult-onset Still disease

176

0.84

0.21

3.3

2.5

0.58

0.72

ug/l

—

100

Viral warts

477

4884

0.97

0.21

2.6

2.8

0.63

0.73

ug/l

2.71

290

3049

Secondary polycythaemia

190

1832

1.05

0.21

3.1

2.8

0.72

0.74

ug/l

0.17

125

1143

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

110

0.80

0.21

3.4

2.8

0.87

0.66

ug/l

—

Hypertrophy of breast in women and men

400

3894

1.03

0.21

3.3

3.0

0.66

0.74

ug/l

1.25

259

2481

Wide developmental disorders, excluding more controls

537

0.92

0.21

2.0

2.1

0.47

0.60

ug/l

0.80

220

Whooping cough

155

0.83

0.21

2.5

2.4

0.40

0.72

ug/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.1

—

Open wound of ankle and foot

716

7292

0.98

0.21

2.7

2.9

0.69

0.74

ug/l

1.05

453

4633

Single delivery by forceps and vacuum extractor

0.00

0.20

0.0

1.0

—

Benign neoplasm: Scapula and long bones of upper limb

559

1.09

0.20

3.1

2.8

0.77

0.72

ug/l

0.15

337

Burns and corrosions of multiple body regions

673

0.92

0.20

3.3

2.9

0.76

0.78

ug/l

0.06

420

Inflammatory diseases of the central nervous system

497

4859

1.03

0.20

2.8

2.9

0.67

0.73

ug/l

0.67

326

3070

Disorders of phosphorus metabolism and phosphatases

249

0.87

0.20

2.9

0.76

0.68

ug/l

0.16

165

Unspecified parasitic disease

599

1.09

0.20

2.6

3.1

0.60

0.81

ug/l

1.83

404

Hypertrophy of (infrapatellar) fat pad

530

0.91

0.20

2.7

0.57

0.74

ug/l

1.36

313

Hypertensive Renal Disease

292

3004

0.96

0.20

2.8

3.2

0.91

0.82

ug/l

0.80

221

2118

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

452

1.10

0.20

2.6

2.7

0.69

0.68

ug/l

0.05

278

Other facial nerve disorders

130

1241

1.05

0.20

2.9

0.74

0.75

ug/l

0.04

799

Tuberculosis of other organs, strict

117

1228

0.95

0.20

3.0

3.2

0.63

0.83

ug/l

2.43

850

Complications of genitourinary prosthetic devices, implants and grafts

102

967

1.06

0.20

2.7

3.1

0.97

0.79

ug/l

0.54

662

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

541

0.92

0.20

2.5

2.6

0.60

0.79

ug/l

1.57

358

Sarcoidosis

882

8677

1.02

0.20

2.8

2.9

0.76

0.74

ug/l

0.15

546

5536

Flat foot [pes planus] (acquired)

294

3030

0.97

0.20

2.9

2.8

0.76

ug/l

0.00

196

1920

Benign neoplasm: Brain, supratentorial

773

1.07

0.20

2.7

2.9

0.82

0.75

ug/l

0.23

485

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

939

0.94

0.20

2.8

2.7

0.64

0.73

ug/l

0.79

632

Other and unspecified local infections of skin and subcutaneous tissue

604

6160

0.98

0.20

2.9

3.0

0.71

0.76

ug/l

0.88

406

4043

Need for immunization against other single viral diseases

146

1401

1.05

0.20

2.4

2.7

0.79

0.69

ug/l

0.28

108

817

Amoebiasis

270

1.13

0.20

3.5

2.8

0.65

0.69

ug/l

0.16

169

Maxillary retrognathism

568

1.08

0.20

2.6

2.5

0.90

0.72

ug/l

0.42

311

Pedestrian injured in transport accident

374

3645

1.03

0.20

2.6

2.9

0.72

0.73

ug/l

0.08

243

2270

Disorders of conjunctiva

4791

40386

0.99

0.20

3.0

2.8

0.70

0.74

ug/l

1.29

3000

25194

Other and unspecified disorders of binocular movement

203

1.15

0.20

3.3

2.5

0.56

0.70

ug/l

0.76

130

Neuroendocrine tumor and carcinoma of small intestine

902

1.07

0.20

3.0

3.1

0.78

0.79

ug/l

0.03

622

Left ventricular outflow tract obstruction, narrow definition

354

3450

1.03

0.20

2.9

2.8

0.76

0.71

ug/l

0.36

210

2118

Acute myringitis

249

0.87

0.20

2.5

2.7

0.68

0.72

ug/l

0.05

152

Kaposi sarcoma

119

1.23

0.20

3.1

3.0

0.69

ug/l

—

Failure and rejection of transplanted organs and tissues

857

0.93

0.20

2.5

2.8

0.87

0.71

ug/l

0.94

529

Chronic myringitis

269

0.87

0.20

3.2

3.0

0.99

0.69

ug/l

0.45

176

Other and unspecified injuries of wrist and hand

161

1546

1.05

0.20

3.3

2.7

0.65

0.72

ug/l

0.70

106

906

Polyarthritis, unspecified

202

1950

1.04

0.20

3.2

2.9

0.73

0.81

ug/l

0.86

138

1268

Severe visual impairment, monocular

405

1.10

0.20

3.2

3.0

1.27

0.86

ug/l

0.35

272

Endocrine disorders, other/unspecified

787

0.93

0.20

3.9

2.8

0.72

ug/l

0.04

480

Malignant neoplasm of ureter

176

1.18

0.20

2.2

3.1

0.69

0.77

ug/l

0.21

124

Foreign body or object entering through skin

465

4549

1.03

0.20

2.9

2.7

0.65

0.71

ug/l

0.95

302

2765

Shigellosis

185

1.16

0.19

2.0

2.8

0.73

0.71

ug/l

0.03

116

Other specified/unspecified soft tissue disorders

192

1851

1.04

0.19

3.1

3.0

0.83

0.79

ug/l

0.09

130

1235

Calcific tendinitis of shoulder

278

2699

1.03

0.19

2.7

2.8

0.55

0.73

ug/l

6.81

182

1732

Congenital lactase deficiency

1.16

0.19

3.5

2.9

0.63

0.65

ug/l

—

Divergent concomitant strabismus

339

3481

0.97

0.19

2.8

0.84

0.70

ug/l

0.47

214

2086

Marfan's syndrome

279

0.88

0.19

1.6

2.6

0.56

0.70

ug/l

1.01

161

Symptoms and signs concerning food and fluid intake

618

6290

0.98

0.19

3.0

3.2

0.72

0.79

ug/l

0.87

439

4303

Intussusception

519

0.92

0.19

2.7

0.69

0.82

ug/l

0.54

327

Disorders of pituitary gland, other and/or unspecified

252

1.13

0.19

3.1

2.6

0.91

0.64

ug/l

0.49

149

Poisoning by narcotics and psychodysleptics [hallucinogens]

631

0.93

0.19

2.0

2.2

0.37

0.68

ug/l

5.78

272

Benign neoplasm: Urethra

1.17

0.18

4.3

2.9

0.60

0.84

ug/l

—

Other specified/unspecified dorsopathies

169

1628

1.04

0.18

2.9

2.8

0.71

0.77

ug/l

0.24

114

1029

Superficial injury of hip and thigh

849

8619

0.98

0.18

3.0

3.1

0.78

0.83

ug/l

0.50

574

5876

Other specified and unspecified disorders of lens

300

1.11

0.18

4.3

3.1

1.02

0.88

ug/l

0.34

213

Lesion of lateral popliteal nerve

374

3654

1.03

0.18

2.7

3.0

0.68

0.74

ug/l

0.74

243

2368

Foreign body granuloma of skin and subcutaneous tissue

163

0.84

0.18

3.0

2.8

0.50

0.71

ug/l

—

108

Granuloma annulare

404

0.91

0.18

3.5

2.9

0.75

0.80

ug/l

0.19

267

Certain disorders involving the immune mechanism

1264

12482

1.01

0.18

2.8

2.9

0.77

0.73

ug/l

0.43

821

7974

Small fibre neuropathy

205

1986

1.04

0.18

3.1

0.65

0.76

ug/l

1.64

142

1332

Viral meningitis

139

1333

1.05

0.18

2.4

2.5

0.62

0.71

ug/l

0.70

706

Benign neoplasm: Urethra

1.15

0.18

4.3

3.4

0.60

0.72

ug/l

—

Family history of other conditions

271

1.11

0.18

3.4

2.3

0.72

0.70

ug/l

0.08

146

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1061

10469

1.02

0.18

3.0

2.8

0.81

0.73

ug/l

1.01

747

7306

Nonpyogenic thrombosis of intracranial venous system

368

1.10

0.18

3.4

2.8

0.76

0.72

ug/l

0.08

229

Impacted maxillary canine

153

0.84

0.18

2.8

3.1

0.81

0.84

ug/l

—

105

Cushing syndrome

434

0.91

0.18

3.5

3.0

0.80

0.72

ug/l

0.20

288

Paralytic strabismus

484

4744

1.02

0.18

2.9

3.2

0.75

0.76

ug/l

0.10

337

3237

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

158

1.18

0.18

2.3

2.8

0.91

0.77

ug/l

—

112

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

349

0.89

0.18

2.3

2.7

0.74

ug/l

0.00

244

Acquired coagulation factor deficiency

0.72

0.18

1.8

2.7

0.43

0.82

ug/l

—

Tongue abnormality

272

2645

1.03

0.18

3.4

3.1

0.71

0.75

ug/l

0.21

198

1751

Benign neoplasm: Bronchus and lung

945

1.06

0.18

2.7

3.1

0.61

0.78

ug/l

2.03

630

Emotional disorders starting during childhood or adolecense, excluding more controls

436

0.92

0.18

1.6

1.8

0.33

0.58

ug/l

4.70

149

Other and unspecified disorders of autonomic nervous system

173

0.85

0.18

3.3

2.8

0.78

0.71

ug/l

—

120

Toxic effect of other noxious substances eaten as food

148

1.17

0.18

2.5

2.8

0.38

0.64

ug/l

—

Other bursitis of hip

679

1.07

0.18

3.3

3.0

0.77

0.81

ug/l

0.19

452

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

136

1306

1.05

0.18

3.0

2.6

0.62

0.73

ug/l

1.27

749

Pityriasis rosea

224

1.13

0.17

2.5

2.6

0.59

0.71

ug/l

0.54

129

Thyroiditis, ILD-related definition

301

2930

1.03

0.17

3.0

2.9

0.70

0.75

ug/l

0.57

200

1825

Intestinal malabsorption

227

2339

0.97

0.17

2.7

2.9

0.62

0.72

ug/l

1.78

160

1464

Hyperprolactinaemia, drug-induced

110

1.19

0.17

2.2

2.9

0.44

0.72

ug/l

—

Adhesive middle ear disease

719

1.06

0.17

3.1

2.8

0.81

0.77

ug/l

0.18

447

Allergic bronchopulmonary aspergillosis (ABPA)

317

0.89

0.17

3.8

3.0

0.71

0.76

ug/l

0.20

226

Pedestrian injured in collision with two- or three-wheeled motor vehicle

158

1.16

0.17

1.7

2.6

0.57

0.69

ug/l

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

191

1971

0.96

0.17

2.8

0.84

0.73

ug/l

0.59

135

1369

Benign neoplasm of middle ear and respiratory system

629

6187

1.02

0.17

2.9

3.0

0.76

0.77

ug/l

0.15

415

4126

Anorexia

309

0.90

0.17

2.3

2.8

0.53

0.76

ug/l

1.91

192

Other obstructive and reflux uropathy

225

2184

1.03

0.17

2.9

3.1

0.97

0.75

ug/l

1.36

158

1474

Other bursal cyst

818

1.06

0.17

3.8

3.0

0.67

0.76

ug/l

0.55

555

Selective deficiency of immunoglobulin A [IgA]y

158

1.16

0.17

2.8

2.6

0.64

0.70

ug/l

0.17

Osteopathy in diseases classified elsewhere

380

0.91

0.17

3.0

3.1

1.22

0.84

ug/l

0.79

248

Use of teriflunomide

234

1.12

0.17

1.8

1.9

0.57

0.63

ug/l

0.24

103

Specific development disorders of speech and language

151

1399

1.04

0.17

2.5

2.6

0.67

0.74

ug/l

0.36

810

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

341

1.10

0.17

2.9

2.5

0.94

0.76

ug/l

0.31

216

Other specified and unspecified disorders of eyelid

760

1.06

0.17

2.6

2.9

0.55

0.80

ug/l

2.28

487

Diving or jumping into water causing injury other than drowning or submersion

332

1.11

0.17

2.4

2.5

0.50

0.73

ug/l

1.99

189

Haemorrhage, not elsewhere classified

237

2436

0.97

0.17

3.1

3.2

0.72

0.80

ug/l

1.13

170

1675

Right ventricular outflow tract obstruction

141

0.84

0.16

2.2

2.4

0.31

0.83

ug/l

—

Cellulitis of external ear

606

0.93

0.16

2.8

2.7

0.63

0.72

ug/l

0.60

376

Crushing injury of ankle and foot

306

0.89

0.16

2.8

2.9

0.55

0.73

ug/l

0.84

193

Femoral hernia, unilateral

153

1477

1.04

0.16

3.2

3.1

0.87

0.78

ug/l

0.13

106

1016

Inguinal hernia, unilateral

153

1477

1.04

0.16

3.2

3.1

0.87

0.78

ug/l

0.13

106

1016

Inguinal of femoral hernia, unilateral

153

1477

1.04

0.16

3.2

3.1

0.87

0.78

ug/l

0.13

106

1016

Abnormality of white blood cells, not elsewhere classified

400

0.91

0.16

3.7

2.8

0.60

0.67

ug/l

0.54

260

Benign neoplasm: Short bones of upper limb

682

1.06

0.16

2.8

2.5

0.58

0.72

ug/l

1.68

411

Benign neoplasm: Connective and other soft tissue of pelvis

0.77

0.16

5.3

2.4

0.68

0.91

ug/l

—

Other disorders of bone density and structure

101

1056

0.95

0.16

3.2

2.8

0.69

0.74

ug/l

0.22

643

Pedal cyclist injured in transport accident

1420

14049

1.01

0.16

2.8

2.7

0.67

0.73

ug/l

1.86

899

8620

Malignant neoplasm of renal pelvis

409

0.91

0.16

3.3

3.2

0.88

0.86

ug/l

0.04

281

Malignant neoplasm of adrenal gland

207

1.13

0.16

3.0

2.9

1.31

0.75

ug/l

0.75

139

Benign neoplasm: Connective and other soft tissue of pelvis

0.74

0.16

5.3

2.9

0.68

0.84

ug/l

—

Bradycardia, unspecified, drug-induced

140

1.17

0.16

2.6

3.0

1.25

0.89

ug/l

—

100

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

286

0.90

0.16

3.3

2.5

0.83

0.71

ug/l

0.39

181

Abnormal findings on examination of urine, without diagnosis

307

3000

1.03

0.16

3.1

0.92

0.77

ug/l

1.04

217

2026

Burn and corrosion of head and neck

146

1511

0.96

0.16

3.2

2.7

0.74

0.73

ug/l

0.07

913

Acquired clawhand, clubhand, clawfoot and clubfoot

265

0.89

0.16

3.0

2.4

0.80

0.76

ug/l

0.05

156

244

0.89

0.16

2.6

2.5

0.63

0.68

ug/l

0.15

130

Recurrent cholesteatoma of postmastoidectomy cavity

202

0.87

0.16

3.2

3.1

0.66

0.81

ug/l

—

133

Use of galantamine

399

3910

1.02

0.16

2.9

3.4

0.86

0.90

ug/l

0.19

315

2872

Diabetes insipidus

379

0.91

0.16

3.5

2.7

1.17

0.77

ug/l

0.34

233

Disorders of mineral metabolism

490

4989

0.98

0.16

2.9

3.0

0.82

0.75

ug/l

0.64

338

3364

Tooth eruption problems

293

2974

0.97

0.16

2.4

0.64

0.66

ug/l

0.09

158

1576

Congenital deformities of feet

790

0.95

0.16

2.8

2.6

0.55

0.68

ug/l

1.07

440

Malignant neoplasm of palate

191

0.86

0.16

2.2

2.8

0.97

0.68

ug/l

—

124

Benign neoplasm: Ribs, sternum and clavicle

131

1.18

0.16

3.1

2.7

0.54

0.78

ug/l

—

Abscess of anal and rectal regions

694

6839

1.02

0.16

2.7

0.67

0.74

ug/l

1.53

426

4128

Crowding of teeth, including avohilmo

142

1128

1.04

0.15

2.4

0.58

0.66

ug/l

0.73

595

Anaemias

1408

9260

1.01

0.15

2.6

2.2

0.73

0.69

ug/l

0.43

952

4472

Benign neoplasm: Skin of scalp and neck

143

1381

1.04

0.15

3.4

3.1

0.72

0.77

ug/l

0.42

102

914

Impacted teeth

452

4124

1.02

0.15

2.2

2.3

0.60

0.63

ug/l

0.44

230

2069

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

122

1.19

0.15

3.1

2.7

0.69

0.78

ug/l

—

Unspecified urinary incontinence

189

1832

1.03

0.15

3.1

0.76

0.77

ug/l

0.06

140

1221

IgA nephropathy (IgA glomerulonephritis)

186

1807

1.04

0.15

2.5

2.8

0.96

0.73

ug/l

2.06

139

1117

Cervicobrachial syndrome

1177

11904

0.99

0.15

2.7

2.8

0.66

0.75

ug/l

2.40

764

7487

Benign neoplasm: Skin, unspecified

218

2121

1.03

0.15

3.3

3.0

0.84

0.75

ug/l

0.58

147

1391

Convergence insufficiency and excess

286

0.90

0.15

2.5

2.7

0.41

0.68

ug/l

3.02

168

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

295

0.90

0.15

2.0

2.5

0.66

0.75

ug/l

0.24

179

Other embolism and thrombosis

862

8509

1.02

0.15

3.1

3.0

0.72

0.78

ug/l

0.92

603

5675

Congenital malformations of great arteries

604

0.94

0.15

3.0

2.6

1.19

0.69

ug/l

0.79

354

Pyogenic granuloma

900

1.05

0.15

3.1

2.9

0.71

0.75

ug/l

0.23

581

Malignant neoplasm of thyroid gland

243

2367

1.03

0.15

3.1

3.0

0.71

0.75

ug/l

0.35

171

1554

Diffuse large B-cell lymphoma

316

3228

0.97

0.15

2.7

3.2

0.82

0.77

ug/l

0.33

220

2249

Phantom limb syndrome

170

0.86

0.15

2.1

3.1

0.39

0.75

ug/l

—

117

Systemic lupus erythematosus, unspecified

605

1.06

0.15

2.5

2.8

0.80

0.74

ug/l

0.12

392

Toxic effect of corrosive substances

233

0.89

0.15

2.3

2.4

0.67

0.63

ug/l

0.14

115

Other operation for atrial fibrillation

531

1.08

0.15

2.9

3.2

0.72

0.79

ug/l

0.21

365

Benign neoplasm: Floor of mouth

218

1.12

0.15

3.4

2.7

0.74

0.73

ug/l

0.02

141

Infliximab

254

0.90

0.15

1.7

2.1

0.48

0.65

ug/l

0.82

116

Benign neoplasm: Other/unspecified site

777

0.95

0.15

3.1

2.9

0.72

0.76

ug/l

0.18

504

Sixth [abducent] nerve palsy

226

2203

1.03

0.15

3.0

3.1

0.82

0.76

ug/l

0.23

158

1513

Open wound of hip and thigh

222

2163

1.03

0.15

2.8

2.7

0.62

0.71

ug/l

1.51

138

1270

Unspecified hairloss

1.23

0.15

2.4

2.6

0.51

0.67

ug/l

—

Congenital malformations, deformations and chromosomal abnormalities

3443

32766

1.01

0.15

2.7

0.72

ug/l

0.08

2107

19368

Coronary angioplasty

4508

34781

0.99

0.15

3.1

3.2

0.81

0.80

ug/l

0.16

3117

24589

Scar conditions and fibrosis of skin

113

1175

0.96

0.14

3.3

2.8

0.91

0.76

ug/l

0.21

724

Eosinophilia

931

1.05

0.14

2.7

3.0

0.81

0.76

ug/l

0.20

637

Cleft palate

202

0.89

0.14

1.9

0.48

0.67

ug/l

—

Chronic lymphocytic leukaemia

228

2225

1.03

0.14

2.8

3.3

0.79

ug/l

0.01

170

1574

Prurigo nodularis

126

1216

1.04

0.14

3.0

3.1

0.73

0.75

ug/l

0.10

804

Chromosomal abnormalities, not elsewhere classified

478

1.07

0.14

1.9

2.3

0.53

0.64

ug/l

0.80

253

Infarction of spleen

376

0.92

0.14

2.4

3.2

0.62

0.85

ug/l

1.10

262

Preparatory care for dialysis

362

3553

1.02

0.14

2.5

3.0

1.16

0.74

ug/l

6.17

297

2335

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

414

3841

0.98

0.14

1.9

2.0

0.47

0.60

ug/l

5.29

230

1646

Disorders of myoneural junction and muscle in diseases classified elsewhere

243

0.90

0.14

3.7

3.0

0.78

0.70

ug/l

0.17

150

Unequal limb length (acquired)

160

0.87

0.14

3.0

2.4

0.80

0.71

ug/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

755

0.94

0.14

3.9

3.2

0.99

0.83

ug/l

0.27

527

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

200

0.87

0.14

3.0

2.5

0.79

ug/l

0.01

125

Iron deficiency

314

1.09

0.14

3.4

2.8

0.73

0.71

ug/l

0.04

199

Gastrointestinal stromal tumor and sarcoma

736

1.06

0.14

3.5

3.1

0.86

0.77

ug/l

0.56

506

Nephrotic syndrome

214

2086

1.03

0.14

2.6

2.9

0.97

0.75

ug/l

1.32

157

1324

Acute hepatitis B

267

1.11

0.14

2.2

2.8

0.55

0.73

ug/l

0.58

155

Hypertrophic cardiomyopathy

302

3083

0.97

0.14

2.6

3.0

0.65

0.76

ug/l

1.84

205

2051

Other and unspecified haemorrhagic conditions

735

0.95

0.14

3.0

2.9

0.70

0.80

ug/l

0.81

470

Other effects of reduced temperature

117

0.83

0.14

3.7

2.7

0.54

0.85

ug/l

—

Benign neoplasm: Ill-defined sites within the digestive system

296

1.10

0.14

2.7

3.1

0.76

0.73

ug/l

0.05

203

Pericarditis

296

2899

1.03

0.14

2.7

3.0

0.81

0.79

ug/l

0.10

199

1921

Hypospadias

209

1.12

0.14

2.5

2.7

0.76

0.77

ug/l

0.00

127

Other corneal oedema

376

0.92

0.14

3.2

2.9

0.59

0.86

ug/l

2.07

244

Pleural plaque

1192

12029

0.99

0.14

3.6

3.4

0.78

0.84

ug/l

1.02

874

8951

LeFortI or BSSRO operation

126

1305

0.96

0.14

2.5

2.4

0.77

0.67

ug/l

0.47

703

Caught, crushed, jammed or pinched in or between objects

336

3295

1.02

0.14

2.7

0.64

0.70

ug/l

0.90

195

1974

Mental and behavioural disorders due to sedatives or hypnotics

364

3710

0.98

0.14

2.3

2.6

0.48

0.68

ug/l

10.04

259

2079

Septal defects

253

2417

1.03

0.14

2.8

2.7

0.79

0.71

ug/l

0.29

153

1448

Folliculitis decalvans

123

1.17

0.14

2.5

3.0

0.81

0.77

ug/l

—

Livedoid vasculitis

161

1.14

0.14

2.2

2.7

0.58

0.68

ug/l

0.50

Otorrhoea

107

0.83

0.13

3.1

3.2

0.52

0.69

ug/l

—

Disorders of psychological development

286

2710

0.98

0.13

2.2

2.3

0.56

0.68

ug/l

1.54

179

1364

Habit and impulse disorders

795

0.95

0.13

1.9

2.3

0.48

0.64

ug/l

1.83

402

Dissection of cerebral arteries, nonruptured

447

0.93

0.13

2.6

2.9

0.61

0.72

ug/l

0.41

283

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

253

2587

0.97

0.13

2.7

0.70

0.75

ug/l

0.60

164

1776

Other retinal artery occlusion

163

1676

0.97

0.13

3.2

3.3

0.85

0.82

ug/l

0.18

114

1164

Juvenile osteochondrosis

138

1425

0.96

0.13

2.4

2.6

0.57

0.72

ug/l

1.67

803

Benign neoplasm: Mediastinum

179

0.88

0.13

2.4

2.3

1.10

0.74

ug/l

0.29

111

Cleft lip and cleft lip and palate

277

1.09

0.13

3.0

2.4

0.60

0.68

ug/l

0.38

143

Muscular dystrophy

365

0.92

0.13

3.3

2.8

0.67

0.73

ug/l

0.23

238

Injuries involving multiple body regions

194

1890

1.03

0.13

3.0

2.8

0.64

0.74

ug/l

1.70

128

1145

Congenital malformations of eyelid, lacrimal apparatus and orbit

138

0.86

0.13

2.3

2.6

0.67

0.63

ug/l

—

Third [oculomotor] nerve palsy

103

1068

0.96

0.13

2.9

3.0

0.70

0.79

ug/l

0.61

716

Enteritis due to Yersinia enterocolitica

229

1.11

0.13

2.5

2.7

0.80

0.70

ug/l

0.19

133

Procreative management

1386

11798

0.99

0.13

2.3

0.62

0.64

ug/l

0.27

738

5859

Other abnormal immunological findings in serum

599

1.06

0.13

3.3

2.8

0.56

0.66

ug/l

0.69

366

Melanocytic naevi of ear and external auricular canal

229

1.11

0.13

3.0

3.1

0.67

0.77

ug/l

0.23

156

Other diseases of oesophagus

744

7350

1.01

0.13

3.1

0.84

0.81

ug/l

0.13

549

5019

Benign neoplasm: Cornea

1.20

0.13

4.8

2.8

1.39

0.75

ug/l

—

Follicular adenocarcinoma of thyroid gland

278

1.09

0.12

3.9

2.8

0.86

0.76

ug/l

0.22

189

Burns and corrosions of multiple and unspecified body regions

159

1547

1.03

0.12

2.8

0.72

0.74

ug/l

0.14

110

941

Other proliferative retinopathy

230

0.90

0.12

2.7

2.8

1.16

0.78

ug/l

0.74

145

Abrasion of teeth

1685

12288

1.01

0.12

3.1

2.9

0.68

0.73

ug/l

2.37

1151

8049

Other/unspecified enthesopathies, not elsewhere classified

541

5334

1.02

0.12

3.0

2.9

0.70

0.80

ug/l

1.08

335

3504

Phakomatoses, not elsewhere classified

436

0.93

0.12

2.5

2.7

0.74

ug/l

0.02

262

Other and unspecified pemphigoid

415

0.93

0.12

2.4

3.2

1.56

0.82

ug/l

0.37

286

Other congenital malformations of male genital organs

210

1.10

0.12

2.7

2.6

0.52

0.74

ug/l

—

117

Other misadventures during surgical and medical care

120

1162

1.04

0.12

3.2

3.0

0.79

0.77

ug/l

0.07

770

Embedded teeth, including avohilmo

237

2425

0.98

0.12

2.5

0.68

0.67

ug/l

0.03

130

1295

Benign neoplasm: Bone and articular cartilage, unspecified

366

1.08

0.12

3.1

2.4

1.29

0.72

ug/l

0.40

213

Benign neoplasm: Epididymis

388

1.09

0.12

3.4

2.8

0.74

0.68

ug/l

0.22

247

Rubella [German measles]

491

4848

1.02

0.12

2.4

0.61

0.66

ug/l

0.98

263

2642

Palindromic rheumatism

507

0.94

0.12

3.7

2.8

0.80

0.87

ug/l

0.16

326

Other diseases of stomach and duodenum

393

3866

1.02

0.12

3.0

3.1

0.70

0.78

ug/l

1.28

283

2625

Cervical root disorders

445

0.93

0.12

2.2

2.8

0.66

0.80

ug/l

0.70

288

Vitreous prolapse

126

0.85

0.12

3.1

3.3

1.04

0.70

ug/l

—

Injury of blood vessels at abdomen, lower back and pelvis level

250

0.90

0.12

2.1

2.9

0.51

0.73

ug/l

1.64

163

Stomatitis and related lesions

414

4207

0.98

0.12

2.7

0.68

0.77

ug/l

0.68

251

2541

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

133

1.13

0.12

2.5

2.8

0.64

0.70

ug/l

—

Benign neoplasm: Bladder

688

0.95

0.12

4.1

3.2

0.78

0.82

ug/l

0.10

489

Meningitis

263

2683

0.98

0.12

2.9

2.8

0.64

0.71

ug/l

1.22

169

1628

Bronchiectasis

495

4881

1.02

0.12

3.3

0.68

0.81

ug/l

3.13

351

3441

SLE, strict definition

758

1.04

0.12

2.6

2.8

0.78

0.74

ug/l

0.09

483

SLE, ICD10

758

1.04

0.12

2.6

2.8

0.78

0.74

ug/l

0.09

483

Colectomy operation

1230

12405

0.99

0.12

3.1

0.75

0.79

ug/l

0.82

869

8566

Abnormal weight loss

530

5229

1.02

0.12

3.2

3.1

0.74

0.78

ug/l

0.38

377

3587

Other osteochondropathies

477

4838

0.98

0.12

2.8

2.7

0.65

0.70

ug/l

0.98

283

2917

Allergic purpura

144

1400

1.03

0.11

2.7

2.8

0.70

0.75

ug/l

0.21

855

Dermatitis herpetiformis

1004

0.96

0.11

3.1

2.9

0.62

0.77

ug/l

0.96

654

Pneumoconiosis due to dust containing silica

351

0.92

0.11

3.7

3.2

0.67

0.81

ug/l

0.60

231

conjunctival degenerations and deposits

101

976

1.04

0.11

2.8

3.0

0.63

0.77

ug/l

1.66

651

Leiomyosarcoma

291

0.92

0.11

3.4

3.2

0.74

0.81

ug/l

0.31

200

Neurofibromatosis, type 1

211

1.10

0.11

2.8

2.5

0.82

0.64

ug/l

0.59

120

Other and unspecified trigeminal disorders

547

0.95

0.11

2.8

0.58

0.76

ug/l

1.60

354

Other disorders of peripheral nervous system

348

1.08

0.11

2.7

2.9

0.67

0.74

ug/l

0.18

222

Injuries to the thorax

4151

41317

1.01

0.11

3.0

2.9

0.71

0.77

ug/l

3.11

2767

26885

Benign neoplasm: Lip

125

1214

1.04

0.11

3.3

2.7

0.80

0.77

ug/l

0.15

798

Congenital musculoskeletal deformities of head, face, spine and chest

367

1.07

0.11

2.8

2.6

0.69

0.66

ug/l

0.07

204

Bacterial infection, other or unspecified

4677

42350

1.00

0.11

3.0

3.1

0.85

0.78

ug/l

2.60

3407

29012

Unspecified visual impairment (binocular)

642

1.05

0.11

3.3

3.0

0.68

0.82

ug/l

0.91

411

Vitamin A deficiency

167

0.89

0.11

3.1

3.0

0.81

0.96

ug/l

—

118

Tic and related disorders

291

0.92

0.11

3.1

2.3

0.64

0.76

ug/l

0.32

139

Maxillary prognathism

134

1.13

0.11

2.7

2.3

0.62

0.73

ug/l

—

Other retinal disorders in diseases classified elsewhere

166

0.88

0.11

3.3

3.1

0.34

0.70

ug/l

—

113

Tarsal tunnel syndrome

311

0.93

0.11

2.5

2.8

0.72

0.76

ug/l

0.12

196

Oesophagitis

400

4058

0.98

0.11

3.0

0.66

0.78

ug/l

2.09

282

2695

Other and unspecified disorders of orbit

259

0.91

0.11

2.5

2.6

0.51

0.76

ug/l

1.86

158

Benign lipomatous neoplasm of of intra-abdominal organs

154

1.12

0.11

3.2

2.6

0.93

0.77

ug/l

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

125

0.87

0.11

2.6

3.0

0.78

0.99

ug/l

—

Disorders of purine and pyrimidine metabolism, other/unspecified

1.19

0.10

5.0

3.3

0.66

0.57

ug/l

—

Other specific arthropathies, wide

104

1073

0.96

0.10

3.1

2.8

0.69

0.77

ug/l

0.42

669

Disorders of thyroid, IBD co-morbidities

1082

7817

1.01

0.10

3.0

0.73

0.85

ug/l

3.47

723

5076

Other specified/unspecified inflammatory spondylopathies

177

1812

0.97

0.10

2.7

2.6

0.67

0.72

ug/l

0.45

1031

Other specified and unspecified disorders of iris and ciliary body

156

0.89

0.10

4.0

2.5

0.48

0.61

ug/l

—

Congenital malformations of ear causing impairment of hearing

125

1.13

0.10

3.9

2.6

0.79

0.67

ug/l

—

Foreign body in ear

791

1.04

0.10

3.4

2.8

0.82

0.77

ug/l

0.17

492

Speech and linguistic disorders, excluding more controls

212

1955

1.02

0.10

2.3

2.5

0.58

0.74

ug/l

1.56

135

1026

Meningococcal infection

361

0.93

0.10

2.6

0.65

0.68

ug/l

0.11

199

Benign neoplasm: Other and unspecified parts of mouth

202

1979

1.02

0.10

2.8

3.0

0.58

0.76

ug/l

3.35

141

1301

Malignant neoplasm of small intestine

145

1485

0.97

0.10

2.7

3.1

0.78

ug/l

0.01

103

1024

Cleft lip and palate

232

1.09

0.10

3.1

2.4

0.58

0.70

ug/l

0.51

121

Other disorders of optic disc

526

1.05

0.10

3.5

2.9

0.74

0.75

ug/l

0.04

339

Other medical care

3200

31101

1.01

0.10

3.4

3.2

1.10

0.78

ug/l

10.89

2170

21971

Other and unspecified thalassaemias

1.12

0.10

2.2

2.7

0.72

0.63

ug/l

—

Acute epiglottitis

103

1000

1.04

0.10

2.6

2.8

0.71

0.76

ug/l

0.36

599

Dermatopolymyositis (FG)

664

1.05

0.10

2.7

2.9

0.73

0.77

ug/l

0.27

437

Meningitis, viral

135

1.12

0.10

2.0

2.8

0.83

0.73

ug/l

—

Clear cell adenocarcinoma of kidney

388

3829

1.02

0.10

3.1

0.90

0.74

ug/l

2.29

293

2619

Other congenital malformations of brain

135

1.12

0.10

1.8

2.3

0.51

0.61

ug/l

—

Bronchitis, not specified as acute or chronic

629

6356

0.99

0.10

2.7

2.8

0.76

ug/l

0.01

376

3957

Benign neoplasm: Cornea

1.17

0.10

4.8

3.1

1.39

0.69

ug/l

—

Superficial injuries involving multiple body regions

121

1243

0.97

0.10

3.3

2.8

0.61

0.74

ug/l

1.94

747

Myasthenia gravis

109

1060

1.03

0.10

2.7

3.1

0.60

0.75

ug/l

2.06

712

Glaucoma

4354

38069

1.00

0.10

3.2

0.79

0.80

ug/l

0.19

3097

26712

Congenital lens malformations

145

0.89

0.10

2.6

2.5

0.86

0.71

ug/l

—

Sequelae of inflammatory diseases of the central nervous system

155

0.89

0.10

2.5

2.7

0.39

0.76

ug/l

—

Phantom limb syndrome with pain

165

0.89

0.09

2.1

3.0

0.39

0.75

ug/l

—

115

Benign neoplasm of other and unspecified sites

164

1604

1.03

0.09

3.3

2.6

0.71

0.75

ug/l

0.28

112

994

Atypical facial pain

166

1623

1.02

0.09

2.8

2.9

0.54

0.74

ug/l

4.97

112

1041

Diseases of arteries, arterioles and capillaries

6614

49485

1.00

0.09

3.0

3.1

0.79

0.78

ug/l

0.17

4658

33895

Pediculosis, acariasis and other infestations

417

4223

0.98

0.09

2.7

0.62

0.71

ug/l

1.64

264

2571

Used for control exclusion in common control thyroid runs

10309

52384

1.00

0.09

2.9

0.72

0.77

ug/l

3.54

6718

33122

Other and unspecified water transport accidents

253

1.09

0.09

2.8

0.69

0.77

ug/l

0.28

153

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

573

0.95

0.09

3.1

3.0

0.60

0.80

ug/l

1.78

383

Thyroiditis, unspecified

340

1.06

0.09

3.3

2.8

0.66

0.74

ug/l

0.46

221

Congenital malformations of posterior segment of eye

233

1.08

0.09

3.6

2.9

0.67

0.76

ug/l

0.25

149

Other disorders of white blood cells

330

3348

0.98

0.09

2.8

3.1

0.75

0.76

ug/l

0.08

224

2232

Other and unspecified follicular disorders

245

2492

0.98

0.09

2.8

2.9

0.66

0.73

ug/l

1.04

166

1558

Other secondary gonarthrosis

348

3432

1.02

0.09

3.3

3.0

0.61

0.77

ug/l

4.59

247

2276

Infection of intervertebral disc (pyogenic)

104

1068

0.97

0.09

2.9

3.0

0.69

0.77

ug/l

0.33

733

Follicular lymphoma

253

2572

0.98

0.09

2.9

2.7

0.68

0.74

ug/l

0.71

171

1727

Hordeolum and other deep inflammation of eyelid

276

2716

1.02

0.09

2.9

2.8

0.72

0.73

ug/l

0.04

191

1664

Benign neoplasm: Rectum/anal canal icd-9

370

1.06

0.09

3.8

2.7

0.86

0.87

ug/l

0.03

267

Hypertrophic disorders of skin

182

1783

1.02

0.09

3.1

2.8

0.66

0.74

ug/l

0.88

122

1056

Other disorders involving the immune mechanism, not elsewhere classified

216

2198

0.98

0.09

2.6

2.9

0.94

0.73

ug/l

1.90

157

1355

Other and unspecified primary disorders of muscles

351

1.06

0.09

2.8

2.7

0.70

0.74

ug/l

0.09

216

Cervical disc disorders

3117

31300

1.00

0.09

3.0

2.9

0.68

0.79

ug/l

5.23

2110

20414

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

267

0.92

0.09

2.4

1.03

0.76

ug/l

0.64

167

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

694

0.96

0.09

2.6

0.82

0.73

ug/l

0.29

461

Deformity of finger(s)

369

0.94

0.09

3.4

2.8

0.60

0.83

ug/l

1.52

246

Cerebral amyloid angiopathy

297

0.93

0.09

2.7

3.0

0.74

0.80

ug/l

0.16

209

Multifocal fibrosclerosis

253

1.08

0.09

3.1

0.86

0.77

ug/l

0.23

168

Fractures involving multiple body regions

156

1.12

0.09

2.1

2.3

0.71

0.68

ug/l

—

Perichondritis of external ear

997

0.97

0.08

3.3

3.0

0.71

0.80

ug/l

0.64

666

Asymmetry of jaw

351

1.06

0.08

2.2

2.6

0.76

0.67

ug/l

0.22

202

Benign neoplasm: Skin of upper limb, including shoulder

977

0.97

0.08

3.2

2.9

0.76

0.79

ug/l

0.09

636

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

258

2620

0.98

0.08

3.2

2.7

0.75

0.74

ug/l

0.04

186

1759

Other specified acquired deformities of limbs

185

0.91

0.08

2.4

2.5

0.40

0.82

ug/l

—

112

Liposarcoma

589

1.05

0.08

2.9

3.0

0.62

0.75

ug/l

1.15

396

Other congenital malformations of the digestive system

164

1663

0.98

0.08

2.6

3.0

0.67

0.77

ug/l

0.68

118

1069

Disorders of vagus nerve

1.07

0.08

1.6

2.9

0.49

0.75

ug/l

—

Crossbite

188

1709

1.02

0.08

2.8

2.6

0.64

0.70

ug/l

0.56

991

Open wound of abdomen, lower back and pelvis

188

1846

1.02

0.08

2.4

2.7

0.56

0.72

ug/l

3.27

118

1054

Amyloidosis, other/unspecified

113

1103

1.03

0.08

3.1

3.2

0.72

0.79

ug/l

0.43

797

Acute hepatitis A

256

0.93

0.08

2.7

2.9

0.74

0.78

ug/l

0.07

148

Crushing injury of wrist and hand

153

1501

1.03

0.08

2.8

2.9

0.54

0.74

ug/l

5.54

951

Contusion of toe(s) with damage to nail

549

1.04

0.08

2.8

0.64

0.76

ug/l

0.84

316

Atopic dermatitis, strict definition with reimbursement

1119

10924

0.99

0.08

2.5

0.64

0.69

ug/l

1.89

636

6071

Other and unspecified hypertrophic disorders of skin

246

0.93

0.08

3.5

2.9

0.65

0.67

ug/l

0.07

153

Other and unspecified mononeuropathies of upper limb

181

1777

1.02

0.08

2.7

2.8

0.59

0.72

ug/l

2.02

118

1103

Disorders of adrenal gland, other and/or unspecified

205

0.92

0.08

2.7

2.8

2.48

0.68

ug/l

0.55

128

Recurrent and persistent haematuria

510

1.05

0.08

3.6

3.1

1.61

0.83

ug/l

0.47

338

Achalasia of cardia

117

1143

1.03

0.08

3.4

3.0

0.64

0.75

ug/l

0.81

763

Assault by drugs, medicaments and biological substances

0.80

0.08

4.0

2.1

0.60

0.67

ug/l

—

Carcinoid syndrome

631

0.96

0.08

3.2

3.1

0.72

0.76

ug/l

0.21

428

Other and unspecified bullous disorders

441

1.05

0.08

2.6

3.1

0.83

0.79

ug/l

0.06

286

Osteomalacia

378

0.95

0.08

2.6

2.8

0.80

0.73

ug/l

0.16

233

Benign neoplasm: Bladder

638

1.04

0.08

4.1

2.8

0.78

0.82

ug/l

0.10

458

Neuroendocrine tumor and carcinoma of stomach

294

1.07

0.08

2.3

3.2

0.90

0.78

ug/l

0.14

192

Sacroiliitis, not elsewhere classified

144

1410

1.02

0.08

1.9

2.3

0.54

0.68

ug/l

2.52

723

Disorder of thyroid, unspecified

264

1.06

0.08

3.6

3.0

0.60

0.74

ug/l

0.52

183

Purulent endophthalmitis

377

0.94

0.07

3.1

1.03

0.77

ug/l

0.60

251

Other necrotizing vasculopathies

388

3837

1.01

0.07

3.0

3.2

0.68

0.77

ug/l

1.60

296

2624

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

501

1.04

0.07

2.6

2.5

0.79

0.73

ug/l

0.19

314

Melanoma of uvea

610

0.96

0.07

3.4

2.7

0.71

0.77

ug/l

0.32

413

Common variable immunodeficiency

245

1.07

0.07

2.6

2.7

0.58

0.73

ug/l

0.80

137

Tuberculosis of other organs

105

1075

0.97

0.07

3.0

3.1

0.63

0.84

ug/l

2.27

743

Complex cardiac defects

108

1.12

0.07

1.8

2.2

0.33

0.70

ug/l

—

Other disorders starting during childhood or adolescence

506

1.04

0.07

2.4

2.0

0.53

0.65

ug/l

0.78

211

Allergic contact dermatitis

429

4335

0.99

0.07

2.7

2.9

0.83

0.73

ug/l

0.37

266

2715

Weight loss

550

5452

1.01

0.07

3.1

0.73

0.78

ug/l

0.52

393

3742

Other specified congenital malformation syndromes affecting multiple systems

458

0.96

0.07

2.1

2.5

0.71

0.66

ug/l

0.10

244

Bacterial, viral and other infectious agents

615

6101

1.01

0.07

2.5

0.78

0.69

ug/l

0.45

344

3321

Liposarcoma, excluding all cancers (controls excluding all cancers)

730

1.04

0.07

2.8

2.7

0.62

0.73

ug/l

0.77

476

Optic neuritis

124

1266

0.98

0.07

2.7

0.70

0.74

ug/l

0.19

751

Other disorders of thyroid

265

1.06

0.07

3.6

3.0

0.60

0.72

ug/l

0.41

184

Other acute skin changes due to ultraviolet radiation

199

1960

1.02

0.07

3.3

3.0

0.62

0.79

ug/l

3.29

131

1296

Other hammer toe(s) (acquired)

623

5793

1.01

0.07

3.0

3.1

0.70

0.81

ug/l

1.25

420

3981

Oral lichen ruber planus wide, hypothyreosis or thyroxin

101

1034

0.98

0.07

3.4

3.0

0.58

0.77

ug/l

2.41

678

Agoraphobia

828

1.03

0.07

2.4

2.2

0.49

0.67

ug/l

1.75

384

Melanocytic naevi of eyelid, including canthus

356

0.95

0.07

2.3

2.7

1.03

0.73

ug/l

0.32

234

Abnormal findings in cerebrospinal fluid

142

0.90

0.07

3.8

2.4

1.15

0.73

ug/l

—

Malignant neoplasm of other and unspecified urinary organs

213

0.92

0.07

2.9

3.1

0.80

0.81

ug/l

0.02

155

Oral lichen ruber planus, hypothyreosis or thyroxin

177

1.08

0.06

5.4

3.1

0.63

0.79

ug/l

0.40

121

152

0.91

0.06

1.1

2.2

1.02

0.72

ug/l

—

Other specified disorders of muscle

169

1717

0.98

0.06

2.3

2.7

0.53

0.73

ug/l

3.80

105

1023

Other sideroblastic anaemias

213

0.93

0.06

3.2

3.0

0.57

0.79

ug/l

0.89

150

Early lumbar disc prolapse operation

560

5645

0.99

0.06

2.2

2.1

0.55

0.60

ug/l

1.23

247

2547

Diseases of thymus

109

1.12

0.06

2.4

2.9

0.41

0.66

ug/l

—

Personal history of certain other diseases

305

0.95

0.06

2.4

2.6

0.62

0.72

ug/l

0.35

179

Generalized pustular psoriasis

223

0.93

0.06

2.6

3.0

0.65

0.81

ug/l

0.50

144

Benign neoplasm: Ciliary body

168

1.09

0.06

2.4

2.9

0.77

0.75

ug/l

—

116

Use of glatiramer acetate

315

0.95

0.06

1.7

2.3

0.61

0.65

ug/l

0.16

150

Marginal zone B-cell lymphoma

543

1.04

0.06

2.9

3.0

0.74

0.73

ug/l

0.04

365

Contracture of joint

721

1.03

0.06

2.5

2.9

0.60

0.84

ug/l

1.90

445

Diastasis of muscle

355

1.05

0.06

3.3

2.9

0.59

0.78

ug/l

1.14

231

Fracture of shoulder and upper arm

2192

21984

1.00

0.06

2.9

0.74

0.76

ug/l

0.14

1428

13999

DVT of lower extremities and pulmonary embolism

3273

32526

1.00

0.06

3.0

3.1

0.82

0.79

ug/l

0.60

2311

22217

Mononeuritis multiplex

192

0.92

0.06

3.1

2.9

0.53

0.74

ug/l

1.12

139

Injury of nerves and spinal cord at thorax level

336

1.05

0.06

3.3

2.7

0.58

0.76

ug/l

1.10

197

Other abnormal findings in urine

980

0.98

0.06

3.3

3.2

0.86

0.81

ug/l

0.20

676

Explosion of other materials

287

1.06

0.06

2.1

2.8

0.47

0.78

ug/l

1.78

169

Autoimmune thyroiditis

294

0.95

0.06

4.3

2.9

0.64

0.79

ug/l

0.81

192

Other local infections of skin and subcutaneous tissue

667

6713

0.99

0.06

3.0

0.70

0.76

ug/l

1.20

444

4400

Erythema nodosum

789

0.97

0.06

2.9

0.95

0.70

ug/l

0.98

498

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

374

0.95

0.05

2.5

0.87

0.75

ug/l

0.33

235

Malignant immunoproliferative diseases

713

1.03

0.05

2.9

3.1

0.66

0.76

ug/l

0.66

497

Glaucoma secondary to eye inflammation

445

0.96

0.05

3.5

3.0

0.67

0.78

ug/l

0.59

284

Benign neoplasm: Other parts of oropharynx

445

1.04

0.05

2.8

2.5

0.69

0.74

ug/l

0.26

282

Injury of other and unspecified intrathoracic organs

544

5477

0.99

0.05

2.7

3.0

0.73

0.75

ug/l

0.20

348

3545

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

424

4275

0.99

0.05

3.0

0.70

0.75

ug/l

0.53

288

2797

Cholesteatoma of middle ear

373

3762

0.99

0.05

3.3

3.1

0.91

0.77

ug/l

0.64

255

2576

Correction of physiology of bite - demanding therapy visit

198

2006

0.99

0.05

2.5

2.8

0.61

0.71

ug/l

1.60

120

1220

Myotonic disorders

366

1.04

0.05

2.6

0.51

0.72

ug/l

1.92

219

Enteropathogenic Escherichia coli infection

161

0.92

0.05

1.9

3.0

0.60

0.72

ug/l

—

111

Other bullous disorders

141

1432

0.98

0.05

2.9

3.0

0.64

0.77

ug/l

1.03

101

935

Hypertrophy of tongue papillae

584

1.03

0.05

3.1

3.0

0.59

0.76

ug/l

1.52

379

Other and unspecified paralytic syndromes

717

0.97

0.05

2.5

2.7

0.90

0.79

ug/l

0.16

436

Atopic conjunctivitis

124

1219

1.02

0.05

2.1

2.6

0.63

0.73

ug/l

0.96

700

Juvenile Open Angle Glaucoma

313

0.95

0.05

2.8

2.7

0.61

0.80

ug/l

1.15

169

Other and unspecified aplastic anaemias

624

1.03

0.05

2.9

3.0

0.91

0.83

ug/l

0.12

415

Congenital retinoschisis

179

1.08

0.05

3.4

3.0

0.62

0.80

ug/l

—

119

Hypertrophic scar

161

1587

1.02

0.05

3.1

2.7

0.65

0.73

ug/l

0.85

106

932

Asthma and opportunity respiratory infection

234

2366

0.99

0.05

3.1

3.3

0.60

0.78

ug/l

5.28

153

1661

Other and unspecified injuries of thorax

107

1051

1.02

0.05

2.3

2.8

0.52

0.74

ug/l

4.79

643

Emotional disorders starting during childhood or adolescence

421

0.97

0.05

1.6

1.7

0.33

0.56

ug/l

3.96

149

Disorders of iron metabolism

102

1038

0.98

0.05

2.8

3.0

0.67

0.73

ug/l

0.21

676

Other nonthrombocytopenic purpura

446

1.04

0.05

3.2

3.0

0.89

0.73

ug/l

0.27

297

Malignant neoplasm of base of tongue

544

0.96

0.05

2.6

2.9

0.78

0.74

ug/l

0.15

346

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

171

0.93

0.05

3.3

2.4

0.69

0.70

ug/l

—

Benign neoplasm: Brain, unspecified

258

1.05

0.05

3.4

2.4

0.75

ug/l

0.01

149

Torticollis

676

0.97

0.05

2.3

2.4

0.48

0.75

ug/l

2.68

375

Benign neoplasm: Retina

278

1.05

0.05

2.9

3.1

0.73

0.77

ug/l

0.20

187

Sequelae of burns, corrosions and frostbite

292

0.95

0.05

2.0

2.7

0.68

0.74

ug/l

0.16

176

Pedal cyclist injured in other and unspecified transport accidents

669

6653

1.01

0.05

2.6

2.8

0.67

0.72

ug/l

0.78

406

4090

Lymphangioma, anys site

272

0.95

0.05

2.5

0.56

0.75

ug/l

1.20

153

Other and unspecified acute skin changes due to ultraviolet radiation

169

1711

0.99

0.05

3.4

3.0

0.64

0.79

ug/l

2.37

114

1143

Other specified/unspecified necrotizing vasculopathies

764

1.02

0.05

2.7

3.0

0.71

0.79

ug/l

0.35

501

Vertigo of central origin

756

0.98

0.05

3.4

3.0

0.97

0.77

ug/l

0.42

510

Other, unspecified and serous retinal detachments

209

2112

0.99

0.04

3.4

3.1

0.73

0.77

ug/l

0.39

141

1415

Other diseases of jaws

403

4001

1.01

0.04

3.0

2.9

0.82

0.79

ug/l

0.27

257

2544

Tic and related disorders

282

0.96

0.04

3.1

2.2

0.64

0.69

ug/l

0.13

139

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

655

0.97

0.04

3.5

2.9

0.69

0.73

ug/l

0.24

431

Hypothyroidism due to medicaments and other exogenous substances

403

0.96

0.04

2.3

3.2

0.59

0.82

ug/l

0.97

264

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

332

0.96

0.04

2.0

2.6

0.83

0.73

ug/l

0.29

209

Wide developmental disorders

514

0.97

0.04

2.0

0.47

0.56

ug/l

0.48

220

Unspecified multiple injuries

160

1.07

0.04

2.9

2.4

0.79

0.65

ug/l

0.48

Systemic sclerosis, icd10

526

1.03

0.04

2.8

2.7

0.62

0.71

ug/l

0.47

319

Reiter disease

517

1.03

0.04

2.8

2.7

0.52

0.71

ug/l

2.62

313

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

170

1.07

0.04

2.6

2.5

0.84

0.71

ug/l

—

117

Dermatitis due to ingested food

211

1.05

0.04

1.2

2.2

0.64

0.72

ug/l

—

Other or unspecified paralytic strabismus

378

1.04

0.04

3.2

2.9

0.57

0.71

ug/l

1.07

240

Social phobias

293

2906

1.01

0.04

2.6

2.4

0.53

0.67

ug/l

3.62

189

1466

Systemic sclerosis,strict definition

170

0.94

0.04

1.7

2.6

0.45

0.80

ug/l

—

105

Disorders of purine and pyrimidine metabolism

432

0.96

0.04

3.3

3.1

0.76

0.73

ug/l

0.07

307

Other disorders of pigmentation

191

1930

0.99

0.04

3.1

3.0

0.84

0.76

ug/l

0.49

127

1272

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

687

1.03

0.04

3.4

2.6

1.09

0.80

ug/l

0.49

454

Unspecified protein-energy malnutrition

190

0.94

0.04

2.1

3.2

2.24

0.90

ug/l

0.55

125

Benign neoplasm of other and unspecified intrathoracic organs

553

0.97

0.04

3.0

2.5

1.41

0.77

ug/l

1.01

353

Early complications of trauma

276

2782

0.99

0.04

2.7

2.8

0.66

0.74

ug/l

0.96

183

1730

!Aliquae complicationes praecoces traumatis

276

2782

0.99

0.04

2.7

2.8

0.66

0.74

ug/l

0.96

183

1730

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

557

1.03

0.04

2.6

2.5

0.67

0.72

ug/l

0.36

356

Diseases of the respiratory system

5662

28408

1.00

0.04

2.9

3.0

0.74

0.80

ug/l

3.07

3703

18762

Lymphoid leukaemia

413

4105

1.01

0.04

3.0

3.2

0.77

0.78

ug/l

0.01

296

2881

Other and unspecified vasculitis limited to skin

123

1246

0.98

0.04

2.6

2.9

0.64

0.78

ug/l

1.04

805

Protein-energy malnutrition of moderate and mild degree

339

1.04

0.03

2.3

3.2

0.85

0.81

ug/l

0.10

238

Cleft lip, lip and palate or palate

472

0.97

0.03

2.7

2.2

0.59

0.62

ug/l

0.12

222

Malignant neoplasm of bone and articular cartilage of limbs

250

0.95

0.03

2.2

2.8

0.97

0.76

ug/l

0.44

164

Toxoplasmosis

240

0.95

0.03

2.3

2.7

0.45

0.77

ug/l

1.57

141

Amiodarone users

948

9511

1.00

0.03

2.9

3.2

0.73

0.79

ug/l

0.58

665

6664

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

290

0.96

0.03

2.9

3.1

0.53

0.78

ug/l

2.72

204

Lymphangioma, anys site

250

1.04

0.03

2.5

2.2

0.56

0.74

ug/l

1.03

134

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

1155

11516

1.00

0.03

3.4

2.8

1.01

0.72

ug/l

5.69

826

7901

Tracheo-bronchomalasia

159

0.94

0.03

3.0

2.6

0.44

0.61

ug/l

—

100

Benign neoplasm: Brain, unspecified

280

0.96

0.03

3.4

2.8

0.75

0.78

ug/l

0.08

169

Other and unspecified papulosquamous disorders

280

1.04

0.03

2.4

3.0

0.75

0.76

ug/l

0.03

182

Congenital malformations of anterior segment of eye

270

1.04

0.03

2.6

2.9

0.73

0.79

ug/l

0.15

180

Hodgkin lymphoma

168

1664

1.01

0.03

2.8

2.6

0.73

0.71

ug/l

0.13

113

1028

Algoneurodystrophy

100

1014

0.99

0.03

2.2

2.6

0.48

0.69

ug/l

4.47

583

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

748

1.02

0.03

2.6

0.76

0.70

ug/l

0.31

481

Polymorphous light eruption

171

1.06

0.03

2.7

2.8

0.57

0.89

ug/l

—

108

Systemic lupus erythematosus

827

1.02

0.03

2.6

2.8

0.76

0.73

ug/l

0.08

530

Isolated proteinuria with specified morphological lesion

718

1.02

0.03

3.5

3.0

1.30

0.79

ug/l

1.06

471

Other diseases of appendix

479

1.03

0.03

3.5

2.9

0.76

0.71

ug/l

0.20

294

Hypoparathyroidism

893

0.98

0.03

3.0

0.76

0.74

ug/l

0.06

565

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

539

1.02

0.03

3.1

2.6

0.60

0.76

ug/l

1.59

360

Essential (haemorrhagic) thrombocythaemia

191

1926

0.99

0.03

2.8

2.7

0.70

0.73

ug/l

0.28

134

1294

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

911

0.98

0.03

2.4

2.5

0.68

0.67

ug/l

0.03

486

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

571

0.98

0.03

2.8

2.7

0.67

0.74

ug/l

0.34

373

Exclusion endpoint for clefts

571

0.98

0.03

2.3

2.5

0.72

0.67

ug/l

0.15

313

Pyogenic arthritis

507

5048

1.01

0.03

2.9

0.70

0.79

ug/l

1.96

339

3303

Psoriatic arthropathies

653

6554

1.00

0.03

2.8

0.58

0.77

ug/l

10.49

403

4105

Exposure to other and unspecified man-made environmental factors

802

0.98

0.03

2.9

2.7

0.64

0.71

ug/l

0.37

478

Bullous keratopathy

410

1.03

0.03

3.1

3.0

0.54

0.88

ug/l

2.89

268

Gingival hyperplasia

190

1885

1.01

0.03

3.0

2.9

0.76

0.77

ug/l

0.11

151

1212

Other endophthalmitis

261

1.04

0.03

2.9

3.0

0.56

0.77

ug/l

1.04

169

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

206

2075

0.99

0.03

2.5

2.8

0.93

0.73

ug/l

1.86

151

1272

Gender identity disorders

239

0.96

0.02

1.8

2.2

0.37

0.66

ug/l

2.50

119

Other specified and unspecified strabismus

420

1.03

0.02

3.2

2.8

0.62

0.70

ug/l

0.34

253

Eosinophilic disease (BM)

958

1.02

0.02

2.7

3.0

0.81

0.79

ug/l

0.07

640

Congenital malformations of cardiac septa

271

2637

0.99

0.02

2.8

0.78

0.72

ug/l

0.30

166

1580

Tic disorders

269

0.96

0.02

3.4

2.3

0.66

0.67

ug/l

0.01

134

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

101

998

1.01

0.02

2.6

2.4

0.60

0.71

ug/l

0.76

512

Other eating disorders

460

1.02

0.02

2.4

0.51

0.66

ug/l

1.26

260

Other and unspecified drugs and medicaments

401

4028

0.99

0.02

3.0

0.70

0.75

ug/l

0.57

271

2634

Other disorders of the musculoskeletal system and connective tissue

912

9144

1.00

0.02

3.1

3.0

0.77

0.76

ug/l

0.03

626

6028

Sequelae of infectious and parasitic diseases

482

4839

1.00

0.02

2.8

0.72

0.76

ug/l

0.36

301

2971

Injury of nerves at lower leg level

570

1.02

0.02

2.7

0.75

0.79

ug/l

0.13

347

Systemic sclerosis (FG)

530

1.02

0.02

2.8

2.7

0.62

0.80

ug/l

0.93

336

Otorrhagia

399

0.97

0.02

2.5

2.8

0.66

0.85

ug/l

0.66

258

Benign neoplasm: Oesophagus

660

0.98

0.02

2.7

2.6

0.54

0.76

ug/l

2.59

423

Chondrosarcoma

218

0.95

0.02

2.6

2.9

1.16

0.75

ug/l

0.91

147

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

228

0.95

0.02

4.1

3.0

1.00

0.77

ug/l

0.58

145

Chronic periapical parodontitis

1705

17023

1.00

0.02

3.0

2.9

0.79

0.76

ug/l

0.32

1173

10901

Enduring personality changes

228

0.96

0.02

2.1

2.4

0.45

0.69

ug/l

1.70

125

Benign neoplasm: Other/unspecified site

730

1.02

0.02

3.1

2.5

0.72

0.75

ug/l

0.11

472

Bullous disorders

340

3385

1.01

0.02

3.0

3.2

0.83

0.77

ug/l

0.18

232

2334

Calcaneal spur

439

0.98

0.02

3.0

2.9

0.87

0.76

ug/l

0.25

291

Other disorders starting during childhood or adolecense, excluding more controls

520

0.98

0.02

2.4

2.0

0.53

0.75

ug/l

1.14

214

Other and unspecified neuropathies

282

1.04

0.02

3.3

3.1

0.63

0.73

ug/l

0.41

184

Vasculitis limited to skin, not elsewhere classified

133

1341

0.99

0.02

2.6

2.9

0.62

0.77

ug/l

1.25

863

Beningn neoplasm: Meninges, unspecified

521

1.02

0.02

3.7

3.1

0.78

0.84

ug/l

0.31

358

Unspecified fall

3478

34532

1.00

0.02

3.0

0.71

0.77

ug/l

2.48

2301

22496

Other osteochondrodysplasias

282

1.03

0.02

3.1

2.7

0.82

0.65

ug/l

0.28

162

Injury of intra-abdominal organs

147

1481

0.99

0.02

2.7

2.6

0.71

0.72

ug/l

0.03

105

875

Measles

609

0.98

0.02

2.2

0.62

0.60

ug/l

0.10

274

Early lumbar disc prolapse, operated

538

5396

1.00

0.02

2.2

2.1

0.55

0.62

ug/l

1.63

237

2372

Type of accident

1848

18504

1.00

0.02

2.8

0.73

0.75

ug/l

0.34

1148

11727

Family history of other specific disorders

318

0.97

0.02

2.4

2.6

0.79

0.70

ug/l

0.23

203

Congenital malformations of pulmonary and tricuspid valves

113

1.06

0.02

2.1

2.5

0.37

0.79

ug/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1577

15743

1.00

0.02

3.1

2.8

0.79

0.74

ug/l

1.02

1108

11105

Congenital iodine-deficiency syndrome/hypothyroidism

721

1.01

0.01

2.8

3.0

0.58

0.83

ug/l

2.70

473

Nonhereditary hypogammaglobulinemia

418

0.98

0.01

2.8

0.72

0.71

ug/l

0.02

255

Benign neoplasm: Skin of other and unspecified parts of face

629

6275

1.00

0.01

3.2

3.1

0.79

0.80

ug/l

0.21

437

4327

Hypersensitivity pneumonitis due to organic dust

959

0.99

0.01

3.1

3.0

0.82

0.78

ug/l

0.10

637

Lesion of medial popliteal nerve

177

0.95

0.01

1.8

2.7

0.59

0.69

ug/l

—

111

Colour vision deficiencies

183

1.04

0.01

2.7

2.5

0.93

0.69

ug/l

0.84

106

Other specified/unspecified disorders of tympanic membrane

203

1.04

0.01

4.1

3.0

0.77

0.79

ug/l

0.03

132

Aspergillosis

608

0.98

0.01

3.2

3.0

0.64

0.81

ug/l

1.46

402

Malignant neoplasm of thymus

223

1.04

0.01

3.7

2.8

0.90

0.73

ug/l

0.39

151

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

578

0.98

0.01

2.5

2.7

0.93

0.79

ug/l

0.15

390

Other fibroblastic disorders

227

0.96

0.01

3.0

2.7

0.67

0.79

ug/l

0.35

143

Disorders of globe

129

1281

1.01

0.01

3.0

0.79

0.81

ug/l

0.05

855

Direct fill therapy

819

8173

1.00

0.01

2.7

2.8

0.73

ug/l

0.01

570

5139

Dermatopolymyositis

682

1.01

0.01

2.7

3.0

0.73

0.76

ug/l

0.18

441

Unspecified transport accident

263

1.03

0.01

2.0

2.5

0.67

0.70

ug/l

0.07

149

Caries in Clefts patients

243

1.03

0.01

2.7

2.1

0.56

0.66

ug/l

0.46

110

Femoral hernia

257

2580

1.00

0.01

3.3

3.2

0.88

0.77

ug/l

0.27

184

1786

Nosocomial condition (hospital)

293

1.03

0.01

3.4

2.9

0.80

0.85

ug/l

0.12

196

Frontotemporal dementia

387

0.98

0.01

2.4

3.2

0.92

0.83

ug/l

0.08

272

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

118

1188

0.99

0.01

3.3

2.7

0.71

0.73

ug/l

0.07

817

Symptoms and signs involving emotional state

101

1018

0.99

0.01

2.9

2.6

0.67

0.76

ug/l

0.65

583

Atrial septal defect

139

1372

1.01

0.01

2.6

2.7

0.80

0.72

ug/l

0.23

812

Bilateral sagittal split ramus osteotomy operation

110

1092

1.01

0.01

2.6

2.5

0.80

0.68

ug/l

0.56

583

Surgical ablation of atrial fibrillation

567

0.98

0.01

2.5

2.9

0.69

0.70

ug/l

0.04

381

Major anomalies of jaw size

130

1292

1.01

0.01

2.6

2.5

0.71

0.69

ug/l

0.15

745

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

547

0.98

0.01

2.5

2.6

0.69

0.75

ug/l

0.17

368

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

497

0.98

0.01

3.2

2.9

0.65

0.77

ug/l

0.98

306

STROKE

5322

36902

1.00

0.01

2.9

3.0

0.75

0.76

ug/l

0.19

3664

23509

Malignant neoplasm of bone and articular cartilage

567

0.98

0.01

2.4

3.0

0.86

0.76

ug/l

0.38

371

Crystalline deposits in vitreous body

637

0.99

0.01

2.8

3.2

0.85

0.81

ug/l

0.13

447

Event of undetermined intent

374

3731

1.00

0.01

2.8

0.73

0.70

ug/l

0.12

247

2246

Benign neoplasm: Skin of upper limb, including shoulder

943

1.01

0.01

3.2

2.6

0.76

0.74

ug/l

0.07

616

Papilloedema, unspecified

947

0.99

0.01

3.3

2.9

0.85

0.77

ug/l

0.43

608

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

105

1057

0.99

0.01

2.7

2.6

0.80

0.72

ug/l

0.38

683

Deep bite

397

3465

1.00

0.01

2.9

2.8

0.63

0.70

ug/l

1.72

229

2109

Fenamates

803

5408

1.00

0.00

3.0

2.8

0.71

0.86

ug/l

4.11

539

3704

Benign neoplasm: Heart

164

1.04

0.00

3.1

2.6

2.21

0.81

ug/l

0.66

115

Aortic aneurysm

2954

29035

1.00

0.00

3.1

3.3

0.82

ug/l

0.01

2118

20706

Benign neoplasm: Heart

176

0.96

0.00

3.1

3.0

2.21

0.74

ug/l

0.71

121

Other congenital malformations of tongue, mouth and pharynx

195

0.97

0.00

3.2

2.3

0.71

0.72

ug/l

0.03

111

Other congenital malformations of heart

174

1.04

0.00

1.9

2.5

0.47

0.80

ug/l

2.98

101

Open wounds involving multiple body regions

196

0.96

0.00

2.6

0.71

0.77

ug/l

0.15

104

Myocarditis

395

3940

1.00

0.00

2.4

2.8

0.65

0.72

ug/l

1.23

225

2358

Increased muscle tone

274

1.02

0.00

3.0

2.7

0.74

ug/l

0.00

176

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

314

1.02

0.00

2.5

3.0

0.77

ug/l

0.01

218

Impaction of intestines

326

0.98

0.00

2.8

2.9

0.61

0.95

ug/l

2.11

204

Benign neoplasm: Bone and articular cartilage, unspecified

396

0.98

0.00

3.1

2.8

1.29

0.75

ug/l

0.37

235

Disorders of plasma-protein metabolism, not elsewhere classified

436

0.98

0.00

1.9

3.0

0.75

0.70

ug/l

0.14

275

Benign neoplasm: Other parts of oropharynx

466

0.98

0.00

2.8

2.9

0.69

0.75

ug/l

0.31

296

Localized skin eruption due to drugs and medicaments

516

0.99

0.00

3.4

3.0

0.76

0.74

ug/l

0.05

332

SLE (Finngen)

846

0.99

0.00

2.6

2.8

0.76

0.71

ug/l

0.12

535

Chronic periodontitis

1307

13077

1.00

0.00

2.7

2.9

0.78

0.76

ug/l

0.13

974

8573

Benign neoplasm: Duodenum

146

1466

1.00

0.00

3.1

2.7

0.63

0.74

ug/l

1.36

111

983

Low back pain

5822

44833

1.00

0.00

2.9

0.67

0.79

ug/l

12.76

3818

28368

Dental pulpitis 3, only avohilmo

362

0.99

0.00

1.0

1.2

0.31

0.40

ug/l

1.80

103

Congenital malformations of heart and great arteries

735

7117

1.00

0.00

2.8

0.74

0.72

ug/l

0.25

448

4346

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

227

2269

1.00

0.00

2.8

2.7

0.61

0.70

ug/l

1.41

137

1346

CR(E)ST syndrome

247

1.01

0.00

2.3

2.7

0.47

0.78

ug/l

1.81

155

Idiopathic urticaria

536

1.01

0.00

2.6

2.8

0.76

0.72

ug/l

0.08

317

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

985

1.01

0.00

3.3

2.6

0.79

0.78

ug/l

0.01

659

Benign neoplasm: Short bones of upper limb

724

0.99

0.00

2.8

0.58

0.72

ug/l

1.85

447

Von Willebrand disease

198

1.01

0.00

2.9

2.4

0.48

0.69

ug/l

1.58

104

Other acquired deformities of ankle and foot

282

0.99

0.00

3.3

2.6

0.79

0.90

ug/l

0.25

181

Other lesions of median nerve

114

1144

1.00

0.00

2.9

3.0

0.73

0.78

ug/l

0.29

774

Benign neoplasm: Skin of lower limb, including hip

130

1304

1.00

0.00

3.0

0.73

0.76

ug/l

0.09

859

Localized adiposity

144

0.97

0.00

1.9

2.5

0.66

0.73

ug/l

—

Disorders of sphingolipid metabolism and other lipid storage disorders

174

0.97

0.00

2.4

3.2

0.90

0.70

ug/l

0.33

122

Cystic kidney disease

192

1916

1.00

0.00

3.0

2.9

1.17

0.74

ug/l

1.97

145

1208

Henoch-Schönlein purpura nephritis (HSPN)

194

0.98

0.00

2.5

2.8

0.71

0.74

ug/l

0.07

115

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

196

1.02

0.00

3.8

2.6

0.71

0.78

ug/l

0.13

137

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

215

2146

1.00

0.00

3.1

2.5

0.77

0.71

ug/l

0.41

130

1314

Benign neoplasm: Central nervous system, other parts/unspecified

206

1.02

0.00

3.0

2.5

0.83

0.78

ug/l

0.08

126

Other and unspecified diseases of spleen

224

0.98

0.00

3.7

2.9

0.71

0.87

ug/l

0.43

144

Renal tubulo-interstitial disorders in diseases classified elsewhere

648

1.00

0.00

2.5

3.0

0.98

0.71

ug/l

1.05

421

Discontinuity and dislocation of ear ossicles

286

1.02

0.00

3.3

2.8

0.70

0.76

ug/l

0.11

187

Abscess of external ear

732

1.00

0.00

2.7

0.76

0.69

ug/l

0.25

440

Autonomic disorders

125

1252

1.00

0.00

2.8

2.9

0.70

0.75

ug/l

0.26

810

Sequelae of other and unspecified effects of external causes

291

1.00

0.00

2.7

3.0

0.70

0.77

ug/l

0.27

177

Other specified/unspecified spondylopathies

148

1482

1.00

0.00

3.1

0.77

0.82

ug/l

0.12

106

1024

Ankle and foot

331

1.00

0.00

2.8

3.1

0.66

0.74

ug/l

0.30

219

Postprocedural disorders of eye and adnexa, not elsewhere classified

148

1.02

0.00

3.5

2.9

0.42

0.79

ug/l

—

Other hyperalimentation

142

0.98

0.00

3.0

2.9

0.71

ug/l

—

Erythrasma

148

1.02

0.00

3.1

2.7

0.40

0.70

ug/l

—

104

Carcinoma in situ of oral cavity, oesophagus and stomach

429

1.00

0.00

1.8

3.0

0.66

0.78

ug/l

0.36

285

Adenocarcinoma of small intestine

182

0.99

0.00

2.3

3.0

0.91

0.67

ug/l

—

125

Intercostal neuropathy

461

1.00

0.00

2.8

3.0

0.56

0.73

ug/l

1.36

312

Exophthalmic conditions

449

1.00

0.00

3.2

2.6

0.57

0.76

ug/l

1.57

274

Pigmented purpuric dermatosis

519

1.00

0.00

2.8

3.0

1.07

0.80

ug/l

0.66

334

Benign neoplasm: Tonsil

571

1.00

0.00

2.5

2.6

0.65

0.71

ug/l

0.43

366

Other intracranial haemorrhages

247

2471

1.00

0.00

3.4

1.19

0.82

ug/l

1.24

171

1775

Allergic contact dermatitis due to drugs in contact with skin

841

1.00

0.00

2.7

3.1

0.77

0.74

ug/l

0.11

568

Diseases of spleen

102

1019

1.00

0.00

2.9

0.71

0.78

ug/l

0.46

670

Systemic sclerosis

539

1.00

0.00

2.8

0.62

0.72

ug/l

0.51

332

Disorders of magnesium metabolism

542

1.00

0.00

2.6

3.2

0.71

0.74

ug/l

0.12

394

Other and unspecified disorders of skin and subcutaneous tissue

335

3347

1.00

0.00

3.6

3.1

0.72

0.76

ug/l

0.49

238

2249

Benign intracranial hypertension

123

0.97

0.00

2.3

2.5

0.69

0.64

ug/l

—

Use of dimethyl fumarate

163

0.98

0.00

1.8

2.0

0.60

0.57

ug/l

—

Narcolepsy and cataplexy

267

1.01

0.00

3.4

3.0

0.50

0.81

ug/l

1.94

166

Exposure to sunlight

117

1.03

0.00

1.9

2.6

0.57

0.68

ug/l

—

Transient synovitis

233

0.99

0.00

2.3

2.7

0.74

0.76

ug/l

0.04

148

Mumps

190

1895

1.00

0.00

2.5

0.65

0.68

ug/l

0.15

105

1034

Traumatic amputation of hip and thigh

115

1.06

0.00

2.0

3.1

4.75

0.73

ug/l

—

Mastocytosis

233

0.99

0.00

2.4

2.8

0.58

0.76

ug/l

0.86

142

Disorder of carbohydrate metabolism, other/unspecified

207

1.02

0.00

1.9

2.7

0.45

0.69

ug/l

1.67

120

Typhoid and paratyphoid fevers

237

1.01

0.00

2.7

2.8

0.54

0.90

ug/l

1.56

137

Pityriasis lichenoides chronica

213

0.98

0.00

2.5

2.9

0.42

0.79

ug/l

2.64

140

Personal history of allergy to drugs, medicaments and biological substances

357

1.01

0.00

3.0

2.6

0.53

0.71

ug/l

1.17

219

Corneal pigmentations and deposits

227

1.02

0.00

2.7

2.9

0.71

0.79

ug/l

0.27

143

Bacterial meningitis

206

2055

1.00

0.00

2.9

2.8

0.61

0.73

ug/l

2.08

132

1243

Benign neoplasm: Small intestine

230

2305

1.00

0.00

2.9

3.2

0.67

0.77

ug/l

0.92

177

1574

Abnormality of red blood cells

295

1.02

0.00

2.6

2.8

0.69

0.81

ug/l

0.41

180

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

485

1.01

0.00

2.6

0.60

0.72

ug/l

0.94

313

Pyoderma gangrenosum

286

1.02

0.00

2.9

0.58

0.76

ug/l

1.08

183

Effects of heat and light

404

0.99

0.00

3.9

2.9

0.60

0.75

ug/l

0.70

244

Symptoms and signs involving appearance and behaviour

326

1.01

0.00

2.8

2.7

0.44

0.78

ug/l

5.11

195

Haemorrhagic disorder due to circulating anticoagulants

804

0.99

0.00

3.0

3.1

0.76

0.84

ug/l

0.32

555

Migraine with aura, drug-induced

234

0.98

0.00

1.8

2.7

0.62

0.70

ug/l

0.41

144

Calcific tendinitis

505

0.99

0.00

2.4

2.9

0.71

0.74

ug/l

0.13

340

Benign neoplasm: Central nervous system, other parts/unspecified

212

0.99

0.00

3.0

2.7

0.83

0.94

ug/l

0.15

123

Carcinoma in situ of middle ear and respiratory system

342

0.99

0.00

3.4

2.7

0.85

0.78

ug/l

0.24

240

Injury of blood vessels at neck level

258

1.01

0.00

2.8

2.6

1.03

0.74

ug/l

0.37

154

Superficial injury of ankle and foot, unspecified

185

1.03

0.00

2.6

2.7

0.56

0.69

ug/l

—

Other degenerative disorders of eyelid and periocular area

165

1.04

0.00

2.0

3.0

0.87

0.75

ug/l

0.10

111

Hypersplenism

268

1.01

0.00

3.0

2.9

0.70

0.73

ug/l

0.06

175

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

248

1.01

0.00

3.6

2.4

0.86

0.75

ug/l

0.25

155

Other and unspecified syphilis

205

0.97

0.00

2.3

2.5

0.78

0.68

ug/l

0.27

108

Other and unspecified pemphigus

215

1.03

0.00

3.3

2.9

0.76

0.68

ug/l

0.08

139

Apocrine sweat disorders, other sweat gland disorders

168

1.01

0.00

2.5

2.9

0.63

0.72

ug/l

0.30

114

Osteosarcoma, excluding all cancers (controls excluding all cancers)

195

0.97

0.00

1.8

2.5

0.70

0.76

ug/l

0.13

117

Choroidal detachment

125

0.95

0.00

2.4

3.0

0.48

0.88

ug/l

—

Hand

262

0.99

0.00

3.3

2.8

0.69

0.70

ug/l

0.03

161

Fibrosarcoma

442

0.99

0.00

2.6

3.0

0.59

0.76

ug/l

1.48

286

Acne conglobata

192

0.99

0.00

2.5

2.4

0.71

0.67

ug/l

0.08

Benign lipomatous neoplasm of of intra-abdominal organs

169

1.01

0.00

3.2

2.9

0.93

0.67

ug/l

—

105

Idiopathic progressive neuropathy

112

0.98

0.00

3.5

2.7

1.30

0.81

ug/l

0.45

All dysplastic lesions of the vulva

0.00

0.0

1.0

—

Postpartum care and examination

0.00

0.0

1.0

—

Porphyria cutanea tarda

0.97

0.00

3.4

3.3

0.72

0.76

ug/l

—

Secondary lactase deficiency

0.86

0.00

2.4

3.4

0.39

0.77

ug/l

—

Serous carcinoma of ovary

0.00

0.0

1.0

—

Amenorrhoea

0.00

0.0

1.0

—

Nutritional and metabolic disorders in diseases classified elsewhere

0.00

0.0

2.5

—

1.28

—

Use of apomorphine

0.91

0.00

3.0

0.51

0.76

ug/l

—

Maternal care for cervical incompetence

0.00

0.0

1.0

—

Disorders in reading

260

1.00

0.00

1.8

1.9

0.40

0.61

ug/l

1.56

Endometriosis of rectovaginal septum and vagina

0.00

0.0

1.0

—

Cyst of Bartholin Gland

0.00

0.0

1.0

—

Toxic effect of other inorganic substances

0.84

0.00

5.8

3.0

0.56

0.80

ug/l

—

Injury of nerves at hip and thigh level

210

1.00

0.00

2.7

3.3

1.34

0.82

ug/l

0.42

147

Localized hypertrichosis

0.00

0.0

2.5

—

Other infestations

130

1.00

0.00

3.0

2.9

0.53

0.74

ug/l

—

Placenta praevia

0.00

0.0

1.1

—

Acromegaly and pituitary gigantism

320

1.00

0.00

2.2

2.6

0.51

0.73

ug/l

2.04

187

Ependymoma, excluding all cancers (controls excluding all cancers)

1.02

0.00

3.5

2.2

0.67

1.04

ug/l

—

Female infertility, tubal origin

0.00

0.0

1.0

—

Polyhydramnios

0.00

0.0

1.1

—

Cardiovascular devices associated with adverse incidents

1.07

0.00

5.7

3.2

1.05

0.75

ug/l

—

Scleritis and episcleritis in diseases classified elsewhere

1.04

0.00

2.3

3.1

1.04

0.66

ug/l

—

Failed induction of labour

0.00

0.0

1.1

—

Primary ovarian failure

0.00

0.0

1.0

—

Polycystic ovarian syndrome

0.00

0.0

1.0

—

Infections of breast associated with childbirth

0.00

0.0

1.0

—

Ependymoma

0.88

0.00

3.5

2.8

0.67

0.86

ug/l

—

Oligomenorrhoea

0.00

0.0

1.0

—

Congenital malformations of gallbladder, bile ducts and liver

300

1.00

0.00

3.2

3.0

0.69

0.78

ug/l

0.25

203

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.0

1.0

—

Other disorders of carbohydrate metabolism

270

1.00

0.00

1.7

2.8

0.52

0.68

ug/l

1.06

163

Hirsutism in women

0.00

0.0

1.0

—

Acute thyroiditis

130

1.00

0.00

3.5

2.9

0.62

0.73

ug/l

—

Unspecified/other endometriosis

0.00

0.0

1.0

—

Disorders of glycoprotein metabolism

0.90

0.00

4.8

3.0

1.81

0.61

ug/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS